data_2lt9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lt9 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 558' ' ' ALA . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 556' ' ' SER . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.488 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.54 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.833 0.349 . . . . 62.4 110.394 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 74.12 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 73.12 107.134 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.31 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.22 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 73.21 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.43 114.037 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.43 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 73.1 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 75.32 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.31 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.2 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.55 108.09 170.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 55.32 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.43 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 65.21 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 75.53 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 71.21 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 75.23 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.495 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 75.04 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.33 107.765 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.54 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.32 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.22 110.132 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 72.52 107.93 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 74.24 110.665 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.45 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 64.11 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 74.13 113.702 -174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.22 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.54 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.411 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.14 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 73.34 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 73.52 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 74.21 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 71.01 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 74.01 108.408 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 73.33 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 74.15 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 71.22 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.34 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.1 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.33 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.2 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 53.34 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.21 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 52.44 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 74.24 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.52 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 65.54 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 72.02 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.24 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.05 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.12 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.21 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.12 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 74.43 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.15 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 74.54 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 75.25 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 74.24 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.15 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.41 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 65.14 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.43 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 73.22 110.592 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.35 112.007 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 73.42 106.808 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.15 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.495 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.22 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 75.23 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 72.13 106.862 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.15 113.864 -169.841 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 107.336 -1.357 . . . . 72.13 107.336 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 74.31 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 72.01 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 74.12 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 75.0 105.523 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 75.41 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.03 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 73.34 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 72.34 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 73.31 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.484 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.4 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.411 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.4 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 73.25 114.023 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 73.5 117.995 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.52 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.51 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.33 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.41 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 71.41 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.34 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 73.12 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.4 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 73.1 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 74.23 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 62.52 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.53 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.11 108.374 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.981 -1.118 . . . . 73.34 107.981 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 72.24 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 72.03 109.022 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.33 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.42 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 74.4 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.23 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.31 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 73.34 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 74.25 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 74.02 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 75.12 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 72.31 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 71.33 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.05 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 71.42 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.12 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 75.14 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.418 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.2 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 73.32 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.34 105.856 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 75.44 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.4 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.13 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.22 110.797 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.23 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.33 109.349 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 74.31 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.51 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 53.32 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.53 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 75.01 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 73.14 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 64.35 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 74.41 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 71.34 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.43 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 70.43 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 74.34 110.776 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 64.22 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.2 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.44 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.24 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.52 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.51 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.11 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 73.13 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.33 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 74.53 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 75.44 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.22 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 74.43 110.911 -172.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.04 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.55 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.44 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.35 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.44 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 72.55 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.558 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 75.52 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.31 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.12 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.558 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.11 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 71.3 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 73.24 106.658 171.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 75.44 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 74.32 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.21 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 72.22 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.12 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 74.54 106.625 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 64.15 108.016 -179.237 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.04 109.804 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 75.21 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.34 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.52 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 62.25 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.2 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.32 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.31 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.32 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 74.11 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.3 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 75.01 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 72.41 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 . . . . . 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.55 107.808 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.45 117.305 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 74.15 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.34 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.22 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 73.1 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.44 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 75.12 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 65.4 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 62.42 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 74.21 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 71.43 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 75.14 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.43 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 75.44 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 73.2 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 75.32 106.165 178.065 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.51 109.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 74.22 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.4 106.716 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 73.34 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 74.51 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 71.43 110.303 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.13 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 74.33 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 74.32 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 75.21 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.13 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.11 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 74.23 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.54 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.3 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.15 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 73.31 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 73.43 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 75.25 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 74.12 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.45 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.14 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.54 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.33 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.33 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 75.13 108.828 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.51 112.65 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 72.41 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.32 113.09 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 73.12 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 73.33 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.13 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 75.54 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.41 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.24 115.301 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.33 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 73.04 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 74.4 109.361 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.31 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.44 109.545 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.43 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.21 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 73.12 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 73.14 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.21 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.45 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.21 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.32 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 71.43 102.113 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.22 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.21 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.4 111.582 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.11 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.44 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.21 110.144 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 75.01 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 70.44 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 74.21 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 61.34 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.23 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.561 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 75.2 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.44 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 70.32 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 74.13 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 75.32 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.23 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 71.14 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 72.3 109.788 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 73.31 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 73.1 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 -177.92 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 107.276 -1.379 . . . . 52.13 107.276 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.4 112.795 -170.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.15 109.756 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.11 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 64.22 107.768 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 73.04 107.904 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.42 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.02 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 75.31 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.22 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.63 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.53 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 70.02 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 75.13 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.63 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 . . . . . 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 71.4 107.39 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.519 0.326 0 N-CA-C 116.891 1.516 . . . . 72.52 116.891 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.53 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 74.42 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 75.44 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.04 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.31 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.02 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.15 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.34 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 73.21 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 74.52 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.45 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.49 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.22 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.13 103.193 174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.42 106.61 175.79 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 107.705 -1.22 . . . . 75.43 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.14 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 64.13 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 74.11 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 73.24 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 74.11 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.41 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 64.03 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.23 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 75.45 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.31 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.11 107.937 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 71.03 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 72.03 110.926 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 64.13 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.1 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 73.52 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.23 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 75.24 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 73.53 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 74.41 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.1 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.53 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.14 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 74.2 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.33 109.722 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 51.44 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.32 109.049 171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.24 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.41 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.23 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 73.42 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 74.22 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 75.14 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.42 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.23 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 72.23 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.35 108.622 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 71.23 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.3 104.957 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.43 112.223 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 73.2 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 72.14 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.41 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.42 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 73.31 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.33 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 41.54 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 75.22 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.41 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.03 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.33 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 75.0 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 70.44 110.581 -169.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.24 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.14 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.42 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 65.53 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 74.11 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.591 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.31 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.14 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.14 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.591 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.32 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.44 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 73.43 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.35 109.094 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 74.01 112.505 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.43 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 74.44 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 74.11 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.41 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 74.31 106.157 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.43 109.328 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.723 0.773 . . . . 73.53 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 74.0 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 74.13 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.11 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.34 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 60.14 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 75.14 108.107 174.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.4 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.32 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 72.1 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.567 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.13 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.14 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.3 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 625' ' ' GLU 0.269 12.9 mmm180 . . . . . 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 75.32 106.813 175.858 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.528 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.229 -0.218 0 N-CA-C 116.931 1.532 . . . . 53.33 116.931 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.24 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 72.23 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 74.22 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 72.44 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 72.41 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.35 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.24 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 72.54 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.45 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 75.21 105.121 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 72.42 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.409 ' HA ' HG22 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.41 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.24 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.31 105.989 176.627 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.13 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.35 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.34 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . 0.512 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.22 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 73.3 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.14 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 65.02 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.33 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 73.44 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 75.25 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.21 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.31 109.912 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.42 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 65.12 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.53 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 72.24 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 45.21 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 75.23 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.35 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 72.52 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.22 106.333 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 72.53 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 72.22 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 74.52 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.512 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 73.31 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 62.12 110.815 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.52 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 71.24 109.972 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.35 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 70.04 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 72.44 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 71.0 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . 0.541 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.33 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.22 104.872 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 74.13 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 64.14 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.4 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.43 107.534 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 568' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.44 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.03 106.73 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 71.35 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 74.42 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 73.14 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.12 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.43 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 75.43 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 63.41 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.15 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.05 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.1 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.24 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.24 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 54.12 107.947 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.21 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.23 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 71.24 110.387 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.11 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.45 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 74.0 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 75.31 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.21 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.32 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.41 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 73.31 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 75.3 105.321 168.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.2 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.11 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 75.03 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 73.42 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.54 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 74.23 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.54 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.34 105.097 -175.435 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 109.538 -0.541 . . . . 74.51 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.31 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.2 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 75.42 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 71.14 105.355 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 73.33 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.2 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.04 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 74.2 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 63.2 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 74.45 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.644 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 624' ' ' MET . . . . . 0.541 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 71.4 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 75.11 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.644 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 . . . . . 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.41 107.777 179.511 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.42 116.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 75.4 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 64.03 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 70.43 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.22 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 75.34 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.31 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.44 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.13 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 72.41 107.42 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.33 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 75.24 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.43 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 71.01 106.232 177.089 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 74.34 108.614 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 74.32 108.689 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.31 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 74.34 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.34 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 75.04 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 72.44 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.34 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 73.2 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.2 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.04 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.2 108.687 167.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.34 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.13 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 74.35 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.42 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.23 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.51 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.31 109.231 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 75.13 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 74.42 105.927 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.42 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.01 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.45 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.32 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.24 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.25 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 70.04 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 74.24 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 73.34 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.23 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.45 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.12 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.51 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.22 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.11 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.13 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 62.11 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.45 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 74.5 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 74.02 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 75.41 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.51 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 74.04 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.52 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 75.03 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.12 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.45 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 61.43 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 60.43 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.44 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.35 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.23 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 71.11 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.12 111.527 -170.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.45 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.43 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 75.2 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 74.03 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 71.55 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 75.13 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 72.34 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 72.13 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 74.12 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.23 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 75.42 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 73.23 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.14 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 73.41 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 73.44 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 75.52 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.21 105.58 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 75.51 109.521 -176.11 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.44 108.97 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 74.21 109.296 -168.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.44 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 74.1 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.12 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 75.22 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.44 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.21 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.2 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.21 110.694 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.21 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.45 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.13 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 74.03 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 625' ' ' GLU 0.294 23.5 mmm180 . . . . . 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.54 104.651 178.962 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.13 116.465 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 71.2 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.15 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 74.32 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.54 111.853 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 63.51 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.03 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.32 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 72.52 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.43 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 71.15 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 65.33 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 73.13 103.979 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.14 106.225 175.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.746 -0.835 . . . . 73.44 108.746 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.11 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.53 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . 0.55 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 71.3 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.33 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.43 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.01 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 75.13 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 71.33 110.311 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 75.41 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.44 106.63 165.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.15 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 71.52 110.016 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.22 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 74.25 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.41 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 71.35 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.44 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.2 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 73.33 105.642 169.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 73.31 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.55 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 75.42 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.55 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 74.43 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.23 112.045 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.21 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 73.43 109.801 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 74.1 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.43 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 63.33 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.496 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 72.33 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.15 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.41 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.42 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 71.1 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.23 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.43 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.14 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 74.52 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.12 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.41 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.15 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 50.43 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 578' ' ' GLU . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.13 106.718 172.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 72.43 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.23 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.2 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 574' ' ' LYS . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.43 114.655 -171.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.34 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 75.23 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 75.12 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 74.11 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 73.05 110.561 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.43 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.42 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 75.41 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.4 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 72.23 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 74.15 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 74.34 106.876 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.43 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 75.13 118.855 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.2 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 74.21 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.14 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 71.3 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 73.33 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.14 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.11 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.34 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.3 106.67 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.11 108.188 -177.295 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.025 -1.102 . . . . 71.33 108.025 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.31 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 71.25 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.55 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 70.43 106.554 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.4 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.4 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.41 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 64.11 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.42 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 74.12 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 75.13 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 75.41 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 . . . . . 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 75.02 107.604 177.598 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.503 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 72.45 115.754 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.23 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.14 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.22 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 74.24 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 72.1 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 75.43 114.647 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.22 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.31 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.32 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.12 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 75.01 108.669 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.14 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 73.15 106.305 173.74 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 107.462 -1.31 . . . . 73.4 107.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 75.24 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 73.32 105.863 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.14 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.23 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 65.0 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 73.03 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.13 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.45 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.32 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 72.54 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 73.21 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 70.24 108.609 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.42 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.14 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 73.33 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 73.21 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 75.25 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.15 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.459 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.33 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.32 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.31 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 74.23 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.33 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 74.13 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.52 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 557' ' ' GLY . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.12 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.13 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.33 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.15 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.13 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.14 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.44 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.54 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.55 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.42 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.14 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.1 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 74.21 108.367 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 75.42 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 72.51 104.403 -170.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.13 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.1 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 72.02 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 71.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.21 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 72.35 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 64.15 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.13 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.13 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 72.11 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.32 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 74.33 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.34 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.4 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 74.51 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.4 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 75.31 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.01 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 74.13 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.05 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 64.01 116.216 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.32 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 595' ' ' VAL . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.43 119.125 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.32 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 75.22 105.686 170.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 74.54 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 72.01 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 64.54 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.02 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.459 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.43 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 74.44 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.13 108.811 -178.26 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 73.14 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.15 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.44 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.3 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.33 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.4 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.32 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.45 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.54 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.15 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.53 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 75.32 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 73.41 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 . . . . . 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.1 109.744 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.469 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 74.35 115.721 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.05 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 72.51 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 71.43 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 70.01 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 64.4 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.45 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 74.13 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 73.45 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.24 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 74.12 107.56 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.35 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.34 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.35 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.41 105.626 176.568 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.726 -1.213 . . . . 61.13 107.726 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.12 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.15 107.271 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 74.15 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 73.13 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 75.42 108.081 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.3 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 63.32 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.34 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 75.11 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.34 109.515 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.12 107.418 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.01 108.533 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 63.14 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 72.01 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.15 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.11 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 62.45 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.13 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.467 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.13 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.24 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.44 106.245 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 75.12 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 74.11 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 74.15 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.01 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 75.55 110.246 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.32 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 64.54 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 75.44 109.647 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 73.4 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 51.22 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.35 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 73.12 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 75.24 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.44 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.44 115.129 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 71.2 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . 0.447 ' C ' ' HD3' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.01 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.04 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 73.33 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.2 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.4 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 75.44 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 73.51 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.31 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 75.23 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.1 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 72.45 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 74.44 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 74.43 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.4 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 70.54 109.32 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.44 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.04 109.044 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 75.42 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.42 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.12 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 63.34 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 72.24 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 55.44 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 595' ' ' VAL . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.31 117.072 169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 64.22 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.22 104.547 168.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 74.42 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.4 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 74.13 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.01 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.12 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.02 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 73.32 104.98 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.35 110.666 -173.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.212 1.006 . . . . 71.42 111.913 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.54 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 75.21 105.661 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.43 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.23 106.758 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.14 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.42 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 74.23 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.32 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.645 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.33 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 71.32 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.44 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.645 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 . . . . . 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 75.14 107.814 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.644 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.3 115.981 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.1 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 75.23 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 55.04 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 74.31 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 74.01 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 65.35 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.24 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 74.13 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 74.41 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.32 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 75.04 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 75.11 109.082 -171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 74.43 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 72.12 105.535 173.588 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.108 0.48 . . . . 70.11 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.21 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.411 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 75.24 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 73.15 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.23 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 74.43 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.23 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.11 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.23 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.21 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 73.02 109.454 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.15 108.212 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 73.25 108.206 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.21 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.01 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.21 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.23 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.11 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.451 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.41 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 71.22 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.11 105.45 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 72.54 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.34 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 70.12 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.22 110.287 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 75.45 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.42 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 74.33 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.12 111.919 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.35 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.41 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.45 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . 0.568 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 74.23 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 73.45 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 74.33 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.11 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.4 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 75.51 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.35 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 71.31 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 72.13 111.306 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.14 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 71.3 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.24 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.43 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.23 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.52 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.02 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 73.41 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.42 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.53 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.3 109.296 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.13 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 73.2 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 72.53 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.24 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 70.42 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.22 115.669 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.31 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 74.52 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.53 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 74.32 104.122 170.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.41 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 75.14 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 70.14 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 64.3 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 74.1 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 75.24 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.55 106.175 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 64.4 109.61 -172.15 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.177 -0.675 . . . . 73.44 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.43 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 74.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.13 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.01 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 75.32 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.03 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.11 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 72.01 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.524 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.55 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 624' ' ' MET . . . . . 0.568 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 74.31 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.456 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.42 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.524 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 73.14 116.25 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 44.14 116.67 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.43 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.52 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 74.25 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.01 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.52 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 659' ' ' LYS . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.34 114.659 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 64.14 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 657' ' ' HIS . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.22 109.522 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.4 108.612 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.14 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.33 109.023 -171.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 73.14 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.2 106.593 175.062 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.13 108.549 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.32 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 71.11 108.883 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 74.22 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.3 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 550' ' ' VAL . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.31 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.1 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 75.01 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.14 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.45 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 70.14 107.598 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.42 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 74.44 106.732 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 74.15 102.109 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.44 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 53.44 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.14 110.18 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.35 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 74.2 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.44 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.12 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 74.14 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 73.24 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.34 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.03 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.15 110.318 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.43 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.31 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 75.4 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.43 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 63.3 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 74.03 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 75.44 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 73.13 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 75.24 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 72.43 107.587 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.54 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.22 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.35 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 71.24 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 73.21 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.11 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.24 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.418 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.44 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.34 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.14 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.24 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . 0.418 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.44 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.21 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.54 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 73.54 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 73.32 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 64.15 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 74.23 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.42 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.14 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.24 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.41 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.34 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.588 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.51 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.4 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 72.0 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.588 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.41 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.564 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.04 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.3 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.13 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 74.32 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 71.21 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.478 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 74.53 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 73.12 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.51 105.581 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.35 110.014 -171.16 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.24 0.577 0 N-CA-C 104.589 -2.374 . . . . 75.3 104.589 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.02 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.4 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.32 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 74.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.51 109.277 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.2 108.005 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 73.13 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.44 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.55 110.46 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.44 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.64 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.21 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 63.44 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 71.34 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.64 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 . . . . . 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 72.24 106.272 -179.301 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.42 116.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.32 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.23 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 72.31 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.684 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.13 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.11 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 74.1 112.739 173.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 74.42 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 72.11 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.54 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.15 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.468 0.175 . . . . 63.42 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 64.31 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.413 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.2 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 74.4 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.31 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.53 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 73.22 112.616 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.54 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 72.1 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.31 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.32 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 73.42 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.43 108.542 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.32 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.13 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 73.43 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.34 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 74.21 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.05 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.401 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 75.11 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.21 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.13 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.24 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.52 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.54 109.064 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.15 109.582 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 74.04 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.33 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.2 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 62.11 112.943 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 74.01 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.02 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 73.33 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . 0.49 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.52 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 75.13 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.23 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 75.02 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 75.13 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.21 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.12 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.3 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.12 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.13 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.42 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.14 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 75.14 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 64.23 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.45 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.13 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.1 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.33 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 63.01 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.31 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.21 112.145 -171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.33 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.51 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 74.43 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 73.41 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.01 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.23 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.42 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 74.24 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 594' ' ' THR . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.05 111.469 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.1 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 592' ' ' ASP . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.02 114.026 -168.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 74.13 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 75.12 107.48 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.23 111.323 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.33 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 73.0 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.53 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 73.33 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 75.3 106.865 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 71.03 109.596 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.073 -1.825 . . . . 72.32 106.073 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 72.05 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.34 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.22 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 73.12 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 64.12 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 75.33 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.41 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.43 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.3 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.635 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.2 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 624' ' ' MET . . . . . 0.49 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 72.11 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.44 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 . . . . . 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.4 107.591 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.224 -0.529 0 N-CA-C 115.028 0.771 . . . . 51.11 115.028 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.23 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 63.5 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.13 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.43 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.42 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.22 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.13 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.34 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.44 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.45 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.22 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.31 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.44 106.191 176.126 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 74.3 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.41 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.407 ' H ' HG21 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 75.22 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 75.13 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 74.04 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.4 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.33 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 75.32 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.23 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 73.53 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.407 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.44 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.14 109.625 166.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 65.22 105.16 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 74.11 107.522 168.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.54 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 75.12 110.205 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 52.13 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.33 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 71.44 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.54 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.32 106.481 172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.24 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 75.34 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.4 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.406 HH11 ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.11 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.407 HG21 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 71.24 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.33 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.34 113.183 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . 0.406 ' HB3' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 63.33 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 75.05 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.13 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.24 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.34 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 72.54 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 64.53 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 71.3 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 71.22 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.41 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.43 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.31 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.54 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 74.33 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.43 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 51.44 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 72.32 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.01 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.21 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.43 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.3 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.33 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.45 110.59 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.35 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 72.44 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.54 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.42 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.34 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.24 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.54 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 75.55 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 74.12 114.692 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.24 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 75.22 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.401 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 73.24 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.54 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.32 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 597' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 72.34 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 74.2 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 72.22 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 70.23 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.43 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.34 107.627 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 75.12 109.28 -178.077 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 107.396 -1.335 . . . . 73.53 107.396 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.21 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.52 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 73.25 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 74.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 74.43 108.632 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 74.0 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.22 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 74.34 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 71.55 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.55 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.444 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 75.44 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.4 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.456 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 72.34 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.444 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.54 114.711 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 63.21 116.348 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 73.32 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.33 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 74.21 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 75.23 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.34 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.32 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 659' ' ' LYS . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.23 112.694 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.34 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 657' ' ' HIS . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 74.15 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 74.34 107.337 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 65.2 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.407 ' HA ' HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 74.14 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 72.41 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.43 104.957 177.134 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 74.1 109.308 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 63.01 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.34 108.558 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.14 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.32 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 75.32 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 74.31 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 64.23 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 70.11 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 73.25 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.11 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 73.32 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 71.13 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 73.33 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.23 109.724 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.53 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 71.31 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.463 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 72.45 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 72.15 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 75.22 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.44 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.12 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 75.41 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.41 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.31 111.309 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 72.41 109.527 170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 61.43 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.44 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.31 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 73.52 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . 0.556 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.12 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.42 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 75.01 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.24 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.43 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.53 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.13 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 75.45 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 72.31 110.443 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 75.34 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.21 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 74.31 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 71.33 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 62.21 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.44 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.31 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.53 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.2 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.31 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 75.2 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.1 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 74.01 110.527 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 74.41 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.44 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.33 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.52 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.41 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.44 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.578 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 73.14 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.1 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 72.32 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.578 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.24 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 75.23 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 74.24 105.296 168.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.21 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 64.33 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.11 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 64.11 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 74.25 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 73.41 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 75.45 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 60.25 107.641 -176.63 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 74.52 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 73.24 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.21 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.24 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.14 106.897 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 75.34 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.23 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 64.23 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.51 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 74.51 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.608 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.43 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 624' ' ' MET . . . . . 0.556 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 74.34 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 75.43 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.608 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 73.44 107.94 179.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.524 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 52.44 115.685 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 74.31 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.42 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.22 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.43 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 64.13 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.33 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 72.22 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 71.41 109.404 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 74.11 105.078 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 72.1 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 74.31 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.31 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 75.34 105.468 173.056 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 106.198 -1.778 . . . . 74.41 106.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 73.21 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 73.24 106.92 171.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.14 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 74.14 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.44 113.514 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.2 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 73.12 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.23 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.13 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.44 108.718 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 73.33 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 72.5 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 75.34 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.24 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.11 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.5 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.403 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 72.13 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 73.44 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.31 105.068 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.54 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.51 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.22 108.696 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 74.45 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.22 112.317 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 75.31 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.34 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . 0.428 ' HB3' HH11 ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.02 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.44 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.24 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 75.22 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 73.24 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 71.14 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 74.05 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 74.22 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 73.01 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . 0.403 ' HD2' HG21 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.23 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.41 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.24 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.23 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 72.11 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 61.33 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.32 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 75.31 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.21 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 74.52 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.4 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.11 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 74.42 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.33 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.23 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.41 112.029 -174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.24 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.33 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.3 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 71.51 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 73.32 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.12 104.492 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.51 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 75.33 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 72.41 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.23 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 592' ' ' ASP . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.41 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 593' ' ' GLU . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.14 103.382 169.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 72.24 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 64.31 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.33 107.11 175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 74.45 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.403 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 74.21 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.43 105.993 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t . . . . . 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.33 109.768 -173.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.181 -1.044 . . . . 75.21 108.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.51 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.22 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 74.02 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 73.2 106.685 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.33 108.024 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.43 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.33 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.22 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 75.33 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.03 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.608 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.53 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.43 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.21 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.608 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 . . . . . 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 75.01 112.061 176.556 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.604 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.33 117.5 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 74.35 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 75.23 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 74.52 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 71.34 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 65.04 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.11 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 74.24 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.21 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 74.11 108.569 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 70.41 107.167 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.01 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 71.04 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 74.14 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 63.14 106.162 177.132 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.44 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 74.13 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.33 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.23 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.11 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.15 113.787 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 74.04 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.01 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 74.25 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.404 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.52 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.32 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 72.4 107.957 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.31 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.41 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.43 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.32 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 72.41 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.22 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 73.52 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 75.24 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.51 106.685 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 74.1 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.22 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.12 109.632 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.44 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.22 111.51 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 75.42 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 65.2 110.373 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.23 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 74.34 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 53.31 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.22 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.43 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 63.45 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.24 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 65.54 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.14 108.098 173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.03 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 71.54 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 72.13 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 73.24 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.12 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 75.02 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 63.41 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 71.22 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.33 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.33 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.33 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.05 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.34 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.35 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . 0.479 ' CD ' ' HZ3' ' A' ' 601' ' ' LYS . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.54 108.28 171.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.31 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 64.42 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.14 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 61.22 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 70.01 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 72.45 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 75.11 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 70.33 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.03 116.111 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.31 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 595' ' ' VAL . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 74.43 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.13 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.34 105.923 169.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 75.14 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.51 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 74.34 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 73.1 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.23 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . 0.479 ' HZ3' ' CD ' ' A' ' 581' ' ' GLU . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.4 107.458 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.55 105.741 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 75.41 110.047 -177.455 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.45 0.643 . . . . 74.41 111.767 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.23 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.42 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 74.33 105.585 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 73.11 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 73.35 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.24 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.02 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 73.35 110.469 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 75.21 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.641 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.51 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.33 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 72.22 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.641 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 . . . . . 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 72.31 107.855 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.468 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 74.33 115.984 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.51 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 74.45 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 72.11 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.35 111.215 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 65.4 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.14 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.35 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.4 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.55 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 75.23 107.622 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 75.43 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.404 ' HA ' HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 70.25 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 73.32 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 73.34 106.307 176.14 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.866 0.365 . . . . 72.22 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.45 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.426 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.41 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 75.32 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.44 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 75.32 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 71.34 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.31 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.54 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 74.21 108.434 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 74.12 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 74.31 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.32 111.918 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.01 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 75.32 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 74.43 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 74.42 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 74.54 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.3 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.14 103.787 169.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.44 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 75.53 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.34 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 73.42 109.704 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.45 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.11 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 52.03 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.35 114.233 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.43 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.23 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.44 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 71.3 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.53 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.31 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 73.42 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.24 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.12 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.04 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.24 110.418 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.35 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 72.41 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 73.14 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HZ1' ' CD ' ' A' ' 578' ' ' GLU . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.01 106.932 175.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 75.51 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.32 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.2 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 574' ' ' LYS . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 71.41 115.924 -162.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.21 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.35 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.54 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.43 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.43 109.779 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.13 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.53 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 74.51 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.33 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.55 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 74.23 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.632 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.41 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 74.11 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 74.25 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.632 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 74.51 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 74.43 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 593' ' ' GLU . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 73.44 103.414 171.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.3 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 71.52 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.01 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.31 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.44 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 72.32 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 74.4 107.583 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.52 110.306 -176.556 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.033 -0.729 . . . . 53.12 109.033 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.03 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.54 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.35 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 75.21 106.474 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.42 108.154 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.32 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 75.54 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 71.13 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.44 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 73.52 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.61 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 74.15 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.11 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.61 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 . . . . . 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 71.12 110.498 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.57 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 72.3 115.573 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.51 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 64.32 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 73.1 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.3 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 73.22 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.21 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.43 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.32 109.183 -176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 75.15 108.474 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.42 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.44 107.805 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 75.01 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 72.41 104.732 175.29 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.845 0.355 . . . . 73.53 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.45 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.11 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 74.21 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 71.41 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.31 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.24 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.11 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 72.31 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 65.12 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 75.12 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 74.31 108.318 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 72.2 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 55.11 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.22 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 70.15 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.45 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.4 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.52 109.532 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 75.1 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 73.53 104.284 169.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 62.22 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.3 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 74.5 109.874 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.13 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.21 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 70.3 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.21 111.671 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.44 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 75.42 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 74.25 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.12 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 74.34 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 73.01 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.24 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.11 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 72.33 108.257 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.21 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.32 111.1 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.21 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.31 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.2 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 74.01 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 54.34 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 52.43 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 71.12 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.24 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 74.25 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.23 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 72.25 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.31 108.723 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.42 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.21 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.42 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 61.34 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.51 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 72.14 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.443 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.52 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 72.1 115.36 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 75.04 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 71.4 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.33 113.812 -168.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 70.31 106.717 174.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 74.21 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 74.52 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 75.13 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.21 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 74.13 107.324 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.41 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 74.15 103.692 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.2 107.789 -174.137 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.82 -1.178 . . . . 74.15 107.82 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 73.35 106.023 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.03 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.23 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.31 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 64.52 107.362 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.42 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.45 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 75.43 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 74.12 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 74.41 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.624 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.44 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 71.14 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.3 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.624 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.21 106.739 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.446 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 71.24 117.183 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.43 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 73.11 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.32 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.42 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.11 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 659' ' ' LYS . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.33 112.247 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 71.14 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 657' ' ' HIS . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 75.13 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.44 105.986 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.23 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.54 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.43 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 74.12 105.302 175.457 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 107.696 -1.224 . . . . 72.25 107.696 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.44 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' ILE . . . . . 0.409 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.13 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.44 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 73.5 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' PHE . . . . . 0.469 ' CZ ' HG12 ' A' ' 550' ' ' VAL . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.33 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.21 113.168 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 74.31 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.44 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 75.24 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' ILE . . . . . 0.427 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 73.22 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 63.15 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 72.4 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.35 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.42 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.24 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 64.14 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 74.31 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 73.54 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.32 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' VAL . . . . . 0.469 HG12 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.23 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 75.12 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.12 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 71.02 108.173 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' ARG . . . . . 0.425 ' C ' ' HE ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 72.24 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 74.44 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.32 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.34 112.901 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.11 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 73.01 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 561' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 74.24 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.13 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 75.32 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 71.12 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.41 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.45 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.24 106.335 171.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.51 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.23 104.303 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 570' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 74.11 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.12 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.34 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.22 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 74.42 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.4 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.15 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.24 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.32 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.31 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 74.13 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 74.52 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.33 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.14 111.631 -172.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.42 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.42 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 54.21 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 75.24 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.12 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 74.2 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 590' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 72.41 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 72.34 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 592' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 64.13 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 593' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.24 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 594' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.51 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.42 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 73.54 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 75.14 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 74.21 106.744 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 74.53 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.42 109.228 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 73.03 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.43 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 70.4 111.936 -172.688 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 613' ' ' ASN . . . . . 0.41 HD22 ' HG3' ' A' ' 661' ' ' GLU . 1.1 t-20 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 70.13 107.862 -172.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.44 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.34 108.003 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 74.42 107.797 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 64.41 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 74.42 108.741 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.02 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.12 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 75.03 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.52 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 623' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.4 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.34 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 625' ' ' GLU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.23 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear orig core ' A' A ' 626' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 . . . . . 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.54 113.94 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.58 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 73.23 117.357 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 72.33 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 65.42 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 72.14 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.13 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.14 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.14 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 70.31 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.01 107.317 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 75.12 104.33 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' GLU . . . . . 0.41 ' HG3' HD22 ' A' ' 613' ' ' ASN . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.24 109.45 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' VAL . . . . . 0.427 ' HA ' HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.34 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.41 104.245 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 71.12 106.109 176.893 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -53.77 135.06 42.07 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.714 0.634 . . . . 0.0 109.36 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 558' ' ' ALA . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 556' ' ' SER . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.431 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . 0.431 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.488 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.22 143.69 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.08 123.85 46.64 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.959 -170.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.3 -21.23 3.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.18 168.01 0.14 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 54.59 21.46 3.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.985 1.314 . . . . 0.0 113.703 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.59 135.69 38.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -91.75 12.61 20.73 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -135.05 135.56 41.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.31 131.51 40.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.43 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -105.29 152.31 23.06 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.506 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 163.23 -55.02 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.1 64.74 1.89 Allowed Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.854 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.72 130.76 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 8.7 t -149.57 176.65 10.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.05 149.91 49.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.509 0.671 . . . . 0.0 110.621 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.31 81.27 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.81 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.7 m -70.23 -45.32 66.76 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -155.88 125.96 6.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.428 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -147.78 73.99 1.29 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 170.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.76 114.83 4.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 28.0 mt -136.98 -178.52 5.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -80.26 172.08 14.23 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.4 -44.81 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.663 0.744 . . . . 0.0 111.518 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.34 -42.4 95.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.525 1.155 . . . . 0.0 110.483 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -76.34 -19.54 58.12 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.365 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -44.45 76.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.452 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -88.12 -50.08 6.61 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.295 164.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.98 92.66 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -75.43 -38.39 59.78 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -58.54 -47.68 83.39 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 122.469 -0.145 . . . . 0.0 111.343 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.56 -42.86 97.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.178 0.513 . . . . 0.0 109.96 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.08 -32.5 74.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.17 -21.3 59.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.335 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.5 mtt -77.91 -41.7 35.63 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.54 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.37 16.99 30.39 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.422 ' HA ' HG21 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt -96.51 111.68 27.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -165.17 166.13 19.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 133.81 53.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.057 0.456 . . . . 0.0 110.288 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 4.6 t 52.05 -155.31 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -153.0 165.53 35.26 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -130.92 139.83 50.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -147.67 153.16 38.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -152.56 160.53 43.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.8 p -152.42 160.39 43.28 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 9.1 t -160.45 158.19 28.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.8 t 70.35 140.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.001 1.438 . . . . 0.0 111.428 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.337 -178.332 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.834 -0.432 . . . . 75.44 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -59.37 141.78 53.75 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.861 0.725 . . . . 62.4 110.394 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 74.12 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 73.12 107.134 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.31 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.22 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 73.21 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.43 114.037 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.43 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 73.1 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 75.32 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.31 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.2 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.55 108.09 170.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 55.32 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.461 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.43 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 65.21 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 75.53 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 71.21 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 75.23 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.495 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 75.04 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.33 107.765 172.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.54 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.32 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.22 110.132 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 72.52 107.93 177.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 74.24 110.665 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.45 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 64.11 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 74.13 113.702 -174.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.22 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.54 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.411 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.14 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 73.34 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 73.52 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 74.21 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 71.01 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 74.01 108.408 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 73.33 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 74.15 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 71.22 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.34 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.1 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.33 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.2 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 53.34 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.21 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 52.44 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 74.24 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.52 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 65.54 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 72.02 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.24 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.05 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.12 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.21 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.12 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 74.43 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.15 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 74.54 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.457 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 75.25 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 74.24 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.15 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.457 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.41 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 65.14 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.43 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 73.22 110.592 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.35 112.007 -177.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 73.42 106.808 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.15 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.495 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.22 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 75.23 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 72.13 106.862 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.01 143.62 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.15 113.864 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.11 142.5 54.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.213 -1.358 . . . . 71.45 109.569 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.54 145.22 54.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.489 1.292 . . . . 70.33 114.489 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -148.03 -41.74 0.17 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.485 0.92 . . . . 72.41 113.485 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -109.91 -29.38 8.29 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.599 0.963 . . . . 73.45 113.599 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -109.79 163.85 13.12 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.158 1.91 . . . . 74.44 116.158 -171.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -123.02 170.92 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.538 -1.282 . . . . 75.23 107.538 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 87.85 154.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 126.668 1.987 . . . . 74.33 112.828 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.92 130.95 48.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.148 -2.167 . . . . 70.11 105.148 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -117.49 164.14 15.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.336 -1.357 . . . . 72.13 107.336 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 74.31 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 72.01 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 74.12 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 75.0 105.523 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 74.12 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 75.41 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.03 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 73.34 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 72.34 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 73.31 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.484 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.4 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.411 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.4 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.484 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 74.43 -40.72 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 73.25 114.023 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.32 35.02 69.18 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 110.081 -1.208 . . . . 71.21 110.081 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.39 139.8 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.956 0.884 . . . . 74.41 112.25 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 48.0 t -146.4 -49.65 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.95 -2.241 . . . . 74.41 104.95 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.62 164.02 39.17 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.331 -3.211 . . . . 72.13 102.331 171.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.28 119.8 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.321 -1.363 . . . . 73.42 107.321 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 68.4 p -118.54 172.28 7.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.694 -0.685 . . . . 74.3 111.967 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 22.1 t0 55.11 35.79 25.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.351 1.241 . . . . 63.54 114.351 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -93.86 57.11 2.42 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.482 -0.933 . . . . 73.35 108.482 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -67.84 115.76 7.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.422 -1.263 . . . . 75.53 108.446 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.49 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 24.4 mt -146.85 -172.96 4.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.483 -2.043 . . . . 75.41 105.483 -169.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -64.43 151.86 43.05 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.588 -2.375 . . . . 74.22 104.588 168.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 21.7 m -64.76 -24.04 34.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 113.066 0.765 . . . . 74.31 113.066 -161.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.93 -45.46 70.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.05 0.929 . . . . 72.13 109.208 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.43 -20.44 54.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.036 -0.983 . . . . 71.34 111.953 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 1.8 mt-10 -58.2 -41.69 84.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.215 -0.291 . . . . 74.54 110.215 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.98 -48.76 7.52 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 119.55 -0.86 . . . . 74.13 111.904 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.95 93.61 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.156 1.169 . . . . 73.42 114.156 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -73.92 -40.66 62.96 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.787 -0.82 . . . . 75.42 108.787 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -60.26 -46.43 89.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.085 -0.507 . . . . 70.32 111.834 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.72 -41.37 92.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.466 -0.568 . . . . 74.41 109.466 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.01 77.4 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.106 -0.371 . . . . 74.22 110.832 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.96 -19.5 62.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.25 0.463 . . . . 74.13 112.25 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 65.0 mtt -69.82 -41.51 74.88 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.779 -1.193 . . . . 75.23 107.779 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.73 12.4 14.08 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 73.5 117.995 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.52 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.51 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.33 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.41 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 71.41 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.34 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 73.12 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.4 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 73.1 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 74.23 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 62.52 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.53 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.18 109.08 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.11 108.374 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -167.65 157.88 10.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.614 -1.624 . . . . 75.23 106.614 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -71.27 80.93 0.73 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.017 0.826 . . . . 73.5 110.835 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 1.8 p -167.65 172.03 9.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.102 -0.703 . . . . 75.34 109.102 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.56 169.39 17.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.318 -0.993 . . . . 71.21 108.318 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -67.11 163.32 20.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.013 0.911 . . . . 65.14 111.935 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.08 153.02 36.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.712 -1.588 . . . . 74.11 106.712 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 2.1 3.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.41 1.263 . . . . 74.45 114.41 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 19.6 p 58.0 -171.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.738 1.215 . . . . 74.12 110.695 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 4.9 t -158.41 157.15 31.72 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.286 -1.375 . . . . 73.21 107.286 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.56 127.34 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 102.745 -3.058 . . . . 75.35 102.745 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.259 1.573 0 N-CA-C 104.658 -2.349 . . . . 71.04 104.658 -175.306 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.842 0 N-CA-C 107.552 -1.277 . . . . 75.32 107.552 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.25 22.92 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.981 -1.118 . . . . 73.34 107.981 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 72.24 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 72.03 109.022 176.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.33 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.42 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 74.4 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.23 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.31 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 73.34 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 74.25 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.43 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 74.02 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 75.12 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 72.31 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.519 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 71.33 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.05 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 71.42 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.12 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 75.14 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.418 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.2 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 73.32 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.34 105.856 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 75.44 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.4 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.13 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.22 110.797 -177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.23 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.33 109.349 171.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 74.31 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.51 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 53.32 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.53 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 75.01 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 73.14 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 64.35 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 74.41 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 71.34 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.43 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 70.43 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 74.34 110.776 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 64.22 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.2 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.44 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.24 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.52 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.51 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.11 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 73.13 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.33 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 74.53 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 75.44 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.22 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 74.43 110.911 -172.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.04 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.55 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.44 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.35 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.44 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 72.55 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.558 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 75.52 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.31 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.12 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.558 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.11 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 71.3 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.451 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 73.24 106.658 171.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 75.44 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 74.32 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.21 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 72.22 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.12 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 74.54 106.625 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.48 143.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 64.15 108.016 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -118.28 126.64 52.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.612 0.765 . . . . 73.13 109.663 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.72 147.76 24.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.575 -0.898 . . . . 74.04 108.575 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.31 9.13 7.56 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.647 1.351 . . . . 73.24 114.647 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.18 -33.45 75.42 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 117.878 2.547 . . . . 73.42 117.878 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -138.74 154.58 48.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 117.111 2.263 . . . . 73.41 117.111 -171.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 30.51 6.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.717 -1.129 . . . . 71.31 108.176 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.63 153.73 18.46 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.6 1.333 . . . . 74.24 114.6 -171.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.87 130.61 35.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.44 -1.689 . . . . 72.42 106.44 171.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.4 158.71 22.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.04 109.804 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 75.21 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.34 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.52 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 62.25 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.2 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.32 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.31 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.32 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 74.11 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.3 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 75.01 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 72.41 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.609 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 165.14 -52.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.55 107.808 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.08 63.11 2.11 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 110.655 -0.978 . . . . 53.51 110.655 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 2.9 tt -55.95 121.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.308 -0.997 . . . . 75.13 108.308 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 33.7 m -146.24 164.16 33.18 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.0 -1.481 . . . . 70.4 107.0 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -69.19 144.72 53.67 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.306 -0.998 . . . . 75.2 108.306 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.94 155.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.201 -1.037 . . . . 72.01 108.201 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 23.2 p -111.04 -84.59 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.486 . . . . 74.52 112.311 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.5 79.48 8.92 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.674 0.99 . . . . 71.44 113.674 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -90.06 59.76 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.373 -0.973 . . . . 74.42 108.373 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 99.59 0.1 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.486 -1.234 . . . . 75.22 112.751 -176.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 56.5 mt -142.05 -179.15 6.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.996 -2.224 . . . . 73.13 104.996 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 156.56 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.832 -1.914 . . . . 74.12 105.832 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.1 -45.41 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.153 0.797 . . . . 74.53 113.153 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -58.21 -48.81 79.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.551 0.691 . . . . 74.42 111.462 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -77.5 -19.49 55.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.145 0.424 . . . . 64.21 112.145 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.7 -44.63 77.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.858 -0.423 . . . . 71.42 109.858 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -87.85 -47.9 8.24 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.824 -0.75 . . . . 74.31 111.907 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.0 80.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.767 1.025 . . . . 75.54 113.767 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.84 -37.5 40.35 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 122.003 -0.436 . . . . 74.41 109.886 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -61.25 -46.25 91.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.364 -0.38 . . . . 74.11 111.122 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.77 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.498 0.666 . . . . 73.24 109.648 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.15 71.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.093 0.473 . . . . 74.53 111.343 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.88 -17.46 59.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.156 -0.474 . . . . 71.22 111.734 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 54.4 mtt -79.56 -41.42 27.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.395 -1.705 . . . . 72.41 106.395 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.7 15.77 27.69 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.45 117.305 166.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 74.15 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.34 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.22 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 73.1 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.44 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 75.12 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 65.4 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 62.42 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 74.21 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 71.43 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 75.14 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.43 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 75.44 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 73.2 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.53 102.25 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 75.32 106.165 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -172.48 138.16 0.88 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 106.437 -1.69 . . . . 74.11 106.437 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.86 91.74 2.0 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.672 0.749 . . . . 73.52 109.648 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 23.2 t -166.85 -177.15 3.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.352 -2.092 . . . . 63.44 105.352 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.21 156.5 41.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.404 -1.702 . . . . 73.31 106.404 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.58 164.82 36.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.011 -1.107 . . . . 73.42 108.011 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 60.47 -179.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.557 1.143 . . . . 71.23 114.064 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 51.63 58.46 5.47 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.668 0.988 . . . . 72.43 113.668 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 40.3 t -58.52 147.88 30.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.105 -0.952 . . . . 74.33 109.654 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 39.6 p -82.65 -10.23 59.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.203 -0.453 . . . . 74.41 111.606 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.42 160.49 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.293 -1.002 . . . . 74.42 108.293 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 103.444 -2.798 . . . . 72.04 103.444 178.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 CA--C 1.516 -0.327 0 N-CA-C 109.182 -0.674 . . . . 62.3 109.182 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -64.6 152.43 42.13 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.51 109.112 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 74.22 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.4 106.716 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 73.34 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 74.51 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 71.43 110.303 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.13 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 74.33 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 74.32 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 75.21 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.13 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.11 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 74.23 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.54 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.3 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.15 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 73.31 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 73.43 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 75.25 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 74.12 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.45 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.14 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.54 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.33 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.33 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 75.13 108.828 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.51 112.65 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 72.41 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.32 113.09 -175.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 73.12 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 73.33 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.13 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 75.54 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.41 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.24 115.301 173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.33 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 73.04 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 74.4 109.361 176.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.31 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.44 109.545 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.43 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.21 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 73.12 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 73.14 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.21 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.45 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.21 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.32 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 71.43 102.113 178.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.22 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.21 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.4 111.582 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.11 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.44 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.21 110.144 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 75.01 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 70.44 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 74.21 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 61.34 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.23 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.561 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 75.2 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.44 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 70.32 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 74.13 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 75.32 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.23 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 71.14 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 72.3 109.788 175.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 73.31 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 73.1 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.92 143.64 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 72.44 108.026 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.08 134.8 54.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.912 0.885 . . . . 72.22 112.498 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.16 154.61 27.67 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 105.765 -1.939 . . . . 72.44 105.765 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.8 4.27 19.75 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.185 1.18 . . . . 73.02 114.185 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -65.15 -38.45 90.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.787 2.143 . . . . 71.51 116.787 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -144.07 137.36 27.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.055 1.872 . . . . 72.33 116.055 -170.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.22 112.99 16.99 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.539 -0.755 . . . . 70.35 110.42 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -152.2 143.56 23.34 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 112.836 0.68 . . . . 73.23 112.836 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -84.73 119.63 25.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.194 -2.521 . . . . 75.01 104.194 166.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -117.74 159.33 23.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.276 -1.379 . . . . 52.13 107.276 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.4 112.795 -170.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.15 109.756 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.11 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 64.22 107.768 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 73.04 107.904 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.42 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.02 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 75.31 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.22 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.63 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.53 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 70.02 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 75.13 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.63 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 164.3 -49.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 71.4 107.39 179.045 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.21 58.22 3.74 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.266 -1.134 . . . . 63.2 110.266 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.1 tt -52.1 123.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.924 -0.638 . . . . 73.23 111.228 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.4 m -151.0 154.81 37.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.649 -2.352 . . . . 74.53 104.649 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.41 153.29 22.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.489 -1.671 . . . . 75.45 106.489 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 10.3 p -148.28 140.16 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.46 -0.941 . . . . 72.21 108.46 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.0 t -131.24 -3.05 3.91 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.83 1.789 . . . . 75.45 115.83 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -77.59 -21.01 53.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.914 0.864 . . . . 75.34 109.336 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -83.36 72.66 10.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.234 -0.894 . . . . 72.32 111.537 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -65.81 129.77 40.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.045 -0.98 . . . . 75.34 108.785 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.499 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 91.8 mt -127.9 -173.58 2.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 103.592 -2.744 . . . . 73.23 103.592 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -65.35 149.99 49.04 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 103.387 -2.82 . . . . 60.43 103.387 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.06 -25.6 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.616 0.598 . . . . 74.22 112.616 -160.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.53 -49.85 65.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.994 0.902 . . . . 65.21 109.342 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.85 -25.49 63.76 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 114.735 -1.121 . . . . 74.43 111.7 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 0.7 OUTLIER -59.38 -43.31 92.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.619 -0.832 . . . . 73.14 110.891 -177.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.21 -44.71 10.67 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.009 -1.076 . . . . 75.11 111.317 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.89 86.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.23 0.923 . . . . 72.44 112.361 -173.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -42.06 70.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 121.031 0.443 . . . . 73.42 110.405 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.38 -46.13 89.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.995 -0.548 . . . . 75.34 111.64 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -63.32 -41.25 92.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.272 0.558 . . . . 75.42 109.684 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.61 72.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.527 0.679 . . . . 63.52 110.881 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -77.89 -17.94 56.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.907 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 52.5 mtt -71.57 -41.2 69.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.907 -1.516 . . . . 74.11 106.907 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.426 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.47 13.45 22.98 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 116.891 1.516 . . . . 72.52 116.891 166.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.53 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 74.42 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 75.44 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.04 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.31 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.02 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.15 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.34 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 73.21 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 74.52 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.45 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.49 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.22 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.13 103.193 174.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt -87.64 124.23 40.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.42 106.61 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.25 -179.68 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.075 1.88 . . . . 74.31 116.075 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.8 -176.71 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.533 1.133 . . . . 74.24 112.108 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 95.6 p -136.75 174.18 10.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.574 -0.528 . . . . 73.12 109.574 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -162.03 158.28 24.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.63 -1.248 . . . . 73.52 107.63 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -113.91 133.39 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.232 -1.025 . . . . 74.43 108.232 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -99.0 56.16 1.04 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.699 -1.223 . . . . 72.1 107.699 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -69.76 111.14 5.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.3 -1.318 . . . . 73.4 110.408 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 57.2 p -82.5 142.67 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 64.02 109.612 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 41.7 p -132.28 159.74 38.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.611 -1.626 . . . . 74.22 106.611 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.9 164.34 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.952 -1.87 . . . . 73.51 105.952 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 102.781 -3.044 . . . . 64.52 102.781 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 105.28 -2.118 . . . . 74.31 105.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.08 139.49 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.705 -1.22 . . . . 75.43 107.705 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.14 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 64.13 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 74.11 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 73.24 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . 0.485 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 74.11 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.41 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 64.03 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.23 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.409 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 75.45 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.31 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.11 107.937 169.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 71.03 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 72.03 110.926 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 64.13 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.1 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 73.52 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.23 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 75.24 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 73.53 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.485 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 74.41 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.1 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.53 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.14 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 74.2 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.33 109.722 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 51.44 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.32 109.049 171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.24 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.41 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.23 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 73.42 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 74.22 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 75.14 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.42 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.23 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 72.23 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.35 108.622 171.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 71.23 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.3 104.957 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.43 112.223 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 73.2 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 72.14 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.41 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.42 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 73.31 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.33 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 41.54 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 75.22 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.41 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.03 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.33 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 75.0 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 70.44 110.581 -169.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.24 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.14 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.42 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 65.53 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 74.11 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.591 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.31 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.14 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.14 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.591 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.32 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.44 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 73.43 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.35 109.094 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 74.01 112.505 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.43 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 74.44 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.411 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 74.11 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.41 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 74.31 106.157 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.65 142.46 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.43 109.328 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.38 156.07 21.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.709 0.803 . . . . 74.25 111.592 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -133.38 151.44 51.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.071 -1.085 . . . . 73.24 108.071 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -89.22 121.21 31.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.583 0.23 . . . . 65.43 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.63 -152.47 0.32 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.373 1.069 . . . . 74.4 113.318 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 61.01 -158.07 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.943 0.897 . . . . 72.15 112.232 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.81 -72.73 0.19 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.918 -0.401 . . . . 75.31 109.918 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 60.91 168.45 0.09 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.772 1.767 . . . . 73.41 115.772 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -147.41 83.57 1.55 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 104.056 -2.572 . . . . 65.44 104.056 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -89.94 153.13 20.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.64 -0.824 . . . . 73.53 110.936 -170.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 74.0 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 74.13 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.11 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.34 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 60.14 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 75.14 108.107 174.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.4 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.32 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 72.1 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.567 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.13 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.14 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.3 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.573 ' HG2' ' O ' ' A' ' 625' ' ' GLU 0.269 12.9 mmm180 157.04 -57.23 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 75.32 106.813 175.858 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.3 71.76 1.27 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.525 -1.43 . . . . 75.21 109.525 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.3 tt -57.59 119.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.641 . . . . 74.51 109.827 -179.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.0 t -164.13 161.46 22.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.878 -2.638 . . . . 74.34 103.878 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.37 137.06 36.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.834 -0.802 . . . . 74.12 108.834 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 26.2 t -115.23 82.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.896 -1.52 . . . . 72.12 106.896 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.89 1.64 5.29 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.515 0.674 . . . . 73.41 112.362 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.38 4.19 13.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.927 0.87 . . . . 73.23 109.317 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -114.36 132.66 56.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.98 -0.748 . . . . 73.31 108.98 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -122.36 134.35 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.879 -1.897 . . . . 75.11 105.879 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 73.4 mt -136.49 176.2 8.92 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 105.849 -1.908 . . . . 75.1 105.849 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.5 t -63.91 150.36 45.16 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 104.366 -2.457 . . . . 71.35 104.366 169.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.05 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.808 0.67 . . . . 72.21 112.808 -160.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -47.53 74.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.895 0.855 . . . . 63.21 109.37 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -74.38 -24.21 59.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.988 -1.006 . . . . 73.1 111.775 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.06 -39.16 88.81 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.404 -0.518 . . . . 72.42 110.087 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.75 -47.77 8.38 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 119.537 -0.865 . . . . 73.13 111.381 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.64 87.56 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.331 0.863 . . . . 61.44 113.331 -170.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -69.29 -40.22 77.86 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.14 -0.689 . . . . 64.53 109.14 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -62.63 -47.83 82.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.038 0.384 . . . . 75.14 112.038 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.5 mt -60.12 -41.99 88.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.055 0.455 . . . . 74.52 110.14 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.43 76.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.044 0.45 . . . . 71.43 110.766 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -80.47 -17.13 52.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.649 0.611 . . . . 75.13 112.649 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 60.4 mtm -74.51 -41.72 60.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.566 -1.642 . . . . 74.11 106.566 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.528 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.53 16.6 29.9 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 116.931 1.532 . . . . 53.33 116.931 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.24 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 72.23 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 74.22 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 72.44 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 72.41 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.35 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.24 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 72.54 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.45 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 75.21 105.121 176.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 72.42 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.409 ' HA ' HG22 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.41 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.24 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt -92.03 92.57 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.31 105.989 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -173.39 128.16 0.43 Allowed 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.586 -2.005 . . . . 73.32 105.586 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.37 135.52 45.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.637 0.653 . . . . 71.51 109.39 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 89.1 p -154.61 158.56 39.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.783 -0.451 . . . . 73.34 109.783 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -82.41 142.1 32.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.111 -0.7 . . . . 71.41 109.111 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -138.34 161.92 35.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.108 -1.071 . . . . 70.35 108.108 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -148.95 142.38 25.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.324 -0.621 . . . . 75.2 109.324 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -124.29 138.67 54.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.551 -0.907 . . . . 71.41 108.551 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.7 m -78.33 163.06 26.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.207 -0.451 . . . . 61.4 109.958 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.5 t -149.01 163.18 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.608 -2.367 . . . . 74.52 104.608 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 7.4 m 51.31 -176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.825 1.65 . . . . 74.42 115.02 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.528 -0.749 . . . . 73.3 111.202 -176.318 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 109.337 -0.616 . . . . 72.32 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -72.64 143.52 48.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.13 109.278 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.35 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.34 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . 0.512 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.22 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 73.3 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.14 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 65.02 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.33 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 73.44 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 75.25 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.21 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 74.53 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.31 109.912 171.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.42 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 65.12 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.53 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 72.24 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 45.21 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 75.23 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.35 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 72.52 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.22 106.333 171.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 72.53 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 72.22 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 74.52 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.512 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 73.31 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 62.12 110.815 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.52 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 71.24 109.972 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.35 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 70.04 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 72.44 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.492 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 71.0 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.541 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.33 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.22 104.872 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 74.13 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 64.14 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.4 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.43 107.534 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 568' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.44 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.03 106.73 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 71.35 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 74.42 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 73.14 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.12 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.43 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 75.43 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 63.41 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.15 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.05 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.1 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.24 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . 0.466 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.24 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 54.12 107.947 -169.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.21 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.23 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 71.24 110.387 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.11 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.45 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 74.0 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.511 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 75.31 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.21 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.32 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.41 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 73.31 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 75.3 105.321 168.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.2 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.11 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 75.03 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 73.42 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.438 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.54 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 74.23 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.54 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.55 143.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.34 105.097 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.99 97.64 3.35 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.667 0.617 . . . . 73.13 112.667 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.67 152.46 28.66 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 106.921 -1.511 . . . . 70.51 106.921 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -93.96 128.8 40.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.972 1.841 . . . . 73.33 115.972 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.0 -63.71 0.21 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.839 0.681 . . . . 74.21 112.839 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 27.66 0.68 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.224 1.194 . . . . 73.21 114.224 -172.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -74.94 155.28 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.356 1.243 . . . . 73.52 114.356 -170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 -153.02 0.44 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 104.216 -2.512 . . . . 74.14 104.216 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.9 103.96 6.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.881 -1.526 . . . . 74.43 106.881 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -89.46 163.42 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.538 -0.541 . . . . 74.51 109.538 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.31 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.2 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 75.42 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 71.14 105.355 177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 73.33 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.2 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.04 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 74.2 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 63.2 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 74.45 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.644 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' MET . . . . . 0.541 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 71.4 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 75.11 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.644 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 164.32 -57.15 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.41 107.777 179.511 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.95 71.84 1.24 Allowed Glycine 0 C--O 1.224 -0.508 0 N-CA-C 107.932 -2.067 . . . . 73.31 107.932 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.22 119.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.99 0.9 . . . . 72.13 110.458 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 30.5 p -168.77 -172.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 102.255 -3.239 . . . . 74.44 102.255 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.14 161.07 36.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 0.455 . . . . 75.12 109.815 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.37 129.17 70.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.034 -1.469 . . . . 74.52 107.034 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.9 t -94.9 -19.03 20.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.833 0.825 . . . . 64.3 110.166 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.2 -30.49 70.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.303 -0.862 . . . . 74.42 112.269 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.69 136.85 34.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.09 -0.707 . . . . 74.51 109.09 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' A' ' 641' ' ' GLU . 56.2 tptt -120.93 135.56 55.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.715 -1.217 . . . . 74.42 107.715 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.77 -179.52 5.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.167 -2.16 . . . . 72.13 105.167 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -67.42 155.89 37.9 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.369 -2.086 . . . . 73.34 105.369 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.53 -25.11 36.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.08 0.77 . . . . 75.41 113.08 -162.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.56 -47.84 62.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.121 0.962 . . . . 62.13 109.302 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.79 -20.87 61.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 65.34 111.293 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' A' ' 635' ' ' LYS . 1.9 mt-10 -59.51 -41.97 91.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.185 -0.302 . . . . 75.25 110.185 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -87.69 -48.73 7.64 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 112.746 0.647 . . . . 74.15 112.746 166.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.48 73.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.084 1.142 . . . . 72.34 114.084 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -67.9 -40.03 83.51 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 109.017 -0.734 . . . . 63.54 109.017 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -47.54 84.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 111.743 0.275 . . . . 73.14 111.743 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.79 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 75.51 109.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.63 84.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.417 -0.356 . . . . 63.03 110.446 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -73.73 -24.73 59.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.173 -0.467 . . . . 71.23 112.106 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.3 mtm -67.54 -41.27 84.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.919 -1.511 . . . . 74.23 106.919 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.56 24.82 57.3 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.42 116.178 167.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 75.4 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 64.03 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 70.43 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.22 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 75.34 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.31 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.44 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.13 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 72.41 107.42 175.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.33 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.413 ' HA ' HG21 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 75.24 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.43 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.4 109.58 23.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 71.01 106.232 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . 0.483 ' HG2' ' H ' ' A' ' 667' ' ' SER . 77.9 tt0 -166.81 149.09 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.258 -1.015 . . . . 71.34 108.258 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -68.57 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.51 0.672 . . . . 74.3 111.266 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' SER . . . . . 0.483 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 33.2 t -85.45 151.57 23.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.202 -0.666 . . . . 72.13 109.202 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.88 161.84 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.462 -0.94 . . . . 75.3 108.462 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.35 146.94 30.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.289 -1.004 . . . . 71.13 108.289 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.58 132.25 34.89 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.977 -1.49 . . . . 74.43 106.977 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -129.4 -3.01 4.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.658 1.725 . . . . 72.3 115.658 -174.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 35.6 t -69.51 129.78 40.64 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.121 -1.437 . . . . 73.1 107.121 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.0 m -139.21 -49.55 0.5 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.714 0.635 . . . . 72.32 112.714 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.6 160.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.657 -1.979 . . . . 74.32 105.657 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.124 -2.917 . . . . 74.32 103.124 177.369 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.216 -0.669 0 N-CA-C 107.837 -1.171 . . . . 74.12 107.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.73 34.08 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 74.34 108.614 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 74.32 108.689 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.31 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 74.34 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.34 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 75.04 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 72.44 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.34 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 73.2 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.2 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.04 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.2 108.687 167.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.34 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.13 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 74.35 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.42 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.23 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.51 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.31 109.231 177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 75.13 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 74.42 105.927 170.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.42 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.01 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.45 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.32 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.24 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.25 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 70.04 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 74.24 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 73.34 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.23 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.45 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.12 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.51 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.22 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.11 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.13 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 62.11 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.45 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 74.5 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 74.02 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 75.41 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.51 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 74.04 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.52 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 75.03 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.12 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.45 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 61.43 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 60.43 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.44 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.35 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.23 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 71.11 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.12 111.527 -170.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.45 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.43 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 75.2 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 74.03 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 71.55 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 75.13 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 72.34 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 72.13 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 74.12 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.532 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.23 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 75.42 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 73.23 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.14 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 73.41 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 73.44 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 75.52 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.21 105.58 178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.33 141.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 75.51 109.521 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.25 133.4 43.59 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.634 0.774 . . . . 74.12 111.006 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.24 172.04 18.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.465 -1.68 . . . . 71.23 106.465 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.12 -29.7 8.81 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.923 0.342 . . . . 73.42 111.923 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -103.74 45.86 0.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.816 0.817 . . . . 75.33 111.472 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -72.43 161.79 30.34 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.424 -0.807 . . . . 73.45 110.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.17 48.01 1.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 122.611 1.196 . . . . 74.03 111.369 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 58.97 -117.65 0.91 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.535 -1.211 . . . . 73.3 112.356 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -83.44 88.95 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.945 -0.761 . . . . 72.22 108.945 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.56 152.99 21.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.44 108.97 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 74.21 109.296 -168.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.44 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 74.1 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.12 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 75.22 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.44 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.21 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.2 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.21 110.694 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.21 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.546 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.45 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.13 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 74.03 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 625' ' ' GLU 0.294 23.5 mmm180 146.15 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.54 104.651 178.962 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.9 72.99 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.472 -1.051 . . . . 61.5 110.472 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.17 136.75 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.109 0.957 . . . . 71.42 113.036 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.2 m -131.76 -72.68 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.089 -2.56 . . . . 75.52 104.089 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -148.85 161.53 41.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.023 -2.214 . . . . 75.14 105.023 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.74 73.18 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.876 1.322 . . . . 73.33 108.204 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 36.0 p -75.87 -9.22 58.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.156 -0.929 . . . . 74.31 112.189 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -80.83 -10.51 59.71 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.248 0.619 . . . . 75.0 112.308 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -77.55 66.3 3.24 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.487 1.291 . . . . 71.11 114.487 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 116.23 13.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.167 -1.42 . . . . 72.24 107.167 173.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 9.3 mt -132.73 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.932 -0.766 . . . . 72.44 108.932 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -69.38 168.22 14.87 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.087 -1.82 . . . . 73.02 106.087 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.0 -46.5 87.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.723 0.773 . . . . 75.14 111.445 -171.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.51 -47.88 82.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.057 -0.974 . . . . 74.35 110.984 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -74.39 -19.79 60.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.929 -1.032 . . . . 74.21 112.189 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -45.17 80.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.053 -0.499 . . . . 73.52 110.012 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.93 -49.27 7.18 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 119.483 -0.887 . . . . 75.03 112.028 167.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.73 90.11 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.931 1.086 . . . . 44.04 113.931 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -74.63 -37.03 62.91 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.811 -0.811 . . . . 73.34 108.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -62.13 -46.76 87.57 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.853 -0.158 . . . . 74.13 111.186 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.48 -43.63 94.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.645 -0.502 . . . . 74.44 109.645 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.21 97.9 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.256 -0.278 . . . . 64.23 110.454 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.19 -22.96 64.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.805 0.442 . . . . 73.55 112.107 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 11.9 mmt -70.42 -41.39 72.98 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.335 -1.357 . . . . 71.44 107.335 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 59.06 9.87 8.24 Favored Glycine 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.13 116.465 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 71.2 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.15 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 74.32 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.54 111.853 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 63.51 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.03 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.32 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 72.52 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.43 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 74.23 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 71.15 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.428 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 65.33 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 73.13 103.979 176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt -93.67 100.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.14 106.225 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -167.86 133.32 1.92 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.851 -1.537 . . . . 75.23 106.851 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 83.74 2.92 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.043 0.925 . . . . 75.43 110.208 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 85.6 p -162.45 158.32 23.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.76 -2.311 . . . . 53.21 104.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -145.79 132.17 19.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.99 0.424 . . . . 73.13 110.572 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 162.19 41.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 104.999 -2.223 . . . . 71.43 104.999 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -136.76 -12.75 1.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.296 0.85 . . . . 74.51 113.296 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.9 mptt 56.82 18.98 4.12 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.843 1.423 . . . . 75.45 114.843 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.98 125.54 26.96 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.016 -0.428 . . . . 74.3 110.34 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 -18.89 47.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.435 -0.348 . . . . 71.3 111.566 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 16.8 t 73.78 154.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.995 1.434 . . . . 61.12 107.693 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.504 1.122 . . . . 65.45 110.693 -174.157 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 106.854 -1.536 . . . . 73.52 106.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.72 28.67 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.746 -0.835 . . . . 73.44 108.746 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.11 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.53 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . 0.55 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 71.3 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.33 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.43 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.01 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 75.13 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 71.33 110.311 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 75.41 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.44 106.63 165.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.15 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 71.52 110.016 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.22 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 74.25 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.41 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 71.35 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.44 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.2 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 73.33 105.642 169.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 73.31 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.55 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 75.42 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.55 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 74.43 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.23 112.045 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.21 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 73.43 109.801 173.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 74.1 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.43 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 63.33 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.496 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 72.33 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.15 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.41 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.42 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 71.1 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.23 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.43 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.14 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 74.52 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.12 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.41 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.15 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 50.43 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.456 ' HZ2' ' CD ' ' A' ' 578' ' ' GLU . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.13 106.718 172.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 72.43 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.23 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.2 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 574' ' ' LYS . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.43 114.655 -171.419 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.34 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 75.23 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 75.12 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 74.11 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 73.05 110.561 -172.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.43 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.42 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 75.41 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.4 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 72.23 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 74.15 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 74.34 106.876 176.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.43 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 75.13 118.855 176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.2 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 74.21 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.14 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 71.3 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 73.33 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.14 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.11 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.34 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.3 106.67 178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t -83.9 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.11 108.188 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -123.0 -175.61 3.21 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.511 0.93 . . . . 74.03 113.511 -169.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 71.17 -35.65 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 117.499 2.407 . . . . 75.04 117.499 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.69 163.57 25.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.411 1.005 . . . . 74.14 112.251 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -121.96 144.12 49.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.708 -0.849 . . . . 71.54 108.708 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -105.17 -51.57 3.0 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.294 0.497 . . . . 74.43 110.424 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.5 6.24 5.71 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.86 0.838 . . . . 75.54 109.27 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 64.89 -65.0 0.15 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.135 1.902 . . . . 74.22 116.135 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -93.1 72.86 4.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 106.213 -1.773 . . . . 71.52 106.213 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.39 148.57 23.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.728 -1.123 . . . . 71.33 108.025 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.31 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 71.25 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.55 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 70.43 106.554 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.4 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 74.42 107.462 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.4 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.41 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 64.11 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.42 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 74.12 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 75.13 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.522 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 75.41 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 161.94 -58.34 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 75.02 107.604 177.598 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.16 69.06 1.41 Allowed Glycine 0 C--O 1.225 -0.417 0 N-CA-C 110.069 -1.213 . . . . 75.22 110.069 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.82 127.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.254 0.55 . . . . 71.22 110.537 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 12.7 t -160.1 168.51 25.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.755 -2.313 . . . . 74.12 104.755 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.92 150.02 40.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.389 -1.337 . . . . 74.12 107.389 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.99 134.64 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.204 -1.036 . . . . 75.5 108.204 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 60.3 p -85.31 -10.55 56.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.871 1.804 . . . . 64.24 115.871 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.31 -8.52 58.99 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.553 -0.717 . . . . 71.23 110.003 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -81.82 60.74 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.05 0.929 . . . . 75.52 111.399 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.54 135.43 56.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.178 -1.374 . . . . 74.44 108.834 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 78.7 mt -136.66 -176.8 4.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 104.319 -2.474 . . . . 73.2 104.319 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -66.25 148.04 52.43 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 102.943 -2.984 . . . . 65.23 102.943 167.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -64.17 -24.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.503 0.557 . . . . 62.14 112.503 -160.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.72 -45.94 77.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.701 0.763 . . . . 75.3 109.778 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.01 -25.02 58.5 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.379 -0.828 . . . . 65.04 111.608 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.24 -39.6 83.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 121.121 -0.232 . . . . 75.13 110.681 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.3 -49.22 7.4 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 119.66 -0.816 . . . . 71.21 111.375 168.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.42 81.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.014 1.116 . . . . 71.12 114.014 -168.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -67.13 -40.2 86.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.565 -0.902 . . . . 75.32 108.565 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -63.87 -50.03 70.41 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.427 0.529 . . . . 75.32 112.427 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.7 -41.49 85.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.739 -0.467 . . . . 74.45 109.739 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.77 99.21 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.86 -0.422 . . . . 74.0 109.86 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -72.49 -20.4 61.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.161 0.8 . . . . 74.55 113.161 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 37.3 mtt -69.47 -41.42 76.21 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.673 -1.603 . . . . 75.41 106.673 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.503 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.41 16.3 27.72 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 72.45 115.754 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.23 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.14 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.22 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 74.24 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 72.1 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 75.43 114.647 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.22 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.31 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.32 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.12 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 75.01 108.669 -171.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.14 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.68 110.28 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 73.15 106.305 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 666' ' ' GLU . 13.7 tt0 -169.87 -159.72 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.529 -1.286 . . . . 75.14 107.529 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . 0.484 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 40.3 tt0 -60.61 136.11 57.96 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.835 -0.54 . . . . 72.25 110.161 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 12.9 t -158.15 160.13 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.235 -1.395 . . . . 74.51 107.235 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -153.12 147.45 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.198 -1.038 . . . . 74.33 108.198 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -77.65 164.26 25.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.739 0.78 . . . . 63.51 112.322 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.08 152.66 40.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.512 -0.921 . . . . 74.11 108.512 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -80.34 124.02 28.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.33 -0.989 . . . . 70.25 108.33 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 43.7 t -64.15 150.03 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.646 -1.983 . . . . 55.45 105.646 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 7.3 m -52.02 -54.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.076 1.139 . . . . 75.01 114.076 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 47.7 t 66.02 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 124.575 1.172 . . . . 70.12 110.648 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.332 -0.842 . . . . 74.31 111.082 -178.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 102.697 -3.075 . . . . 73.22 102.697 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -90.95 163.51 14.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 73.4 107.462 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 75.24 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 73.32 105.863 174.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.14 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.23 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 65.0 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 73.03 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.13 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.45 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.32 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.412 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 72.54 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 73.21 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 70.24 108.609 172.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.42 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.413 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.14 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 73.33 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 73.21 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 75.25 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.15 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.459 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.33 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.32 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.31 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 74.23 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.33 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 74.13 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.52 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.406 ' C ' ' H ' ' A' ' 557' ' ' GLY . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.12 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.13 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.33 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.15 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.13 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.14 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.44 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.54 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.55 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.42 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.14 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.1 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 74.21 108.367 172.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 75.42 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 72.51 104.403 -170.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.461 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.13 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.1 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 72.02 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 71.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.21 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 72.35 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 64.15 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.13 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.13 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 72.11 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.32 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 74.33 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.34 111.137 -173.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.4 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 74.51 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.4 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 75.31 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.01 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 74.13 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.05 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 64.01 116.216 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.32 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.473 ' C ' ' H ' ' A' ' 595' ' ' VAL . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.43 119.125 170.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.32 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.473 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 75.22 105.686 170.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 74.54 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 72.01 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 64.54 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.02 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.459 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.43 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 74.44 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.01 143.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.13 108.811 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.51 147.26 26.09 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.593 1.331 . . . . 74.24 114.593 -174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.99 146.4 40.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.1 -1.074 . . . . 73.44 108.1 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.76 107.31 13.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.072 -0.392 . . . . 74.42 110.24 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 608' ' ' TYR . 1.5 tm-20 -157.16 -169.95 3.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.011 -1.107 . . . . 75.43 108.011 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . 0.481 ' H ' ' CD ' ' A' ' 607' ' ' GLU . 53.1 m-85 -129.85 -37.46 1.53 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.983 1.846 . . . . 75.24 115.983 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -126.32 33.35 5.03 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.522 0.934 . . . . 72.13 113.522 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -79.24 81.49 5.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.32 1.6 . . . . 74.55 115.32 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.42 73.88 10.44 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 106.945 -1.502 . . . . 72.11 106.945 167.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.53 161.86 15.98 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.064 -0.717 . . . . 71.24 109.064 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 73.14 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.15 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.44 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.3 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.33 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.4 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.32 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.45 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.54 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.15 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.621 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.53 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 75.32 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.493 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 73.41 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.621 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 168.16 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.1 109.744 178.299 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.89 52.76 3.97 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 110.981 -0.848 . . . . 63.25 110.981 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.52 128.62 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.466 0.65 . . . . 71.12 110.193 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 32.7 t -160.87 168.8 23.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 103.669 -2.715 . . . . 71.31 103.669 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.06 141.9 52.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.968 -1.493 . . . . 62.31 106.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.35 122.15 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.58 0.705 . . . . 75.31 110.91 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 45.9 p -81.9 171.21 14.72 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 75.4 108.966 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 58.12 25.5 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.245 1.572 . . . . 75.34 115.245 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -77.19 124.05 27.28 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 106.662 -1.607 . . . . 71.2 106.662 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -128.15 95.16 4.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.867 -1.16 . . . . 74.03 107.867 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.53 173.57 11.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.342 -1.355 . . . . 70.51 107.342 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.0 t -66.95 153.28 43.96 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 104.95 -2.241 . . . . 74.31 104.95 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.2 m -65.36 -26.0 38.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 112.873 0.694 . . . . 73.33 112.873 -161.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.6 -45.31 75.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.196 0.998 . . . . 73.22 109.457 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.96 -21.52 56.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.045 -0.979 . . . . 63.04 111.486 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.96 -41.31 82.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.496 -0.482 . . . . 75.51 109.86 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -87.95 -50.38 6.46 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 119.878 -0.729 . . . . 73.43 111.568 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.31 94.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.882 1.067 . . . . 75.13 113.882 -168.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -71.89 -42.2 67.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.801 -0.814 . . . . 73.14 108.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -59.16 -48.57 81.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.74 -0.664 . . . . 75.22 111.778 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.6 mt -62.57 -41.01 90.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.943 0.401 . . . . 75.55 110.233 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.04 79.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.937 0.399 . . . . 74.51 110.469 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.86 -22.05 59.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.045 0.387 . . . . 73.22 112.045 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.5 mtm -74.44 -41.29 61.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.724 -1.584 . . . . 63.42 106.724 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.469 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.28 21.23 46.92 Favored Glycine 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 74.35 115.721 169.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.05 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 72.51 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 71.43 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 70.01 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 64.4 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.45 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 74.13 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 73.45 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.24 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 74.12 107.56 174.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.35 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG21 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.34 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.35 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt -91.15 110.38 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.41 105.626 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -173.81 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.665 -1.152 . . . . 72.54 109.898 -170.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.72 91.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.496 -1.229 . . . . 75.43 112.323 -169.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 36.5 m -77.58 80.51 4.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.37 -0.832 . . . . 74.54 110.475 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -58.95 142.76 50.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.799 -0.815 . . . . 70.32 108.799 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.29 38.54 26.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.388 0.675 . . . . 71.53 112.521 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.78 -40.57 66.39 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.854 1.057 . . . . 74.44 113.854 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 73.9 mttt 51.03 24.51 1.9 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.899 2.185 . . . . 73.03 116.899 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 69.5 m -81.86 145.18 30.51 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.905 -0.776 . . . . 61.42 108.905 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.3 t -149.6 173.07 14.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.992 -1.484 . . . . 72.1 106.992 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -5.68 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.293 0.37 . . . . 73.42 110.442 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.246 0.891 0 N-CA-C 105.306 -2.109 . . . . 64.44 105.306 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 109.752 -0.462 . . . . 73.11 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -102.94 153.38 20.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.726 -1.213 . . . . 61.13 107.726 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.12 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.15 107.271 173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 74.15 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 73.13 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 75.42 108.081 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.3 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 63.32 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.34 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 75.11 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.34 109.515 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.12 107.418 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.01 108.533 170.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 63.14 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 72.01 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.15 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.11 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 62.45 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.13 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.467 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.13 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.24 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.44 106.245 171.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 75.12 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 74.11 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 74.15 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.413 ' HE ' ' C ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.01 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 75.55 110.246 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.32 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 64.54 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 75.44 109.647 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 73.4 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 51.22 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.35 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 73.12 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 75.24 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.44 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.44 115.129 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 71.2 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.447 ' C ' ' HD3' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.01 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.04 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 73.33 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.2 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.4 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 75.44 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 73.51 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.31 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 75.23 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.1 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 72.45 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 74.44 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 74.43 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.4 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 70.54 109.32 -172.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.44 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.04 109.044 175.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 75.42 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.42 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.12 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 63.34 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 72.24 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.5 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 55.44 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 595' ' ' VAL . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.31 117.072 169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 64.22 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.22 104.547 168.752 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 74.42 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.4 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 74.13 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.01 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.467 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.12 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.02 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 73.32 104.98 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.37 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.35 110.666 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -72.86 135.01 45.09 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.6 -0.889 . . . . 74.04 108.6 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.19 160.65 38.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.377 0.271 . . . . 63.32 110.516 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.98 -13.03 29.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.697 0.258 . . . . 75.31 111.697 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.46 159.55 35.06 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.904 0.705 . . . . 71.33 112.904 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -105.85 -9.91 16.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.641 -0.709 . . . . 74.33 109.864 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 51.64 -98.57 0.07 Allowed 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.223 1.009 . . . . 63.41 113.388 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 30.16 1.71 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.909 1.232 . . . . 75.21 112.553 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 64.69 104.25 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.535 1.534 . . . . 74.21 109.962 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.8 152.07 21.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.674 -1.148 . . . . 71.42 111.913 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.54 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 75.21 105.661 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.43 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.23 106.758 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.14 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.42 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 74.23 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.32 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.645 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.33 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 71.32 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.547 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.44 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.645 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 166.81 -56.07 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 75.14 107.814 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.0 70.9 1.31 Allowed Glycine 0 C--O 1.224 -0.527 0 N-CA-C 110.237 -1.145 . . . . 55.54 110.237 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.03 120.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.15 -0.685 . . . . 75.44 109.15 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.8 m -148.66 169.36 20.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.761 -1.57 . . . . 74.35 106.761 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.4 146.74 52.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.008 -0.738 . . . . 73.11 109.008 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.61 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.936 -0.575 . . . . 71.34 112.029 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.58 -163.23 0.15 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.199 0.6 . . . . 75.24 110.223 -176.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -72.03 108.09 5.08 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.687 -0.633 . . . . 75.4 111.829 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.68 133.86 46.45 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 103.021 -2.955 . . . . 74.43 103.021 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 105.7 14.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.063 -1.055 . . . . 73.2 109.993 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.94 165.5 24.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.826 -1.079 . . . . 74.3 110.051 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.2 t -79.94 170.56 16.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.354 -1.721 . . . . 72.13 106.354 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.28 -44.71 92.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.939 0.876 . . . . 73.41 111.21 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.7 -44.58 93.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.008 -0.996 . . . . 72.33 110.999 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.82 -19.74 58.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.884 -1.053 . . . . 73.53 112.071 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.39 -44.87 84.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.506 -0.553 . . . . 74.13 109.506 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.75 -44.01 11.46 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 120.208 -0.597 . . . . 72.34 112.335 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.75 93.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.801 0.728 . . . . 65.14 112.514 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -70.36 -46.1 64.78 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.434 -0.95 . . . . 74.04 108.434 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -55.14 -46.87 75.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 75.35 112.724 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.3 mt -62.19 -41.55 91.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.944 -0.391 . . . . 71.34 109.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.31 77.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.411 0.624 . . . . 70.11 111.4 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -69.92 -24.25 63.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.123 -0.49 . . . . 74.41 110.321 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -83.13 -41.49 18.46 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 118.81 -1.156 . . . . 72.11 109.51 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.644 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 57.88 12.98 12.0 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.3 115.981 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.1 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 75.23 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 55.04 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 74.31 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 74.01 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 65.35 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.24 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 74.13 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 74.41 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.32 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 75.04 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 75.11 109.082 -171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 74.43 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.83 117.86 37.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 72.12 105.535 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -142.48 170.51 15.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.167 0.587 . . . . 73.34 110.72 -169.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -58.34 -23.31 56.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.818 0.847 . . . . 73.42 112.612 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 33.0 t -132.41 140.76 48.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.451 0.643 . . . . 74.14 111.144 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -98.33 161.87 13.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 74.11 109.896 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -109.76 137.48 47.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.342 -0.844 . . . . 74.01 108.731 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -133.78 96.35 3.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 75.33 109.318 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -82.89 110.35 17.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.936 -0.575 . . . . 71.11 110.425 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 60.7 p -99.2 160.5 14.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.459 -0.941 . . . . 73.13 108.459 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.8 t -153.71 165.99 34.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.936 -1.505 . . . . 65.13 106.936 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.32 167.25 26.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.589 -2.004 . . . . 75.12 105.589 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.252 1.222 0 O-C-N 123.765 0.666 . . . . 75.5 109.403 176.412 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 107.711 -1.218 . . . . 63.32 107.711 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -63.53 153.92 34.15 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.077 0.861 . . . . 70.11 110.914 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.21 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.411 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 75.24 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 73.15 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.23 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 74.43 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.23 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.11 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.23 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.21 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 73.02 109.454 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.15 108.212 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 73.25 108.206 170.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.21 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.01 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.21 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 64.51 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.23 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.11 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.451 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.41 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 71.22 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.11 105.45 172.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 72.54 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.34 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 70.12 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.22 110.287 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.411 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 75.45 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.42 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 74.33 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.12 111.919 -175.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.35 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.41 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.45 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.568 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 74.23 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 73.45 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 74.33 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.11 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.4 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 75.51 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.35 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 71.31 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 72.13 111.306 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.14 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 71.3 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.24 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.43 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.23 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.52 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.02 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 73.41 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.42 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.53 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.3 109.296 -171.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.13 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 73.2 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 72.53 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.24 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 70.42 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.555 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.22 115.669 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.31 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.555 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 74.52 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.53 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 74.32 104.122 170.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.41 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 75.14 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 70.14 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 64.3 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.451 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 74.1 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 75.24 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.55 106.175 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -85.93 143.62 11.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 64.4 109.61 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.41 136.01 54.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.728 -1.124 . . . . 73.33 113.458 -170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.62 142.6 37.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.36 0.664 . . . . 74.21 112.492 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -126.67 -53.65 1.44 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 110.301 -0.259 . . . . 74.03 110.301 170.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.31 163.86 35.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.314 0.246 . . . . 75.14 110.758 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 74.99 170.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.447 1.899 . . . . 74.42 114.974 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.04 -177.03 0.09 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.692 1.197 . . . . 74.23 112.782 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.85 -61.83 0.08 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.472 2.027 . . . . 62.21 116.472 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -127.31 77.17 1.72 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.917 -1.512 . . . . 74.02 106.917 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -89.55 152.71 21.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.381 -0.827 . . . . 73.44 109.177 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.43 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 74.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.13 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.01 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 75.32 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.03 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.11 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 72.01 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.524 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.55 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' MET . . . . . 0.568 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 74.31 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.456 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.42 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.524 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 78.18 -53.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 73.14 116.25 169.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.79 67.27 1.97 Allowed Glycine 0 C--O 1.227 -0.308 0 N-CA-C 109.311 -1.515 . . . . 65.15 109.311 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.2 tt -47.6 121.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.613 0.721 . . . . 73.24 111.198 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.2 m -143.53 173.39 11.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.722 -1.214 . . . . 72.51 107.722 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -175.82 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.721 0.296 . . . . 74.44 110.523 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.32 39.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.438 0.903 . . . . 73.45 113.438 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -21.1 61.68 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.058 0.762 . . . . 72.55 113.058 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.69 -21.81 25.01 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.832 0.678 . . . . 70.32 112.832 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 56.9 mmt-85 -81.18 130.29 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.309 -0.997 . . . . 61.13 108.309 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -116.39 118.1 31.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.85 -1.537 . . . . 73.33 106.85 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.88 175.76 9.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.528 -0.76 . . . . 73.11 109.693 -167.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.8 t -79.53 168.23 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.81 -1.922 . . . . 74.15 105.81 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.14 -43.42 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.061 0.934 . . . . 75.23 111.665 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.37 -44.22 97.54 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.178 -0.919 . . . . 72.14 110.852 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.22 -21.08 54.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.387 -0.824 . . . . 74.33 111.302 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.43 -42.27 82.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.632 -0.506 . . . . 72.54 109.632 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -87.81 -46.85 9.08 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 119.676 -0.809 . . . . 73.34 112.144 167.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.5 95.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.327 0.862 . . . . 65.21 113.327 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -73.37 -41.65 63.14 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.854 -0.795 . . . . 73.32 108.854 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -59.21 -49.31 78.35 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.207 0.447 . . . . 75.5 112.207 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -61.47 -42.3 93.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.067 0.461 . . . . 75.43 109.855 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.46 -35.87 82.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.76 0.314 . . . . 75.21 111.007 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.86 -28.37 64.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 74.23 110.747 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.78 -41.6 74.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.65 -1.241 . . . . 62.2 107.65 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.52 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.25 5.8 2.66 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 44.14 116.67 168.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.43 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.52 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 74.25 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.01 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.52 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . 0.413 ' C ' ' H ' ' A' ' 659' ' ' LYS . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.34 114.659 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 64.14 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 657' ' ' HIS . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.22 109.522 -176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.4 108.612 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.14 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.33 109.023 -171.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 73.14 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt -89.32 103.57 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.2 106.593 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -174.6 -32.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.742 -1.117 . . . . 73.4 111.722 -173.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 69.97 -49.51 0.63 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.604 1.562 . . . . 74.04 114.361 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 16.9 t -34.15 107.43 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.322 1.971 . . . . 74.35 116.322 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -91.68 63.33 4.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.982 -1.008 . . . . 73.34 112.709 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -81.82 -0.09 41.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.423 -0.798 . . . . 71.52 112.817 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.41 59.94 3.65 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.955 -1.128 . . . . 72.52 107.955 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.54 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 115.325 1.602 . . . . 74.03 115.325 -169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 81.6 p -162.32 169.29 20.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.949 0.404 . . . . 64.33 111.232 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.2 m -138.17 142.77 40.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.072 -2.936 . . . . 72.31 103.072 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 -37.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.577 0.703 . . . . 64.15 110.309 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 101.094 -3.669 . . . . 75.14 101.094 178.525 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 110.277 -0.268 . . . . 73.14 110.277 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -76.65 142.88 40.45 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.13 108.549 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.32 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 71.11 108.883 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 74.22 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.3 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . 0.422 ' CZ ' HG13 ' A' ' 550' ' ' VAL . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.31 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.1 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 75.01 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.14 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.45 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 70.14 107.598 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.42 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 74.44 106.732 169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 74.15 102.109 175.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.44 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 53.44 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.14 110.18 176.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.35 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 74.2 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.44 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.12 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.422 HG13 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 74.14 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 75.14 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 73.24 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.34 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.03 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.15 110.318 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.43 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.31 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 75.4 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.43 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 63.3 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 74.03 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 75.44 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 73.13 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 75.24 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 72.43 107.587 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.54 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.22 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.35 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 71.24 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 73.21 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.11 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.24 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.418 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.44 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.34 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.14 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.24 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . 0.418 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.44 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.21 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.54 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 73.54 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 73.32 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 64.15 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 74.23 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.42 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.14 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.24 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.41 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.34 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.588 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.51 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.4 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.564 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 72.0 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.588 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.41 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.564 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.04 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.3 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.13 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 74.32 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 71.21 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.478 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 74.53 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 73.12 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.51 105.581 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.65 143.67 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.35 110.014 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.53 136.17 44.83 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.944 0.498 . . . . 73.04 112.332 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -152.93 39.55 0.53 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.848 0.832 . . . . 74.15 110.935 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 59.92 8.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.506 2.78 . . . . 65.42 118.506 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -85.72 177.17 7.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.847 0.749 . . . . 74.01 109.879 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.61 -30.22 1.89 Allowed 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 114.588 1.329 . . . . 75.14 114.588 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 36.52 -107.28 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.407 1.262 . . . . 74.1 114.407 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.52 -177.38 5.22 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 105.353 -2.092 . . . . 74.12 105.353 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 43.4 tt0 -57.2 120.82 8.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.024 -0.732 . . . . 74.35 109.024 172.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.21 163.31 15.84 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.589 -2.374 . . . . 75.3 104.589 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.02 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . 0.46 ' CE1' HG22 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.4 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.32 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 74.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.51 109.277 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.2 108.005 173.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 73.13 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.44 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.55 110.46 176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.44 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.64 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.21 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 63.44 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 71.34 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.64 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 162.08 -46.09 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 72.24 106.272 -179.301 . . . . . . . . 4 3 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.09 37.67 73.0 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.97 -1.652 . . . . 75.21 108.97 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.78 143.05 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 114.318 1.229 . . . . 74.3 114.318 -169.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.1 t -148.91 160.43 43.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 102.663 -3.088 . . . . 60.45 102.663 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -63.19 134.19 55.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.735 -1.579 . . . . 73.51 106.735 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.53 121.75 26.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.703 0.764 . . . . 73.11 110.043 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 18.8 p -86.84 -18.85 29.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.776 -0.647 . . . . 73.22 111.836 -176.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.36 -5.49 14.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.641 1.348 . . . . 64.51 114.641 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -79.81 59.29 3.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.067 0.46 . . . . 73.24 111.8 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -72.58 124.87 26.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.162 -1.051 . . . . 74.23 108.162 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 48.1 mt -141.84 -172.29 3.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 105.895 -1.891 . . . . 73.02 105.895 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.2 t -67.21 155.93 37.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.196 -2.149 . . . . 65.13 105.196 168.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 17.0 m -65.44 -23.13 32.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.713 1.005 . . . . 62.41 113.713 -161.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.92 -48.83 22.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.328 1.061 . . . . 71.42 109.173 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.84 -22.5 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.227 -1.351 . . . . 71.13 111.537 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -52.07 61.45 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.684 -0.487 . . . . 73.2 109.684 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.66 -44.87 10.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.818 -1.153 . . . . 71.32 111.196 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.36 93.97 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.509 0.929 . . . . 72.23 113.509 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -80.34 -38.9 29.61 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.197 -0.601 . . . . 71.31 109.738 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 -59.32 -51.1 71.39 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 119.047 -0.501 . . . . 74.43 110.781 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.1 -44.7 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.346 0.521 . . . . 75.33 111.039 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.88 78.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 74.31 110.912 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -76.07 -26.39 56.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.388 0.514 . . . . 75.31 112.388 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -67.48 -41.71 84.14 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.505 -1.665 . . . . 75.44 106.505 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.74 13.76 19.48 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.42 116.986 166.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.32 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.23 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 72.31 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.684 173.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.13 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.11 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 74.1 112.739 173.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 74.42 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 74.01 108.117 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 72.11 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.46 HG22 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.54 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.15 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt -88.49 118.55 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.57 -93.9 0.03 OUTLIER 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.129 -1.851 . . . . 63.31 115.443 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -27.2 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.098 1.518 . . . . 74.34 115.098 -163.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 2.2 p -71.88 4.71 3.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.381 -1.281 . . . . 72.41 114.096 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.57 117.55 18.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.259 0.552 . . . . 74.13 109.8 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.82 166.09 32.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.913 -1.884 . . . . 64.04 105.913 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.57 34.6 2.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.485 0.659 . . . . 73.11 110.385 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -59.17 -48.01 83.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.599 -0.728 . . . . 74.13 112.351 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 67.7 m -110.3 132.03 54.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.502 0.667 . . . . 72.24 112.748 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 20.6 p -133.45 -47.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.025 -2.213 . . . . 73.52 105.025 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.36 160.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 100.532 -3.877 . . . . 74.13 100.532 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.259 1.597 0 N-CA-C 102.905 -2.998 . . . . 65.11 102.905 178.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--O 1.219 -0.514 0 N-CA-C 107.795 -1.187 . . . . 74.13 107.795 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -68.88 153.1 44.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.374 0.533 . . . . 63.42 110.615 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 64.31 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.413 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.2 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 74.4 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.31 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.53 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 73.22 112.616 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.54 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 72.1 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.31 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.32 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 73.42 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.43 108.542 170.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.32 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.406 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.13 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 73.43 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.34 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 74.21 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.05 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.401 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 75.11 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.21 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.13 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.24 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.52 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.54 109.064 -176.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.15 109.582 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 74.04 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.33 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.2 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 62.11 112.943 -174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 74.01 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.02 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 73.33 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.49 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.52 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 75.13 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.23 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 75.02 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 75.13 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.21 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.12 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.3 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.12 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.13 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.42 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.14 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 75.14 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 64.23 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.45 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.13 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.1 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.33 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 63.01 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.31 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.21 112.145 -171.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.33 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.51 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 74.43 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 73.41 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.01 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.23 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.42 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 74.24 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' A' ' 594' ' ' THR . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.05 111.469 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.44 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.1 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.405 ' H ' ' C ' ' A' ' 592' ' ' ASP . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.02 114.026 -168.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 74.13 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 75.12 107.48 -176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.23 111.323 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.33 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 73.0 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.401 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.53 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 73.33 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 75.3 106.865 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.02 143.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 71.03 109.596 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -127.42 149.42 50.1 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.239 0.829 . . . . 74.31 113.239 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 58.26 -5.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 119.319 3.081 . . . . 73.13 119.319 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.17 -33.67 73.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.616 0.644 . . . . 65.52 111.588 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -147.47 165.82 29.12 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.035 -0.728 . . . . 74.24 109.035 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.63 71.46 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.347 0.594 . . . . 75.31 112.566 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 610' ' ' ARG . 1.7 tm-20 -82.74 -179.42 7.43 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.96 -0.564 . . . . 72.21 110.546 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . 0.422 ' H ' ' CD ' ' A' ' 609' ' ' GLU . 16.9 mtm180 -93.05 -40.94 10.24 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.067 0.547 . . . . 75.1 110.764 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -158.61 126.47 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.94 -0.763 . . . . 65.32 108.94 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -104.98 146.75 28.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.073 -1.825 . . . . 72.32 106.073 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 72.05 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.34 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.22 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 73.12 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 64.12 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 75.33 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.41 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.43 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.3 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.635 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.2 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' MET . . . . . 0.49 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 72.11 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.44 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.635 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 162.79 -50.11 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.4 107.591 178.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 75.67 62.71 2.62 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 108.851 -1.699 . . . . 73.42 108.851 -173.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.98 119.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.925 0.869 . . . . 71.44 110.881 -175.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 46.1 m -146.51 154.88 42.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 103.912 -2.625 . . . . 74.14 103.912 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -84.86 77.12 10.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.316 0.507 . . . . 74.54 111.457 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 73.0 t 62.05 120.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 117.196 2.295 . . . . 75.53 117.196 173.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 16.1 p -89.34 -49.56 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.275 -1.009 . . . . 72.34 108.275 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.88 114.45 3.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.044 -0.724 . . . . 74.42 109.044 173.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -147.54 80.12 1.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.607 -0.886 . . . . 73.41 108.607 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.84 117.56 14.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.974 -1.491 . . . . 74.33 106.974 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 34.8 mt -138.13 177.86 7.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.76 0.424 . . . . 74.44 110.477 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.3 t -79.44 171.34 15.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.845 -1.539 . . . . 71.4 106.845 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.56 -45.11 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.822 0.82 . . . . 74.44 111.635 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.87 -42.08 98.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.244 1.021 . . . . 63.21 110.869 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -76.67 -19.17 58.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.952 -1.022 . . . . 74.43 111.246 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.2 -40.94 78.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 119.105 -0.474 . . . . 71.33 110.01 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.25 -47.73 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.915 -0.714 . . . . 73.2 112.137 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.4 83.11 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.372 0.879 . . . . 74.22 113.372 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.24 -38.08 36.45 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 109.197 -0.668 . . . . 74.03 109.197 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -58.73 -46.15 88.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.579 0.228 . . . . 74.12 111.281 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.6 mt -63.63 -41.98 94.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.5 0.667 . . . . 74.33 109.495 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.36 75.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.214 -0.448 . . . . 75.35 111.176 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.1 -27.77 64.86 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.223 0.209 . . . . 74.32 110.858 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.3 mtt -69.73 -41.69 74.96 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.234 -1.395 . . . . 73.12 107.234 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.4 20.0 42.96 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.313 -0.858 . . . . 51.11 115.028 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.23 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 63.5 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.13 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.43 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.42 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.22 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.13 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.34 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.44 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.45 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.22 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.31 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.21 92.73 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.44 106.191 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -165.69 90.18 0.46 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.662 -1.154 . . . . 73.22 108.235 -175.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.89 -126.28 2.19 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.721 -0.672 . . . . 72.34 111.596 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.6 p -136.88 27.99 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.681 -1.229 . . . . 65.23 107.681 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.41 58.2 0.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.458 1.281 . . . . 74.34 114.458 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -102.23 140.42 36.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.869 -0.519 . . . . 75.51 110.278 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.02 4.67 0.56 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.769 1.766 . . . . 75.5 115.769 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -83.36 43.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.316 -0.865 . . . . 71.13 111.5 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 16.4 m -78.11 152.3 32.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.218 -0.301 . . . . 73.43 111.742 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -149.66 162.73 39.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.341 -1.355 . . . . 72.34 107.341 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.04 160.19 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 105.453 -2.055 . . . . 62.44 105.453 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.77 -0.633 . . . . 74.14 109.715 176.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 N-CA-C 108.11 -1.071 . . . . 73.13 108.11 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.19 145.5 21.22 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 74.3 109.329 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.41 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.407 ' H ' HG21 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 75.22 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 75.13 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 74.04 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.4 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.33 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 75.32 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.23 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 73.53 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.407 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.44 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.14 109.625 166.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 65.22 105.16 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 74.11 107.522 168.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.54 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 75.12 110.205 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 52.13 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.33 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.447 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 71.44 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.54 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.32 106.481 172.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.24 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 75.34 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.4 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.406 HH11 ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.11 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.407 HG21 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 71.24 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.33 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 555' ' ' THR . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.34 113.183 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . 0.406 ' HB3' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 63.33 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 75.05 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.13 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.456 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.24 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.34 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 72.54 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 64.53 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 71.3 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 71.22 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.41 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.43 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.31 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.54 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 74.33 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.43 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 51.44 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 72.32 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.01 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.21 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.43 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.3 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.33 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.45 110.59 -172.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.35 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 72.44 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.54 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.42 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.34 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.24 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.54 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 75.55 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 74.12 114.692 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.24 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 75.22 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.401 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 73.24 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.54 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . 0.418 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.32 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 597' ' ' THR . . . . . 0.418 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 72.34 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 74.2 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 72.22 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.447 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 70.23 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.43 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.34 107.627 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.6 143.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 75.12 109.28 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.31 143.71 48.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.151 0.98 . . . . 73.42 112.219 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.3 129.71 37.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.489 0.662 . . . . 73.55 112.315 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.1 64.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.3 0.571 . . . . 64.14 111.878 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -139.47 135.2 33.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.262 -2.125 . . . . 72.21 105.262 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -66.82 164.05 18.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 116.098 1.888 . . . . 74.52 116.098 -170.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.72 37.74 15.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 72.04 111.337 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.18 104.77 16.76 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.332 0.587 . . . . 75.3 111.783 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -77.15 90.28 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.059 -0.719 . . . . 74.34 109.059 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.35 152.61 21.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.396 -1.335 . . . . 73.53 107.396 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.21 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.52 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 73.25 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 74.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 74.43 108.632 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 74.0 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.22 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 74.34 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 71.55 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.55 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.444 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 75.44 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.4 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.456 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 72.34 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.444 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 77.89 -52.25 0.51 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.54 114.711 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.02 60.42 6.06 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 109.945 -1.262 . . . . 73.03 109.945 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -35.33 -49.55 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 115.901 1.815 . . . . 72.53 115.901 -175.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 7.5 t 52.75 -137.14 1.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.518 0.327 . . . . 74.33 110.697 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.98 140.23 52.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.644 -1.613 . . . . 74.4 106.644 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.45 84.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.362 -0.977 . . . . 71.11 108.362 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 85.2 m -116.53 -38.31 3.54 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.461 1.282 . . . . 74.13 114.461 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -2.12 11.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.552 1.315 . . . . 61.42 114.552 -176.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -81.97 79.11 8.58 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.912 -0.492 . . . . 74.53 111.895 -174.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -69.17 126.06 28.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.722 -1.214 . . . . 73.32 107.722 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.5 mt -136.82 -174.62 3.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.381 -2.452 . . . . 74.42 104.381 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.0 t -66.7 155.15 38.8 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 104.988 -2.227 . . . . 60.02 104.988 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.3 m -65.75 -23.22 32.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.311 0.856 . . . . 72.34 113.311 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -72.32 -49.6 33.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.02 0.914 . . . . 73.42 109.082 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -70.42 -21.3 62.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.691 -1.141 . . . . 65.5 111.86 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.21 -46.86 79.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 119.275 -0.393 . . . . 74.23 110.587 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.93 -46.39 9.42 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 119.82 -0.752 . . . . 74.11 112.744 167.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.21 -49.58 77.29 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.404 0.89 . . . . 64.11 113.404 -169.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -65.99 -43.62 87.27 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 108.184 -1.043 . . . . 74.1 108.184 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -56.83 -47.75 79.59 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.998 0.37 . . . . 72.31 111.998 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.3 -42.08 94.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.13 0.491 . . . . 74.44 109.733 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.41 75.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.014 -0.429 . . . . 72.43 111.492 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.58 -23.52 60.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.242 0.217 . . . . 75.11 110.555 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.4 mtt -69.65 -41.78 75.11 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.168 -1.049 . . . . 72.24 108.168 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.41 15.85 25.88 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 63.21 116.348 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 73.32 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.33 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 74.21 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 75.23 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.34 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.32 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . 0.405 ' C ' ' H ' ' A' ' 659' ' ' LYS . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.23 112.694 178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.34 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' A' ' 657' ' ' HIS . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 74.15 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 74.34 107.337 175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 65.2 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.407 ' HA ' HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 74.14 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 72.41 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.94 92.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.43 104.957 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -169.41 142.91 2.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.329 -1.36 . . . . 73.42 107.329 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 51.95 -173.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.888 1.81 . . . . 74.34 115.888 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 26.6 m -81.19 145.77 30.83 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.678 -0.639 . . . . 72.31 111.448 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.63 156.93 23.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.836 -0.62 . . . . 75.44 109.395 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -58.21 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.989 -1.486 . . . . 71.4 106.989 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.75 169.14 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.693 1.368 . . . . 75.22 114.693 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.46 32.43 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.669 -0.696 . . . . 74.12 111.642 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.3 p -77.64 38.95 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.964 0.727 . . . . 75.44 112.964 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.6 p -117.97 -3.58 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.985 -0.746 . . . . 72.34 108.985 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.2 m -143.63 169.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.581 -1.637 . . . . 71.15 106.581 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 116.707 -1.615 . . . . 70.32 106.965 175.917 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.222 -0.347 0 N-CA-C 108.627 -0.879 . . . . 74.52 108.627 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -80.97 152.06 28.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 74.1 109.308 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 63.01 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.34 108.558 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.14 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.32 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . 0.438 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 75.32 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 74.31 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 64.23 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 70.11 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 73.25 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.11 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 73.32 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 71.13 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 73.33 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.23 109.724 178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.53 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 71.31 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.463 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 72.45 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 72.15 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.438 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 75.22 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.44 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.12 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 75.41 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.41 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.31 111.309 -175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 72.41 109.527 170.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 61.43 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.44 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.31 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 73.52 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . 0.556 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.12 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.42 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 75.01 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.24 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.43 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.53 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.13 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 75.45 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 72.31 110.443 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 75.34 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.21 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 74.31 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 71.33 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 62.21 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.44 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.31 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.53 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.2 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.31 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 75.2 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.1 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 74.01 110.527 -171.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 74.41 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.44 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.33 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.52 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.41 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.44 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.578 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 73.14 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.1 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 72.32 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.578 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.24 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 75.23 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.453 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 74.24 105.296 168.1 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.21 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 64.33 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.11 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 64.11 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 74.25 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 73.41 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 75.45 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.17 142.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 60.25 107.641 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -133.75 119.2 18.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.884 -0.784 . . . . 75.21 108.884 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -144.94 61.86 1.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.899 0.856 . . . . 63.31 109.111 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 63.83 -136.79 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.621 -1.172 . . . . 63.24 113.205 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.46 64.3 2.78 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.443 0.639 . . . . 74.41 112.173 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.83 113.98 26.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.203 0.816 . . . . 74.34 113.203 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 52.01 -137.42 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 118.231 -0.89 . . . . 72.54 111.573 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.24 -44.98 0.07 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 119.769 3.248 . . . . 74.33 119.769 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -150.15 79.81 1.36 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.538 -0.912 . . . . 74.45 108.538 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -89.65 149.03 22.98 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 74.52 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 73.24 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.21 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.24 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.14 106.897 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 75.34 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.23 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 64.23 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.51 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 74.51 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.608 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.43 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' MET . . . . . 0.556 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 74.34 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 75.43 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.608 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 162.2 -59.18 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 73.44 107.94 179.434 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.4 72.89 1.24 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.962 -1.255 . . . . 65.32 109.962 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.36 121.48 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.246 -0.65 . . . . 75.32 109.246 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 16.0 t -165.44 -179.07 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.688 -2.338 . . . . 73.31 104.688 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -125.29 146.31 49.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.879 -0.786 . . . . 73.22 108.879 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.34 -19.67 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.031 -0.531 . . . . 74.32 111.35 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.87 -168.75 0.1 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.122 0.569 . . . . 75.32 110.514 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 32.3 t70 62.64 -14.8 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 116.98 2.215 . . . . 74.41 116.98 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.52 79.27 7.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.015 -1.053 . . . . 71.01 111.849 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -66.99 134.42 51.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.791 -1.559 . . . . 75.43 106.791 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 58.0 mt -136.88 -169.7 2.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 103.855 -2.646 . . . . 75.14 103.855 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.3 t -70.05 149.79 47.3 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 102.386 -3.19 . . . . 71.31 102.386 166.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.5 -21.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.514 0.561 . . . . 74.53 112.514 -162.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 -47.64 67.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.971 0.891 . . . . 75.05 109.372 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.12 -21.28 60.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.021 -0.991 . . . . 72.44 112.296 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.795 -0.362 . . . . 73.14 110.479 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -87.89 -43.03 12.1 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 119.236 -0.986 . . . . 74.31 112.632 169.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.42 94.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.008 0.822 . . . . 73.35 113.065 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -68.04 -40.8 82.77 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.576 -0.898 . . . . 71.04 108.576 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -59.99 -46.68 88.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.069 0.396 . . . . 75.44 112.069 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.56 -40.31 88.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.488 0.661 . . . . 73.03 109.681 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.41 75.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 61.33 110.989 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -72.21 -24.91 61.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 73.12 111.335 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 50.8 mtt -73.59 -41.55 62.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.904 -1.147 . . . . 72.31 107.904 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.524 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.17 19.83 40.55 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 52.44 115.685 169.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 74.31 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.42 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.22 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 74.42 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.43 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 64.13 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . 0.401 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.33 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 72.22 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 71.41 109.404 -176.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 74.11 105.078 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 72.1 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 74.31 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.31 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.39 112.92 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 75.34 105.468 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.88 161.06 14.99 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.386 0.674 . . . . 74.51 112.008 -175.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -88.35 -43.68 11.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.358 -1.349 . . . . 64.54 107.358 167.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.7 t -70.03 117.75 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.361 -0.836 . . . . 64.3 112.64 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -146.93 146.28 30.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.106 -0.702 . . . . 72.43 109.106 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -135.78 129.8 33.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.335 -0.987 . . . . 72.32 108.335 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -84.59 134.23 34.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.108 -1.441 . . . . 74.22 107.108 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -125.93 -55.69 1.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.46 1.282 . . . . 74.41 114.46 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 7.3 t 59.17 -169.83 0.13 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.388 0.675 . . . . 74.11 110.206 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 8.1 t -157.02 -33.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 64.34 111.61 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.34 150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.81 1.244 . . . . 75.02 109.569 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.515 -3.143 . . . . 74.35 102.515 -179.031 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.69 14.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.198 -1.778 . . . . 74.41 106.198 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 73.21 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 73.24 106.92 171.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.14 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 74.14 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.44 113.514 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.2 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 73.12 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.409 HG21 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.23 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.13 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.44 108.718 167.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 73.33 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 72.5 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 75.34 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.24 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.11 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.5 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.403 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 72.13 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 73.44 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.31 105.068 170.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.54 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.51 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.22 108.696 -178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.428 HH11 ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 74.45 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.22 112.317 176.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 75.31 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.34 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . 0.428 ' HB3' HH11 ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.02 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.44 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.24 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.517 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 75.22 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 73.24 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 71.14 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 74.05 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 74.22 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 73.01 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . 0.403 ' HD2' HG21 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.23 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.41 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.24 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.23 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 72.11 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 61.33 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.32 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 75.31 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.21 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 74.52 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.4 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.11 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 74.42 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.33 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.23 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.41 112.029 -174.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.24 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.33 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.3 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 71.51 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 73.32 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.12 104.492 172.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.51 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 75.33 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.451 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 72.41 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.23 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.451 ' H ' ' C ' ' A' ' 592' ' ' ASP . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.41 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 593' ' ' GLU . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.14 103.382 169.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 72.24 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 64.31 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.33 107.11 175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 74.45 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.403 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 74.21 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.43 105.993 178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -82.35 142.23 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.33 109.768 -173.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -132.06 133.13 44.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.051 0.541 . . . . 72.44 112.44 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -169.5 -65.42 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 105.949 -1.871 . . . . 72.13 105.949 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.27 158.63 43.08 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 102.81 -3.033 . . . . 72.4 102.81 171.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 -29.38 9.95 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.083 1.512 . . . . 62.22 115.083 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 62.07 -58.71 0.12 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.067 2.247 . . . . 74.22 117.067 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.18 176.49 7.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.484 -0.561 . . . . 65.44 109.484 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.36 -20.49 10.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.71 1.004 . . . . 75.24 113.71 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -153.08 84.81 1.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.89 0.7 . . . . 64.4 112.89 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.86 158.56 16.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.181 -1.044 . . . . 75.21 108.181 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.51 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.22 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 74.02 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 73.2 106.685 176.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.33 108.024 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.43 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.33 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.22 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 75.33 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.03 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.608 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.53 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.43 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.517 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.21 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.608 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 166.49 -76.13 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 75.01 112.061 176.556 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.13 106.16 2.06 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 105.105 -3.198 . . . . 74.52 105.105 -163.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.09 126.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.704 0.288 . . . . 74.42 110.251 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.9 m 62.31 -33.02 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.647 2.832 . . . . 64.24 118.647 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.4 -170.2 0.16 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.416 0.687 . . . . 64.54 111.886 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -34.06 126.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.615 1.566 . . . . 74.12 114.794 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 20.2 p -72.23 -14.27 61.74 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 114.45 1.278 . . . . 64.52 114.45 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.94 12.93 1.55 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.75 0.648 . . . . 75.21 112.75 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -81.06 64.0 5.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.732 0.777 . . . . 75.12 112.042 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.5 136.29 56.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.451 -1.315 . . . . 75.05 107.451 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.02 -172.29 3.37 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.104 -1.813 . . . . 74.12 106.104 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -69.04 150.94 47.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 103.2 -2.889 . . . . 73.41 103.2 166.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.17 -23.69 33.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 112.802 0.668 . . . . 75.51 112.802 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.11 -47.32 68.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.848 0.833 . . . . 73.55 109.522 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.11 -24.33 59.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.96 -1.018 . . . . 72.24 111.522 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.3 -39.49 79.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 119.759 -0.162 . . . . 62.41 111.136 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.76 -51.06 6.07 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.334 -0.946 . . . . 74.53 111.832 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.16 78.93 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 114.281 1.215 . . . . 55.01 114.281 -168.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -40.39 86.28 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.673 -0.862 . . . . 74.52 108.673 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -63.89 -46.47 84.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.716 -0.675 . . . . 74.01 112.291 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.8 mt -59.09 -40.93 82.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 122.941 0.496 . . . . 74.51 110.467 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.34 -36.6 84.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.663 0.744 . . . . 71.41 110.039 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.31 -17.58 56.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.579 0.585 . . . . 72.02 112.579 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.9 mtt -69.26 -41.29 77.1 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.232 -1.766 . . . . 73.4 106.232 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.604 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.14 10.22 6.88 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.33 117.5 167.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 74.35 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 75.23 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 74.52 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 71.34 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 65.04 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.11 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 74.24 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.21 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 74.11 108.569 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 70.41 107.167 176.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.01 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.409 ' HA ' HG21 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 71.04 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 74.14 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.99 95.35 4.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 63.14 106.162 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . 0.461 ' CD ' ' HG ' ' A' ' 667' ' ' SER . 57.9 tt0 -165.46 134.03 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.983 -1.858 . . . . 75.51 105.983 -176.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -8.19 21.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' SER . . . . . 0.461 ' HG ' ' CD ' ' A' ' 665' ' ' GLU . 79.0 p -69.91 152.39 44.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 73.33 107.952 175.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.2 151.11 23.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.712 0.634 . . . . 74.2 112.712 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.496 -0.775 . . . . 75.14 110.187 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -156.91 137.49 13.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.598 -0.519 . . . . 73.44 109.598 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -125.94 149.8 48.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.638 -0.875 . . . . 74.43 108.638 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 78.8 p -134.08 36.9 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.352 -1.351 . . . . 73.25 107.352 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 175.64 8.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.685 -1.143 . . . . 74.0 109.912 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.8 p -142.65 149.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 103.48 -2.785 . . . . 72.51 103.48 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 C--O 1.253 1.267 0 O-C-N 124.649 1.218 . . . . 65.34 112.248 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 103.728 -2.693 . . . . 75.41 103.728 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -86.21 150.01 24.68 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.44 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 74.13 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.33 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.23 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.11 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.15 113.787 -178.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 74.04 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.01 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 74.25 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.404 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.52 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.32 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 72.4 107.957 168.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.31 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.479 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.41 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.43 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.32 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 72.41 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.22 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.487 ' HG2' ' CG2' ' A' ' 600' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 73.52 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 75.24 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.51 106.685 171.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 74.1 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.22 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.12 109.632 178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.44 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' THR . . . . . . . . . . . . . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.22 111.51 -175.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 75.42 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 65.2 110.373 176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.23 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 74.34 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 53.31 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.22 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.43 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 63.45 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.24 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 65.54 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.14 108.098 173.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.03 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 71.54 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 72.13 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.464 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 73.24 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.12 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 75.02 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 63.41 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 71.22 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.33 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.33 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.33 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.05 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.34 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.35 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . 0.479 ' CD ' ' HZ3' ' A' ' 601' ' ' LYS . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.54 108.28 171.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.31 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 64.42 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.14 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 61.22 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 70.01 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 72.45 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 75.11 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.403 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 70.33 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.03 116.111 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.31 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' C ' ' H ' ' A' ' 595' ' ' VAL . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 74.43 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.13 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.443 ' H ' ' C ' ' A' ' 593' ' ' GLU . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.34 105.923 169.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 75.14 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.51 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 74.34 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 73.1 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.487 ' CG2' ' HG2' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.23 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . 0.479 ' HZ3' ' CD ' ' A' ' 581' ' ' GLU . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.4 107.458 176.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.55 105.741 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.35 143.55 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 75.41 110.047 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -113.6 135.48 53.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 61.02 113.421 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.6 165.38 23.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.049 -2.945 . . . . 73.14 103.049 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.39 -98.3 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.15 0.886 . . . . 71.22 110.786 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 60.03 174.36 0.09 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.183 0.993 . . . . 74.13 113.108 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -138.3 49.37 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.377 -0.827 . . . . 75.01 110.176 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -116.69 0.1 Allowed 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 117.582 2.438 . . . . 72.44 117.582 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -119.79 166.42 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.094 -1.004 . . . . 73.32 113.607 -164.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -84.51 89.87 7.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.518 -1.66 . . . . 72.51 106.518 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -89.83 159.73 16.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 74.41 111.767 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.23 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.42 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 74.33 105.585 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 73.11 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 73.35 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.24 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.02 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 73.35 110.469 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 75.21 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.641 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.51 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.33 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 72.22 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.641 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 162.28 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 72.31 107.855 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.44 69.89 1.34 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.739 -1.744 . . . . 73.11 108.739 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -57.02 124.52 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.441 0.639 . . . . 73.31 109.39 -179.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.1 t -162.88 -177.21 5.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.302 -2.481 . . . . 72.32 104.302 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.8 163.23 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.823 -1.547 . . . . 73.23 106.823 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.19 134.69 44.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.519 -0.919 . . . . 73.04 108.519 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 7.8 m -94.92 76.99 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.217 -1.031 . . . . 72.41 108.217 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.63 -74.5 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.842 -0.799 . . . . 74.24 108.842 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.98 131.24 49.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.485 -0.561 . . . . 73.01 109.485 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -126.62 151.48 47.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.635 -1.246 . . . . 72.54 107.635 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.94 -173.4 3.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.36 -1.719 . . . . 75.42 106.36 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.3 t -66.21 156.34 34.45 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.506 -2.035 . . . . 74.43 105.506 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.6 -22.55 31.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.226 0.825 . . . . 74.14 113.226 -161.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.83 -48.3 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.198 0.999 . . . . 72.1 108.807 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.16 -19.01 61.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.576 -1.193 . . . . 73.51 112.444 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -55.21 -52.46 63.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 71.52 109.798 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.94 -37.71 16.18 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.289 -0.964 . . . . 73.41 111.827 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.16 -44.1 95.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.469 1.031 . . . . 62.43 112.505 -174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.63 -38.38 67.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.305 -0.628 . . . . 74.34 109.305 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -58.61 -46.43 87.03 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 120.431 0.158 . . . . 74.41 111.052 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.22 -39.64 86.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 122.088 -0.382 . . . . 74.35 110.528 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.51 73.79 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.933 -0.479 . . . . 65.1 111.074 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.49 -31.77 70.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.251 -0.277 . . . . 71.43 110.251 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 2.3 mtt -73.01 -41.51 64.18 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.4 -0.593 . . . . 64.12 109.4 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.468 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.33 18.3 35.39 Favored Glycine 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 74.33 115.984 169.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.51 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 74.45 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 72.11 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.35 111.215 174.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 65.4 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.14 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.35 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.4 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.55 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 75.23 107.622 175.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 75.43 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.404 ' HA ' HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 70.25 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 73.32 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt -96.33 107.19 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 73.34 106.307 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.1 158.78 14.74 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.005 -0.739 . . . . 71.25 109.005 -173.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.74 -47.09 76.46 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.045 0.758 . . . . 73.41 113.045 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 28.0 t -68.76 148.2 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.454 0.645 . . . . 74.22 111.297 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -137.34 135.58 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.783 -1.192 . . . . 73.11 107.783 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -116.11 131.62 56.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.235 -0.654 . . . . 72.11 109.235 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.33 120.35 42.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.374 -2.084 . . . . 60.32 105.374 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -139.29 130.05 26.09 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 38.1 m -143.84 173.18 11.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.876 -1.157 . . . . 74.34 107.876 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.2 t -121.89 -176.85 3.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.213 -1.773 . . . . 73.14 106.213 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.2 17.35 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.04 0.448 . . . . 64.0 111.471 -173.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.002 -1.475 . . . . 73.32 108.808 -179.478 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 110.049 -0.352 . . . . 72.33 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.59 143.64 29.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.774 0.671 . . . . 72.22 110.161 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.45 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.426 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.41 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 75.32 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.44 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 75.32 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 71.34 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.31 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.54 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 74.21 108.434 -178.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 74.12 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 168.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 74.31 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.32 111.918 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.01 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 75.32 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 74.43 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 74.42 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 74.54 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.3 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.14 103.787 169.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.44 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 75.53 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.34 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 73.42 109.704 -177.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.45 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.11 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 52.03 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.35 114.233 -172.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.43 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.23 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.44 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 71.3 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.53 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.31 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 73.42 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.24 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.12 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.04 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.24 110.418 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.35 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 72.41 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 73.14 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . 0.475 ' HZ1' ' CD ' ' A' ' 578' ' ' GLU . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.01 106.932 175.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 75.51 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.32 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.2 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . 0.475 ' CD ' ' HZ1' ' A' ' 574' ' ' LYS . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 71.41 115.924 -162.776 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.21 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.35 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.54 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.43 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.43 109.779 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.13 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.53 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 74.51 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.33 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.55 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 74.23 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.632 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.41 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 74.11 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 74.25 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.632 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 74.51 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 74.43 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.419 ' H ' ' C ' ' A' ' 593' ' ' GLU . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 73.44 103.414 171.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.3 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 71.52 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.01 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.31 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . 0.428 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.44 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 72.32 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 74.4 107.583 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.75 137.98 34.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.52 110.306 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.42 134.49 42.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.043 -0.981 . . . . 64.34 112.303 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -133.88 24.79 3.96 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.627 -1.249 . . . . 72.4 107.627 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 62.82 -171.99 0.16 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.554 1.141 . . . . 72.4 112.13 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 62.3 178.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.424 1.09 . . . . 63.21 113.154 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -162.2 -24.21 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.228 0.825 . . . . 61.15 113.228 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.03 -18.45 64.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.565 0.697 . . . . 63.23 110.105 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -31.4 70.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.643 0.979 . . . . 72.51 113.643 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 46.46 102.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.152 1.908 . . . . 65.13 116.152 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -90.58 151.04 21.48 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.033 -0.729 . . . . 53.12 109.033 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.03 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.54 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.35 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 75.21 106.474 177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.42 108.154 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.32 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 75.54 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 71.13 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.44 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 73.52 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.61 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 74.15 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.11 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.61 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 167.13 -74.05 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 71.12 110.498 176.72 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.53 83.95 1.75 Allowed Glycine 0 C--O 1.216 -1.001 0 N-CA-C 108.444 -1.862 . . . . 73.34 108.444 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -20.87 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.832 -0.684 . . . . 71.54 111.52 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.2 p -56.39 140.87 44.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.32 -0.4 . . . . 72.12 110.455 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.45 142.0 58.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.594 0.711 . . . . 74.4 111.761 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.73 128.91 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.123 -0.944 . . . . 73.21 108.84 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 37.1 p -76.55 -14.5 60.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.346 1.239 . . . . 74.55 114.346 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.34 -11.5 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.132 -0.355 . . . . 72.34 111.137 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -81.13 36.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.698 0.629 . . . . 74.42 112.698 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -70.1 121.41 17.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.074 -1.084 . . . . 74.41 108.074 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.72 -168.74 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.807 -1.553 . . . . 74.25 106.807 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -68.63 167.23 15.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.113 -1.81 . . . . 63.13 106.113 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 85.8 t -58.48 -45.25 90.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.812 0.815 . . . . 70.13 111.302 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.55 -47.06 87.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.038 -0.983 . . . . 74.45 111.06 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.82 -23.73 59.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.349 -0.841 . . . . 73.31 111.475 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.43 -40.64 87.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.815 -0.439 . . . . 74.2 109.815 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.85 -47.55 8.51 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.04 -0.664 . . . . 73.45 111.524 170.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.2 84.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.295 0.85 . . . . 70.35 113.295 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -74.26 -42.19 60.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.198 -0.667 . . . . 75.14 109.198 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -61.32 -46.33 90.71 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.575 -0.739 . . . . 72.31 112.244 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.49 -40.85 85.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.133 0.492 . . . . 74.11 109.803 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.41 73.27 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.853 -0.529 . . . . 63.41 110.665 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -20.73 59.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.555 0.342 . . . . 75.53 111.537 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 34.8 mtt -75.27 -41.31 57.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.703 -1.591 . . . . 75.35 106.703 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.57 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.46 21.03 47.64 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 72.3 115.573 166.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.51 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 64.32 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 73.1 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.3 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 73.22 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.21 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.43 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.32 109.183 -176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 75.15 108.474 177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.42 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.44 107.805 -175.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 75.01 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.44 112.31 27.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 72.41 104.732 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -166.69 -115.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 105.34 -2.096 . . . . 74.01 105.34 -171.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.98 150.06 43.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.185 -2.154 . . . . 74.32 105.185 174.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 34.3 m -79.9 46.24 0.77 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.304 0.573 . . . . 65.51 112.057 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -63.4 -43.68 96.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.602 1.334 . . . . 64.23 114.602 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.31 148.87 42.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 114.218 1.192 . . . . 62.41 114.218 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -134.08 144.09 48.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.153 -1.795 . . . . 73.24 106.153 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -73.74 116.91 14.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 75.43 110.094 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.6 p -85.77 169.45 13.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.272 -0.422 . . . . 75.51 110.24 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.3 t -142.62 170.95 14.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.482 -1.673 . . . . 73.1 106.482 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 32.3 m -129.84 162.79 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 122.461 0.304 . . . . 54.0 110.454 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.581 -1.199 . . . . 74.44 111.08 178.367 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 118.78 -0.629 . . . . 71.41 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.93 154.29 30.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.799 0.687 . . . . 73.53 110.256 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.45 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.449 ' H ' HG21 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.11 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 74.21 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 71.41 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.31 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.24 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.11 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 72.31 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 65.12 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 75.12 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . 0.558 ' H ' ' HB2' ' A' ' 669' ' ' GLU . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 74.31 108.318 174.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 72.2 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 55.11 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.22 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 70.15 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.45 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.4 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.52 109.532 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 75.1 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 73.53 104.284 169.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 62.22 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 74.03 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.3 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 74.5 109.874 -177.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.449 HG21 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.13 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.21 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 70.3 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.21 111.671 -176.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.44 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 75.42 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 74.25 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.12 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 74.34 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 73.01 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.24 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.11 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 72.33 108.257 171.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.21 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.32 111.1 -177.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.21 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.31 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.2 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 74.01 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 54.34 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 52.43 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 71.12 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.24 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 74.25 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.23 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 72.25 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.31 108.723 -174.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.42 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.21 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.42 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 61.34 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.51 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 72.14 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.443 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.52 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 72.1 115.36 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 75.04 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 71.4 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.33 113.812 -168.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . 0.412 ' H ' ' C ' ' A' ' 593' ' ' GLU . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 70.31 106.717 174.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 74.21 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 74.52 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 75.13 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.21 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 74.13 107.324 177.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.41 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 74.15 103.692 172.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t -85.72 143.59 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.2 107.789 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -127.93 161.14 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 72.41 112.146 -168.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 66.4 -30.52 0.15 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.905 2.557 . . . . 75.3 117.905 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.66 58.71 3.87 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.475 0.917 . . . . 75.32 113.475 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . 0.574 ' HG3' ' H ' ' A' ' 608' ' ' TYR . 3.8 tp10 62.5 -169.33 0.18 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.368 1.067 . . . . 75.51 112.088 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . 0.574 ' H ' ' HG3' ' A' ' 607' ' ' GLU . 3.3 p90 -164.14 173.85 11.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.74 -1.207 . . . . 75.12 107.74 -176.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -136.83 70.55 1.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.75 0.648 . . . . 64.21 112.75 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.84 -55.59 0.43 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.459 2.022 . . . . 63.53 116.459 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -172.14 109.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.763 -2.31 . . . . 75.04 104.763 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.43 150.9 22.3 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.82 -1.178 . . . . 74.15 107.82 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 73.35 106.023 -178.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.03 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.23 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.31 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 64.52 107.362 -178.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.42 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.45 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 75.43 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 74.12 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 74.41 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.624 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.44 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 71.14 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.513 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.3 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.624 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 161.46 -48.26 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.21 106.739 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.74 54.02 20.82 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 109.201 -1.56 . . . . 52.42 109.201 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.58 116.14 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.953 0.883 . . . . 72.53 110.22 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 6.1 p -146.52 155.94 42.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 103.081 -2.933 . . . . 74.44 103.081 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.82 130.38 39.35 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.493 -0.483 . . . . 73.44 110.073 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.7 127.25 40.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.302 -1.37 . . . . 73.04 107.302 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 47.2 p -67.02 -24.32 66.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.816 1.043 . . . . 73.52 113.816 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -137.39 104.78 5.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.948 0.88 . . . . 74.42 111.775 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -126.7 35.96 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.82 -1.178 . . . . 75.12 107.82 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -62.42 112.75 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.928 -1.033 . . . . 74.45 109.011 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 57.9 mt -146.51 179.01 7.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.158 -1.793 . . . . 72.55 106.158 -170.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 10.5 t -61.99 148.35 44.16 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 105.467 -2.049 . . . . 75.11 105.467 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 22.3 m -59.89 -25.08 31.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 114.524 1.305 . . . . 75.23 114.524 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -66.45 -46.14 77.45 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.684 0.754 . . . . 75.33 109.421 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.57 -21.81 48.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.181 -0.918 . . . . 74.34 111.839 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.6 -41.49 90.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.352 -0.24 . . . . 73.35 110.352 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.01 -47.09 8.8 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.394 -0.922 . . . . 73.55 111.166 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.419 0.896 . . . . 71.13 113.419 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -70.84 -38.01 73.18 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.242 -0.651 . . . . 72.44 109.242 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.13 -46.23 88.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 120.51 0.195 . . . . 74.51 110.775 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.6 -41.93 94.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 110.031 -0.359 . . . . 73.22 110.031 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.74 81.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.817 0.342 . . . . 53.24 110.975 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.45 -25.41 62.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.128 -0.487 . . . . 74.55 110.311 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 35.4 mtt -75.43 -42.17 54.1 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 118.616 -1.234 . . . . 74.52 108.405 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.446 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.09 -2.08 0.29 Allowed Glycine 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 71.24 117.183 166.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.43 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 73.11 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.32 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.42 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.11 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . 0.427 ' C ' ' H ' ' A' ' 659' ' ' LYS . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.33 112.247 176.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 71.14 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 657' ' ' HIS . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 75.13 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.44 105.986 177.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.23 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.415 ' HA ' HG22 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.54 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.43 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.45 122.56 48.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 74.12 105.302 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -164.08 171.98 14.4 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.639 -1.245 . . . . 75.42 107.639 -168.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.49 56.09 0.85 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.914 0.864 . . . . 52.11 109.717 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.7 m -149.04 159.6 44.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.261 -0.899 . . . . 74.44 111.659 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -135.01 131.38 37.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.108 -1.812 . . . . 72.34 106.108 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . 0.558 ' HB2' ' H ' ' A' ' 540' ' ' HIS . 7.2 tp10 -81.44 136.79 35.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.814 1.042 . . . . 74.51 113.814 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.24 124.02 29.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.343 -0.984 . . . . 74.14 108.343 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -136.49 151.64 49.67 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.036 -1.468 . . . . 73.24 107.036 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 77.5 p -159.04 173.7 16.06 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.938 -1.134 . . . . 72.34 107.938 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -151.16 169.66 21.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.764 -1.939 . . . . 75.13 105.764 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 167.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.919 -1.882 . . . . 73.32 105.919 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 C--O 1.256 1.396 0 CA-C-O 117.411 -1.281 . . . . 73.42 109.118 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.159 -1.052 . . . . 74.41 108.159 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -99.34 165.92 11.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.696 -1.224 . . . . 72.25 107.696 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.44 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' ILE . . . . . 0.409 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.13 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.44 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 73.5 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' PHE . . . . . 0.469 ' CZ ' HG12 ' A' ' 550' ' ' VAL . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.33 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.21 113.168 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 74.31 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.44 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 75.24 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' ILE . . . . . 0.427 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 73.22 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 63.15 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 72.4 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.35 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.42 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.24 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 64.14 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 74.31 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 73.54 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.32 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' VAL . . . . . 0.469 HG12 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.23 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 75.12 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.12 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 71.02 108.173 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.425 ' C ' ' HE ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 72.24 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 74.44 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.32 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.34 112.901 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.11 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 73.01 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 561' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 74.24 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.13 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 75.32 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 71.12 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.41 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.45 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.24 106.335 171.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.51 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.23 104.303 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 570' ' ' GLU . . . . . 0.558 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 74.11 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.12 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.34 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.22 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 74.42 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.4 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.15 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.24 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.32 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.31 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 74.13 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 74.52 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.33 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.14 111.631 -172.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.42 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.42 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 54.21 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 75.24 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.12 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 74.2 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 590' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 72.41 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 72.34 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 592' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 64.13 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 593' ' ' GLU . . . . . 0.5 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.24 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 594' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.51 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.42 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 73.54 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 75.14 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 74.21 106.744 175.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 74.53 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 600' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.42 109.228 177.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 73.03 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.43 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.9 143.59 10.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 70.4 111.936 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -80.72 104.69 11.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.815 1.246 . . . . 74.25 113.136 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.84 160.36 43.31 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.205 -1.406 . . . . 74.04 107.205 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.1 -25.61 25.71 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.213 -1.032 . . . . 75.34 108.213 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 61.6 175.06 0.12 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.743 1.217 . . . . 73.4 114.279 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -143.08 -11.95 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.675 0.991 . . . . 72.21 113.675 -167.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -101.27 -85.0 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.97 1.47 . . . . 71.22 114.97 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -157.44 178.43 10.31 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.57 -0.706 . . . . 75.4 111.76 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -59.69 125.73 24.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.757 -1.942 . . . . 70.43 105.757 159.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -111.35 162.12 15.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 613' ' ' ASN . . . . . 0.41 HD22 ' HG3' ' A' ' 661' ' ' GLU . 1.1 t-20 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 70.13 107.862 -172.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.44 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.34 108.003 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 74.42 107.797 176.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 64.41 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 74.42 108.741 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.02 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.12 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 75.03 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.52 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' TRP . . . . . 0.616 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.4 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.34 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' GLU . . . . . 0.505 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.23 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' ARG . . . . . 0.616 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 172.38 -53.51 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.54 113.94 175.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 86.26 66.67 1.38 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-O 122.699 1.166 . . . . 74.43 110.88 -172.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -59.3 127.68 18.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.241 -0.979 . . . . 73.13 110.041 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.3 m 58.31 17.12 4.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 116.025 1.861 . . . . 62.24 116.025 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.8 145.33 53.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 75.41 108.82 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.1 t 56.93 91.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 122.324 1.059 . . . . 72.24 112.186 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 39.2 p -73.09 -9.91 59.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.836 -0.62 . . . . 65.42 111.146 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.59 14.69 4.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.717 0.77 . . . . 74.23 112.218 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -79.13 74.3 5.69 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.6 -0.687 . . . . 75.13 110.071 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' LYS . . . . . 0.44 ' HZ1' ' CD ' ' A' ' 641' ' ' GLU . 56.9 tptt -66.78 132.4 47.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.491 -0.929 . . . . 74.2 108.491 178.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.8 mt -135.14 -177.19 4.53 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.465 -2.05 . . . . 74.54 105.465 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -67.32 157.25 34.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 105.83 -1.915 . . . . 75.33 105.83 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.89 -23.64 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.847 0.684 . . . . 74.34 112.847 -162.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.24 -48.97 54.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.446 1.117 . . . . 72.32 109.091 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -71.68 -23.76 61.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 74.32 112.305 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' GLU . . . . . 0.44 ' CD ' ' HZ1' ' A' ' 635' ' ' LYS . 2.5 mt-10 -52.4 -47.53 66.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 119.115 -0.469 . . . . 74.1 110.888 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -88.03 -49.84 6.79 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.441 -0.904 . . . . 72.22 112.749 165.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.48 81.5 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.655 1.354 . . . . 74.44 114.655 -167.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -68.79 -39.77 79.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.273 -1.01 . . . . 75.41 108.273 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.59 -49.03 78.94 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 122.483 -0.136 . . . . 71.42 111.334 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.24 -42.3 89.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 122.817 0.447 . . . . 62.53 110.743 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.22 82.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.139 0.495 . . . . 74.23 110.515 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.75 -17.07 59.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.086 -0.506 . . . . 75.14 112.199 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 53.4 mtt -73.02 -40.74 64.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.82 -1.548 . . . . 72.34 106.82 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.58 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.0 16.74 26.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 73.23 117.357 166.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 72.33 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 65.42 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 72.14 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.13 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.14 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.14 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 70.31 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.01 107.317 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 75.12 104.33 177.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' GLU . . . . . 0.41 ' HG3' HD22 ' A' ' 613' ' ' ASN . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.24 109.45 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' VAL . . . . . 0.427 ' HA ' HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.34 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.41 104.245 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.81 92.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 71.12 106.109 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -175.07 129.09 0.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 104.072 -2.566 . . . . 73.32 104.072 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.44 117.04 12.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.148 0.886 . . . . 70.13 110.987 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.6 m -160.61 154.01 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.014 -1.476 . . . . 72.24 107.014 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -145.64 152.54 39.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.536 -0.542 . . . . 74.45 109.536 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.34 165.01 37.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.68 -1.6 . . . . 73.03 106.68 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -142.75 136.51 28.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 75.22 111.775 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -140.62 159.74 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.704 -1.591 . . . . 72.31 106.704 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 65.1 p -149.91 165.72 31.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.009 -1.478 . . . . 54.3 107.009 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 73.4 p -133.2 -173.56 3.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.455 -0.943 . . . . 73.41 108.455 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.83 160.53 21.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 103.702 -2.703 . . . . 74.33 103.702 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.312 -0.851 . . . . 64.41 110.716 178.746 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.541 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.421 HG22 HG12 ' A' ' 662' ' ' VAL . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.405 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 557' ' ' GLY . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 555' ' ' THR . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 578' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.429 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.422 ' HD3' HD21 ' A' ' 654' ' ' LEU . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.687 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.687 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 654' ' ' LEU . . . . . 0.422 HD21 ' HD3' ' A' ' 621' ' ' PRO . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 550' ' ' VAL . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.833 0.349 . . . . 52.13 110.394 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 34.44 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.566 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 72.32 107.134 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.31 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.22 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 65.43 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' GLU . . . . . 0.488 ' HG3' HD21 ' A' ' 553' ' ' LEU . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.43 114.037 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.43 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 61.44 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 74.24 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.31 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.2 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 548' ' ' MET . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.55 108.09 170.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 40.42 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.43 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 62.14 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 71.52 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 65.24 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 73.03 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 73.44 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 598' ' ' ILE . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.33 107.765 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.22 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.32 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.488 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.22 110.132 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.538 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 71.3 107.93 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 44.32 110.665 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.45 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 32.1 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.538 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 54.33 113.702 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.22 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.54 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.424 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.14 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 62.31 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 71.32 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 72.44 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 64.14 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 566' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 598' ' ' ILE . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 70.31 108.408 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 72.35 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 64.42 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 62.5 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.34 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.1 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.33 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.2 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 40.23 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.21 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 42.32 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 73.03 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.52 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 61.45 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 64.32 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.24 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.05 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.12 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.21 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.12 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 70.21 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.15 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 62.4 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 64.13 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 64.04 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.15 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.499 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.41 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 54.35 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.43 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 597' ' ' THR . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 54.33 110.592 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.35 112.007 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 550' ' ' VAL . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 65.52 106.808 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.15 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.22 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 64.11 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 543' ' ' GLU . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 62.34 106.862 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.1 113.864 -169.841 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 107.336 -1.357 . . . . 52.3 107.336 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 73.15 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 54.2 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 61.51 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.428 HD12 HG11 ' A' ' 550' ' ' VAL . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 74.33 105.523 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 25.45 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 74.25 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.03 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 65.21 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 70.42 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 70.32 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.32 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.424 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.4 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 70.25 114.023 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 53.01 117.995 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.52 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.51 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.33 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.41 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 63.41 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.34 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 71.11 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.4 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 72.51 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 73.03 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 52.41 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.53 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.11 108.374 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.981 -1.118 . . . . 53.24 107.981 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 51.41 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 71.23 109.022 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.33 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.42 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 73.54 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.23 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.31 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 65.55 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 73.51 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.69 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 64.33 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 64.43 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 54.43 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 61.32 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.05 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 62.25 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.12 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 73.12 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.431 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.2 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 71.1 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.34 105.856 171.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 62.13 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.4 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.13 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.73 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.22 110.797 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.23 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.73 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.33 109.349 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 72.12 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.32 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 43.4 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.53 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 74.32 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 61.13 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 61.43 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 71.11 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 64.33 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.43 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 61.2 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 62.13 110.776 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 63.54 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.2 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.44 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.24 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.52 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.51 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.11 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 72.2 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.33 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 73.05 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 53.22 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.22 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 61.23 110.911 -172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.04 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.55 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.44 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.35 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.44 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 71.1 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.602 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 72.4 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.31 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.12 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.11 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 62.11 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 64.3 106.658 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 550' ' ' VAL . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 64.22 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.21 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 54.55 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.12 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 63.2 106.625 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 63.24 108.016 -179.237 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.04 109.804 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 73.14 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.34 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.52 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 54.43 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.2 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.32 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.31 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.32 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 72.03 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.678 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.3 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 73.51 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 71.35 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.678 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 . . . . . 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.55 107.808 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.548 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.45 117.305 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 72.41 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.34 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.22 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 71.34 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.44 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 74.53 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 63.45 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 55.23 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 73.45 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 64.24 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 73.12 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 72.12 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 70.43 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 70.02 106.165 178.065 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.51 109.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 64.1 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.4 106.716 172.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 70.33 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 72.33 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.604 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 63.15 110.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.13 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 70.52 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 73.44 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 65.32 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.13 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.11 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 71.3 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.54 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.3 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.15 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 72.3 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 61.31 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 65.21 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 63.34 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.45 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.14 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.21 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.33 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.33 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 62.31 108.828 177.149 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.51 112.65 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 61.35 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.481 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.32 113.09 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 51.32 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 72.4 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.13 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 72.14 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.41 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.24 115.301 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.33 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 72.31 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 568' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 580' ' ' PHE . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 71.11 109.361 176.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.31 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.44 109.545 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.43 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.21 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 61.23 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 64.31 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.21 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.45 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.21 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.23 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 580' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 568' ' ' THR . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 70.21 102.113 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.22 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.21 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.4 111.582 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.11 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.44 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.21 110.144 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 74.31 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 64.42 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 64.43 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 44.13 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.23 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.611 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 60.35 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.44 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 53.34 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 72.25 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 71.34 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 616' ' ' ILE . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.23 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 53.35 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 63.12 109.788 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 62.15 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 71.45 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 52.4 108.026 -177.92 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 107.276 -1.379 . . . . 52.13 107.276 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 613' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.4 112.795 -170.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 614' ' ' PHE . . . . . 0.472 ' CE1' HG21 ' A' ' 662' ' ' VAL . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.15 109.756 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.11 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 598' ' ' ILE . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.604 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 72.22 107.904 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.42 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.02 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 73.05 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.22 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.698 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.53 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 61.13 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 73.45 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.698 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 . . . . . 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 70.13 107.39 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.519 0.326 0 N-CA-C 116.891 1.516 . . . . 72.52 116.891 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.53 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 61.3 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 74.52 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.04 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.31 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.02 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.15 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.34 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 70.23 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 72.3 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.45 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.22 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 613' ' ' ASN . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.13 103.193 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.42 106.61 175.79 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 107.705 -1.22 . . . . 75.43 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.14 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 45.3 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 71.22 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 71.32 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 618' ' ' LEU . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 63.42 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.41 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 61.41 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.23 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 70.53 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.31 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 662' ' ' VAL . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.11 107.937 169.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 61.23 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 71.31 110.926 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 52.32 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.1 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 62.33 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.23 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 73.12 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 62.03 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 53.21 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.1 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.53 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.14 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 51.54 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.736 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.23 109.722 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 43.11 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.736 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.32 109.049 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.24 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.24 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.23 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 62.32 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 63.1 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 64.12 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.42 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.23 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 70.2 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.35 108.622 171.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 70.4 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.404 HG22 ' HD2' ' A' ' 567' ' ' ARG . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.3 104.957 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.43 112.223 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 43.01 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 52.11 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.41 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.42 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 62.23 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.33 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 33.21 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 74.5 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.11 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.03 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.33 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 64.4 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 61.34 110.581 -169.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.24 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.14 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.32 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 51.11 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 54.32 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.655 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.31 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.14 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.14 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.655 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.32 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.44 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 71.41 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.35 109.094 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 72.21 112.505 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.42 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 70.42 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 583' ' ' ALA . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 73.02 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.41 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 73.11 106.157 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.13 109.328 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.723 0.773 . . . . 73.53 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 73.13 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 64.04 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.11 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.21 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 31.32 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.61 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 64.43 108.107 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.4 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.32 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 63.43 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.625 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.13 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.14 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.3 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.625 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.269 12.9 mmm180 . . . . . 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 71.45 106.813 175.858 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.546 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.229 -0.218 0 N-CA-C 116.931 1.532 . . . . 52.44 116.931 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.24 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 43.41 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 54.23 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 55.33 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 42.14 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.35 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.24 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 62.34 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.45 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 64.45 105.121 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 63.12 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.41 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.24 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.31 105.989 176.627 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.13 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.35 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.34 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 532' ' ' PHE . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.22 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 63.4 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.14 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 63.33 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.33 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 72.31 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 73.34 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.636 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.21 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 62.22 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.31 109.912 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.42 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 60.22 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.53 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 65.25 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 24.01 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 74.41 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.455 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.35 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 64.44 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.488 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.22 106.333 171.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 65.53 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 65.21 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 72.2 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 72.21 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 51.44 110.815 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.21 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 61.5 109.972 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.35 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 64.21 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 34.13 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 52.44 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 562' ' ' VAL . . . . . 0.498 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.33 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 563' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 586' ' ' GLU . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.15 104.872 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 64.13 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 62.11 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.4 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.43 107.534 172.053 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 568' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.44 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' A' ' 567' ' ' ARG . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.03 106.73 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 65.51 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 64.43 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 65.21 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.02 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.15 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 61.41 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 60.02 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.15 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.05 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.1 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.24 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 582' ' ' ASP . . . . . 0.416 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.24 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 52.14 107.947 -169.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.21 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.23 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 586' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 563' ' ' ILE . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 70.34 110.387 176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.11 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 73.11 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 74.41 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.21 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.32 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.41 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 71.12 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 70.22 105.321 168.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.2 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.11 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 71.41 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 72.01 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.54 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 62.24 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.54 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.04 105.097 -175.435 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 109.538 -0.541 . . . . 71.52 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.15 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.2 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 64.42 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 550' ' ' VAL . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 64.22 105.355 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 64.43 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.2 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.04 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 73.31 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 62.03 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 62.42 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.717 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 624' ' ' MET . . . . . 0.498 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 31.34 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 73.21 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.717 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 . . . . . 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.41 107.777 179.511 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.42 116.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 54.55 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 54.22 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 63.44 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.22 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 74.41 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.31 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.44 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.13 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 550' ' ' VAL . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 62.43 107.42 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.33 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.23 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 63.54 106.232 177.089 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 73.53 108.614 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.44 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 43.55 108.689 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.2 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 71.43 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.34 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 71.44 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 62.41 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.24 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 52.1 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.2 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.04 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 662' ' ' VAL . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.2 108.687 167.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.13 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.13 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 71.34 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.31 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.01 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.51 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.31 109.231 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 71.01 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 73.43 105.927 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.42 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.01 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.45 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.32 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.665 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.24 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.21 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 61.21 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 71.44 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 72.4 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.23 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.12 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.51 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.22 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.11 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.13 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 54.41 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.45 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 64.22 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 65.45 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 73.31 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.51 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 71.12 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.52 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 73.21 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.12 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.45 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 50.22 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 32.23 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.44 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.32 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.23 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 65.11 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.12 111.527 -170.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.45 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.43 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 64.21 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 61.25 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 55.55 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 74.02 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.62 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 70.15 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 61.43 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 72.41 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.23 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 54.12 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 71.01 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.14 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 64.53 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.495 ' HB ' HG22 ' A' ' 550' ' ' VAL . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 60.32 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 74.32 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.21 105.58 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 73.31 109.521 -176.11 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.44 108.97 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 613' ' ' ASN . . . . . 0.406 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 72.1 109.296 -168.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.44 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 73.42 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.12 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 54.51 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.44 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.21 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.2 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 654' ' ' LEU . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.21 110.694 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.21 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.597 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.45 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.13 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 72.42 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.597 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.294 23.5 mmm180 . . . . . 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.54 104.651 178.962 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.13 116.465 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 62.04 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.15 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 54.42 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 654' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.54 111.853 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 32.54 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.03 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.24 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 44.23 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.43 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 64.01 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 62.32 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 62.1 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 613' ' ' ASN . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 72.21 103.979 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.14 106.225 175.736 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.746 -0.835 . . . . 71.21 108.746 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.11 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.31 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 532' ' ' PHE . . . . . 0.564 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 70.5 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.33 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 618' ' ' LEU . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.43 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.01 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 73.12 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 65.13 110.311 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 74.54 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 662' ' ' VAL . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.44 106.63 165.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.15 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 52.42 110.016 177.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.22 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 72.21 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.41 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 64.02 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.47 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.44 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.2 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 70.0 105.642 169.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 42.34 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.55 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 70.23 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.564 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 71.22 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.23 112.045 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.13 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 555' ' ' THR . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 62.2 109.801 173.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 70.13 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.25 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 43.5 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.514 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 62.54 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.15 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.41 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.42 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 63.41 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.23 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.43 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.14 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 71.44 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.12 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.41 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.15 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 45.32 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.13 106.718 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 62.45 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.23 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.2 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.43 114.655 -171.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.34 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 74.31 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 51.21 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 73.35 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 64.33 110.561 -172.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.43 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.42 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 63.21 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.03 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 63.34 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 70.13 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 71.13 106.876 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.43 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 54.23 118.855 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.2 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 73.04 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.14 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 63.33 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.463 ' HB ' HG22 ' A' ' 550' ' ' VAL . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 72.12 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.14 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.11 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.34 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.3 106.67 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.11 108.188 -177.295 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.025 -1.102 . . . . 63.12 108.025 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.31 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 64.11 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.55 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 598' ' ' ILE . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 62.22 106.554 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.4 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 72.12 107.462 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.4 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.41 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 54.01 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.42 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.682 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 72.41 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 71.24 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 72.02 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.682 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 . . . . . 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 73.55 107.604 177.598 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.517 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 71.04 115.754 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.14 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.14 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.22 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 62.21 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 71.22 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 73.42 114.647 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.22 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.31 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.32 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.12 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 74.32 108.669 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.14 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 65.32 106.305 173.74 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 107.462 -1.31 . . . . 73.4 107.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 21.34 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.718 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 72.12 105.863 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.14 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.23 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 64.24 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 52.05 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.13 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.45 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.32 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.691 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 65.11 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 65.52 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 662' ' ' VAL . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 54.42 108.609 172.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.42 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.14 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 72.21 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 63.45 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 70.3 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.15 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.468 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.33 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.32 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.31 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 61.42 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.33 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 72.14 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.52 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 531' ' ' ILE . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.12 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.13 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.663 ' H ' HG23 ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.33 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.15 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.13 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.14 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.3 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.21 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.55 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.42 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.14 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.1 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 63.4 108.367 172.029 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 74.25 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.446 HG22 ' HD2' ' A' ' 567' ' ' ARG . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 70.35 104.403 -170.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.13 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.1 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 64.51 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 52.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.21 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 64.12 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 61.11 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.13 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.13 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 71.32 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.32 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 71.2 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.34 111.137 -173.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.4 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 71.1 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.4 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 73.43 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.01 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 72.51 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.05 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 60.21 116.216 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.32 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.43 119.125 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.32 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 72.24 105.686 170.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 73.42 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 60.43 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 61.32 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.02 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.42 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 72.35 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.04 108.811 -178.26 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.064 -0.717 . . . . 64.32 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 71.13 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.15 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.44 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.3 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.33 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.23 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.32 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.45 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.3 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.15 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 73.3 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 72.1 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 . . . . . 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.1 109.744 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 53.02 115.721 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.05 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 63.14 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 70.52 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 63.11 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 54.5 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.45 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 52.33 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 70.33 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.24 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 539' ' ' ILE . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 62.41 107.56 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.35 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.691 HG13 HG23 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.34 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.35 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.41 105.626 176.568 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.726 -1.213 . . . . 61.13 107.726 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.12 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.15 107.271 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 54.54 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 71.44 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.573 ' CE1' HD21 ' A' ' 618' ' ' LEU . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 72.5 108.081 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.3 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 45.23 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.34 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 62.42 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.34 109.515 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.12 107.418 170.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 662' ' ' VAL . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.01 108.533 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 52.3 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 64.4 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.15 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.11 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 52.25 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.13 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.13 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.24 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.44 106.245 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 73.52 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 73.53 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 73.54 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.01 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 64.43 110.246 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.32 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 33.34 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 554' ' ' ARG . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 45.34 109.647 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 72.42 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 43.32 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.35 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 63.05 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 74.51 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.43 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.44 115.129 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 65.01 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.01 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.04 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 71.45 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.2 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.4 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 42.23 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 72.22 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.31 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 64.23 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.1 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 71.22 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 71.44 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 63.12 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.4 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 62.45 109.32 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.44 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.04 109.044 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 63.34 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.42 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.12 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 62.05 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 43.1 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 52.14 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.31 117.072 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 62.31 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.22 104.547 168.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 73.11 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.4 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 71.33 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.01 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.478 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.12 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.02 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 62.43 104.98 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.12 110.666 -173.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.212 1.006 . . . . 71.42 111.913 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.54 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 598' ' ' ILE . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 74.12 105.661 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.21 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.0 106.758 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.14 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.42 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 62.22 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.11 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.712 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.33 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 62.52 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.44 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.712 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 . . . . . 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 74.51 107.814 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.664 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.3 115.981 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.1 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 74.43 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 23.23 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 71.23 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 54.33 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 63.41 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.24 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 72.44 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 42.11 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.32 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 65.23 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 539' ' ' ILE . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 71.2 109.082 -171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 72.32 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 54.31 105.535 173.588 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.108 0.48 . . . . 61.42 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.21 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.687 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 72.04 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 70.23 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.23 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 64.41 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.23 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.11 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.23 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.21 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.714 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 72.01 109.454 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.15 108.212 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 662' ' ' VAL . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 72.53 108.206 170.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.21 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.01 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.21 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 62.33 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.23 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.11 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.465 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.01 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 70.3 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.11 105.45 172.908 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 53.43 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.24 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 54.35 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.22 110.287 -177.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 73.12 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.42 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 63.04 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.433 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.12 111.919 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.35 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.41 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.467 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.45 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 562' ' ' VAL . . . . . 0.54 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 73.24 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 72.2 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 73.12 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.11 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.4 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 74.54 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.35 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 41.51 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 64.44 111.306 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.14 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 61.13 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.24 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.43 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.23 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.52 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.02 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 62.22 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.42 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.53 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.3 109.296 -171.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.13 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 71.21 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 63.42 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.24 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 63.43 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.609 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.22 115.669 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.31 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 71.21 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.34 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 71.03 104.122 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.41 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 71.13 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 62.12 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 60.4 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 54.14 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 64.43 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 543' ' ' GLU . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.35 106.175 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 60.01 109.61 -172.15 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.177 -0.675 . . . . 73.44 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.43 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 63.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.13 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.01 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 74.41 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.03 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.11 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 53.14 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.561 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.25 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 624' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 73.34 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.467 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.42 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.561 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 44.42 116.25 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.539 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 34.41 116.67 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.43 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.52 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 70.45 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.01 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.35 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.34 114.659 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 61.03 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.22 109.522 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.4 108.612 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.14 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.714 HG13 HG23 ' A' ' 539' ' ' ILE . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.33 109.023 -171.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 72.31 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.2 106.593 175.062 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.13 108.549 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.32 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 54.13 108.883 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 73.14 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.3 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.31 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.1 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 64.1 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.14 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.45 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.427 HD13 HG13 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 53.21 107.598 177.76 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.42 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 548' ' ' MET . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 73.31 106.732 169.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 545' ' ' ILE . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 71.4 102.109 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.2 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 33.34 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 545' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 542' ' ' SER . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.14 110.18 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.35 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 62.53 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.51 ' HB2' HG11 ' A' ' 541' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.44 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.12 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 63.52 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 74.51 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 72.43 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.34 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.03 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.15 110.318 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.43 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.31 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.43 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 62.43 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 52.32 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 64.32 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 72.21 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 71.21 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 566' ' ' PHE . . . . . 0.452 ' CE2' HG23 ' A' ' 598' ' ' ILE . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 63.31 107.587 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.54 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.22 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.35 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 61.52 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 64.41 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.11 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.24 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 574' ' ' LYS . . . . . 0.453 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.15 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.34 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.14 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.24 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 578' ' ' GLU . . . . . 0.453 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.44 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.21 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.54 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 55.14 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 52.23 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 51.14 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 73.31 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.42 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.14 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.24 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.41 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.34 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.51 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 65.3 t30 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.4 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 64.02 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.659 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.41 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.04 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.3 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.13 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 65.2 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.452 HG23 ' CE2' ' A' ' 566' ' ' PHE . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 55.43 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 61.24 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 72.15 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' A' ' 543' ' ' GLU . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.51 105.581 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.35 110.014 -171.16 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.24 0.577 0 N-CA-C 104.589 -2.374 . . . . 75.3 104.589 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.02 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 614' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.4 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.32 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 71.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.51 109.277 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 534' ' ' PHE . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.2 108.005 173.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 72.45 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.44 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.419 ' HD3' HD21 ' A' ' 654' ' ' LEU . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.55 110.46 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.44 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.704 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.21 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 62.34 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 64.12 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.704 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 . . . . . 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 64.42 106.272 -179.301 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.42 116.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.32 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.23 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 64.33 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 654' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.684 173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.13 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.11 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 54.03 112.739 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 71.54 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 73.52 108.117 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 64.12 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.54 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.15 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.468 0.175 . . . . 63.42 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 21.33 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.2 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 72.01 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.31 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.53 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' GLU . . . . . 0.469 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 65.21 112.616 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.54 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 55.12 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.31 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.32 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 64.42 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 662' ' ' VAL . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.43 108.542 170.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.32 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.13 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 61.24 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.34 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 63.42 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.05 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.409 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 65.5 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.21 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.01 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.24 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.52 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.54 109.064 -176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.15 109.582 -176.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 53.13 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.33 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.2 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.565 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 60.3 112.943 -174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 61.53 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.02 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 60.41 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 562' ' ' VAL . . . . . 0.418 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.52 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 74.2 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.23 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 73.13 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 72.14 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.21 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.12 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.3 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.12 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.13 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.42 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.14 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 73.44 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 52.51 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.45 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.13 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.1 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.33 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 53.21 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.31 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.21 112.145 -171.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.33 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.51 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 73.2 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 62.55 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.01 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.23 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.507 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.42 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 64.41 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.05 111.469 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.1 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.02 114.026 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 72.53 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 63.21 107.48 -176.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.23 111.323 -178.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.33 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 72.13 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.53 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 62.42 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.417 HG21 ' HA ' ' A' ' 543' ' ' GLU . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 74.22 106.865 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 62.4 109.596 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.073 -1.825 . . . . 72.32 106.073 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 64.32 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.34 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.22 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 44.41 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 61.53 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 51.54 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.41 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.43 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.3 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.701 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.2 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 624' ' ' MET . . . . . 0.418 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 64.13 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.44 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.701 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 . . . . . 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.4 107.591 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.224 -0.529 0 N-CA-C 115.028 0.771 . . . . 44.52 115.028 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.23 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 52.44 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.13 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.43 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.42 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.22 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.13 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.34 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.44 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.45 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.2 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.31 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.44 106.191 176.126 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 52.3 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.41 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.657 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 63.23 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 64.54 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 62.32 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.4 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.33 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 61.33 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.2 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 70.12 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.706 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.44 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 662' ' ' VAL . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.14 109.625 166.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 542' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 545' ' ' ILE . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 43.45 105.16 171.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 63.13 107.522 168.624 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.54 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 542' ' ' SER . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 74.42 110.205 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 51.53 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.33 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 62.15 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.54 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.32 106.481 172.368 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.24 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 71.0 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.4 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.11 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 52.43 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.33 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.34 113.183 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.536 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 55.41 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.13 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.463 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.24 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.34 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 64.53 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 63.42 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 62.31 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 70.25 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.41 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.43 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.31 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.54 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 61.5 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.43 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 43.34 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 64.31 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.01 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.21 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.43 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.3 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.33 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.45 110.59 -172.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.35 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 71.21 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.54 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.42 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.13 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.12 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 65.13 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 52.52 114.692 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.24 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 72.4 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.417 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 62.42 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.54 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 596' ' ' LYS . . . . . 0.443 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.32 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 597' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 45.04 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 72.11 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 71.35 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 64.23 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.43 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.34 107.627 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 72.13 109.28 -178.077 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 107.396 -1.335 . . . . 64.24 107.396 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.21 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.52 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 71.14 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 73.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 62.11 108.632 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 73.45 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.22 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 72.23 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 62.12 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.55 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.477 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 74.02 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.4 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.463 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 54.42 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.477 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.54 114.711 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 51.01 116.348 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 62.4 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.33 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 63.45 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 44.22 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.34 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.32 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.23 112.694 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.34 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 41.1 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 71.24 107.337 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 43.5 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.706 HG13 HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 71.22 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 42.14 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.43 104.957 177.134 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 55.43 109.308 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 55.44 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.486 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.34 108.558 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.14 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.32 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.483 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 73.2 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 73.01 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 60.43 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 64.11 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 52.05 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.11 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 62.33 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 545' ' ' ILE . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.67 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 61.03 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 71.41 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 545' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 542' ' ' SER . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.23 109.724 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.53 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 61.24 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 51.13 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 53.5 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 64.14 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.44 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.12 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 74.43 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.41 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.744 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.31 111.309 -175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.744 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 71.12 109.527 170.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 60.35 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.44 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.31 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 71.55 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 562' ' ' VAL . . . . . 0.526 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.12 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.42 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 72.3 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.24 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.11 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.53 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.13 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 65.43 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 54.25 110.443 -179.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 52.11 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.21 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 52.24 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 45.34 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 42.42 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.44 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.31 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.53 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.2 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.31 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 63.22 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.1 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 63.12 110.527 -171.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 71.42 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.44 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.33 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.52 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.41 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.44 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.649 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 71.25 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.1 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 64.2 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.24 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 50.32 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 72.22 105.296 168.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.21 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 41.24 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.11 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 51.5 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 64.13 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 55.53 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 72.41 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 50.11 107.641 -176.63 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 72.13 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 71.54 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.21 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.24 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.14 106.897 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 70.15 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.23 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 52.22 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.51 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 70.23 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.674 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.43 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 624' ' ' MET . . . . . 0.526 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 60.4 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 64.01 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.674 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 55.21 107.94 179.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 32.14 115.685 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 72.03 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.42 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.22 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 73.41 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.43 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 53.44 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 657' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.33 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 42.24 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 62.34 109.404 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 54.01 105.078 176.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 71.23 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 61.44 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.11 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 72.32 105.468 173.056 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 106.198 -1.778 . . . . 73.14 106.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 71.44 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.556 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 64.35 106.92 171.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.14 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 70.34 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 535' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 553' ' ' LEU . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.44 113.514 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.2 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 62.35 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.732 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.23 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.13 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 662' ' ' VAL . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.44 108.718 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 53.41 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 62.04 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 64.34 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.24 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.11 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.31 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.413 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 71.54 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 54.44 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.31 105.068 170.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.54 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.51 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.435 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.22 108.696 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 73.11 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.22 112.317 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 45.42 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.34 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.458 ' HB2' ' CD ' ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.02 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.44 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.24 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 74.35 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 65.11 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 61.34 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 63.34 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 51.11 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 72.32 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.546 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.23 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.41 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.546 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.24 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.23 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 71.23 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 51.04 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.32 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 71.34 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.21 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 45.54 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.4 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.11 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 73.51 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.33 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.23 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.41 112.029 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.24 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.33 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.3 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 64.03 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 70.51 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 589' ' ' PHE . . . . . 0.404 ' HD2' ' HA ' ' A' ' 594' ' ' THR . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.12 104.492 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.619 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.45 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 63.7 t30 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 42.31 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 64.44 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.619 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.23 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 589' ' ' PHE . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.41 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.14 103.382 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 71.35 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 53.41 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.33 107.11 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 64.33 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 64.11 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.43 105.993 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t . . . . . 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.1 109.768 -173.735 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.181 -1.044 . . . . 72.52 108.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.51 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.22 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 73.44 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.403 HG21 HG21 ' A' ' 598' ' ' ILE . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 51.32 106.685 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.33 108.024 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.43 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.33 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.22 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 73.11 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.03 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.53 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.43 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.21 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 . . . . . 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 72.52 112.061 176.556 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.624 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.33 117.5 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 71.03 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 61.51 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 61.53 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 61.12 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 63.01 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.11 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 71.54 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.21 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 72.43 108.569 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 550' ' ' VAL . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 63.25 107.167 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.01 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 63.22 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 63.52 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 52.23 106.162 177.132 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.44 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 72.21 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.33 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.23 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.11 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.15 113.787 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 73.35 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.01 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.671 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.52 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.32 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 548' ' ' MET . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 71.21 107.957 168.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.31 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.41 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.43 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.32 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 50.45 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.22 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.421 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 70.54 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 62.31 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 616' ' ' ILE . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.2 106.685 171.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 64.43 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.22 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.12 109.632 178.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.44 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.22 111.51 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 53.41 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 557' ' ' GLY . . . . . 0.773 ' H ' HG23 ' A' ' 555' ' ' THR . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 35.33 110.373 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.23 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 72.43 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 44.35 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.22 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.43 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 52.11 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.24 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 60.02 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 566' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 598' ' ' ILE . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.14 108.098 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.03 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 63.24 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 64.43 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 72.31 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.12 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 73.24 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 52.53 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 64.31 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.33 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.33 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.33 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.05 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.34 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.35 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.54 108.28 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.31 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 63.33 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.14 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 41.4 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 65.33 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 70.43 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 72.3 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 65.44 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.03 116.111 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.31 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 62.22 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.13 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.34 105.923 169.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 62.24 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.51 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 550' ' ' VAL . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 71.3 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 65.54 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.23 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.4 107.458 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.14 105.741 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 74.3 110.047 -177.455 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.45 0.643 . . . . 74.41 111.767 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.23 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 62.43 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.42 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 550' ' ' VAL . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 62.54 105.585 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 64.03 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 71.52 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.24 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.02 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 621' ' ' PRO . . . . . 0.417 ' HD3' HD21 ' A' ' 654' ' ' LEU . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 64.31 110.469 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 61.54 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.71 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.43 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.33 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 60.01 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.71 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 . . . . . 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 55.44 107.855 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.473 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 64.44 115.984 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.51 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 70.3 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 64.11 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 654' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 621' ' ' PRO . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.35 111.215 174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 62.53 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.14 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.35 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.4 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.11 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 539' ' ' ILE . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 73.1 107.622 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 62.23 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.671 HG13 HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 63.33 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 62.31 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 72.03 106.307 176.14 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.866 0.365 . . . . 64.1 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.45 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.678 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.1 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 74.2 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.44 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 65.23 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 64.3 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.31 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.54 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.718 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 72.21 108.434 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 62.13 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 168.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 53.15 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.01 111.918 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.01 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 63.31 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 41.51 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 71.21 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 64.04 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.3 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.421 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.14 103.787 169.438 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.44 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 71.43 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.34 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.427 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 62.54 109.704 -177.037 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.45 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.11 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 43.42 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.35 114.233 -172.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.43 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.23 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.44 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 62.04 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.53 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.31 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 63.22 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.24 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.12 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.04 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.24 110.418 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.35 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 71.04 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 60.23 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.01 106.932 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 71.31 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.12 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.2 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 62.11 115.924 -162.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.21 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.35 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.54 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.43 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.43 109.779 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.13 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.33 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 62.12 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.33 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.55 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 63.12 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.2 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.2 t30 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 72.13 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 65.34 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 61.04 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 63.21 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 71.54 103.414 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.3 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 53.45 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 616' ' ' ILE . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.01 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.31 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 583' ' ' ALA . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.44 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 71.52 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 543' ' ' GLU . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 73.04 107.583 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.52 110.306 -176.556 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.033 -0.729 . . . . 53.03 109.033 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.03 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.54 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.35 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 598' ' ' ILE . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 73.42 106.474 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.42 108.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.21 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 71.35 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 70.12 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.44 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 61.42 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 60.3 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.11 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 . . . . . 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 65.13 110.498 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.594 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 71.4 115.573 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.51 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 41.15 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 64.13 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.3 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 64.32 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.21 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.43 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.32 109.183 -176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 539' ' ' ILE . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 71.34 108.474 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.42 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.718 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.44 107.805 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 74.21 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 65.04 104.732 175.29 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.845 0.355 . . . . 55.34 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.45 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.739 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.11 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 62.4 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 64.44 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.31 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.24 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.11 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 61.11 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 64.15 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.734 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 73.42 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 72.53 108.318 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 71.42 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 43.03 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.22 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 63.25 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.45 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.4 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.52 109.532 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 74.0 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 70.14 104.284 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 53.01 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 73.14 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.3 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 73.44 109.874 -177.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.13 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.21 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 43.52 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.21 111.671 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.44 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 74.2 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 71.11 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.12 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 73.11 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 71.34 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 565' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.15 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.11 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.428 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 55.44 108.257 171.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.21 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.32 111.1 -177.468 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.21 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.31 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.2 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 71.3 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 51.53 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 42.13 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 65.32 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.24 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 72.31 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.23 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 71.33 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.31 108.723 -174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.42 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.21 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 586' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.42 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 44.54 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.51 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 64.34 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.535 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.52 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 64.21 115.36 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 71.4 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.535 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 51.41 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 594' ' ' THR . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.0 113.812 -168.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 62.25 106.717 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 72.2 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 61.54 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 73.51 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.21 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 583' ' ' ALA . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 64.1 107.324 177.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.41 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 602' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 543' ' ' GLU . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 71.32 103.692 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.2 107.789 -174.137 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.82 -1.178 . . . . 74.15 107.82 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 62.34 106.023 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.03 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.23 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.31 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 617' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 44.52 107.362 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.42 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.45 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 71.21 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 70.53 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 72.35 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.693 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.11 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 70.31 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.3 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.693 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.21 106.739 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.462 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 50.14 117.183 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.43 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 61.35 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.32 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.42 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.11 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.33 112.247 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 61.4 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 74.2 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 550' ' ' VAL . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.44 105.986 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.23 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.54 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.43 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 64.15 105.302 175.457 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 107.696 -1.224 . . . . 61.31 107.696 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.44 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' ILE . . . . . 0.664 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.13 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.44 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 51.41 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' PHE . . . . . 0.596 ' CE1' HD21 ' A' ' 618' ' ' LEU . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.33 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 553' ' ' LEU . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.11 113.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 54.25 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.44 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 72.04 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 539' ' ' ILE . . . . . 0.575 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 52.32 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 51.21 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 53.22 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 543' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.35 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.11 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.24 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 63.11 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 72.53 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 62.1 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.32 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 550' ' ' VAL . . . . . 0.573 HG22 HD12 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.23 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 74.5 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.12 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 553' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 60.22 108.173 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 554' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 555' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 63.12 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 65.24 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.32 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 558' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.34 112.901 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.11 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 64.11 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 561' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 73.02 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.13 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 74.52 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 70.21 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.41 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.45 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 567' ' ' ARG . . . . . 0.497 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.24 106.335 171.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.51 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 569' ' ' VAL . . . . . 0.497 HG22 ' HD2' ' A' ' 567' ' ' ARG . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.23 104.303 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 570' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 71.21 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.12 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.34 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.22 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 73.45 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.4 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.15 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.13 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.32 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.31 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 71.35 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 70.33 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.33 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.14 111.631 -172.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.42 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.42 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 53.54 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 64.42 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.12 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 72.42 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 590' ' ' LYS . . . . . 0.567 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 62.35 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 52.01 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 592' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 63.43 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 593' ' ' GLU . . . . . 0.567 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.24 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 594' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 594' ' ' THR . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.51 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.42 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 64.44 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 64.34 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 598' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 616' ' ' ILE . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 72.14 106.744 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 64.55 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.42 109.228 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 65.31 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.43 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 62.34 111.936 -172.688 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 62.3 107.862 -172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.44 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 615' ' ' PHE . . . . . 0.414 ' HB2' ' HD2' ' A' ' 659' ' ' LYS . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.34 108.003 -173.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 616' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 598' ' ' ILE . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 61.21 107.797 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 43.33 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 618' ' ' LEU . . . . . 0.596 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 52.24 108.741 173.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.02 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.12 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 62.33 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.52 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.4 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.34 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 625' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.23 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear build core ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 . . . . . 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.54 113.94 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 63.03 117.357 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 71.33 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 64.43 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 63.11 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.13 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.14 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.14 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 51.41 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 615' ' ' PHE . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.01 107.317 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 72.03 104.33 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.2 109.45 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 662' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.34 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.41 104.245 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 63.22 106.109 176.893 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -53.77 135.06 42.07 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.714 0.634 . . . . 0.0 109.36 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.541 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.421 HG22 HG12 ' A' ' 662' ' ' VAL . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.405 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 557' ' ' GLY . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 555' ' ' THR . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 578' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.22 143.69 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.08 123.85 46.64 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.959 -170.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.3 -21.23 3.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.18 168.01 0.14 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 54.59 21.46 3.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.985 1.314 . . . . 0.0 113.703 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.59 135.69 38.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -91.75 12.61 20.73 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -135.05 135.56 41.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.31 131.51 40.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.43 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -105.29 152.31 23.06 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.429 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.422 ' HD3' HD21 ' A' ' 654' ' ' LEU . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.687 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.687 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 163.23 -55.02 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.1 64.74 1.89 Allowed Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.854 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.72 130.76 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 8.7 t -149.57 176.65 10.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.05 149.91 49.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.509 0.671 . . . . 0.0 110.621 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.31 81.27 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.81 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.7 m -70.23 -45.32 66.76 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -155.88 125.96 6.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.428 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -147.78 73.99 1.29 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 170.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.76 114.83 4.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 28.0 mt -136.98 -178.52 5.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -80.26 172.08 14.23 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.4 -44.81 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.663 0.744 . . . . 0.0 111.518 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.34 -42.4 95.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.525 1.155 . . . . 0.0 110.483 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -76.34 -19.54 58.12 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.365 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -44.45 76.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.452 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -88.12 -50.08 6.61 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.295 164.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.98 92.66 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -75.43 -38.39 59.78 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -58.54 -47.68 83.39 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 122.469 -0.145 . . . . 0.0 111.343 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.56 -42.86 97.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.178 0.513 . . . . 0.0 109.96 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.08 -32.5 74.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.17 -21.3 59.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.335 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.5 mtt -77.91 -41.7 35.63 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.37 16.99 30.39 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' LEU . . . . . 0.422 HD21 ' HD3' ' A' ' 621' ' ' PRO . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 550' ' ' VAL . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt -96.51 111.68 27.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -165.17 166.13 19.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 133.81 53.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.057 0.456 . . . . 0.0 110.288 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 4.6 t 52.05 -155.31 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -153.0 165.53 35.26 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -130.92 139.83 50.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -147.67 153.16 38.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -152.56 160.53 43.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.8 p -152.42 160.39 43.28 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 9.1 t -160.45 158.19 28.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.8 t 70.35 140.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.001 1.438 . . . . 0.0 111.428 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.337 -178.332 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.834 -0.432 . . . . 72.31 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -59.37 141.78 53.75 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.861 0.725 . . . . 52.13 110.394 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 34.44 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.566 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 72.32 107.134 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.31 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.22 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 65.43 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' GLU . . . . . 0.488 ' HG3' HD21 ' A' ' 553' ' ' LEU . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.43 114.037 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.43 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 61.44 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 74.24 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.31 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.2 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 548' ' ' MET . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.55 108.09 170.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 40.42 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.43 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 62.14 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 71.52 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 65.24 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 73.03 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 73.44 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 598' ' ' ILE . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.33 107.765 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.22 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.32 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.488 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.22 110.132 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.538 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 71.3 107.93 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 44.32 110.665 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.45 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 32.1 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.538 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 54.33 113.702 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.22 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.54 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.424 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.14 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 62.31 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 71.32 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 72.44 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 64.14 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 566' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 598' ' ' ILE . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 70.31 108.408 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 72.35 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 64.42 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 62.5 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.34 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.1 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.33 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.2 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 40.23 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.21 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 42.32 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 73.03 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.52 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 61.45 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 64.32 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.24 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.05 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.12 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.21 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.12 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 70.21 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.15 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 62.4 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 64.13 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 64.04 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.15 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.499 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.41 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 54.35 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.43 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 597' ' ' THR . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 54.33 110.592 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.35 112.007 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 550' ' ' VAL . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 65.52 106.808 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.15 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.22 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 64.11 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 543' ' ' GLU . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 62.34 106.862 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.01 143.62 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.1 113.864 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.11 142.5 54.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.213 -1.358 . . . . 71.45 109.569 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.54 145.22 54.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.489 1.292 . . . . 70.33 114.489 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -148.03 -41.74 0.17 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.485 0.92 . . . . 72.41 113.485 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -109.91 -29.38 8.29 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.599 0.963 . . . . 73.45 113.599 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -109.79 163.85 13.12 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.158 1.91 . . . . 74.44 116.158 -171.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -123.02 170.92 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.538 -1.282 . . . . 75.23 107.538 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 87.85 154.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 126.668 1.987 . . . . 74.2 112.828 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.92 130.95 48.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.148 -2.167 . . . . 64.15 105.148 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -117.49 164.14 15.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.336 -1.357 . . . . 52.3 107.336 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 73.15 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 54.2 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 61.51 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.428 HD12 HG11 ' A' ' 550' ' ' VAL . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 74.33 105.523 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 25.45 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 74.25 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.03 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 65.21 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 70.42 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 70.32 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.3 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.32 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.424 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.4 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 74.43 -40.72 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 70.25 114.023 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.32 35.02 69.18 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 110.081 -1.208 . . . . 43.12 110.081 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.39 139.8 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.956 0.884 . . . . 74.41 112.25 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 48.0 t -146.4 -49.65 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.95 -2.241 . . . . 74.41 104.95 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.62 164.02 39.17 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.331 -3.211 . . . . 72.13 102.331 171.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.28 119.8 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.321 -1.363 . . . . 73.42 107.321 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 68.4 p -118.54 172.28 7.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.694 -0.685 . . . . 61.25 111.967 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 22.1 t0 55.11 35.79 25.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.351 1.241 . . . . 61.21 114.351 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -93.86 57.11 2.42 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.482 -0.933 . . . . 73.35 108.482 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -67.84 115.76 7.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.422 -1.263 . . . . 73.14 108.446 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.46 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 24.4 mt -146.85 -172.96 4.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.483 -2.043 . . . . 74.11 105.483 -169.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -64.43 151.86 43.05 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.588 -2.375 . . . . 64.33 104.588 168.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 21.7 m -64.76 -24.04 34.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 113.066 0.765 . . . . 74.31 113.066 -161.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.93 -45.46 70.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.05 0.929 . . . . 72.13 109.208 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.43 -20.44 54.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.036 -0.983 . . . . 71.34 111.953 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 641' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 1.8 mt-10 -58.2 -41.69 84.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.215 -0.291 . . . . 74.54 110.215 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.98 -48.76 7.52 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 119.55 -0.86 . . . . 74.13 111.904 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.95 93.61 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.156 1.169 . . . . 73.42 114.156 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -73.92 -40.66 62.96 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.787 -0.82 . . . . 75.42 108.787 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -60.26 -46.43 89.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.085 -0.507 . . . . 64.22 111.834 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.72 -41.37 92.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.466 -0.568 . . . . 74.12 109.466 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.01 77.4 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.106 -0.371 . . . . 71.13 110.832 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.96 -19.5 62.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.25 0.463 . . . . 51.34 112.25 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 65.0 mtt -69.82 -41.51 74.88 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.779 -1.193 . . . . 75.23 107.779 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.73 12.4 14.08 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 53.01 117.995 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.52 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.51 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.33 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.41 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 63.41 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.34 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 71.11 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.4 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 72.51 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 73.03 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 52.41 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.53 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.18 109.08 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.11 108.374 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -167.65 157.88 10.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.614 -1.624 . . . . 75.23 106.614 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -71.27 80.93 0.73 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.017 0.826 . . . . 72.02 110.835 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 1.8 p -167.65 172.03 9.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.102 -0.703 . . . . 55.24 109.102 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.56 169.39 17.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.318 -0.993 . . . . 71.21 108.318 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -67.11 163.32 20.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.013 0.911 . . . . 54.11 111.935 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.08 153.02 36.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.712 -1.588 . . . . 64.23 106.712 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 2.1 3.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.41 1.263 . . . . 74.45 114.41 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 19.6 p 58.0 -171.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.738 1.215 . . . . 74.12 110.695 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 4.9 t -158.41 157.15 31.72 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.286 -1.375 . . . . 73.21 107.286 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.56 127.34 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 102.745 -3.058 . . . . 74.04 102.745 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.259 1.573 0 N-CA-C 104.658 -2.349 . . . . 71.04 104.658 -175.306 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.842 0 N-CA-C 107.552 -1.277 . . . . 75.32 107.552 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.25 22.92 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.981 -1.118 . . . . 53.24 107.981 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 51.41 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 71.23 109.022 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.33 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.42 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 73.54 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.23 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.31 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 65.55 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 73.51 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.69 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 64.33 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 64.43 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.21 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 54.43 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 61.32 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.05 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 62.25 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.12 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 73.12 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.431 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.2 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 71.1 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.34 105.856 171.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 62.13 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.44 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.4 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.13 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.73 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.22 110.797 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.23 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.73 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.33 109.349 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 72.12 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.32 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 43.4 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.53 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 74.32 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 61.13 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 61.43 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 71.11 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 64.33 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.43 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 61.2 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 62.13 110.776 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 63.54 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.2 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.44 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.24 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.52 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.51 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.11 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 72.2 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.33 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 73.05 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 53.22 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.22 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 61.23 110.911 -172.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.04 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.55 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.44 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.35 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.44 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 71.1 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.602 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 72.4 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.31 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.12 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.11 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 62.11 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 64.3 106.658 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 72.42 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 550' ' ' VAL . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 64.22 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.21 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 54.55 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.12 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 63.2 106.625 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.48 143.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 63.24 108.016 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -118.28 126.64 52.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.612 0.765 . . . . 73.13 109.663 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.72 147.76 24.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.575 -0.898 . . . . 71.02 108.575 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.31 9.13 7.56 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.647 1.351 . . . . 73.24 114.647 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.18 -33.45 75.42 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 117.878 2.547 . . . . 73.42 117.878 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -138.74 154.58 48.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 117.111 2.263 . . . . 73.41 117.111 -171.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 30.51 6.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.717 -1.129 . . . . 63.33 108.176 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.63 153.73 18.46 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.6 1.333 . . . . 74.24 114.6 -171.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.87 130.61 35.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.44 -1.689 . . . . 72.42 106.44 171.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.4 158.71 22.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.04 109.804 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 73.14 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.34 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.52 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 54.43 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.2 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.32 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.31 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.32 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 72.03 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.678 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.3 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 73.51 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 71.35 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.678 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 165.14 -52.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.55 107.808 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.08 63.11 2.11 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 110.655 -0.978 . . . . 53.51 110.655 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 2.9 tt -55.95 121.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.308 -0.997 . . . . 44.45 108.308 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 33.7 m -146.24 164.16 33.18 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.0 -1.481 . . . . 70.4 107.0 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -69.19 144.72 53.67 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.306 -0.998 . . . . 75.2 108.306 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.94 155.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.201 -1.037 . . . . 71.13 108.201 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 23.2 p -111.04 -84.59 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.486 . . . . 74.52 112.311 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.5 79.48 8.92 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.674 0.99 . . . . 71.44 113.674 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -90.06 59.76 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.373 -0.973 . . . . 74.42 108.373 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 99.59 0.1 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.486 -1.234 . . . . 72.45 112.751 -176.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 56.5 mt -142.05 -179.15 6.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.996 -2.224 . . . . 73.13 104.996 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 156.56 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.832 -1.914 . . . . 73.21 105.832 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.1 -45.41 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.153 0.797 . . . . 61.44 113.153 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -58.21 -48.81 79.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.551 0.691 . . . . 74.42 111.462 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -77.5 -19.49 55.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.145 0.424 . . . . 53.53 112.145 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.7 -44.63 77.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.858 -0.423 . . . . 71.42 109.858 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -87.85 -47.9 8.24 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.824 -0.75 . . . . 74.31 111.907 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.0 80.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.767 1.025 . . . . 52.11 113.767 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.84 -37.5 40.35 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 122.003 -0.436 . . . . 73.33 109.886 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -61.25 -46.25 91.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.364 -0.38 . . . . 74.11 111.122 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.77 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.498 0.666 . . . . 73.24 109.648 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.15 71.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.093 0.473 . . . . 74.53 111.343 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.88 -17.46 59.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.156 -0.474 . . . . 64.04 111.734 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 54.4 mtt -79.56 -41.42 27.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.395 -1.705 . . . . 72.41 106.395 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.548 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.7 15.77 27.69 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.45 117.305 166.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 72.41 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.34 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.22 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 71.34 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.44 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 74.53 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 63.45 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 55.23 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 73.45 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 64.24 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 73.12 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 72.12 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 70.43 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.53 102.25 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 70.02 106.165 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -172.48 138.16 0.88 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 106.437 -1.69 . . . . 74.11 106.437 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.86 91.74 2.0 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.672 0.749 . . . . 73.52 109.648 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 23.2 t -166.85 -177.15 3.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.352 -2.092 . . . . 61.01 105.352 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.21 156.5 41.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.404 -1.702 . . . . 73.31 106.404 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.58 164.82 36.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.011 -1.107 . . . . 72.3 108.011 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 60.47 -179.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.557 1.143 . . . . 71.23 114.064 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 51.63 58.46 5.47 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.668 0.988 . . . . 72.43 113.668 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 40.3 t -58.52 147.88 30.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.105 -0.952 . . . . 62.43 109.654 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 39.6 p -82.65 -10.23 59.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.606 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.42 160.49 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.293 -1.002 . . . . 74.42 108.293 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 103.444 -2.798 . . . . 62.33 103.444 178.874 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 CA--C 1.516 -0.327 0 N-CA-C 109.182 -0.674 . . . . 62.12 109.182 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -64.6 152.43 42.13 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.51 109.112 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 64.1 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.4 106.716 172.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 70.33 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 72.33 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.604 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 63.15 110.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.13 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 70.52 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 73.44 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 65.32 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.13 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.11 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 71.3 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.54 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.3 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.15 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 72.3 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 61.31 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 65.21 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 63.34 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.45 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.14 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.21 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.33 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.33 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 62.31 108.828 177.149 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.51 112.65 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 61.35 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.481 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.32 113.09 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 51.32 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 72.4 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.13 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 72.14 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.41 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.24 115.301 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.33 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 72.31 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 568' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 580' ' ' PHE . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 71.11 109.361 176.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.31 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.451 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.44 109.545 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.43 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.21 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 61.23 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 64.31 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.21 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.45 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.21 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.23 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 580' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 568' ' ' THR . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 70.21 102.113 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.22 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.21 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.4 111.582 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.11 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.44 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.21 110.144 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 74.31 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 64.42 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 64.43 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 44.13 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.23 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.611 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 60.35 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.44 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 53.34 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 72.25 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 71.34 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 616' ' ' ILE . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.23 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 53.35 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 63.12 109.788 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 62.15 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 71.45 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.92 143.64 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 52.4 108.026 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.08 134.8 54.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.912 0.885 . . . . 72.22 112.498 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 605' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 607' ' ' GLU . 10.4 tp10 -158.16 154.61 27.67 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 105.765 -1.939 . . . . 72.44 105.765 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.8 4.27 19.75 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.185 1.18 . . . . 72.52 114.185 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 605' ' ' GLU . 31.4 tt0 -65.15 -38.45 90.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.787 2.143 . . . . 71.51 116.787 -171.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -144.07 137.36 27.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.055 1.872 . . . . 62.31 116.055 -170.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.22 112.99 16.99 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.539 -0.755 . . . . 70.35 110.42 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -152.2 143.56 23.34 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 112.836 0.68 . . . . 72.02 112.836 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -84.73 119.63 25.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.194 -2.521 . . . . 75.01 104.194 166.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -117.74 159.33 23.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.276 -1.379 . . . . 52.13 107.276 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 613' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.4 112.795 -170.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 614' ' ' PHE . . . . . 0.472 ' CE1' HG21 ' A' ' 662' ' ' VAL . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.15 109.756 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.11 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 598' ' ' ILE . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 54.03 107.768 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.604 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 72.22 107.904 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.42 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.02 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 73.05 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.22 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.698 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.53 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 61.13 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 73.45 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.698 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 164.3 -49.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 70.13 107.39 179.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.21 58.22 3.74 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.266 -1.134 . . . . 62.45 110.266 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 628' ' ' ILE . 1.1 tt -52.1 123.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.924 -0.638 . . . . 73.23 111.228 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.4 m -151.0 154.81 37.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.649 -2.352 . . . . 60.3 104.649 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.41 153.29 22.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.489 -1.671 . . . . 75.45 106.489 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 10.3 p -148.28 140.16 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.46 -0.941 . . . . 72.21 108.46 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.0 t -131.24 -3.05 3.91 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.83 1.789 . . . . 75.45 115.83 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -77.59 -21.01 53.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.914 0.864 . . . . 75.34 109.336 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -83.36 72.66 10.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.234 -0.894 . . . . 72.32 111.537 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -65.81 129.77 40.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.045 -0.98 . . . . 74.24 108.785 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.516 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 91.8 mt -127.9 -173.58 2.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 103.592 -2.744 . . . . 71.42 103.592 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -65.35 149.99 49.04 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 103.387 -2.82 . . . . 60.43 103.387 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.06 -25.6 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.616 0.598 . . . . 73.11 112.616 -160.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.53 -49.85 65.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.994 0.902 . . . . 54.42 109.342 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.85 -25.49 63.76 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 114.735 -1.121 . . . . 60.32 111.7 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' GLU . . . . . 0.516 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 0.7 OUTLIER -59.38 -43.31 92.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.619 -0.832 . . . . 73.1 110.891 -177.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.21 -44.71 10.67 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.009 -1.076 . . . . 75.11 111.317 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.89 86.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.23 0.923 . . . . 72.44 112.361 -173.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -42.06 70.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 121.031 0.443 . . . . 72.24 110.405 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.38 -46.13 89.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.995 -0.548 . . . . 64.23 111.64 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -63.32 -41.25 92.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.272 0.558 . . . . 75.42 109.684 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.61 72.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.527 0.679 . . . . 63.52 110.881 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -77.89 -17.94 56.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 73.14 111.907 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 52.5 mtt -71.57 -41.2 69.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.907 -1.516 . . . . 74.11 106.907 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.47 13.45 22.98 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 116.891 1.516 . . . . 72.52 116.891 166.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.53 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 61.3 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 74.52 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.04 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.31 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.02 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.15 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.34 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 70.23 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 72.3 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.45 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.22 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 613' ' ' ASN . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.13 103.193 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt -87.64 124.23 40.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.42 106.61 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.25 -179.68 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.075 1.88 . . . . 63.23 116.075 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.8 -176.71 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.533 1.133 . . . . 72.55 112.108 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 95.6 p -136.75 174.18 10.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.574 -0.528 . . . . 73.12 109.574 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -162.03 158.28 24.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.63 -1.248 . . . . 73.52 107.63 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -113.91 133.39 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.232 -1.025 . . . . 74.43 108.232 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -99.0 56.16 1.04 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.699 -1.223 . . . . 72.1 107.699 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -69.76 111.14 5.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.3 -1.318 . . . . 73.4 110.408 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 57.2 p -82.5 142.67 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 64.02 109.612 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 41.7 p -132.28 159.74 38.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.611 -1.626 . . . . 74.22 106.611 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.9 164.34 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.952 -1.87 . . . . 61.3 105.952 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 102.781 -3.044 . . . . 64.52 102.781 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 105.28 -2.118 . . . . 74.31 105.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.08 139.49 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.705 -1.22 . . . . 75.43 107.705 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.14 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 45.3 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 71.22 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 71.32 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 618' ' ' LEU . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 63.42 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.41 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 61.41 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.23 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 70.53 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.31 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 662' ' ' VAL . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.11 107.937 169.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 61.23 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 71.31 110.926 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 52.32 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.1 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 62.33 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.23 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 73.12 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 62.03 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 53.21 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.1 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.53 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.14 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 51.54 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.736 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.23 109.722 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 43.11 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.736 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.32 109.049 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.24 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.24 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.23 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 62.32 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 63.1 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 64.12 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.42 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.23 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 70.2 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.35 108.622 171.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 70.4 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.404 HG22 ' HD2' ' A' ' 567' ' ' ARG . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.3 104.957 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.47 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.43 112.223 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 43.01 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 52.11 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.41 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.42 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 62.23 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.33 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 33.21 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 74.5 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.11 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.03 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.33 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 64.4 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 61.34 110.581 -169.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.24 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.14 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.32 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 51.11 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 54.32 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.44 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.655 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.31 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.14 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.14 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.655 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.32 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.44 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 71.41 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.35 109.094 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 72.21 112.505 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.42 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 70.42 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 583' ' ' ALA . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 73.02 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.41 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 73.11 106.157 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.65 142.46 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.13 109.328 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.38 156.07 21.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.709 0.803 . . . . 73.14 111.592 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -133.38 151.44 51.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.071 -1.085 . . . . 73.24 108.071 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -89.22 121.21 31.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.583 0.23 . . . . 62.32 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.63 -152.47 0.32 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.373 1.069 . . . . 74.4 113.318 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 61.01 -158.07 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.943 0.897 . . . . 72.15 112.232 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.81 -72.73 0.19 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.918 -0.401 . . . . 75.31 109.918 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 60.91 168.45 0.09 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.772 1.767 . . . . 63.24 115.772 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -147.41 83.57 1.55 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 104.056 -2.572 . . . . 65.44 104.056 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -89.94 153.13 20.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.64 -0.824 . . . . 73.53 110.936 -170.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 73.13 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 64.04 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.11 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.21 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 31.32 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.61 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 64.43 108.107 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.4 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.32 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 63.43 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.34 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.625 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.13 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.14 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.3 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.625 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.269 12.9 mmm180 157.04 -57.23 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 71.45 106.813 175.858 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.3 71.76 1.27 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.525 -1.43 . . . . 62.35 109.525 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 628' ' ' ILE . 1.3 tt -57.59 119.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.641 . . . . 74.51 109.827 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.0 t -164.13 161.46 22.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.878 -2.638 . . . . 73.3 103.878 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.37 137.06 36.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.834 -0.802 . . . . 74.12 108.834 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 26.2 t -115.23 82.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.896 -1.52 . . . . 72.12 106.896 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.89 1.64 5.29 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.515 0.674 . . . . 73.41 112.362 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.38 4.19 13.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.927 0.87 . . . . 63.51 109.317 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -114.36 132.66 56.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.98 -0.748 . . . . 73.31 108.98 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -122.36 134.35 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.879 -1.897 . . . . 75.11 105.879 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 73.4 mt -136.49 176.2 8.92 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 105.849 -1.908 . . . . 75.1 105.849 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.5 t -63.91 150.36 45.16 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 104.366 -2.457 . . . . 70.43 104.366 169.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.05 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.808 0.67 . . . . 70.15 112.808 -160.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -47.53 74.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.895 0.855 . . . . 63.21 109.37 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -74.38 -24.21 59.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.988 -1.006 . . . . 73.1 111.775 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.06 -39.16 88.81 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.404 -0.518 . . . . 62.2 110.087 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.75 -47.77 8.38 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 119.537 -0.865 . . . . 73.13 111.381 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.64 87.56 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.331 0.863 . . . . 61.44 113.331 -170.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -69.29 -40.22 77.86 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.14 -0.689 . . . . 44.2 109.14 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -62.63 -47.83 82.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.038 0.384 . . . . 75.14 112.038 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.5 mt -60.12 -41.99 88.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.055 0.455 . . . . 64.45 110.14 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.43 76.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.044 0.45 . . . . 71.43 110.766 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -80.47 -17.13 52.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.649 0.611 . . . . 72.43 112.649 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 60.4 mtm -74.51 -41.72 60.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.566 -1.642 . . . . 74.11 106.566 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.546 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.53 16.6 29.9 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 116.931 1.532 . . . . 52.44 116.931 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.24 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 43.41 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 54.23 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 55.33 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 42.14 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.35 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.24 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 62.34 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.45 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 64.45 105.121 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 63.12 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.41 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.24 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt -92.03 92.57 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.31 105.989 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -173.39 128.16 0.43 Allowed 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.586 -2.005 . . . . 73.32 105.586 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.37 135.52 45.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.637 0.653 . . . . 65.24 109.39 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 89.1 p -154.61 158.56 39.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.783 -0.451 . . . . 73.34 109.783 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -82.41 142.1 32.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.111 -0.7 . . . . 71.41 109.111 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -138.34 161.92 35.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.108 -1.071 . . . . 54.4 108.108 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -148.95 142.38 25.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.324 -0.621 . . . . 75.2 109.324 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -124.29 138.67 54.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.551 -0.907 . . . . 70.34 108.551 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.7 m -78.33 163.06 26.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.207 -0.451 . . . . 61.4 109.958 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.5 t -149.01 163.18 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.608 -2.367 . . . . 73.21 104.608 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 7.4 m 51.31 -176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.825 1.65 . . . . 63.33 115.02 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.528 -0.749 . . . . 73.14 111.202 -176.318 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 109.337 -0.616 . . . . 72.32 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -72.64 143.52 48.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.13 109.278 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.35 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.34 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 532' ' ' PHE . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.22 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 63.4 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.14 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 63.33 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.33 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 72.31 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 73.34 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.636 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.21 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 62.22 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.31 109.912 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.42 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 60.22 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.53 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 65.25 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 24.01 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 74.41 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.455 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.35 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 64.44 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.488 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.22 106.333 171.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 65.53 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 65.21 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 72.2 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 72.21 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 51.44 110.815 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.21 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 61.5 109.972 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.35 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 64.21 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 34.13 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 52.44 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.498 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.33 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 563' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 586' ' ' GLU . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.15 104.872 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 64.13 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 62.11 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.4 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.43 107.534 172.053 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 568' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.44 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' A' ' 567' ' ' ARG . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.03 106.73 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.463 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 65.51 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 64.43 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 65.21 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.02 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.15 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 61.41 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 60.02 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.15 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.05 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.1 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.24 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 582' ' ' ASP . . . . . 0.416 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.24 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 52.14 107.947 -169.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.21 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.23 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 586' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 563' ' ' ILE . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 70.34 110.387 176.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.11 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.22 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 73.11 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 74.41 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.21 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.32 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.41 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 71.12 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 70.22 105.321 168.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.2 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.11 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 71.41 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 72.01 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.54 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 62.24 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.54 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.55 143.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.04 105.097 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.99 97.64 3.35 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.667 0.617 . . . . 64.04 112.667 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.67 152.46 28.66 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 106.921 -1.511 . . . . 64.03 106.921 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -93.96 128.8 40.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.972 1.841 . . . . 73.33 115.972 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.0 -63.71 0.21 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.839 0.681 . . . . 74.21 112.839 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 27.66 0.68 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.224 1.194 . . . . 72.35 114.224 -172.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -74.94 155.28 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.356 1.243 . . . . 72.31 114.356 -170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 -153.02 0.44 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 104.216 -2.512 . . . . 74.14 104.216 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.9 103.96 6.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.881 -1.526 . . . . 74.43 106.881 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -89.46 163.42 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.538 -0.541 . . . . 71.52 109.538 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.15 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.2 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 64.42 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 550' ' ' VAL . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 64.22 105.355 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 64.43 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.2 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.04 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 73.31 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 62.03 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 62.42 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.717 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.3 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 624' ' ' MET . . . . . 0.498 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 31.34 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 73.21 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.717 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 164.32 -57.15 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.41 107.777 179.511 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.95 71.84 1.24 Allowed Glycine 0 C--O 1.224 -0.508 0 N-CA-C 107.932 -2.067 . . . . 61.54 107.932 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.22 119.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.99 0.9 . . . . 72.13 110.458 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 30.5 p -168.77 -172.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 102.255 -3.239 . . . . 74.44 102.255 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.14 161.07 36.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 0.455 . . . . 75.12 109.815 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.37 129.17 70.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.034 -1.469 . . . . 73.45 107.034 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.9 t -94.9 -19.03 20.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.833 0.825 . . . . 63.33 110.166 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.2 -30.49 70.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.303 -0.862 . . . . 74.42 112.269 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.69 136.85 34.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.09 -0.707 . . . . 74.32 109.09 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -120.93 135.56 55.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.715 -1.217 . . . . 74.42 107.715 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.77 -179.52 5.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.167 -2.16 . . . . 72.13 105.167 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -67.42 155.89 37.9 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.369 -2.086 . . . . 60.24 105.369 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.53 -25.11 36.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.08 0.77 . . . . 73.12 113.08 -162.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.56 -47.84 62.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.121 0.962 . . . . 62.13 109.302 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.79 -20.87 61.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 65.31 111.293 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.51 -41.97 91.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.185 -0.302 . . . . 71.31 110.185 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -87.69 -48.73 7.64 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 112.746 0.647 . . . . 61.33 112.746 166.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.48 73.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.084 1.142 . . . . 72.34 114.084 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -67.9 -40.03 83.51 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 109.017 -0.734 . . . . 63.54 109.017 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -47.54 84.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 111.743 0.275 . . . . 73.14 111.743 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.79 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 71.3 109.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.63 84.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.417 -0.356 . . . . 63.03 110.446 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -73.73 -24.73 59.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.173 -0.467 . . . . 64.34 112.106 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.3 mtm -67.54 -41.27 84.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.919 -1.511 . . . . 64.23 106.919 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.56 24.82 57.3 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.42 116.178 167.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 54.55 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 54.22 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 63.44 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.22 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 74.41 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.31 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.44 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.13 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 550' ' ' VAL . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 62.43 107.42 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.33 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 74.13 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.23 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.4 109.58 23.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 63.54 106.232 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 665' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 667' ' ' SER . 77.9 tt0 -166.81 149.09 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.258 -1.015 . . . . 62.44 108.258 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -68.57 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.51 0.672 . . . . 72.11 111.266 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 667' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 33.2 t -85.45 151.57 23.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.202 -0.666 . . . . 54.25 109.202 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.88 161.84 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.462 -0.94 . . . . 63.13 108.462 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.35 146.94 30.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.289 -1.004 . . . . 71.13 108.289 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.58 132.25 34.89 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.977 -1.49 . . . . 74.43 106.977 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -129.4 -3.01 4.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.658 1.725 . . . . 72.3 115.658 -174.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 35.6 t -69.51 129.78 40.64 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.121 -1.437 . . . . 73.1 107.121 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.0 m -139.21 -49.55 0.5 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.714 0.635 . . . . 51.13 112.714 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.6 160.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.657 -1.979 . . . . 71.24 105.657 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.124 -2.917 . . . . 74.32 103.124 177.369 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.216 -0.669 0 N-CA-C 107.837 -1.171 . . . . 74.12 107.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.73 34.08 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 73.53 108.614 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.44 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 43.55 108.689 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.2 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 71.43 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.34 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 71.44 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 62.41 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.24 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 52.1 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.2 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.3 m80 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.04 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 662' ' ' VAL . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.2 108.687 167.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.13 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.13 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 71.34 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.31 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.01 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.51 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.31 109.231 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 71.01 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 73.43 105.927 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.42 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.01 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.45 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.32 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.665 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.24 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.21 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 61.21 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 71.44 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 72.4 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.23 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.12 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.51 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.22 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.11 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.13 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 54.41 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.45 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 64.22 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 65.45 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 73.31 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.51 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 71.12 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.52 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 73.21 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.12 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.45 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 50.22 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 32.23 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.44 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.32 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.23 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 65.11 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.12 111.527 -170.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.45 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.43 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 64.21 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 61.25 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 55.55 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 74.02 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.62 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 70.15 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 61.43 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 72.41 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.23 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 54.12 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 71.01 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.14 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 64.53 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.495 ' HB ' HG22 ' A' ' 550' ' ' VAL . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 60.32 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 74.32 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.44 107.53 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.24 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.21 105.58 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.33 141.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 73.31 109.521 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.25 133.4 43.59 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.634 0.774 . . . . 74.12 111.006 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.24 172.04 18.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.465 -1.68 . . . . 65.33 106.465 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.12 -29.7 8.81 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.923 0.342 . . . . 73.42 111.923 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -103.74 45.86 0.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.816 0.817 . . . . 75.33 111.472 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -72.43 161.79 30.34 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.424 -0.807 . . . . 71.01 110.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.17 48.01 1.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 122.611 1.196 . . . . 61.5 111.369 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 58.97 -117.65 0.91 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.535 -1.211 . . . . 72.22 112.356 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -83.44 88.95 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.945 -0.761 . . . . 63.32 108.945 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.56 152.99 21.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.44 108.97 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 613' ' ' ASN . . . . . 0.406 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 72.1 109.296 -168.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.44 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 73.42 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.12 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 54.51 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.44 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.21 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.2 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 654' ' ' LEU . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.21 110.694 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.21 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.597 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.45 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.13 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 72.42 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.597 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.294 23.5 mmm180 146.15 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.54 104.651 178.962 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.9 72.99 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.472 -1.051 . . . . 50.34 110.472 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.17 136.75 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.109 0.957 . . . . 71.34 113.036 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.2 m -131.76 -72.68 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.089 -2.56 . . . . 75.52 104.089 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -148.85 161.53 41.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.023 -2.214 . . . . 75.14 105.023 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.74 73.18 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.876 1.322 . . . . 62.11 108.204 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 36.0 p -75.87 -9.22 58.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.156 -0.929 . . . . 74.31 112.189 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -80.83 -10.51 59.71 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.248 0.619 . . . . 74.22 112.308 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -77.55 66.3 3.24 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.487 1.291 . . . . 64.12 114.487 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 116.23 13.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.167 -1.42 . . . . 63.02 107.167 173.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 9.3 mt -132.73 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.932 -0.766 . . . . 72.44 108.932 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -69.38 168.22 14.87 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.087 -1.82 . . . . 61.15 106.087 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.0 -46.5 87.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.723 0.773 . . . . 73.33 111.445 -171.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.51 -47.88 82.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.057 -0.974 . . . . 72.45 110.984 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -74.39 -19.79 60.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.929 -1.032 . . . . 53.5 112.189 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -45.17 80.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.053 -0.499 . . . . 73.23 110.012 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.93 -49.27 7.18 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 119.483 -0.887 . . . . 75.03 112.028 167.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.73 90.11 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.931 1.086 . . . . 41.11 113.931 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -74.63 -37.03 62.91 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.811 -0.811 . . . . 72.21 108.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -62.13 -46.76 87.57 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.853 -0.158 . . . . 74.13 111.186 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.48 -43.63 94.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.645 -0.502 . . . . 74.44 109.645 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.21 97.9 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.256 -0.278 . . . . 64.23 110.454 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.19 -22.96 64.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.805 0.442 . . . . 61.43 112.107 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 11.9 mmt -70.42 -41.39 72.98 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.335 -1.357 . . . . 71.44 107.335 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 59.06 9.87 8.24 Favored Glycine 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.13 116.465 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 62.04 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.15 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 54.42 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.54 111.853 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 32.54 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.03 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.24 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 44.23 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.43 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 64.01 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 62.32 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 62.1 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 613' ' ' ASN . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 72.21 103.979 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt -93.67 100.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.14 106.225 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -167.86 133.32 1.92 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.851 -1.537 . . . . 64.1 106.851 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 83.74 2.92 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.043 0.925 . . . . 75.43 110.208 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 85.6 p -162.45 158.32 23.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.76 -2.311 . . . . 53.21 104.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -145.79 132.17 19.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.99 0.424 . . . . 73.13 110.572 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 162.19 41.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 104.999 -2.223 . . . . 71.43 104.999 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -136.76 -12.75 1.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.296 0.85 . . . . 74.51 113.296 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.9 mptt 56.82 18.98 4.12 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.843 1.423 . . . . 71.1 114.843 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.98 125.54 26.96 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.016 -0.428 . . . . 74.3 110.34 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 -18.89 47.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.435 -0.348 . . . . 71.3 111.566 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 16.8 t 73.78 154.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.995 1.434 . . . . 55.21 107.693 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.504 1.122 . . . . 65.45 110.693 -174.157 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 106.854 -1.536 . . . . 64.01 106.854 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.72 28.67 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.746 -0.835 . . . . 71.21 108.746 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.11 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.31 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 532' ' ' PHE . . . . . 0.564 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 70.5 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.33 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 618' ' ' LEU . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.43 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.01 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 73.12 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 65.13 110.311 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 74.54 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 662' ' ' VAL . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.44 106.63 165.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.15 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 52.42 110.016 177.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.22 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 72.21 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.41 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 64.02 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.47 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.44 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.2 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 70.0 105.642 169.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 42.34 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.55 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 70.23 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.564 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 71.22 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.23 112.045 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.13 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 555' ' ' THR . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 62.2 109.801 173.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 70.13 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.25 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 43.5 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.514 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 62.54 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.15 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.41 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.42 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 63.41 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.23 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.43 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.14 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 71.44 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.12 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.41 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.15 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 45.32 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.13 106.718 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 62.45 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.23 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.2 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.43 114.655 -171.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.34 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 74.31 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 51.21 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 73.35 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 64.33 110.561 -172.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.43 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.42 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 63.21 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.03 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 63.34 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 70.13 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 71.13 106.876 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.43 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 54.23 118.855 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.2 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 73.04 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.14 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 63.33 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.463 ' HB ' HG22 ' A' ' 550' ' ' VAL . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 72.12 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.14 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.11 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.34 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.3 106.67 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t -83.9 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.11 108.188 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -123.0 -175.61 3.21 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.511 0.93 . . . . 72.5 113.511 -169.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 71.17 -35.65 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 117.499 2.407 . . . . 75.04 117.499 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.69 163.57 25.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.411 1.005 . . . . 72.31 112.251 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -121.96 144.12 49.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.708 -0.849 . . . . 71.14 108.708 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -105.17 -51.57 3.0 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.294 0.497 . . . . 74.43 110.424 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.5 6.24 5.71 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.86 0.838 . . . . 75.54 109.27 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 64.89 -65.0 0.15 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.135 1.902 . . . . 71.33 116.135 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -93.1 72.86 4.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 106.213 -1.773 . . . . 71.52 106.213 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.39 148.57 23.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.728 -1.123 . . . . 63.12 108.025 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.31 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 64.11 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.55 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 598' ' ' ILE . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 62.22 106.554 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.4 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 72.12 107.462 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.4 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.41 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 54.01 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.42 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.682 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 72.41 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 71.24 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 72.02 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.682 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 161.94 -58.34 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 73.55 107.604 177.598 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.16 69.06 1.41 Allowed Glycine 0 C--O 1.225 -0.417 0 N-CA-C 110.069 -1.213 . . . . 61.34 110.069 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.82 127.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.254 0.55 . . . . 71.22 110.537 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 12.7 t -160.1 168.51 25.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.755 -2.313 . . . . 74.12 104.755 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.92 150.02 40.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.389 -1.337 . . . . 74.11 107.389 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.99 134.64 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.204 -1.036 . . . . 75.5 108.204 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 60.3 p -85.31 -10.55 56.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.871 1.804 . . . . 61.13 115.871 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.31 -8.52 58.99 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.553 -0.717 . . . . 51.14 110.003 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -81.82 60.74 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.05 0.929 . . . . 55.31 111.399 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.54 135.43 56.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.178 -1.374 . . . . 74.44 108.834 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 78.7 mt -136.66 -176.8 4.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 104.319 -2.474 . . . . 72.33 104.319 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -66.25 148.04 52.43 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 102.943 -2.984 . . . . 53.24 102.943 167.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -64.17 -24.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.503 0.557 . . . . 62.14 112.503 -160.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.72 -45.94 77.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.701 0.763 . . . . 72.22 109.778 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.01 -25.02 58.5 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.379 -0.828 . . . . 65.04 111.608 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.24 -39.6 83.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 121.121 -0.232 . . . . 75.13 110.681 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.3 -49.22 7.4 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 119.66 -0.816 . . . . 71.21 111.375 168.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.42 81.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.014 1.116 . . . . 54.51 114.014 -168.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -67.13 -40.2 86.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.565 -0.902 . . . . 72.04 108.565 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -63.87 -50.03 70.41 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.427 0.529 . . . . 74.22 112.427 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.7 -41.49 85.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.739 -0.467 . . . . 74.45 109.739 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.77 99.21 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.86 -0.422 . . . . 73.52 109.86 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -72.49 -20.4 61.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.161 0.8 . . . . 74.55 113.161 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 37.3 mtt -69.47 -41.42 76.21 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.673 -1.603 . . . . 75.41 106.673 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.517 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.41 16.3 27.72 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 71.04 115.754 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.14 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.14 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.22 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 62.21 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 71.22 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 73.42 114.647 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.22 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.31 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.32 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.12 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 74.32 108.669 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.14 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.68 110.28 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 65.32 106.305 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 665' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 666' ' ' GLU . 13.7 tt0 -169.87 -159.72 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.529 -1.286 . . . . 74.24 107.529 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 40.3 tt0 -60.61 136.11 57.96 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.835 -0.54 . . . . 72.25 110.161 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 12.9 t -158.15 160.13 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.235 -1.395 . . . . 61.41 107.235 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -153.12 147.45 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.198 -1.038 . . . . 72.51 108.198 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -77.65 164.26 25.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.739 0.78 . . . . 61.43 112.322 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.08 152.66 40.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.512 -0.921 . . . . 74.11 108.512 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -80.34 124.02 28.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.33 -0.989 . . . . 70.25 108.33 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 43.7 t -64.15 150.03 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.646 -1.983 . . . . 55.45 105.646 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 7.3 m -52.02 -54.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.076 1.139 . . . . 75.01 114.076 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 47.7 t 66.02 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 124.575 1.172 . . . . 65.43 110.648 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.332 -0.842 . . . . 73.45 111.082 -178.701 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 102.697 -3.075 . . . . 65.02 102.697 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -90.95 163.51 14.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 73.4 107.462 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 21.34 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.718 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 72.12 105.863 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.14 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.23 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 64.24 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 52.05 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.13 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.45 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.32 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.691 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 65.11 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 65.52 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 662' ' ' VAL . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 54.42 108.609 172.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.42 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.14 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 72.21 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 63.45 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 70.3 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.15 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.468 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.33 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.32 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.31 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 61.42 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.33 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 72.14 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.52 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 531' ' ' ILE . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.12 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.13 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.663 ' H ' HG23 ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.33 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.15 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.13 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.14 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.3 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.21 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.55 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.42 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.14 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.1 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 63.4 108.367 172.029 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 74.25 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.446 HG22 ' HD2' ' A' ' 567' ' ' ARG . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 70.35 104.403 -170.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.13 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.1 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 64.51 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 52.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.21 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 64.12 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 61.11 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.13 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.13 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 71.32 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.32 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 71.2 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.34 111.137 -173.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.4 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 71.1 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.4 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 73.43 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.01 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 72.51 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.05 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 60.21 116.216 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.32 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.43 119.125 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.32 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 72.24 105.686 170.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 73.42 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 60.43 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 61.32 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.02 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.42 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 72.35 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.01 143.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.04 108.811 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.51 147.26 26.09 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.593 1.331 . . . . 70.05 114.593 -174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.99 146.4 40.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.1 -1.074 . . . . 73.44 108.1 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.76 107.31 13.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.072 -0.392 . . . . 74.42 110.24 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 608' ' ' TYR . 1.5 tm-20 -157.16 -169.95 3.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.011 -1.107 . . . . 71.22 108.011 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 608' ' ' TYR . . . . . 0.43 ' H ' ' CD ' ' A' ' 607' ' ' GLU . 53.1 m-85 -129.85 -37.46 1.53 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.983 1.846 . . . . 65.22 115.983 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -126.32 33.35 5.03 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.522 0.934 . . . . 72.13 113.522 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -79.24 81.49 5.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.32 1.6 . . . . 74.55 115.32 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.42 73.88 10.44 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 106.945 -1.502 . . . . 72.11 106.945 167.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.53 161.86 15.98 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.064 -0.717 . . . . 64.32 109.064 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 71.13 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.15 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.44 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.3 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.33 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.23 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.32 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.45 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.3 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.15 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.2 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 73.3 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 72.1 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 168.16 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.1 109.744 178.299 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.89 52.76 3.97 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 110.981 -0.848 . . . . 63.25 110.981 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.52 128.62 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.466 0.65 . . . . 71.12 110.193 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 32.7 t -160.87 168.8 23.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 103.669 -2.715 . . . . 71.31 103.669 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.06 141.9 52.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.968 -1.493 . . . . 62.31 106.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.35 122.15 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.58 0.705 . . . . 75.31 110.91 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 45.9 p -81.9 171.21 14.72 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 75.4 108.966 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 58.12 25.5 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.245 1.572 . . . . 75.34 115.245 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -77.19 124.05 27.28 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 106.662 -1.607 . . . . 65.45 106.662 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -128.15 95.16 4.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.867 -1.16 . . . . 71.42 107.867 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.53 173.57 11.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.342 -1.355 . . . . 70.51 107.342 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.0 t -66.95 153.28 43.96 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 104.95 -2.241 . . . . 74.31 104.95 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.2 m -65.36 -26.0 38.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 112.873 0.694 . . . . 73.02 112.873 -161.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.6 -45.31 75.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.196 0.998 . . . . 73.22 109.457 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.96 -21.52 56.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.045 -0.979 . . . . 63.04 111.486 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.96 -41.31 82.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.496 -0.482 . . . . 41.54 109.86 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -87.95 -50.38 6.46 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 119.878 -0.729 . . . . 54.34 111.568 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.31 94.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.882 1.067 . . . . 72.43 113.882 -168.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -71.89 -42.2 67.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.801 -0.814 . . . . 73.14 108.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -59.16 -48.57 81.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.74 -0.664 . . . . 75.22 111.778 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.6 mt -62.57 -41.01 90.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.943 0.401 . . . . 75.55 110.233 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.04 79.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.937 0.399 . . . . 74.51 110.469 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.86 -22.05 59.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.045 0.387 . . . . 73.22 112.045 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.5 mtm -74.44 -41.29 61.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.724 -1.584 . . . . 53.33 106.724 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.28 21.23 46.92 Favored Glycine 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 53.02 115.721 169.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.05 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 63.14 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 70.52 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 63.11 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 54.5 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.45 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 52.33 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 70.33 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.24 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 539' ' ' ILE . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 62.41 107.56 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.35 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.691 HG13 HG23 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.34 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.35 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt -91.15 110.38 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.41 105.626 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -173.81 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.665 -1.152 . . . . 72.54 109.898 -170.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.72 91.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.496 -1.229 . . . . 75.43 112.323 -169.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 36.5 m -77.58 80.51 4.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.37 -0.832 . . . . 72.2 110.475 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -58.95 142.76 50.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.799 -0.815 . . . . 70.32 108.799 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.29 38.54 26.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.388 0.675 . . . . 65.32 112.521 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.78 -40.57 66.39 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.854 1.057 . . . . 63.45 113.854 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 73.9 mttt 51.03 24.51 1.9 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.899 2.185 . . . . 61.32 116.899 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 69.5 m -81.86 145.18 30.51 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.905 -0.776 . . . . 61.42 108.905 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.3 t -149.6 173.07 14.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.992 -1.484 . . . . 63.53 106.992 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -5.68 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.293 0.37 . . . . 71.22 110.442 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.246 0.891 0 N-CA-C 105.306 -2.109 . . . . 64.44 105.306 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 109.752 -0.462 . . . . 62.14 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -102.94 153.38 20.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.726 -1.213 . . . . 61.13 107.726 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.12 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.15 107.271 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 54.54 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 71.44 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.573 ' CE1' HD21 ' A' ' 618' ' ' LEU . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 72.5 108.081 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.3 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 45.23 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.34 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 62.42 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.34 109.515 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.12 107.418 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 662' ' ' VAL . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.01 108.533 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 52.3 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 64.4 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.15 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.11 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 52.25 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.13 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.13 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.24 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.44 106.245 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 73.52 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 73.53 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 73.54 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.01 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 64.43 110.246 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.32 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 33.34 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 554' ' ' ARG . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 45.34 109.647 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 72.42 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 43.32 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.35 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 63.05 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 74.51 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.43 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.44 115.129 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 65.01 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.426 ' C ' ' HD3' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.01 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.04 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 71.45 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.2 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.4 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 42.23 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 72.22 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.31 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 64.23 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.1 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 71.22 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 71.44 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 63.12 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.4 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 62.45 109.32 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.44 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.04 109.044 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 63.34 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.42 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.12 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 62.05 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 43.1 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 52.14 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.31 117.072 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 62.31 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.22 104.547 168.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 73.11 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.4 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 71.33 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.01 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.478 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.12 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.02 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 62.43 104.98 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.37 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.12 110.666 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -72.86 135.01 45.09 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.6 -0.889 . . . . 71.34 108.6 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.19 160.65 38.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.377 0.271 . . . . 60.41 110.516 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.98 -13.03 29.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.697 0.258 . . . . 73.13 111.697 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.46 159.55 35.06 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.904 0.705 . . . . 71.33 112.904 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -105.85 -9.91 16.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.641 -0.709 . . . . 74.33 109.864 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 51.64 -98.57 0.07 Allowed 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.223 1.009 . . . . 63.41 113.388 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 30.16 1.71 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.909 1.232 . . . . 75.11 112.553 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 64.69 104.25 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.535 1.534 . . . . 70.13 109.962 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.8 152.07 21.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.674 -1.148 . . . . 71.42 111.913 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.54 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.23 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 598' ' ' ILE . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 74.12 105.661 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.21 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.0 106.758 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.14 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.42 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 62.22 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.11 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.712 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.33 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 62.52 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.44 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.712 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 166.81 -56.07 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 74.51 107.814 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.0 70.9 1.31 Allowed Glycine 0 C--O 1.224 -0.527 0 N-CA-C 110.237 -1.145 . . . . 55.54 110.237 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.03 120.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.15 -0.685 . . . . 75.44 109.15 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.8 m -148.66 169.36 20.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.761 -1.57 . . . . 74.35 106.761 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.4 146.74 52.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.008 -0.738 . . . . 64.31 109.008 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.61 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.936 -0.575 . . . . 71.34 112.029 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.58 -163.23 0.15 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.199 0.6 . . . . 75.24 110.223 -176.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -72.03 108.09 5.08 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.687 -0.633 . . . . 75.4 111.829 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.68 133.86 46.45 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 103.021 -2.955 . . . . 73.55 103.021 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 105.7 14.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.063 -1.055 . . . . 72.15 109.993 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.94 165.5 24.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.826 -1.079 . . . . 74.3 110.051 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.2 t -79.94 170.56 16.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.354 -1.721 . . . . 72.13 106.354 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.28 -44.71 92.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.939 0.876 . . . . 73.41 111.21 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.7 -44.58 93.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.008 -0.996 . . . . 60.22 110.999 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.82 -19.74 58.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.884 -1.053 . . . . 73.53 112.071 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.39 -44.87 84.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.506 -0.553 . . . . 74.13 109.506 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.75 -44.01 11.46 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 120.208 -0.597 . . . . 72.34 112.335 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.75 93.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.801 0.728 . . . . 65.14 112.514 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -70.36 -46.1 64.78 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.434 -0.95 . . . . 62.52 108.434 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -55.14 -46.87 75.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 55.03 112.724 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.3 mt -62.19 -41.55 91.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.944 -0.391 . . . . 34.33 109.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.31 77.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.411 0.624 . . . . 70.11 111.4 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -69.92 -24.25 63.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.123 -0.49 . . . . 71.4 110.321 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -83.13 -41.49 18.46 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 118.81 -1.156 . . . . 71.14 109.51 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.664 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 57.88 12.98 12.0 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.3 115.981 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.1 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 74.43 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 23.23 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 71.23 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 54.33 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 63.41 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.24 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 72.44 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 42.11 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.32 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 65.23 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 539' ' ' ILE . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 71.2 109.082 -171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 72.32 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.83 117.86 37.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 54.31 105.535 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -142.48 170.51 15.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.167 0.587 . . . . 64.31 110.72 -169.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -58.34 -23.31 56.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.818 0.847 . . . . 73.42 112.612 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 33.0 t -132.41 140.76 48.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.451 0.643 . . . . 74.14 111.144 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -98.33 161.87 13.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 74.11 109.896 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -109.76 137.48 47.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.342 -0.844 . . . . 74.01 108.731 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -133.78 96.35 3.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 75.33 109.318 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -82.89 110.35 17.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.936 -0.575 . . . . 62.15 110.425 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 60.7 p -99.2 160.5 14.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.459 -0.941 . . . . 64.22 108.459 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.8 t -153.71 165.99 34.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.936 -1.505 . . . . 64.52 106.936 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.32 167.25 26.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.589 -2.004 . . . . 75.12 105.589 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.252 1.222 0 O-C-N 123.765 0.666 . . . . 65.43 109.403 176.412 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 107.711 -1.218 . . . . 63.32 107.711 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -63.53 153.92 34.15 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.077 0.861 . . . . 61.42 110.914 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.21 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.687 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 72.04 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 70.23 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.23 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 64.41 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.23 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.11 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.23 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.21 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.714 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 72.01 109.454 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.15 108.212 171.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 662' ' ' VAL . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 72.53 108.206 170.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.21 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.01 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.21 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 62.33 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.23 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.11 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.465 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.01 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 70.3 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.11 105.45 172.908 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 53.43 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.24 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 54.35 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.22 110.287 -177.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 73.12 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.42 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 63.04 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.433 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.12 111.919 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.35 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.41 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.467 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.45 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.54 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 73.24 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 72.2 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 73.12 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.11 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.4 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 74.54 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.35 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 41.51 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 64.44 111.306 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.14 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 61.13 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.24 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.43 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.23 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.52 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.02 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 62.22 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.42 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.53 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.3 109.296 -171.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.13 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 71.21 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 63.42 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.24 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 63.43 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.609 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.11 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.22 115.669 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.31 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 71.21 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.34 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 71.03 104.122 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.41 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 71.13 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 62.12 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 60.4 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 54.14 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 64.43 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 543' ' ' GLU . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.35 106.175 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -85.93 143.62 11.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 60.01 109.61 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.41 136.01 54.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.728 -1.124 . . . . 72.1 113.458 -170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.62 142.6 37.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.36 0.664 . . . . 74.21 112.492 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -126.67 -53.65 1.44 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 110.301 -0.259 . . . . 74.03 110.301 170.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.31 163.86 35.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.314 0.246 . . . . 75.14 110.758 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 74.99 170.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.447 1.899 . . . . 74.42 114.974 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.04 -177.03 0.09 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.692 1.197 . . . . 74.23 112.782 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.85 -61.83 0.08 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.472 2.027 . . . . 61.31 116.472 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -127.31 77.17 1.72 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.917 -1.512 . . . . 74.02 106.917 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -89.55 152.71 21.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.381 -0.827 . . . . 73.44 109.177 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.43 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 63.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.14 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.13 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.01 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 74.41 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.03 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.11 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 53.14 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.15 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.561 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.25 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 624' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 73.34 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.467 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.42 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.561 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 78.18 -53.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 44.42 116.25 169.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.79 67.27 1.97 Allowed Glycine 0 C--O 1.227 -0.308 0 N-CA-C 109.311 -1.515 . . . . 65.15 109.311 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.2 tt -47.6 121.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.613 0.721 . . . . 73.24 111.198 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.2 m -143.53 173.39 11.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.722 -1.214 . . . . 72.32 107.722 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -175.82 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.721 0.296 . . . . 71.41 110.523 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.32 39.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.438 0.903 . . . . 71.34 113.438 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -21.1 61.68 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.058 0.762 . . . . 52.51 113.058 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.69 -21.81 25.01 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.832 0.678 . . . . 70.32 112.832 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 56.9 mmt-85 -81.18 130.29 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.309 -0.997 . . . . 61.13 108.309 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -116.39 118.1 31.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.85 -1.537 . . . . 72.2 106.85 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.88 175.76 9.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.528 -0.76 . . . . 73.11 109.693 -167.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.8 t -79.53 168.23 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.81 -1.922 . . . . 71.33 105.81 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.14 -43.42 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.061 0.934 . . . . 64.03 111.665 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.37 -44.22 97.54 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.178 -0.919 . . . . 72.14 110.852 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.22 -21.08 54.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.387 -0.824 . . . . 74.33 111.302 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.43 -42.27 82.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.632 -0.506 . . . . 72.54 109.632 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -87.81 -46.85 9.08 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 119.676 -0.809 . . . . 62.4 112.144 167.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.5 95.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.327 0.862 . . . . 63.32 113.327 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -73.37 -41.65 63.14 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.854 -0.795 . . . . 73.32 108.854 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -59.21 -49.31 78.35 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.207 0.447 . . . . 75.5 112.207 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -61.47 -42.3 93.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.067 0.461 . . . . 75.43 109.855 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.46 -35.87 82.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.76 0.314 . . . . 75.21 111.007 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.86 -28.37 64.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 70.12 110.747 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.78 -41.6 74.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.65 -1.241 . . . . 61.13 107.65 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.539 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.25 5.8 2.66 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 34.41 116.67 168.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.43 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.52 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 70.45 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.01 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.35 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.34 114.659 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 61.03 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.22 109.522 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.4 108.612 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.14 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.714 HG13 HG23 ' A' ' 539' ' ' ILE . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.33 109.023 -171.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 72.31 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt -89.32 103.57 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.2 106.593 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -174.6 -32.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.742 -1.117 . . . . 64.52 111.722 -173.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 69.97 -49.51 0.63 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.604 1.562 . . . . 64.11 114.361 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 16.9 t -34.15 107.43 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.322 1.971 . . . . 74.35 116.322 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -91.68 63.33 4.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.982 -1.008 . . . . 73.34 112.709 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -81.82 -0.09 41.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.423 -0.798 . . . . 44.44 112.817 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.41 59.94 3.65 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.955 -1.128 . . . . 72.52 107.955 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.54 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 115.325 1.602 . . . . 70.43 115.325 -169.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 81.6 p -162.32 169.29 20.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.949 0.404 . . . . 54.33 111.232 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.2 m -138.17 142.77 40.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.072 -2.936 . . . . 72.31 103.072 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 -37.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.577 0.703 . . . . 64.15 110.309 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 101.094 -3.669 . . . . 75.14 101.094 178.525 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 528' ' ' HIS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 59.0 m-70 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 110.277 -0.268 . . . . 55.41 110.277 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -76.65 142.88 40.45 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.13 108.549 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.32 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 54.13 108.883 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 73.14 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.3 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.31 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.1 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 64.1 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.14 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.45 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.427 HD13 HG13 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 53.21 107.598 177.76 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.42 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 548' ' ' MET . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 73.31 106.732 169.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 545' ' ' ILE . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 71.4 102.109 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.2 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 33.34 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 545' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 542' ' ' SER . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.14 110.18 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.35 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 62.53 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.51 ' HB2' HG11 ' A' ' 541' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.44 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.12 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 63.52 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 74.51 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 72.43 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.34 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.03 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.15 110.318 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.43 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.31 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 73.32 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.43 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 62.43 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 52.32 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 64.32 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 72.21 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 71.21 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 566' ' ' PHE . . . . . 0.452 ' CE2' HG23 ' A' ' 598' ' ' ILE . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 63.31 107.587 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.54 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.22 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.35 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 61.52 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 64.41 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.11 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.24 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 574' ' ' LYS . . . . . 0.453 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.15 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.34 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.14 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.24 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 578' ' ' GLU . . . . . 0.453 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.44 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.21 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.54 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 55.14 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 52.23 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 51.14 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 73.31 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.42 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.14 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.24 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.41 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.34 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.51 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 65.3 t30 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.4 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 64.02 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.659 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.41 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.04 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.3 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.13 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 65.2 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.452 HG23 ' CE2' ' A' ' 566' ' ' PHE . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.31 105.975 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 55.43 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 61.24 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 72.15 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' A' ' 543' ' ' GLU . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.51 105.581 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.65 143.67 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.35 110.014 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.53 136.17 44.83 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.944 0.498 . . . . 73.04 112.332 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -152.93 39.55 0.53 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.848 0.832 . . . . 74.15 110.935 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 59.92 8.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.506 2.78 . . . . 55.51 118.506 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -85.72 177.17 7.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.847 0.749 . . . . 70.13 109.879 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.61 -30.22 1.89 Allowed 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 114.588 1.329 . . . . 61.25 114.588 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 36.52 -107.28 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.407 1.262 . . . . 74.1 114.407 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 610' ' ' ARG . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 611' ' ' GLN . 0.0 OUTLIER -163.52 -177.38 5.22 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 105.353 -2.092 . . . . 65.03 105.353 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 611' ' ' GLN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 610' ' ' ARG . 43.4 tt0 -57.2 120.82 8.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.024 -0.732 . . . . 74.35 109.024 172.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.21 163.31 15.84 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.589 -2.374 . . . . 75.3 104.589 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.02 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 614' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.4 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.32 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 71.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.51 109.277 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 534' ' ' PHE . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.2 108.005 173.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 72.45 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.44 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.419 ' HD3' HD21 ' A' ' 654' ' ' LEU . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.55 110.46 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.44 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.704 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.21 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 62.34 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 64.12 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.704 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 162.08 -46.09 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 64.42 106.272 -179.301 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.09 37.67 73.0 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.97 -1.652 . . . . 75.21 108.97 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.78 143.05 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 114.318 1.229 . . . . 73.41 114.318 -169.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.1 t -148.91 160.43 43.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 102.663 -3.088 . . . . 60.45 102.663 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -63.19 134.19 55.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.735 -1.579 . . . . 73.51 106.735 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.53 121.75 26.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.703 0.764 . . . . 73.11 110.043 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 18.8 p -86.84 -18.85 29.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.776 -0.647 . . . . 64.23 111.836 -176.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.36 -5.49 14.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.641 1.348 . . . . 54.12 114.641 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -79.81 59.29 3.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.067 0.46 . . . . 73.21 111.8 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -72.58 124.87 26.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.162 -1.051 . . . . 62.41 108.162 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 48.1 mt -141.84 -172.29 3.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 105.895 -1.891 . . . . 70.32 105.895 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.2 t -67.21 155.93 37.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.196 -2.149 . . . . 64.43 105.196 168.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 17.0 m -65.44 -23.13 32.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.713 1.005 . . . . 52.52 113.713 -161.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.92 -48.83 22.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.328 1.061 . . . . 71.42 109.173 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.84 -22.5 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.227 -1.351 . . . . 71.13 111.537 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -52.07 61.45 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.684 -0.487 . . . . 73.2 109.684 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.66 -44.87 10.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.818 -1.153 . . . . 71.32 111.196 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.36 93.97 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.509 0.929 . . . . 44.21 113.509 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -80.34 -38.9 29.61 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.197 -0.601 . . . . 62.22 109.738 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 -59.32 -51.1 71.39 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 119.047 -0.501 . . . . 72.22 110.781 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.1 -44.7 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.346 0.521 . . . . 54.52 111.039 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.88 78.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 63.42 110.912 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -76.07 -26.39 56.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.388 0.514 . . . . 75.31 112.388 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -67.48 -41.71 84.14 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.505 -1.665 . . . . 75.44 106.505 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 528' ' ' HIS . . . 58.74 13.76 19.48 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.42 116.986 166.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.32 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.23 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 64.33 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.11 110.684 173.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.13 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.11 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 54.03 112.739 173.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 71.54 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 73.52 108.117 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 64.12 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.54 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.15 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt -88.49 118.55 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.57 -93.9 0.03 OUTLIER 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.129 -1.851 . . . . 63.31 115.443 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -27.2 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.098 1.518 . . . . 72.33 115.098 -163.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 2.2 p -71.88 4.71 3.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.381 -1.281 . . . . 65.13 114.096 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.57 117.55 18.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.259 0.552 . . . . 74.13 109.8 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.82 166.09 32.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.913 -1.884 . . . . 53.15 105.913 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.57 34.6 2.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.485 0.659 . . . . 73.11 110.385 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -59.17 -48.01 83.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.599 -0.728 . . . . 71.22 112.351 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 67.7 m -110.3 132.03 54.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.502 0.667 . . . . 72.24 112.748 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 20.6 p -133.45 -47.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.025 -2.213 . . . . 73.11 105.025 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.36 160.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 100.532 -3.877 . . . . 74.13 100.532 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.259 1.597 0 N-CA-C 102.905 -2.998 . . . . 65.11 102.905 178.645 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--O 1.219 -0.514 0 N-CA-C 107.795 -1.187 . . . . 71.02 107.795 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -68.88 153.1 44.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.374 0.533 . . . . 63.42 110.615 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 21.33 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.2 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 72.01 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.31 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.53 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' GLU . . . . . 0.469 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 65.21 112.616 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.54 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 55.12 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.31 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.32 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 64.42 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 662' ' ' VAL . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.43 108.542 170.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.32 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.13 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 61.24 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.34 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 63.42 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.05 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.409 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 65.5 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.21 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.01 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.24 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.52 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.54 109.064 -176.087 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.15 109.582 -176.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 53.13 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.33 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.2 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.565 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 60.3 112.943 -174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 61.53 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.02 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 60.41 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.418 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.52 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 74.2 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.23 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 73.13 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 72.14 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.21 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.12 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.3 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.12 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.13 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.42 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.14 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.02 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 73.44 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 52.51 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.45 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.13 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.1 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.33 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 53.21 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.31 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.21 112.145 -171.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.33 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.51 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 73.2 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 62.55 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.01 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.23 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.507 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.42 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 64.41 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.05 111.469 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.1 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.02 114.026 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 72.53 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 63.21 107.48 -176.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.23 111.323 -178.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.33 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 72.13 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.53 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 62.42 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.417 HG21 ' HA ' ' A' ' 543' ' ' GLU . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 74.22 106.865 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.02 143.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 62.4 109.596 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -127.42 149.42 50.1 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.239 0.829 . . . . 72.24 113.239 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 58.26 -5.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 119.319 3.081 . . . . 72.42 119.319 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.17 -33.67 73.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.616 0.644 . . . . 65.52 111.588 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -147.47 165.82 29.12 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.035 -0.728 . . . . 61.02 109.035 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.63 71.46 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.347 0.594 . . . . 72.23 112.566 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.74 -179.42 7.43 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.96 -0.564 . . . . 65.11 110.546 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -93.05 -40.94 10.24 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.067 0.547 . . . . 73.14 110.764 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -158.61 126.47 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.94 -0.763 . . . . 64.34 108.94 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -104.98 146.75 28.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.073 -1.825 . . . . 72.32 106.073 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 64.32 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.34 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.22 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 44.41 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 61.53 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 51.54 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.41 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.13 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.43 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.3 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.701 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.2 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 624' ' ' MET . . . . . 0.418 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 64.13 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.44 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.701 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 162.79 -50.11 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.4 107.591 178.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 75.67 62.71 2.62 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 108.851 -1.699 . . . . 73.42 108.851 -173.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.98 119.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.925 0.869 . . . . 53.23 110.881 -175.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 46.1 m -146.51 154.88 42.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 103.912 -2.625 . . . . 74.14 103.912 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -84.86 77.12 10.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.316 0.507 . . . . 74.54 111.457 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 73.0 t 62.05 120.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 117.196 2.295 . . . . 73.13 117.196 173.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 16.1 p -89.34 -49.56 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.275 -1.009 . . . . 40.25 108.275 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.88 114.45 3.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.044 -0.724 . . . . 74.42 109.044 173.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -147.54 80.12 1.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.607 -0.886 . . . . 73.41 108.607 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.84 117.56 14.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.974 -1.491 . . . . 72.21 106.974 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 34.8 mt -138.13 177.86 7.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.76 0.424 . . . . 71.13 110.477 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.3 t -79.44 171.34 15.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.845 -1.539 . . . . 62.23 106.845 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.56 -45.11 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.822 0.82 . . . . 74.32 111.635 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.87 -42.08 98.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.244 1.021 . . . . 63.21 110.869 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -76.67 -19.17 58.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.952 -1.022 . . . . 74.43 111.246 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.2 -40.94 78.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 119.105 -0.474 . . . . 71.33 110.01 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.25 -47.73 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.915 -0.714 . . . . 73.2 112.137 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.4 83.11 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.372 0.879 . . . . 74.22 113.372 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.24 -38.08 36.45 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 109.197 -0.668 . . . . 74.03 109.197 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -58.73 -46.15 88.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.579 0.228 . . . . 73.55 111.281 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.6 mt -63.63 -41.98 94.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.5 0.667 . . . . 74.33 109.495 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.36 75.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.214 -0.448 . . . . 62.54 111.176 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.1 -27.77 64.86 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.223 0.209 . . . . 53.32 110.858 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.3 mtt -69.73 -41.69 74.96 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.234 -1.395 . . . . 64.32 107.234 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.4 20.0 42.96 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.313 -0.858 . . . . 44.52 115.028 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.23 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 52.44 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.13 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.43 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.42 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.22 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.13 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.34 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.44 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.45 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.2 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.31 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.21 92.73 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.44 106.191 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -165.69 90.18 0.46 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.662 -1.154 . . . . 73.22 108.235 -175.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.89 -126.28 2.19 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.721 -0.672 . . . . 72.34 111.596 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.6 p -136.88 27.99 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.681 -1.229 . . . . 65.23 107.681 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.41 58.2 0.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.458 1.281 . . . . 61.34 114.458 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -102.23 140.42 36.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.869 -0.519 . . . . 75.51 110.278 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.02 4.67 0.56 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.769 1.766 . . . . 63.13 115.769 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -83.36 43.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.316 -0.865 . . . . 71.13 111.5 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 16.4 m -78.11 152.3 32.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.218 -0.301 . . . . 73.43 111.742 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -149.66 162.73 39.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.341 -1.355 . . . . 72.34 107.341 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.04 160.19 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 105.453 -2.055 . . . . 55.0 105.453 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.77 -0.633 . . . . 74.14 109.715 176.04 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 N-CA-C 108.11 -1.071 . . . . 73.13 108.11 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.19 145.5 21.22 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 52.3 109.329 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.41 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.657 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 63.23 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 64.54 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 62.32 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.4 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.33 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 61.33 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.2 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 70.12 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.706 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.44 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 662' ' ' VAL . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.14 109.625 166.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 542' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 545' ' ' ILE . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 43.45 105.16 171.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 63.13 107.522 168.624 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.54 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 542' ' ' SER . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 74.42 110.205 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 51.53 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.33 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 62.15 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.54 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.32 106.481 172.368 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.24 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 71.0 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.4 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.11 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 52.43 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.33 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.34 113.183 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.536 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 55.41 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 72.14 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.13 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.463 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.24 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.34 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 64.53 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 63.42 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 62.31 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.12 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 70.25 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.41 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.43 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.31 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.54 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 61.5 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.43 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 43.34 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 64.31 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.01 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.21 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.43 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.3 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.33 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.45 110.59 -172.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.35 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 71.21 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.54 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.42 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.13 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.12 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 65.13 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 52.52 114.692 -177.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.24 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 72.4 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.417 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 62.42 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.54 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 596' ' ' LYS . . . . . 0.443 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.32 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 597' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 45.04 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 72.11 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 71.35 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 64.23 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.43 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.34 107.627 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.6 143.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 72.13 109.28 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.31 143.71 48.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.151 0.98 . . . . 71.52 112.219 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.3 129.71 37.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.489 0.662 . . . . 73.55 112.315 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.1 64.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.3 0.571 . . . . 64.14 111.878 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -139.47 135.2 33.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.262 -2.125 . . . . 72.21 105.262 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -66.82 164.05 18.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 116.098 1.888 . . . . 73.34 116.098 -170.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.72 37.74 15.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 72.03 111.337 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.18 104.77 16.76 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.332 0.587 . . . . 75.3 111.783 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -77.15 90.28 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.059 -0.719 . . . . 74.34 109.059 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.35 152.61 21.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.396 -1.335 . . . . 64.24 107.396 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.21 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.52 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 71.14 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 73.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 62.11 108.632 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 73.45 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.22 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 72.23 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 62.12 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.55 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.477 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 74.02 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.4 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.463 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 54.42 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.477 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 77.89 -52.25 0.51 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.54 114.711 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.02 60.42 6.06 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 109.945 -1.262 . . . . 73.03 109.945 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -35.33 -49.55 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 115.901 1.815 . . . . 72.22 115.901 -175.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 7.5 t 52.75 -137.14 1.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.518 0.327 . . . . 64.11 110.697 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.98 140.23 52.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.644 -1.613 . . . . 64.31 106.644 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.45 84.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.362 -0.977 . . . . 55.42 108.362 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 85.2 m -116.53 -38.31 3.54 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.461 1.282 . . . . 71.2 114.461 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -2.12 11.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.552 1.315 . . . . 55.1 114.552 -176.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -81.97 79.11 8.58 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.912 -0.492 . . . . 74.53 111.895 -174.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -69.17 126.06 28.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.722 -1.214 . . . . 73.32 107.722 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.5 mt -136.82 -174.62 3.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.381 -2.452 . . . . 74.31 104.381 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.0 t -66.7 155.15 38.8 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 104.988 -2.227 . . . . 60.02 104.988 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.3 m -65.75 -23.22 32.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.311 0.856 . . . . 41.22 113.311 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -72.32 -49.6 33.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.02 0.914 . . . . 73.42 109.082 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -70.42 -21.3 62.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.691 -1.141 . . . . 63.14 111.86 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.21 -46.86 79.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 119.275 -0.393 . . . . 74.23 110.587 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.93 -46.39 9.42 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 119.82 -0.752 . . . . 63.21 112.744 167.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.21 -49.58 77.29 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.404 0.89 . . . . 61.23 113.404 -169.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -65.99 -43.62 87.27 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 108.184 -1.043 . . . . 65.32 108.184 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -56.83 -47.75 79.59 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.998 0.37 . . . . 72.31 111.998 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.3 -42.08 94.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.13 0.491 . . . . 71.53 109.733 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.41 75.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.014 -0.429 . . . . 72.43 111.492 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.58 -23.52 60.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.242 0.217 . . . . 75.11 110.555 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.4 mtt -69.65 -41.78 75.11 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.168 -1.049 . . . . 72.24 108.168 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.41 15.85 25.88 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 51.01 116.348 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 62.4 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.33 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 63.45 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 44.22 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.34 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.32 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.23 112.694 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.34 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 41.1 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 71.24 107.337 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 43.5 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.706 HG13 HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 71.22 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 42.14 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.94 92.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.43 104.957 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -169.41 142.91 2.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.329 -1.36 . . . . 73.33 107.329 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 51.95 -173.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.888 1.81 . . . . 44.43 115.888 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 26.6 m -81.19 145.77 30.83 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.678 -0.639 . . . . 72.31 111.448 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.63 156.93 23.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.836 -0.62 . . . . 75.44 109.395 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -58.21 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.989 -1.486 . . . . 70.14 106.989 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.75 169.14 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.693 1.368 . . . . 75.22 114.693 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.46 32.43 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.669 -0.696 . . . . 73.32 111.642 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.3 p -77.64 38.95 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.964 0.727 . . . . 75.44 112.964 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.6 p -117.97 -3.58 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.985 -0.746 . . . . 61.33 108.985 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.2 m -143.63 169.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.581 -1.637 . . . . 71.15 106.581 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 116.707 -1.615 . . . . 61.13 106.965 175.917 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.222 -0.347 0 N-CA-C 108.627 -0.879 . . . . 74.52 108.627 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -80.97 152.06 28.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 55.43 109.308 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 55.44 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.486 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.34 108.558 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.14 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.32 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.483 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 73.2 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 73.01 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 60.43 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 64.11 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 52.05 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.11 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 62.33 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 545' ' ' ILE . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.67 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 61.03 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 71.41 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 545' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 542' ' ' SER . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.23 109.724 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.53 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 61.24 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 51.13 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 53.5 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 64.14 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.44 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.12 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 74.43 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.41 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.744 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.31 111.309 -175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.744 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 71.12 109.527 170.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 60.35 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.44 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.31 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 71.55 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 562' ' ' VAL . . . . . 0.526 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.12 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.42 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 72.3 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.24 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.11 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.53 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.13 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 65.43 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.437 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 54.25 110.443 -179.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 52.11 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.21 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 52.24 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 45.34 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 42.42 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.44 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.31 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.53 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.2 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.31 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 63.22 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.1 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 63.12 110.527 -171.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 71.42 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.44 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.33 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.52 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.41 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.44 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.649 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 71.25 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.1 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 64.2 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.24 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 50.32 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 72.22 105.296 168.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.21 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 41.24 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.11 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 51.5 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 64.13 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 55.53 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 72.41 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.17 142.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 50.11 107.641 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -133.75 119.2 18.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.884 -0.784 . . . . 73.31 108.884 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -144.94 61.86 1.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.899 0.856 . . . . 62.51 109.111 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 63.83 -136.79 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.621 -1.172 . . . . 63.24 113.205 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.46 64.3 2.78 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.443 0.639 . . . . 44.12 112.173 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.83 113.98 26.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.203 0.816 . . . . 73.14 113.203 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 52.01 -137.42 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 118.231 -0.89 . . . . 72.54 111.573 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.24 -44.98 0.07 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 119.769 3.248 . . . . 63.54 119.769 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -150.15 79.81 1.36 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.538 -0.912 . . . . 74.45 108.538 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -89.65 149.03 22.98 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.777 -0.823 . . . . 75.32 108.777 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 72.13 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 71.54 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.21 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.24 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.14 106.897 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 70.15 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.23 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 52.22 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.51 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 70.23 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.674 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.43 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 624' ' ' MET . . . . . 0.526 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 60.4 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 64.01 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.674 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 162.2 -59.18 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 55.21 107.94 179.434 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.4 72.89 1.24 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.962 -1.255 . . . . 65.32 109.962 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.36 121.48 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.246 -0.65 . . . . 54.32 109.246 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 16.0 t -165.44 -179.07 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.688 -2.338 . . . . 73.31 104.688 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -125.29 146.31 49.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.879 -0.786 . . . . 73.13 108.879 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.34 -19.67 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.031 -0.531 . . . . 74.32 111.35 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.87 -168.75 0.1 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.122 0.569 . . . . 75.32 110.514 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 32.3 t70 62.64 -14.8 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 116.98 2.215 . . . . 74.41 116.98 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.52 79.27 7.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.015 -1.053 . . . . 64.31 111.849 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -66.99 134.42 51.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.791 -1.559 . . . . 62.1 106.791 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 58.0 mt -136.88 -169.7 2.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 103.855 -2.646 . . . . 70.22 103.855 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.3 t -70.05 149.79 47.3 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 102.386 -3.19 . . . . 71.31 102.386 166.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.5 -21.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.514 0.561 . . . . 72.55 112.514 -162.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 -47.64 67.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.971 0.891 . . . . 72.22 109.372 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.12 -21.28 60.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.021 -0.991 . . . . 72.44 112.296 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.795 -0.362 . . . . 72.01 110.479 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -87.89 -43.03 12.1 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 119.236 -0.986 . . . . 74.31 112.632 169.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.42 94.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.008 0.822 . . . . 44.25 113.065 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -68.04 -40.8 82.77 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.576 -0.898 . . . . 65.11 108.576 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -59.99 -46.68 88.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.069 0.396 . . . . 72.5 112.069 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.56 -40.31 88.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.488 0.661 . . . . 63.23 109.681 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.41 75.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 61.33 110.989 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -72.21 -24.91 61.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 73.12 111.335 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 50.8 mtt -73.59 -41.55 62.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.904 -1.147 . . . . 72.31 107.904 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.17 19.83 40.55 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 32.14 115.685 169.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 72.03 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.42 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.22 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 73.41 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.43 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 53.44 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 657' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.33 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 42.24 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 62.34 109.404 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 54.01 105.078 176.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 71.23 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 61.44 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.11 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.39 112.92 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 72.32 105.468 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.88 161.06 14.99 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.386 0.674 . . . . 74.51 112.008 -175.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -88.35 -43.68 11.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.358 -1.349 . . . . 63.5 107.358 167.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.7 t -70.03 117.75 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.361 -0.836 . . . . 61.11 112.64 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -146.93 146.28 30.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.106 -0.702 . . . . 72.43 109.106 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -135.78 129.8 33.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.335 -0.987 . . . . 72.32 108.335 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -84.59 134.23 34.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.108 -1.441 . . . . 74.22 107.108 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -125.93 -55.69 1.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.46 1.282 . . . . 74.41 114.46 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 7.3 t 59.17 -169.83 0.13 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.388 0.675 . . . . 72.15 110.206 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 8.1 t -157.02 -33.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 64.34 111.61 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.34 150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.81 1.244 . . . . 73.02 109.569 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.515 -3.143 . . . . 74.35 102.515 -179.031 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 106.388 -1.708 . . . . 73.13 106.388 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.69 14.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.198 -1.778 . . . . 73.14 106.198 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 71.44 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.556 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 64.35 106.92 171.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.14 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.42 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 70.34 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 535' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 553' ' ' LEU . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.44 113.514 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.22 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.2 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 62.35 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.732 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.23 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.13 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 662' ' ' VAL . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.44 108.718 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 53.41 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 62.04 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 64.34 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.24 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.11 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.31 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.413 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 71.54 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 54.44 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.31 105.068 170.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.54 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.51 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.435 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.22 108.696 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 73.11 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.22 112.317 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 45.42 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.34 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.458 ' HB2' ' CD ' ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.02 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.44 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.24 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 74.35 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 65.11 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 61.34 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 63.34 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 51.11 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 72.32 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.546 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.23 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.41 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.546 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.24 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.23 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 71.23 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 51.04 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.32 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 71.34 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.21 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 45.54 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.4 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.11 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 73.51 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.33 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.23 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.41 112.029 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.24 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.33 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.3 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 64.03 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 70.51 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 589' ' ' PHE . . . . . 0.404 ' HD2' ' HA ' ' A' ' 594' ' ' THR . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.12 104.492 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.619 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.45 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 63.7 t30 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 42.31 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 64.44 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.619 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.23 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 589' ' ' PHE . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.41 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.14 103.382 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 71.35 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 53.41 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.33 107.11 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 64.33 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 64.11 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.34 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.43 105.993 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -82.35 142.23 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.1 109.768 -173.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -132.06 133.13 44.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.051 0.541 . . . . 71.5 112.44 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -169.5 -65.42 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 105.949 -1.871 . . . . 62.54 105.949 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.27 158.63 43.08 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 102.81 -3.033 . . . . 72.4 102.81 171.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 -29.38 9.95 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.083 1.512 . . . . 62.22 115.083 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 62.07 -58.71 0.12 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.067 2.247 . . . . 62.01 117.067 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.18 176.49 7.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.484 -0.561 . . . . 65.44 109.484 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.36 -20.49 10.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.71 1.004 . . . . 75.24 113.71 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -153.08 84.81 1.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.89 0.7 . . . . 64.4 112.89 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.86 158.56 16.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.181 -1.044 . . . . 72.52 108.181 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.51 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.22 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 73.44 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.403 HG21 HG21 ' A' ' 598' ' ' ILE . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 51.32 106.685 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.33 108.024 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.43 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.33 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.22 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 73.11 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.03 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.53 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.43 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.21 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 166.49 -76.13 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 72.52 112.061 176.556 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.13 106.16 2.06 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 105.105 -3.198 . . . . 74.52 105.105 -163.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.09 126.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.704 0.288 . . . . 74.42 110.251 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.9 m 62.31 -33.02 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.647 2.832 . . . . 64.24 118.647 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.4 -170.2 0.16 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.416 0.687 . . . . 61.45 111.886 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -34.06 126.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.615 1.566 . . . . 74.12 114.794 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 20.2 p -72.23 -14.27 61.74 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 114.45 1.278 . . . . 64.52 114.45 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.94 12.93 1.55 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.75 0.648 . . . . 60.42 112.75 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -81.06 64.0 5.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.732 0.777 . . . . 74.33 112.042 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.5 136.29 56.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.451 -1.315 . . . . 75.05 107.451 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.02 -172.29 3.37 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.104 -1.813 . . . . 54.41 106.104 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -69.04 150.94 47.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 103.2 -2.889 . . . . 72.31 103.2 166.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.17 -23.69 33.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 112.802 0.668 . . . . 75.51 112.802 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.11 -47.32 68.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.848 0.833 . . . . 73.55 109.522 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.11 -24.33 59.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.96 -1.018 . . . . 72.24 111.522 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.3 -39.49 79.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 119.759 -0.162 . . . . 62.41 111.136 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.76 -51.06 6.07 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.334 -0.946 . . . . 74.53 111.832 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.16 78.93 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 114.281 1.215 . . . . 44.14 114.281 -168.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -40.39 86.28 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.673 -0.862 . . . . 73.43 108.673 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -63.89 -46.47 84.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.716 -0.675 . . . . 73.11 112.291 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.8 mt -59.09 -40.93 82.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 122.941 0.496 . . . . 71.44 110.467 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.34 -36.6 84.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.663 0.744 . . . . 60.35 110.039 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.31 -17.58 56.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.579 0.585 . . . . 72.02 112.579 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.9 mtt -69.26 -41.29 77.1 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.232 -1.766 . . . . 72.25 106.232 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.624 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.14 10.22 6.88 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.33 117.5 167.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 71.03 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 61.51 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 61.53 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 61.12 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 63.01 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.11 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 71.54 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.21 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 72.43 108.569 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 550' ' ' VAL . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 63.25 107.167 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.01 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 63.22 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 63.52 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.99 95.35 4.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 52.23 106.162 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -165.46 134.03 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.983 -1.858 . . . . 75.51 105.983 -176.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -8.19 21.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.435 1.643 . . . . 74.42 115.435 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 79.0 p -69.91 152.39 44.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 73.33 107.952 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.2 151.11 23.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.712 0.634 . . . . 73.11 112.712 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.496 -0.775 . . . . 72.24 110.187 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -156.91 137.49 13.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.598 -0.519 . . . . 73.44 109.598 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -125.94 149.8 48.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.638 -0.875 . . . . 74.43 108.638 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 78.8 p -134.08 36.9 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.352 -1.351 . . . . 71.25 107.352 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 175.64 8.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.685 -1.143 . . . . 71.21 109.912 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.8 p -142.65 149.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 103.48 -2.785 . . . . 72.51 103.48 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 C--O 1.253 1.267 0 O-C-N 124.649 1.218 . . . . 65.34 112.248 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 103.728 -2.693 . . . . 75.41 103.728 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -86.21 150.01 24.68 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.633 -0.877 . . . . 75.42 108.633 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.44 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 72.21 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.33 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.23 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.11 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.15 113.787 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 73.35 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.01 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 62.33 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.671 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.52 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.32 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 548' ' ' MET . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 71.21 107.957 168.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.31 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.41 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.43 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.32 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 50.45 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.22 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.421 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 70.54 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 62.31 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 616' ' ' ILE . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.2 106.685 171.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 64.43 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.22 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.12 109.632 178.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.44 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.22 111.51 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 53.41 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.773 ' H ' HG23 ' A' ' 555' ' ' THR . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 35.33 110.373 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.23 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 72.43 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 44.35 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.22 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.43 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 52.11 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.24 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 60.02 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 566' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 598' ' ' ILE . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.14 108.098 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.03 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 63.24 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 64.43 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 72.31 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.12 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 73.24 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 52.53 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 64.31 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.33 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.33 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.33 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.05 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.34 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.35 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.54 108.28 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.31 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 63.33 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.14 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 41.4 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 65.33 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.43 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 70.43 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 72.3 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 65.44 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.03 116.111 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.31 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 62.22 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.13 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.34 105.923 169.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 62.24 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.51 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 550' ' ' VAL . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 71.3 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 65.54 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.23 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.4 107.458 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.14 105.741 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.35 143.55 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 74.3 110.047 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -113.6 135.48 53.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 61.02 113.421 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.6 165.38 23.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.049 -2.945 . . . . 72.13 103.049 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.39 -98.3 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.15 0.886 . . . . 71.22 110.786 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 60.03 174.36 0.09 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.183 0.993 . . . . 74.13 113.108 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -138.3 49.37 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.377 -0.827 . . . . 75.01 110.176 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -116.69 0.1 Allowed 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 117.582 2.438 . . . . 72.44 117.582 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -119.79 166.42 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.094 -1.004 . . . . 62.4 113.607 -164.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -84.51 89.87 7.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.518 -1.66 . . . . 70.14 106.518 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -89.83 159.73 16.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 74.41 111.767 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.23 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 62.43 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.42 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 550' ' ' VAL . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 62.54 105.585 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 64.03 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 71.52 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.24 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.02 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 621' ' ' PRO . . . . . 0.417 ' HD3' HD21 ' A' ' 654' ' ' LEU . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 64.31 110.469 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 61.54 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.71 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.43 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.33 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 60.01 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.71 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 162.28 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 55.44 107.855 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.44 69.89 1.34 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.739 -1.744 . . . . 73.11 108.739 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 628' ' ' ILE . 0.5 OUTLIER -57.02 124.52 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.441 0.639 . . . . 73.31 109.39 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.1 t -162.88 -177.21 5.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.302 -2.481 . . . . 72.32 104.302 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.8 163.23 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.823 -1.547 . . . . 70.21 106.823 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.19 134.69 44.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.519 -0.919 . . . . 54.35 108.519 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 7.8 m -94.92 76.99 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.217 -1.031 . . . . 63.52 108.217 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.63 -74.5 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.842 -0.799 . . . . 74.24 108.842 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.98 131.24 49.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.485 -0.561 . . . . 73.01 109.485 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -126.62 151.48 47.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.635 -1.246 . . . . 62.04 107.635 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.94 -173.4 3.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.36 -1.719 . . . . 70.23 106.36 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.3 t -66.21 156.34 34.45 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.506 -2.035 . . . . 73.12 105.506 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.6 -22.55 31.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.226 0.825 . . . . 74.14 113.226 -161.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.83 -48.3 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.198 0.999 . . . . 70.22 108.807 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 640' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 643' ' ' ALA . 4.1 mm-40 -72.16 -19.01 61.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.576 -1.193 . . . . 73.51 112.444 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -55.21 -52.46 63.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 64.11 109.798 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.94 -37.71 16.18 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.289 -0.964 . . . . 73.41 111.827 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 643' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 640' ' ' GLU . . . -60.16 -44.1 95.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.469 1.031 . . . . 62.12 112.505 -174.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.63 -38.38 67.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.305 -0.628 . . . . 74.13 109.305 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -58.61 -46.43 87.03 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 120.431 0.158 . . . . 74.41 111.052 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.22 -39.64 86.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 122.088 -0.382 . . . . 71.13 110.528 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.51 73.79 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.933 -0.479 . . . . 65.1 111.074 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.49 -31.77 70.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.251 -0.277 . . . . 62.31 110.251 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 2.3 mtt -73.01 -41.51 64.18 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.4 -0.593 . . . . 64.12 109.4 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.473 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.33 18.3 35.39 Favored Glycine 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 64.44 115.984 169.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.51 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 70.3 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 64.11 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 621' ' ' PRO . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.35 111.215 174.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 62.53 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.14 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.35 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.4 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.11 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 539' ' ' ILE . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 73.1 107.622 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 62.23 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.671 HG13 HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 63.33 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 62.31 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt -96.33 107.19 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 72.03 106.307 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.1 158.78 14.74 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.005 -0.739 . . . . 71.25 109.005 -173.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.74 -47.09 76.46 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.045 0.758 . . . . 73.41 113.045 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 28.0 t -68.76 148.2 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.454 0.645 . . . . 74.22 111.297 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -137.34 135.58 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.783 -1.192 . . . . 62.54 107.783 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -116.11 131.62 56.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.235 -0.654 . . . . 72.11 109.235 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.33 120.35 42.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.374 -2.084 . . . . 42.14 105.374 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -139.29 130.05 26.09 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 38.1 m -143.84 173.18 11.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.876 -1.157 . . . . 63.11 107.876 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.2 t -121.89 -176.85 3.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.213 -1.773 . . . . 73.14 106.213 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.2 17.35 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.04 0.448 . . . . 64.0 111.471 -173.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.002 -1.475 . . . . 73.32 108.808 -179.478 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 110.049 -0.352 . . . . 72.33 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.59 143.64 29.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.774 0.671 . . . . 64.1 110.161 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.45 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.678 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.1 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 74.2 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.44 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 65.23 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 64.3 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.31 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.54 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.718 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 72.21 108.434 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 62.13 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.2 108.399 168.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 53.15 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.01 111.918 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.01 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 63.31 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 41.51 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 71.21 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 64.04 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.3 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.421 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.14 103.787 169.438 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.44 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 71.43 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.34 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.427 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 62.54 109.704 -177.037 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.45 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.11 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 43.42 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.35 114.233 -172.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.43 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.23 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.44 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 62.04 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.53 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.31 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 63.22 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.24 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.41 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.12 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.04 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.24 110.418 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.35 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 71.04 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 60.23 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.01 106.932 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 71.31 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.12 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.2 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 62.11 115.924 -162.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.21 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.35 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.54 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.43 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.43 109.779 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.13 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.33 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 62.12 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.33 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.55 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 63.12 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.2 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 66.2 t30 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 72.13 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 65.34 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 61.04 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 63.21 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 71.54 103.414 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.3 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 53.45 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 616' ' ' ILE . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.01 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.31 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 583' ' ' ALA . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.44 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 71.52 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 543' ' ' GLU . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 73.04 107.583 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.75 137.98 34.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.52 110.306 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.42 134.49 42.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.043 -0.981 . . . . 63.42 112.303 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -133.88 24.79 3.96 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.627 -1.249 . . . . 72.12 107.627 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 62.82 -171.99 0.16 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.554 1.141 . . . . 72.4 112.13 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 62.3 178.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.424 1.09 . . . . 63.21 113.154 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -162.2 -24.21 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.228 0.825 . . . . 61.15 113.228 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.03 -18.45 64.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.565 0.697 . . . . 54.34 110.105 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -31.4 70.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.643 0.979 . . . . 72.51 113.643 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 46.46 102.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.152 1.908 . . . . 65.13 116.152 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -90.58 151.04 21.48 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.033 -0.729 . . . . 53.03 109.033 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.03 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.54 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.35 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 598' ' ' ILE . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 73.42 106.474 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.42 108.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.21 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 71.35 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 70.12 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.44 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 61.42 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.41 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 60.3 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.11 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 167.13 -74.05 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 65.13 110.498 176.72 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.53 83.95 1.75 Allowed Glycine 0 C--O 1.216 -1.001 0 N-CA-C 108.444 -1.862 . . . . 41.4 108.444 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -20.87 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.832 -0.684 . . . . 61.0 111.52 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.2 p -56.39 140.87 44.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.32 -0.4 . . . . 63.14 110.455 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.45 142.0 58.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.594 0.711 . . . . 74.4 111.761 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.73 128.91 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.123 -0.944 . . . . 73.21 108.84 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 37.1 p -76.55 -14.5 60.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.346 1.239 . . . . 74.55 114.346 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.34 -11.5 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.132 -0.355 . . . . 71.42 111.137 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -81.13 36.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.698 0.629 . . . . 74.42 112.698 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -70.1 121.41 17.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.074 -1.084 . . . . 72.32 108.074 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.72 -168.74 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.807 -1.553 . . . . 74.25 106.807 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -68.63 167.23 15.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.113 -1.81 . . . . 63.13 106.113 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 85.8 t -58.48 -45.25 90.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.812 0.815 . . . . 62.32 111.302 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.55 -47.06 87.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.038 -0.983 . . . . 41.41 111.06 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.82 -23.73 59.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.349 -0.841 . . . . 72.33 111.475 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.43 -40.64 87.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.815 -0.439 . . . . 72.03 109.815 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.85 -47.55 8.51 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.04 -0.664 . . . . 73.45 111.524 170.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.2 84.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.295 0.85 . . . . 51.11 113.295 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -74.26 -42.19 60.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.198 -0.667 . . . . 70.24 109.198 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -61.32 -46.33 90.71 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.575 -0.739 . . . . 72.31 112.244 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.49 -40.85 85.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.133 0.492 . . . . 72.52 109.803 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.41 73.27 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.853 -0.529 . . . . 62.51 110.665 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -20.73 59.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.555 0.342 . . . . 75.53 111.537 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 34.8 mtt -75.27 -41.31 57.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.703 -1.591 . . . . 71.34 106.703 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.594 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.46 21.03 47.64 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 71.4 115.573 166.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.51 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 41.15 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 64.13 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.11 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.3 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 64.32 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.21 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.43 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.32 109.183 -176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 539' ' ' ILE . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 71.34 108.474 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.42 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.718 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.44 107.805 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 74.21 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.44 112.31 27.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 65.04 104.732 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -166.69 -115.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 105.34 -2.096 . . . . 71.12 105.34 -171.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.98 150.06 43.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.185 -2.154 . . . . 74.32 105.185 174.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 34.3 m -79.9 46.24 0.77 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.304 0.573 . . . . 43.45 112.057 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -63.4 -43.68 96.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.602 1.334 . . . . 64.23 114.602 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.31 148.87 42.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 114.218 1.192 . . . . 52.21 114.218 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -134.08 144.09 48.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.153 -1.795 . . . . 72.51 106.153 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -73.74 116.91 14.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 75.43 110.094 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.6 p -85.77 169.45 13.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.272 -0.422 . . . . 75.51 110.24 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.3 t -142.62 170.95 14.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.482 -1.673 . . . . 73.1 106.482 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 32.3 m -129.84 162.79 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 122.461 0.304 . . . . 53.52 110.454 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.581 -1.199 . . . . 74.44 111.08 178.367 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 118.78 -0.629 . . . . 71.41 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.93 154.29 30.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.799 0.687 . . . . 55.34 110.256 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.45 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.739 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.11 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 62.4 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 64.44 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.31 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.24 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.11 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 61.11 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 64.15 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.734 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 73.42 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 540' ' ' HIS . . . . . 0.63 ' H ' ' HB2' ' A' ' 669' ' ' GLU . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 72.53 108.318 174.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 71.42 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 43.03 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.22 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 63.25 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.45 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.4 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.52 109.532 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 74.0 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 70.14 104.284 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 53.01 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 73.14 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.3 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 73.44 109.874 -177.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.13 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.21 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 43.52 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.21 111.671 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.44 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 74.2 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 71.11 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.12 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 73.11 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 71.34 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 565' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.15 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.11 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.428 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 55.44 108.257 171.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.21 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.32 111.1 -177.468 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.21 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.31 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.2 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 71.3 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 51.53 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 42.13 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 65.32 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.24 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 72.31 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.23 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 71.33 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.31 108.723 -174.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.42 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.21 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 586' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.42 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 44.54 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.51 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 64.34 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.535 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.52 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 64.21 115.36 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 71.4 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.535 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 51.41 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.445 HG23 ' H ' ' A' ' 594' ' ' THR . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.0 113.812 -168.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 62.25 106.717 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 72.2 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 61.54 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 73.51 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.21 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 583' ' ' ALA . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 64.1 107.324 177.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.41 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 602' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 543' ' ' GLU . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 71.32 103.692 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t -85.72 143.59 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.2 107.789 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -127.93 161.14 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 72.41 112.146 -168.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 66.4 -30.52 0.15 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.905 2.557 . . . . 75.3 117.905 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.66 58.71 3.87 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.475 0.917 . . . . 75.32 113.475 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 607' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 608' ' ' TYR . 3.8 tp10 62.5 -169.33 0.18 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.368 1.067 . . . . 75.51 112.088 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 608' ' ' TYR . . . . . 0.547 ' H ' ' HG3' ' A' ' 607' ' ' GLU . 3.3 p90 -164.14 173.85 11.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.74 -1.207 . . . . 75.12 107.74 -176.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -136.83 70.55 1.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.75 0.648 . . . . 62.11 112.75 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.84 -55.59 0.43 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.459 2.022 . . . . 63.53 116.459 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -172.14 109.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.763 -2.31 . . . . 62.13 104.763 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.43 150.9 22.3 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.82 -1.178 . . . . 74.15 107.82 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 62.34 106.023 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.03 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.23 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.31 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 617' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 44.52 107.362 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.42 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.45 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 71.21 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 70.53 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 72.35 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.693 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.11 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 70.31 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.3 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.693 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 161.46 -48.26 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.21 106.739 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.74 54.02 20.82 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 109.201 -1.56 . . . . 52.42 109.201 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 649' ' ' MET . 1.1 tp -52.58 116.14 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.953 0.883 . . . . 62.44 110.22 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 6.1 p -146.52 155.94 42.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 103.081 -2.933 . . . . 31.45 103.081 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.82 130.38 39.35 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.493 -0.483 . . . . 73.44 110.073 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.7 127.25 40.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.302 -1.37 . . . . 73.04 107.302 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 47.2 p -67.02 -24.32 66.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.816 1.043 . . . . 73.52 113.816 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -137.39 104.78 5.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.948 0.88 . . . . 73.45 111.775 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -126.7 35.96 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.82 -1.178 . . . . 74.03 107.82 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -62.42 112.75 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.928 -1.033 . . . . 72.41 109.011 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 57.9 mt -146.51 179.01 7.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.158 -1.793 . . . . 72.55 106.158 -170.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 10.5 t -61.99 148.35 44.16 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 105.467 -2.049 . . . . 75.11 105.467 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 22.3 m -59.89 -25.08 31.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 114.524 1.305 . . . . 43.21 114.524 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -66.45 -46.14 77.45 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.684 0.754 . . . . 74.34 109.421 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.57 -21.81 48.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.181 -0.918 . . . . 74.34 111.839 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.6 -41.49 90.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.352 -0.24 . . . . 73.35 110.352 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.01 -47.09 8.8 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.394 -0.922 . . . . 73.4 111.166 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.419 0.896 . . . . 71.13 113.419 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -70.84 -38.01 73.18 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.242 -0.651 . . . . 61.21 109.242 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.13 -46.23 88.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 120.51 0.195 . . . . 74.51 110.775 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.6 -41.93 94.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 110.031 -0.359 . . . . 52.34 110.031 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.74 81.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.817 0.342 . . . . 21.11 110.975 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.45 -25.41 62.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.128 -0.487 . . . . 74.55 110.311 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' MET . . . . . 0.569 ' HA ' HD13 ' A' ' 628' ' ' ILE . 35.4 mtt -75.43 -42.17 54.1 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 118.616 -1.234 . . . . 73.21 108.405 176.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.462 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.09 -2.08 0.29 Allowed Glycine 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 50.14 117.183 166.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.43 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 61.35 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.32 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.34 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.42 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.11 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.33 112.247 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 61.4 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 74.2 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 550' ' ' VAL . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.44 105.986 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.23 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.54 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.43 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.45 122.56 48.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 64.15 105.302 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -164.08 171.98 14.4 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.639 -1.245 . . . . 75.42 107.639 -168.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.49 56.09 0.85 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.914 0.864 . . . . 52.11 109.717 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.7 m -149.04 159.6 44.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.261 -0.899 . . . . 74.44 111.659 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -135.01 131.38 37.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.108 -1.812 . . . . 72.34 106.108 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' GLU . . . . . 0.63 ' HB2' ' H ' ' A' ' 540' ' ' HIS . 7.2 tp10 -81.44 136.79 35.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.814 1.042 . . . . 74.51 113.814 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.24 124.02 29.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.343 -0.984 . . . . 74.14 108.343 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -136.49 151.64 49.67 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.036 -1.468 . . . . 64.12 107.036 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 77.5 p -159.04 173.7 16.06 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.938 -1.134 . . . . 53.31 107.938 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -151.16 169.66 21.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.764 -1.939 . . . . 75.13 105.764 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 167.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.919 -1.882 . . . . 73.32 105.919 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 C--O 1.256 1.396 0 CA-C-O 117.411 -1.281 . . . . 73.42 109.118 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.159 -1.052 . . . . 72.3 108.159 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -99.34 165.92 11.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.696 -1.224 . . . . 61.31 107.696 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.44 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' ILE . . . . . 0.664 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.13 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.44 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 51.41 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' PHE . . . . . 0.596 ' CE1' HD21 ' A' ' 618' ' ' LEU . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.33 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 553' ' ' LEU . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.11 113.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 54.25 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.44 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 72.04 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 539' ' ' ILE . . . . . 0.575 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 52.32 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.23 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 51.21 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 53.22 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 543' ' ' GLU . . . . . 0.535 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.35 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.11 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.24 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 63.11 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 72.53 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 62.1 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.32 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' VAL . . . . . 0.573 HG22 HD12 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.23 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 74.5 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.12 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 60.22 108.173 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 555' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 63.12 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 65.24 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.32 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.34 112.901 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.11 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 64.11 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 561' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 73.02 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.13 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 74.52 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 70.21 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.41 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.45 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 567' ' ' ARG . . . . . 0.497 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.24 106.335 171.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.51 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 569' ' ' VAL . . . . . 0.497 HG22 ' HD2' ' A' ' 567' ' ' ARG . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.23 104.303 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 570' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 71.21 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.12 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.34 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.22 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 73.45 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.4 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.15 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.13 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.32 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.31 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 71.35 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 70.33 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.33 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.14 111.631 -172.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.42 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.42 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 53.54 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 64.42 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.12 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 72.42 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 590' ' ' LYS . . . . . 0.567 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 62.35 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 52.01 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 592' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 63.43 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 593' ' ' GLU . . . . . 0.567 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.24 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 594' ' ' THR . . . . . 0.41 HG22 ' H ' ' A' ' 594' ' ' THR . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.51 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.42 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 64.44 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 64.34 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 598' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 616' ' ' ILE . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 72.14 106.744 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 64.55 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.42 109.228 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 65.31 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.43 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.9 143.59 10.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 62.34 111.936 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -80.72 104.69 11.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.815 1.246 . . . . 74.25 113.136 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.84 160.36 43.31 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.205 -1.406 . . . . 74.04 107.205 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.1 -25.61 25.71 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.213 -1.032 . . . . 65.31 108.213 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 61.6 175.06 0.12 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.743 1.217 . . . . 61.24 114.279 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -143.08 -11.95 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.675 0.991 . . . . 72.21 113.675 -167.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -101.27 -85.0 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.97 1.47 . . . . 63.41 114.97 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -157.44 178.43 10.31 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.57 -0.706 . . . . 75.4 111.76 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -59.69 125.73 24.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.757 -1.942 . . . . 61.41 105.757 159.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -111.35 162.12 15.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 62.3 107.862 -172.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.44 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 615' ' ' PHE . . . . . 0.414 ' HB2' ' HD2' ' A' ' 659' ' ' LYS . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.34 108.003 -173.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 616' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 598' ' ' ILE . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 61.21 107.797 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 43.33 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 618' ' ' LEU . . . . . 0.596 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 52.24 108.741 173.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.02 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.12 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 62.33 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.52 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.4 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.34 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 625' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.23 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear build full ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 172.38 -53.51 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.54 113.94 175.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 86.26 66.67 1.38 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-O 122.699 1.166 . . . . 74.43 110.88 -172.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 628' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 628' ' ' ILE . 0.4 OUTLIER -59.3 127.68 18.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.241 -0.979 . . . . 63.23 110.041 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.3 m 58.31 17.12 4.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 116.025 1.861 . . . . 62.24 116.025 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.8 145.33 53.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 75.41 108.82 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.1 t 56.93 91.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 122.324 1.059 . . . . 72.24 112.186 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 39.2 p -73.09 -9.91 59.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.836 -0.62 . . . . 64.4 111.146 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.59 14.69 4.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.717 0.77 . . . . 74.23 112.218 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -79.13 74.3 5.69 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.6 -0.687 . . . . 72.5 110.071 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.78 132.4 47.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.491 -0.929 . . . . 74.2 108.491 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.8 mt -135.14 -177.19 4.53 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.465 -2.05 . . . . 73.52 105.465 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -67.32 157.25 34.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 105.83 -1.915 . . . . 73.41 105.83 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.89 -23.64 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.847 0.684 . . . . 62.45 112.847 -162.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.24 -48.97 54.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.446 1.117 . . . . 63.01 109.091 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -71.68 -23.76 61.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 74.32 112.305 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.4 -47.53 66.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 119.115 -0.469 . . . . 74.1 110.888 -176.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -88.03 -49.84 6.79 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.441 -0.904 . . . . 71.03 112.749 165.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.48 81.5 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.655 1.354 . . . . 74.44 114.655 -167.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -68.79 -39.77 79.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.273 -1.01 . . . . 74.24 108.273 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.59 -49.03 78.94 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 122.483 -0.136 . . . . 71.42 111.334 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.24 -42.3 89.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 122.817 0.447 . . . . 52.45 110.743 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.22 82.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.139 0.495 . . . . 74.21 110.515 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.75 -17.07 59.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.086 -0.506 . . . . 60.2 112.199 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 53.4 mtt -73.02 -40.74 64.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.82 -1.548 . . . . 60.3 106.82 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.0 16.74 26.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 63.03 117.357 166.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 71.33 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 64.43 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 63.11 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.13 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.14 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.14 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 51.41 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 615' ' ' PHE . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.01 107.317 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 72.03 104.33 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.2 109.45 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.34 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.41 104.245 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.81 92.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 63.22 106.109 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -175.07 129.09 0.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 104.072 -2.566 . . . . 73.32 104.072 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.44 117.04 12.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.148 0.886 . . . . 65.4 110.987 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.6 m -160.61 154.01 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.014 -1.476 . . . . 53.03 107.014 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -145.64 152.54 39.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.536 -0.542 . . . . 74.32 109.536 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.34 165.01 37.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.68 -1.6 . . . . 73.03 106.68 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -142.75 136.51 28.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 71.42 111.775 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -140.62 159.74 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.704 -1.591 . . . . 72.31 106.704 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 65.1 p -149.91 165.72 31.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.009 -1.478 . . . . 51.02 107.009 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 73.4 p -133.2 -173.56 3.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.455 -0.943 . . . . 73.04 108.455 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.83 160.53 21.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 103.702 -2.703 . . . . 72.22 103.702 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.312 -0.851 . . . . 63.12 110.716 178.746 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.596 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.541 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.421 HG22 HG12 ' A' ' 662' ' ' VAL . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.405 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 557' ' ' GLY . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 555' ' ' THR . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.429 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.422 ' HD3' HD21 ' A' ' 654' ' ' LEU . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.687 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.687 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . 0.422 HD21 ' HD3' ' A' ' 621' ' ' PRO . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 550' ' ' VAL . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 120.833 0.349 . . . . 52.130000000000003 110.394 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 34.439999999999998 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.566 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 72.319999999999993 107.134 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.310000000000002 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.219999999999999 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 65.430000000000007 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . 0.488 ' HG3' HD21 ' A' ' 553' ' ' LEU . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.430000000000007 114.037 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.430000000000007 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 61.439999999999998 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 74.239999999999995 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.310000000000002 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.200000000000003 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 548' ' ' MET . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.549999999999997 108.09 170.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 40.420000000000002 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.430000000000007 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 62.140000000000001 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 71.519999999999996 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 65.239999999999995 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 73.030000000000001 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 73.439999999999998 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 598' ' ' ILE . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.329999999999998 107.765 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.219999999999999 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.319999999999993 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.488 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.219999999999999 110.132 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.538 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 71.299999999999997 107.93 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 44.32 110.665 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.450000000000003 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 32.100000000000001 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.538 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 54.329999999999998 113.702 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.219999999999999 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.539999999999999 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.424 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.140000000000001 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 62.310000000000002 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 71.319999999999993 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 72.439999999999998 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 64.140000000000001 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 598' ' ' ILE . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 70.310000000000002 108.408 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 72.349999999999994 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 64.420000000000002 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 62.5 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.340000000000003 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.099999999999994 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.329999999999998 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.200000000000003 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 40.229999999999997 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.209999999999994 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 42.32 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 73.030000000000001 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.519999999999996 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 61.450000000000003 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 64.319999999999993 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.239999999999995 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.049999999999997 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.120000000000005 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.209999999999994 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.120000000000005 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 70.209999999999994 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.150000000000006 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 62.399999999999999 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 64.129999999999995 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 64.040000000000006 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.150000000000006 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.499 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.409999999999997 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 54.350000000000001 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.430000000000007 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 597' ' ' THR . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 54.329999999999998 110.592 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.349999999999994 112.007 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 550' ' ' VAL . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 65.519999999999996 106.808 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.150000000000006 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.219999999999999 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 64.109999999999999 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 543' ' ' GLU . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 62.340000000000003 106.862 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.099999999999994 113.864 -169.841 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 C--O 1.242 0.703 0 N-CA-C 107.336 -1.357 . . . . 52.299999999999997 107.336 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 73.150000000000006 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 54.200000000000003 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 61.509999999999998 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.428 HD12 HG11 ' A' ' 550' ' ' VAL . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 74.329999999999998 105.523 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 25.449999999999999 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 74.25 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.030000000000001 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 65.209999999999994 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 70.420000000000002 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 70.319999999999993 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.299999999999997 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.319999999999993 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.424 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.400000000000006 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 70.25 114.023 173.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 53.009999999999998 117.995 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.519999999999996 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.510000000000005 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.329999999999998 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.409999999999997 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 63.409999999999997 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.340000000000003 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 71.109999999999999 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.400000000000006 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 72.510000000000005 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 73.030000000000001 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 52.409999999999997 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.530000000000001 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt . . . . . 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.109999999999999 108.374 177.054 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 107.981 -1.118 . . . . 53.240000000000002 107.981 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 51.409999999999997 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 71.230000000000004 109.022 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.329999999999998 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.420000000000002 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 73.540000000000006 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.230000000000004 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.310000000000002 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 65.549999999999997 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 73.510000000000005 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.69 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 64.329999999999998 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 64.430000000000007 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.209999999999994 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 54.43 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 61.32 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.049999999999997 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 62.25 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.120000000000005 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 73.120000000000005 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.431 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.200000000000003 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 71.099999999999994 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.340000000000003 105.856 171.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 62.130000000000003 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.439999999999998 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.400000000000006 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.129999999999995 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.73 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.219999999999999 110.797 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.229999999999997 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.73 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.329999999999998 109.349 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 72.120000000000005 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.319999999999993 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 43.399999999999999 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.530000000000001 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 74.319999999999993 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 61.130000000000003 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 61.43 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 71.109999999999999 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 64.329999999999998 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.430000000000007 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 61.200000000000003 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 62.130000000000003 110.776 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 63.539999999999999 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.200000000000003 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.439999999999998 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.239999999999995 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.519999999999996 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.510000000000005 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.109999999999999 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 72.200000000000003 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.329999999999998 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 73.049999999999997 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 53.219999999999999 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.219999999999999 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 61.229999999999997 110.911 -172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.040000000000006 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.549999999999997 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.439999999999998 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.349999999999994 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.439999999999998 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 71.099999999999994 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.602 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 72.400000000000006 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.310000000000002 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.120000000000005 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.109999999999999 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 62.109999999999999 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 64.299999999999997 106.658 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 550' ' ' VAL . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 64.219999999999999 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.209999999999994 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 54.549999999999997 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.120000000000005 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 63.200000000000003 106.625 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 63.240000000000002 108.016 -179.237 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.039999999999999 109.804 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 73.140000000000001 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.340000000000003 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.519999999999996 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 54.43 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.200000000000003 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.319999999999993 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.310000000000002 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.319999999999993 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.678 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.299999999999997 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 73.510000000000005 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 71.349999999999994 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.678 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 . . . . . 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.549999999999997 107.808 178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.548 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.450000000000003 117.305 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 72.409999999999997 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.340000000000003 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.219999999999999 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 71.340000000000003 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.439999999999998 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 74.530000000000001 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 63.450000000000003 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 55.229999999999997 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 73.450000000000003 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 64.239999999999995 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 73.120000000000005 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 72.120000000000005 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 70.430000000000007 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 70.019999999999996 106.165 178.065 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.510000000000005 109.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 64.099999999999994 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.400000000000006 106.716 172.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 70.329999999999998 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 72.329999999999998 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.604 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 63.149999999999999 110.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.129999999999995 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 70.519999999999996 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 73.439999999999998 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 65.319999999999993 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.129999999999995 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.109999999999999 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 71.299999999999997 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.539999999999999 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.299999999999997 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.150000000000006 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 72.299999999999997 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 61.310000000000002 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 65.209999999999994 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 63.340000000000003 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.450000000000003 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.140000000000001 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.209999999999994 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.329999999999998 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.329999999999998 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 62.310000000000002 108.828 177.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.510000000000005 112.65 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 61.350000000000001 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.481 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.319999999999993 113.09 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 51.32 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 72.400000000000006 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.129999999999995 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 72.140000000000001 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.409999999999997 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.239999999999995 115.301 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.329999999999998 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 72.310000000000002 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 580' ' ' PHE . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 71.109999999999999 109.361 176.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.310000000000002 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.439999999999998 109.545 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.430000000000007 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.209999999999994 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 61.229999999999997 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 64.310000000000002 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.209999999999994 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.450000000000003 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.209999999999994 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.230000000000004 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 568' ' ' THR . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 70.209999999999994 102.113 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.219999999999999 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.209999999999994 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.400000000000006 111.582 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.109999999999999 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.439999999999998 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.209999999999994 110.144 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 74.310000000000002 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 64.420000000000002 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 64.430000000000007 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 44.130000000000003 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.230000000000004 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.611 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 60.350000000000001 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.439999999999998 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 53.340000000000003 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 72.25 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 71.340000000000003 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 616' ' ' ILE . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.230000000000004 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 53.350000000000001 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 63.119999999999997 109.788 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 62.149999999999999 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 71.450000000000003 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t . . . . . 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 52.399999999999999 108.026 -177.92 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 . . . . . 0 CA--C 1.534 0.358 0 N-CA-C 107.276 -1.379 . . . . 52.130000000000003 107.276 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.400000000000006 112.795 -170.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . 0.472 ' CE1' HG21 ' A' ' 662' ' ' VAL . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.150000000000006 109.756 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.109999999999999 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 598' ' ' ILE . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 54.030000000000001 107.768 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.604 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 72.219999999999999 107.904 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.420000000000002 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.019999999999996 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 73.049999999999997 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.219999999999999 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.698 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.530000000000001 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 61.130000000000003 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 73.450000000000003 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.698 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 . . . . . 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 70.129999999999995 107.39 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.519 0.326 0 N-CA-C 116.891 1.516 . . . . 72.519999999999996 116.891 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.530000000000001 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 61.299999999999997 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 74.519999999999996 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.040000000000006 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.310000000000002 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.019999999999996 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.150000000000006 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.340000000000003 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 70.230000000000004 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 72.299999999999997 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.450000000000003 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.219999999999999 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 613' ' ' ASN . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.129999999999995 103.193 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.420000000000002 106.61 175.79 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.411 0 N-CA-C 107.705 -1.22 . . . . 75.430000000000007 107.705 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.140000000000001 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 45.299999999999997 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 71.219999999999999 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 71.319999999999993 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 618' ' ' LEU . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 63.420000000000002 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.409999999999997 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 61.409999999999997 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.230000000000004 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 70.530000000000001 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.310000000000002 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 662' ' ' VAL . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.109999999999999 107.937 169.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 61.229999999999997 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 71.310000000000002 110.926 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 52.32 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.099999999999994 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 62.329999999999998 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.229999999999997 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 62.030000000000001 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 53.210000000000001 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.099999999999994 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.530000000000001 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.140000000000001 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 51.539999999999999 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.736 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.230000000000004 109.722 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 43.109999999999999 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.736 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.319999999999993 109.049 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.239999999999995 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.239999999999995 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.229999999999997 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 62.32 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 63.100000000000001 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 64.120000000000005 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.420000000000002 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.230000000000004 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 70.200000000000003 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.349999999999994 108.622 171.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 70.400000000000006 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.404 HG22 ' HD2' ' A' ' 567' ' ' ARG . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.299999999999997 104.957 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.430000000000007 112.223 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 43.009999999999998 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 52.109999999999999 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.409999999999997 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.420000000000002 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 62.229999999999997 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.329999999999998 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 33.210000000000001 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 74.5 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.109999999999999 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.030000000000001 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.329999999999998 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 64.400000000000006 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 61.340000000000003 110.581 -169.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.239999999999995 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.140000000000001 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.319999999999993 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 51.109999999999999 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 54.32 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.655 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.310000000000002 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.140000000000001 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.140000000000001 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.655 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.319999999999993 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.439999999999998 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 71.409999999999997 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.349999999999994 109.094 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 72.209999999999994 112.505 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.420000000000002 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 70.420000000000002 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 583' ' ' ALA . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 73.019999999999996 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.409999999999997 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 73.109999999999999 106.157 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.129999999999995 109.328 -179.159 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 . . . . . 0 CA--C 1.507 -0.701 0 CA-C-O 121.723 0.773 . . . . 73.530000000000001 110.936 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 73.129999999999995 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 64.040000000000006 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.109999999999999 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.209999999999994 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 31.32 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.61 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 64.430000000000007 108.107 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.400000000000006 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.319999999999993 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 63.43 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.340000000000003 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.625 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.129999999999995 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.140000000000001 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.299999999999997 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.625 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.269 12.9 mmm180 . . . . . 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 71.450000000000003 106.813 175.858 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.546 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.229 -0.218 0 N-CA-C 116.931 1.532 . . . . 52.439999999999998 116.931 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.239999999999995 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 43.409999999999997 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 54.229999999999997 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 55.329999999999998 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 42.140000000000001 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.349999999999994 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.239999999999995 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 62.340000000000003 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.450000000000003 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 64.450000000000003 105.121 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 63.119999999999997 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.409999999999997 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.239999999999995 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt . . . . . 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.310000000000002 105.989 176.627 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.129999999999995 109.278 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.349999999999994 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.340000000000003 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.219999999999999 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 63.399999999999999 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.140000000000001 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 63.329999999999998 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.329999999999998 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 72.310000000000002 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 73.340000000000003 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.636 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.209999999999994 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 62.219999999999999 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 109.912 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.420000000000002 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 60.219999999999999 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.530000000000001 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 65.25 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 24.010000000000002 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 74.409999999999997 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.455 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.349999999999994 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 64.439999999999998 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.488 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.219999999999999 106.333 171.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 65.530000000000001 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 65.209999999999994 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 72.200000000000003 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 72.209999999999994 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 51.439999999999998 110.815 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.209999999999994 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 61.5 109.972 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.349999999999994 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 64.209999999999994 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 34.130000000000003 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 52.439999999999998 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . 0.498 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.329999999999998 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 586' ' ' GLU . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.150000000000006 104.872 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 64.129999999999995 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 62.109999999999999 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.400000000000006 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.430000000000007 107.534 172.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.439999999999998 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' A' ' 567' ' ' ARG . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.030000000000001 106.73 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 65.510000000000005 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 64.430000000000007 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 65.209999999999994 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.019999999999996 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.149999999999999 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 61.409999999999997 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 60.020000000000003 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.150000000000006 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.049999999999997 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.099999999999994 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.240000000000002 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . 0.416 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.239999999999995 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 52.140000000000001 107.947 -169.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.209999999999994 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.230000000000004 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 563' ' ' ILE . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 70.340000000000003 110.387 176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.109999999999999 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.219999999999999 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 73.109999999999999 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 74.409999999999997 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.209999999999994 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.319999999999993 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.409999999999997 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 71.120000000000005 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 70.219999999999999 105.321 168.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.200000000000003 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.109999999999999 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 71.409999999999997 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 72.010000000000005 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.540000000000006 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 62.240000000000002 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.540000000000006 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.040000000000006 105.097 -175.435 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.465 0.311 0 N-CA-C 109.538 -0.541 . . . . 71.519999999999996 109.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.150000000000006 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.200000000000003 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 64.420000000000002 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 550' ' ' VAL . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 64.219999999999999 105.355 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.200000000000003 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.039999999999999 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 73.310000000000002 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 62.030000000000001 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 62.420000000000002 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.717 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.299999999999997 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . 0.498 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 31.34 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 73.209999999999994 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.717 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 . . . . . 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.409999999999997 107.777 179.511 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.420000000000002 116.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 54.549999999999997 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 54.219999999999999 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 63.439999999999998 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.219999999999999 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.310000000000002 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.439999999999998 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.129999999999995 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 550' ' ' VAL . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 62.43 107.42 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.329999999999998 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 74.129999999999995 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.230000000000004 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 63.539999999999999 106.232 177.089 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 73.530000000000001 108.614 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.44 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 43.549999999999997 108.689 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.200000000000003 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 71.430000000000007 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.340000000000003 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 71.439999999999998 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 62.409999999999997 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.239999999999995 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 52.100000000000001 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.200000000000003 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.040000000000006 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 662' ' ' VAL . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.200000000000003 108.687 167.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.129999999999995 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.129999999999995 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 71.340000000000003 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.310000000000002 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.010000000000005 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.510000000000005 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.310000000000002 109.231 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 71.010000000000005 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 73.430000000000007 105.927 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.420000000000002 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.010000000000005 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.450000000000003 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.319999999999993 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.665 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.239999999999995 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.209999999999994 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 61.210000000000001 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 71.439999999999998 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 72.400000000000006 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.230000000000004 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.120000000000005 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.510000000000005 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.219999999999999 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.109999999999999 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.129999999999995 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 54.409999999999997 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.450000000000003 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 64.219999999999999 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 65.450000000000003 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 73.310000000000002 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.509999999999998 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 71.120000000000005 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.519999999999996 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 73.209999999999994 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.120000000000005 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.450000000000003 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 50.219999999999999 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 32.229999999999997 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.439999999999998 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.319999999999993 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.230000000000004 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 65.109999999999999 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.120000000000005 111.527 -170.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.450000000000003 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.430000000000007 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 64.209999999999994 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 61.25 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 55.549999999999997 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 74.019999999999996 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.62 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 70.150000000000006 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 61.43 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 72.409999999999997 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.230000000000004 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 54.119999999999997 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 71.010000000000005 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.140000000000001 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 64.530000000000001 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.495 ' HB ' HG22 ' A' ' 550' ' ' VAL . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 60.32 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 74.319999999999993 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.439999999999998 107.53 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.209999999999994 105.58 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 73.310000000000002 109.521 -176.11 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.439999999999998 108.97 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . 0.406 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 72.099999999999994 109.296 -168.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.439999999999998 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 73.420000000000002 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.120000000000005 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 54.509999999999998 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.439999999999998 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.210000000000001 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.200000000000003 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 654' ' ' LEU . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.210000000000001 110.694 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.209999999999994 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.597 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.450000000000003 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.129999999999995 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 72.420000000000002 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.597 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.294 23.5 mmm180 . . . . . 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.540000000000006 104.651 178.962 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.129999999999995 116.465 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 62.039999999999999 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.150000000000006 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 54.420000000000002 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 111.853 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 32.539999999999999 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.030000000000001 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.239999999999995 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 44.229999999999997 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.430000000000007 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 64.010000000000005 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 62.32 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 62.100000000000001 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 613' ' ' ASN . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 72.209999999999994 103.979 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.140000000000001 106.225 175.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 108.746 -0.835 . . . . 71.209999999999994 108.746 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.109999999999999 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . 0.564 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 70.5 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.329999999999998 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 618' ' ' LEU . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.430000000000007 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.010000000000005 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 73.120000000000005 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 65.129999999999995 110.311 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 74.540000000000006 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 662' ' ' VAL . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.439999999999998 106.63 165.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.150000000000006 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 52.420000000000002 110.016 177.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.219999999999999 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 72.209999999999994 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.409999999999997 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 64.019999999999996 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.47 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.439999999999998 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.200000000000003 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 70.0 105.642 169.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 42.340000000000003 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.549999999999997 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 70.230000000000004 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.564 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 71.219999999999999 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.230000000000004 112.045 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.129999999999995 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 555' ' ' THR . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 62.200000000000003 109.801 173.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 70.129999999999995 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.25 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 43.5 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.514 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 62.539999999999999 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.150000000000006 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.409999999999997 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.420000000000002 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 63.409999999999997 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.230000000000004 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.430000000000007 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.140000000000001 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 71.439999999999998 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.120000000000005 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.409999999999997 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.150000000000006 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 45.32 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.129999999999995 106.718 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 62.450000000000003 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.230000000000004 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.200000000000003 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.430000000000007 114.655 -171.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.340000000000003 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 74.310000000000002 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 51.210000000000001 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 73.349999999999994 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 64.329999999999998 110.561 -172.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.430000000000007 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.420000000000002 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 63.210000000000001 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.030000000000001 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 63.340000000000003 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 70.129999999999995 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 71.129999999999995 106.876 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.430000000000007 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 54.229999999999997 118.855 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.200000000000003 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 73.040000000000006 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.140000000000001 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 63.329999999999998 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.463 ' HB ' HG22 ' A' ' 550' ' ' VAL . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 72.120000000000005 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.140000000000001 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.109999999999999 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.340000000000003 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.299999999999997 106.67 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.109999999999999 108.188 -177.295 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.025 -1.102 . . . . 63.119999999999997 108.025 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.310000000000002 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 64.109999999999999 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.549999999999997 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 598' ' ' ILE . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 62.219999999999999 106.554 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.400000000000006 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 72.120000000000005 107.462 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.400000000000006 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.409999999999997 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 54.009999999999998 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.420000000000002 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.682 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 72.409999999999997 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 71.239999999999995 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 72.019999999999996 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.682 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 . . . . . 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 73.549999999999997 107.604 177.598 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.517 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 71.040000000000006 115.754 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.140000000000001 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.140000000000001 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.219999999999999 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 62.210000000000001 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 71.219999999999999 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 73.420000000000002 114.647 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.219999999999999 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.310000000000002 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.319999999999993 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.120000000000005 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 74.319999999999993 108.669 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.140000000000001 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt . . . . . 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 65.319999999999993 106.305 173.74 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.561 0 N-CA-C 107.462 -1.31 . . . . 73.400000000000006 107.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 21.34 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.718 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 72.120000000000005 105.863 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.140000000000001 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.230000000000004 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 64.239999999999995 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 52.049999999999997 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.129999999999995 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.450000000000003 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.319999999999993 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.691 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 65.109999999999999 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 65.519999999999996 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 662' ' ' VAL . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 54.420000000000002 108.609 172.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.420000000000002 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.140000000000001 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 72.209999999999994 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 63.450000000000003 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 70.299999999999997 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.150000000000006 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.468 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.329999999999998 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.319999999999993 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.310000000000002 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 61.420000000000002 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.329999999999998 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 72.140000000000001 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.519999999999996 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 531' ' ' ILE . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.120000000000005 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.129999999999995 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.663 ' H ' HG23 ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.329999999999998 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.150000000000006 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.129999999999995 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.140000000000001 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.299999999999997 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.209999999999994 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.549999999999997 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.420000000000002 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.140000000000001 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.099999999999994 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 63.399999999999999 108.367 172.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 74.25 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.446 HG22 ' HD2' ' A' ' 567' ' ' ARG . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 70.349999999999994 104.403 -170.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.130000000000003 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.100000000000001 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 64.510000000000005 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 52.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.209999999999994 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 64.120000000000005 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 61.109999999999999 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.129999999999995 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.129999999999995 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 71.319999999999993 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.319999999999993 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 71.200000000000003 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.340000000000003 111.137 -173.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.400000000000006 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 71.099999999999994 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.400000000000006 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 73.430000000000007 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.010000000000005 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 72.510000000000005 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.049999999999997 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 60.210000000000001 116.216 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.319999999999993 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.430000000000007 119.125 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.319999999999993 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 72.239999999999995 105.686 170.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 73.420000000000002 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 60.43 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 61.32 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.019999999999996 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.420000000000002 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 72.349999999999994 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t . . . . . 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.040000000000006 108.811 -178.26 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.064 -0.717 . . . . 64.319999999999993 109.064 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 71.129999999999995 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.150000000000006 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.439999999999998 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.299999999999997 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.329999999999998 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.230000000000004 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.319999999999993 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.450000000000003 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.299999999999997 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.150000000000006 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.200000000000003 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 73.299999999999997 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 72.099999999999994 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 . . . . . 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.099999999999994 109.744 178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 53.020000000000003 115.721 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.049999999999997 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 63.140000000000001 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 70.519999999999996 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 63.109999999999999 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 54.5 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.450000000000003 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 52.329999999999998 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 70.329999999999998 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.239999999999995 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 539' ' ' ILE . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 62.409999999999997 107.56 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.349999999999994 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.691 HG13 HG23 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.340000000000003 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.349999999999994 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.409999999999997 105.626 176.568 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 107.726 -1.213 . . . . 61.130000000000003 107.726 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.120000000000005 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.150000000000006 107.271 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 54.539999999999999 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 71.439999999999998 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.573 ' CE1' HD21 ' A' ' 618' ' ' LEU . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 72.5 108.081 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.299999999999997 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 45.229999999999997 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.340000000000003 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 62.420000000000002 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.340000000000003 109.515 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.120000000000005 107.418 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 662' ' ' VAL . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.010000000000005 108.533 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 52.299999999999997 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 64.400000000000006 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.150000000000006 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.109999999999999 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 52.25 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.130000000000003 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.129999999999995 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.239999999999995 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.439999999999998 106.245 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 73.519999999999996 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 73.530000000000001 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 73.540000000000006 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.010000000000005 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 64.430000000000007 110.246 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.319999999999993 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 33.340000000000003 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 554' ' ' ARG . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 45.340000000000003 109.647 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 72.420000000000002 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 43.32 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.349999999999994 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 63.049999999999997 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 74.510000000000005 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.430000000000007 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.439999999999998 115.129 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 65.010000000000005 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.010000000000005 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.040000000000006 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 71.450000000000003 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.200000000000003 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.400000000000006 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 42.229999999999997 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 72.219999999999999 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.310000000000002 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 64.230000000000004 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.099999999999994 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 71.219999999999999 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 71.439999999999998 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 63.119999999999997 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.400000000000006 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 62.450000000000003 109.32 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.120000000000005 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.439999999999998 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.040000000000006 109.044 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 63.340000000000003 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.420000000000002 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.120000000000005 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 62.049999999999997 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 43.100000000000001 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 52.140000000000001 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.310000000000002 117.072 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 62.310000000000002 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.219999999999999 104.547 168.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 73.109999999999999 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.400000000000006 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 71.329999999999998 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.010000000000005 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.478 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.120000000000005 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.019999999999996 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 62.43 104.98 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t . . . . . 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.120000000000005 110.666 -173.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 N--CA 1.449 -0.514 0 CA-C-O 122.212 1.006 . . . . 71.420000000000002 111.913 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.540000000000006 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.230000000000004 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 598' ' ' ILE . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 74.120000000000005 105.661 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.210000000000001 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.0 106.758 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.140000000000001 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.420000000000002 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 62.219999999999999 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.109999999999999 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.712 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.329999999999998 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 62.520000000000003 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.439999999999998 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.712 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 . . . . . 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 74.510000000000005 107.814 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.664 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.299999999999997 115.981 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.099999999999994 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 74.430000000000007 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 23.23 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 71.230000000000004 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 54.329999999999998 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 63.409999999999997 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.239999999999995 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 72.439999999999998 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 42.109999999999999 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.319999999999993 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 65.230000000000004 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 539' ' ' ILE . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 71.200000000000003 109.082 -171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 72.319999999999993 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 54.310000000000002 105.535 173.588 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.445 0 CA-C-O 121.108 0.48 . . . . 61.420000000000002 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.210000000000001 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.687 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 72.040000000000006 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 70.230000000000004 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.230000000000004 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 64.409999999999997 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.230000000000004 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.109999999999999 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.230000000000004 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.209999999999994 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.714 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 72.010000000000005 109.454 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.150000000000006 108.212 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 662' ' ' VAL . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 72.530000000000001 108.206 170.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.209999999999994 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.010000000000005 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.209999999999994 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 62.329999999999998 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.229999999999997 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.109999999999999 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.465 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.010000000000005 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 70.299999999999997 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.109999999999999 105.45 172.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 53.43 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.239999999999995 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 54.350000000000001 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.219999999999999 110.287 -177.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 73.120000000000005 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.420000000000002 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 63.039999999999999 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.433 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.120000000000005 111.919 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.349999999999994 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.409999999999997 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.467 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.450000000000003 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . 0.54 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 73.239999999999995 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 72.200000000000003 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 73.120000000000005 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.109999999999999 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.400000000000006 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 74.540000000000006 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.350000000000001 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 41.509999999999998 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 64.439999999999998 111.306 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.140000000000001 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 61.130000000000003 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.240000000000002 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.430000000000007 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.230000000000004 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.519999999999996 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.020000000000003 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 62.219999999999999 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.420000000000002 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.530000000000001 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.299999999999997 109.296 -171.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.129999999999995 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 71.209999999999994 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 63.420000000000002 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.239999999999995 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 63.43 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.609 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.109999999999999 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.219999999999999 115.669 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.310000000000002 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 71.209999999999994 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.340000000000003 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 71.030000000000001 104.122 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.409999999999997 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 71.129999999999995 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 62.119999999999997 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 60.399999999999999 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 54.140000000000001 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 64.430000000000007 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 543' ' ' GLU . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.349999999999994 106.175 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t . . . . . 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 60.009999999999998 109.61 -172.15 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 109.177 -0.675 . . . . 73.439999999999998 109.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.430000000000007 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 63.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.140000000000001 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.129999999999995 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.009999999999998 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 74.409999999999997 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.030000000000001 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.109999999999999 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 53.140000000000001 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.150000000000006 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.561 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.25 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 73.340000000000003 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.467 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.420000000000002 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.561 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 44.420000000000002 116.25 169.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.539 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 34.409999999999997 116.67 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.430000000000007 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.519999999999996 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 70.450000000000003 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.010000000000005 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.349999999999994 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.340000000000003 114.659 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 61.030000000000001 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.219999999999999 109.522 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.400000000000006 108.612 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.140000000000001 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.714 HG13 HG23 ' A' ' 539' ' ' ILE . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.329999999999998 109.023 -171.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 72.310000000000002 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt . . . . . 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.200000000000003 106.593 175.062 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.129999999999995 108.549 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.319999999999993 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 54.130000000000003 108.883 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 73.140000000000001 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.299999999999997 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.310000000000002 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.099999999999994 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 64.099999999999994 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.140000000000001 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.450000000000003 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.427 HD13 HG13 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 53.210000000000001 107.598 177.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.420000000000002 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 548' ' ' MET . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 73.310000000000002 106.732 169.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 545' ' ' ILE . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 71.400000000000006 102.109 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.200000000000003 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 33.340000000000003 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 542' ' ' SER . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.140000000000001 110.18 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.349999999999994 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 62.530000000000001 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.51 ' HB2' HG11 ' A' ' 541' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.439999999999998 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.120000000000005 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 63.520000000000003 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 74.510000000000005 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 72.430000000000007 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.340000000000003 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.030000000000001 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.150000000000006 110.318 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.430000000000007 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.310000000000002 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 73.319999999999993 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.430000000000007 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 62.43 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 52.32 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 64.319999999999993 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 72.209999999999994 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 71.209999999999994 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . 0.452 ' CE2' HG23 ' A' ' 598' ' ' ILE . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 63.310000000000002 107.587 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.540000000000006 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.219999999999999 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.349999999999994 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 61.520000000000003 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 64.409999999999997 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.109999999999999 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.239999999999995 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . 0.453 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.150000000000006 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.340000000000003 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.140000000000001 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.240000000000002 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . 0.453 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.439999999999998 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.210000000000001 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.540000000000006 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 55.140000000000001 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 52.229999999999997 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 51.140000000000001 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 73.310000000000002 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.420000000000002 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.140000000000001 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.239999999999995 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.409999999999997 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.340000000000003 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.509999999999998 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.400000000000006 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 64.019999999999996 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.659 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.409999999999997 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.040000000000006 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.299999999999997 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.129999999999995 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 65.200000000000003 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.452 HG23 ' CE2' ' A' ' 566' ' ' PHE . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.310000000000002 105.975 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 55.43 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 61.240000000000002 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 72.150000000000006 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' A' ' 543' ' ' GLU . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.510000000000005 105.581 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t . . . . . 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.349999999999994 110.014 -171.16 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.24 0.577 0 N-CA-C 104.589 -2.374 . . . . 75.299999999999997 104.589 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.019999999999996 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.400000000000006 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.319999999999993 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 71.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.509999999999998 109.277 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 534' ' ' PHE . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.200000000000003 108.005 173.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 72.450000000000003 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.439999999999998 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.419 ' HD3' HD21 ' A' ' 654' ' ' LEU . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.549999999999997 110.46 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.439999999999998 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.704 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.209999999999994 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 62.340000000000003 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 64.120000000000005 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.704 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 . . . . . 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 64.420000000000002 106.272 -179.301 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.420000000000002 116.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.319999999999993 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.230000000000004 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 64.329999999999998 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 110.684 173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.129999999999995 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.109999999999999 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 54.030000000000001 112.739 173.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 71.540000000000006 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 73.519999999999996 108.117 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 64.120000000000005 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.540000000000006 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.150000000000006 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.468 0.175 . . . . 63.420000000000002 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 21.329999999999998 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.200000000000003 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 72.010000000000005 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.310000000000002 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.530000000000001 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . 0.469 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 65.209999999999994 112.616 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.540000000000006 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 55.119999999999997 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.310000000000002 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.319999999999993 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 64.420000000000002 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 662' ' ' VAL . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.430000000000007 108.542 170.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.319999999999993 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.129999999999995 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 61.240000000000002 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.340000000000003 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 63.420000000000002 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.049999999999997 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.409 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 65.5 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.209999999999994 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.010000000000005 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.239999999999995 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.519999999999996 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.540000000000006 109.064 -176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.150000000000006 109.582 -176.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 53.130000000000003 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.329999999999998 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.200000000000003 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.565 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 60.299999999999997 112.943 -174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 61.530000000000001 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.020000000000003 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 60.409999999999997 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . 0.418 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.519999999999996 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 74.200000000000003 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.230000000000004 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 73.129999999999995 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 72.140000000000001 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.209999999999994 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.120000000000005 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.299999999999997 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.119999999999997 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.129999999999995 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.420000000000002 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.140000000000001 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.019999999999996 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 73.439999999999998 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 52.509999999999998 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.450000000000003 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.129999999999995 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.099999999999994 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.329999999999998 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 53.210000000000001 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.310000000000002 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.209999999999994 112.145 -171.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.329999999999998 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.509999999999998 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 73.200000000000003 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 62.549999999999997 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.010000000000005 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.230000000000004 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.507 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.420000000000002 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 64.409999999999997 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.049999999999997 111.469 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.099999999999994 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.019999999999996 114.026 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 72.530000000000001 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 63.210000000000001 107.48 -176.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.230000000000004 111.323 -178.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.329999999999998 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 72.129999999999995 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.530000000000001 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 62.420000000000002 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.417 HG21 ' HA ' ' A' ' 543' ' ' GLU . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 74.219999999999999 106.865 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 62.399999999999999 109.596 179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 . . . . . 0 C--O 1.238 0.456 0 N-CA-C 106.073 -1.825 . . . . 72.319999999999993 106.073 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 64.319999999999993 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.340000000000003 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.219999999999999 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 44.409999999999997 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 61.530000000000001 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 51.539999999999999 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.409999999999997 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.129999999999995 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.430000000000007 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.299999999999997 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.701 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.200000000000003 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . 0.418 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 64.129999999999995 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.439999999999998 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.701 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 . . . . . 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.400000000000006 107.591 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.224 -0.529 0 N-CA-C 115.028 0.771 . . . . 44.520000000000003 115.028 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.229999999999997 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 52.439999999999998 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.129999999999995 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.430000000000007 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.420000000000002 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.219999999999999 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.130000000000003 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.340000000000003 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.439999999999998 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.450000000000003 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.200000000000003 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.310000000000002 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.439999999999998 106.191 176.126 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 52.299999999999997 109.329 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.409999999999997 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.657 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 63.229999999999997 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 64.540000000000006 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 62.32 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.400000000000006 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.329999999999998 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 61.329999999999998 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.200000000000003 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 70.120000000000005 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.706 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.439999999999998 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 662' ' ' VAL . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.140000000000001 109.625 166.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 545' ' ' ILE . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 43.450000000000003 105.16 171.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 63.130000000000003 107.522 168.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.540000000000006 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 542' ' ' SER . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 74.420000000000002 110.205 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 51.530000000000001 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.329999999999998 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 62.149999999999999 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.540000000000006 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.319999999999993 106.481 172.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.239999999999995 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 71.0 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.400000000000006 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.109999999999999 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 52.43 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.329999999999998 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.340000000000003 113.183 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.536 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 55.409999999999997 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 72.140000000000001 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.129999999999995 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.463 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.239999999999995 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.340000000000003 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 64.530000000000001 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 63.420000000000002 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 62.310000000000002 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.120000000000005 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 70.25 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.409999999999997 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.430000000000007 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.310000000000002 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.540000000000006 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 61.5 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.430000000000007 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 43.340000000000003 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 64.310000000000002 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.010000000000005 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.209999999999994 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.430000000000007 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.299999999999997 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.329999999999998 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.450000000000003 110.59 -172.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.349999999999994 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 71.209999999999994 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.540000000000006 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.420000000000002 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.129999999999995 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.120000000000005 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 65.129999999999995 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 52.520000000000003 114.692 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.239999999999995 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 72.400000000000006 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.417 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 62.420000000000002 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.540000000000006 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . 0.443 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.319999999999993 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 45.039999999999999 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 72.109999999999999 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 71.349999999999994 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 64.230000000000004 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.430000000000007 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.340000000000003 107.627 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 72.129999999999995 109.28 -178.077 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.466 0.344 0 N-CA-C 107.396 -1.335 . . . . 64.239999999999995 107.396 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.209999999999994 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.519999999999996 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 71.140000000000001 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 73.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 62.109999999999999 108.632 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 73.450000000000003 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.219999999999999 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 72.230000000000004 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 62.119999999999997 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.549999999999997 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.477 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 74.019999999999996 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.400000000000006 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.463 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 54.420000000000002 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.477 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.540000000000006 114.711 171.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 51.009999999999998 116.348 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 62.399999999999999 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.329999999999998 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 63.450000000000003 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 44.219999999999999 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.340000000000003 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.319999999999993 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.230000000000004 112.694 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.340000000000003 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 41.100000000000001 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 71.239999999999995 107.337 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 43.5 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.706 HG13 HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 71.219999999999999 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 42.140000000000001 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt . . . . . 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.430000000000007 104.957 177.134 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 55.43 109.308 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 55.439999999999998 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.486 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.340000000000003 108.558 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.140000000000001 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.319999999999993 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.483 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 73.200000000000003 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 73.010000000000005 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 60.43 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 64.109999999999999 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 52.049999999999997 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.109999999999999 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 62.329999999999998 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 545' ' ' ILE . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 71.409999999999997 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 542' ' ' SER . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.230000000000004 109.724 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.530000000000001 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 61.240000000000002 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 51.130000000000003 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 53.5 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 64.140000000000001 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.439999999999998 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.120000000000005 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 74.430000000000007 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.409999999999997 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.744 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.310000000000002 111.309 -175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.744 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 71.120000000000005 109.527 170.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 60.350000000000001 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.439999999999998 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.310000000000002 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 71.549999999999997 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . 0.526 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.120000000000005 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.420000000000002 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 72.299999999999997 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.239999999999995 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.109999999999999 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.530000000000001 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.129999999999995 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 65.430000000000007 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 54.25 110.443 -179.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 52.109999999999999 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.209999999999994 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 52.240000000000002 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 45.340000000000003 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 42.420000000000002 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.439999999999998 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.310000000000002 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.530000000000001 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.200000000000003 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.310000000000002 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 63.219999999999999 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.099999999999994 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 63.119999999999997 110.527 -171.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 71.420000000000002 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.439999999999998 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.329999999999998 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.519999999999996 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.409999999999997 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.439999999999998 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.649 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 71.25 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.099999999999994 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 64.200000000000003 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.239999999999995 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 50.32 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 72.219999999999999 105.296 168.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.209999999999994 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 41.240000000000002 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.109999999999999 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 51.5 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 64.129999999999995 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 55.530000000000001 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 72.409999999999997 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 50.109999999999999 107.641 -176.63 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.777 -0.823 . . . . 75.319999999999993 108.777 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 72.129999999999995 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 71.540000000000006 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.209999999999994 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.239999999999995 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.140000000000001 106.897 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 70.150000000000006 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.230000000000004 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 52.219999999999999 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.509999999999998 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 70.230000000000004 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.674 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.430000000000007 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . 0.526 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 60.399999999999999 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 64.010000000000005 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.674 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 55.210000000000001 107.94 179.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 32.140000000000001 115.685 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 72.030000000000001 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.420000000000002 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.219999999999999 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 73.409999999999997 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.430000000000007 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 53.439999999999998 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.329999999999998 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 42.240000000000002 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 62.340000000000003 109.404 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 54.009999999999998 105.078 176.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 71.230000000000004 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 61.439999999999998 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.109999999999999 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 72.319999999999993 105.468 173.056 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.762 0 N-CA-C 106.198 -1.778 . . . . 73.140000000000001 106.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 71.439999999999998 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.556 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 64.349999999999994 106.92 171.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.140000000000001 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.420000000000002 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 70.340000000000003 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 553' ' ' LEU . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.439999999999998 113.514 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.219999999999999 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.200000000000003 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 62.350000000000001 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.732 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.230000000000004 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.129999999999995 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 662' ' ' VAL . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.439999999999998 108.718 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 53.409999999999997 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 62.039999999999999 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 64.340000000000003 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.239999999999995 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.109999999999999 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.310000000000002 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.413 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 71.540000000000006 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 54.439999999999998 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.310000000000002 105.068 170.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.540000000000006 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.509999999999998 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.435 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.219999999999999 108.696 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 73.109999999999999 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.219999999999999 112.317 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 45.420000000000002 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.340000000000003 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.458 ' HB2' ' CD ' ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.020000000000003 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.439999999999998 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.240000000000002 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 74.349999999999994 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 65.109999999999999 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 61.340000000000003 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 63.340000000000003 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 51.109999999999999 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 72.319999999999993 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.546 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.230000000000004 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.409999999999997 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.546 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.239999999999995 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.634 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.230000000000004 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 71.230000000000004 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 51.039999999999999 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.319999999999993 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 71.340000000000003 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.209999999999994 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 45.539999999999999 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.400000000000006 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.109999999999999 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 73.510000000000005 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.230000000000004 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.409999999999997 112.029 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.239999999999995 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.329999999999998 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.299999999999997 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 64.030000000000001 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 70.510000000000005 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . 0.404 ' HD2' ' HA ' ' A' ' 594' ' ' THR . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.120000000000005 104.492 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.619 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.450000000000003 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 42.310000000000002 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 64.439999999999998 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.619 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.230000000000004 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 589' ' ' PHE . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.409999999999997 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.140000000000001 103.382 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 71.349999999999994 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 53.409999999999997 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.329999999999998 107.11 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 64.329999999999998 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 64.109999999999999 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.340000000000003 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.430000000000007 105.993 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t . . . . . 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.099999999999994 109.768 -173.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 C--O 1.237 0.41 0 N-CA-C 108.181 -1.044 . . . . 72.519999999999996 108.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.510000000000005 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.219999999999999 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 73.439999999999998 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.403 HG21 HG21 ' A' ' 598' ' ' ILE . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 51.32 106.685 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.329999999999998 108.024 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.430000000000007 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.329999999999998 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.219999999999999 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 73.109999999999999 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.030000000000001 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.530000000000001 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.430000000000007 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.209999999999994 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 . . . . . 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 72.519999999999996 112.061 176.556 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.624 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.329999999999998 117.5 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 71.030000000000001 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 61.509999999999998 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 61.530000000000001 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 61.119999999999997 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 63.009999999999998 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.109999999999999 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 71.540000000000006 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.209999999999994 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 72.430000000000007 108.569 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 550' ' ' VAL . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 63.25 107.167 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.010000000000005 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 63.219999999999999 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 63.520000000000003 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt . . . . . 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 52.229999999999997 106.162 177.132 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 108.633 -0.877 . . . . 75.420000000000002 108.633 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.439999999999998 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 72.209999999999994 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.329999999999998 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.230000000000004 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.109999999999999 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.150000000000006 113.787 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 73.349999999999994 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.010000000000005 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 62.329999999999998 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.671 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.519999999999996 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.319999999999993 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 548' ' ' MET . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 71.209999999999994 107.957 168.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.310000000000002 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.409999999999997 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.430000000000007 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.319999999999993 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 50.450000000000003 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.219999999999999 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.421 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 70.540000000000006 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 62.310000000000002 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 616' ' ' ILE . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.200000000000003 106.685 171.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 64.430000000000007 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.219999999999999 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.119999999999997 109.632 178.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.439999999999998 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.219999999999999 111.51 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 53.409999999999997 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . 0.773 ' H ' HG23 ' A' ' 555' ' ' THR . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 35.329999999999998 110.373 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.230000000000004 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 72.430000000000007 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 44.350000000000001 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.219999999999999 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.430000000000007 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 52.109999999999999 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.239999999999995 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 60.020000000000003 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 598' ' ' ILE . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.140000000000001 108.098 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.030000000000001 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 63.240000000000002 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 64.430000000000007 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 72.310000000000002 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.120000000000005 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 73.239999999999995 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 52.530000000000001 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 64.310000000000002 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.329999999999998 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.329999999999998 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.329999999999998 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.049999999999997 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.340000000000003 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.349999999999994 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.540000000000006 108.28 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.310000000000002 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 63.329999999999998 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.140000000000001 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 41.399999999999999 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 65.329999999999998 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.430000000000007 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 70.430000000000007 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 72.299999999999997 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 65.439999999999998 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.030000000000001 116.111 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.310000000000002 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 62.219999999999999 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.129999999999995 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.340000000000003 105.923 169.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 62.240000000000002 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.510000000000005 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 550' ' ' VAL . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 65.540000000000006 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.230000000000004 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.400000000000006 107.458 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.140000000000001 105.741 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 74.299999999999997 110.047 -177.455 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.236 0.391 0 CA-C-O 121.45 0.643 . . . . 74.409999999999997 111.767 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.229999999999997 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 62.43 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.420000000000002 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 550' ' ' VAL . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 62.539999999999999 105.585 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 64.030000000000001 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 71.519999999999996 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.240000000000002 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.019999999999996 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . 0.417 ' HD3' HD21 ' A' ' 654' ' ' LEU . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 64.310000000000002 110.469 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 61.539999999999999 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.71 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.430000000000007 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.329999999999998 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 60.009999999999998 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.71 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 . . . . . 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 55.439999999999998 107.855 178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.473 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 64.439999999999998 115.984 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.510000000000005 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 70.299999999999997 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 64.109999999999999 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 621' ' ' PRO . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.349999999999994 111.215 174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 62.530000000000001 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.140000000000001 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.349999999999994 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.400000000000006 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.435 HD23 HG12 ' A' ' 550' ' ' VAL . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 73.099999999999994 107.622 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 62.229999999999997 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.671 HG13 HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 63.329999999999998 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 62.310000000000002 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt . . . . . 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 72.030000000000001 106.307 176.14 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 120.866 0.365 . . . . 64.099999999999994 110.161 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.450000000000003 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.678 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.099999999999994 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 74.200000000000003 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.439999999999998 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 65.230000000000004 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 64.299999999999997 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.310000000000002 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.540000000000006 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.718 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 72.209999999999994 108.434 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 62.130000000000003 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 168.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 53.149999999999999 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.010000000000005 111.918 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.010000000000005 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 63.310000000000002 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 41.509999999999998 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 71.209999999999994 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 64.040000000000006 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.299999999999997 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.421 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.140000000000001 103.787 169.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.439999999999998 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 71.430000000000007 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.340000000000003 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.427 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 62.539999999999999 109.704 -177.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.450000000000003 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.109999999999999 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 43.420000000000002 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.349999999999994 114.233 -172.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.430000000000007 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.230000000000004 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.439999999999998 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 62.039999999999999 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.530000000000001 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.310000000000002 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 63.219999999999999 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.239999999999995 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.409999999999997 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.120000000000005 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.040000000000006 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.239999999999995 110.418 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.349999999999994 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 71.040000000000006 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 60.229999999999997 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.010000000000005 106.932 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 71.310000000000002 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.119999999999997 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.200000000000003 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 62.109999999999999 115.924 -162.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.209999999999994 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.349999999999994 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.540000000000006 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.430000000000007 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.430000000000007 109.779 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.129999999999995 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.329999999999998 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 62.119999999999997 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.329999999999998 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.549999999999997 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 63.119999999999997 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.200000000000003 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 72.129999999999995 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 65.340000000000003 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 61.039999999999999 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 63.210000000000001 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 71.540000000000006 103.414 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.299999999999997 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 53.450000000000003 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 616' ' ' ILE . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.010000000000005 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.310000000000002 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 583' ' ' ALA . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.439999999999998 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 71.519999999999996 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 543' ' ' GLU . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 73.040000000000006 107.583 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.520000000000003 110.306 -176.556 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 109.033 -0.729 . . . . 53.030000000000001 109.033 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.030000000000001 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.540000000000006 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.349999999999994 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 598' ' ' ILE . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 73.420000000000002 106.474 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.420000000000002 108.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.209999999999994 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 71.349999999999994 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 70.120000000000005 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.439999999999998 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 61.420000000000002 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.409999999999997 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 60.299999999999997 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.109999999999999 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 . . . . . 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 65.129999999999995 110.498 176.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.594 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 71.400000000000006 115.573 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.510000000000005 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 41.149999999999999 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 64.129999999999995 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.109999999999999 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.299999999999997 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 64.319999999999993 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.209999999999994 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.430000000000007 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.319999999999993 109.183 -176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 539' ' ' ILE . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 71.340000000000003 108.474 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.420000000000002 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.718 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.439999999999998 107.805 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 74.209999999999994 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 65.040000000000006 104.732 175.29 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.845 0.355 . . . . 55.340000000000003 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.450000000000003 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.739 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.109999999999999 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 62.399999999999999 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 64.439999999999998 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.310000000000002 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.239999999999995 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.109999999999999 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 61.109999999999999 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 64.150000000000006 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.734 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 73.420000000000002 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 72.530000000000001 108.318 174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 71.420000000000002 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 43.030000000000001 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 63.25 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.450000000000003 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.400000000000006 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.519999999999996 109.532 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 74.0 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 70.140000000000001 104.284 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 53.009999999999998 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 73.140000000000001 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.299999999999997 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 73.439999999999998 109.874 -177.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.129999999999995 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.209999999999994 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 43.520000000000003 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.209999999999994 111.671 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.439999999999998 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 74.200000000000003 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 71.109999999999999 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.120000000000005 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 73.109999999999999 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 71.340000000000003 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.150000000000006 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.109999999999999 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.428 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 55.439999999999998 108.257 171.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.209999999999994 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.319999999999993 111.1 -177.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.210000000000001 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.310000000000002 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.200000000000003 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 71.299999999999997 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 51.530000000000001 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 42.130000000000003 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 65.319999999999993 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.240000000000002 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 72.310000000000002 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.230000000000004 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 71.329999999999998 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.310000000000002 108.723 -174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.420000000000002 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.209999999999994 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.420000000000002 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 44.539999999999999 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.510000000000005 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 64.340000000000003 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.535 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.519999999999996 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 64.209999999999994 115.36 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 71.400000000000006 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.535 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 51.409999999999997 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 594' ' ' THR . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.0 113.812 -168.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 62.25 106.717 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 72.200000000000003 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 61.539999999999999 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 73.510000000000005 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.209999999999994 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 583' ' ' ALA . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 64.099999999999994 107.324 177.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.409999999999997 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 543' ' ' GLU . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 71.319999999999993 103.692 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.200000000000003 107.789 -174.137 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.82 -1.178 . . . . 74.150000000000006 107.82 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . 0.421 ' C ' HD22 ' A' ' 613' ' ' ASN . 0.1 OUTLIER -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 62.340000000000003 106.023 -178.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.030000000000001 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.229999999999997 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.310000000000002 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 44.520000000000003 107.362 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.420000000000002 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.450000000000003 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 71.209999999999994 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 70.530000000000001 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 72.349999999999994 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.693 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.109999999999999 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 70.310000000000002 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.299999999999997 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.693 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 . . . . . 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.209999999999994 106.739 177.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.462 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 50.140000000000001 117.183 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.430000000000007 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 61.350000000000001 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.319999999999993 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.340000000000003 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.420000000000002 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.109999999999999 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.329999999999998 112.247 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 61.399999999999999 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 74.200000000000003 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 550' ' ' VAL . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.439999999999998 105.986 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.230000000000004 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.540000000000006 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.430000000000007 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt . . . . . 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 64.150000000000006 105.302 175.457 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 107.696 -1.224 . . . . 61.310000000000002 107.696 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.439999999999998 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' ILE . . . . . 0.664 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.129999999999995 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.439999999999998 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 51.409999999999997 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' PHE . . . . . 0.596 ' CE1' HD21 ' A' ' 618' ' ' LEU . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.329999999999998 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 553' ' ' LEU . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.109999999999999 113.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 54.25 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.439999999999998 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 72.040000000000006 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' ILE . . . . . 0.575 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 52.32 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.230000000000004 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 51.210000000000001 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 53.219999999999999 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.349999999999994 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.109999999999999 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.239999999999995 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 63.109999999999999 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 72.530000000000001 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 62.100000000000001 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.319999999999993 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' VAL . . . . . 0.573 HG22 HD12 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.230000000000004 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 74.5 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.120000000000005 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 60.219999999999999 108.173 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 63.119999999999997 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 65.239999999999995 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.319999999999993 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 558' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.340000000000003 112.901 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.109999999999999 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 64.109999999999999 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 561' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 73.019999999999996 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.129999999999995 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 74.519999999999996 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 70.209999999999994 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.409999999999997 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.450000000000003 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 567' ' ' ARG . . . . . 0.497 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.239999999999995 106.335 171.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.510000000000005 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 569' ' ' VAL . . . . . 0.497 HG22 ' HD2' ' A' ' 567' ' ' ARG . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.230000000000004 104.303 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 570' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 71.209999999999994 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.119999999999997 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.340000000000003 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 73.450000000000003 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.399999999999999 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.150000000000006 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.129999999999995 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.319999999999993 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.310000000000002 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 71.349999999999994 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 70.329999999999998 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.329999999999998 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.140000000000001 111.631 -172.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.420000000000002 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.420000000000002 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 53.539999999999999 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 64.420000000000002 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.120000000000005 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 72.420000000000002 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 590' ' ' LYS . . . . . 0.567 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 62.350000000000001 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 52.009999999999998 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 592' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 63.43 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 593' ' ' GLU . . . . . 0.567 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.239999999999995 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 594' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 594' ' ' THR . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.510000000000005 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.420000000000002 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 64.439999999999998 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 64.340000000000003 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 598' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 616' ' ' ILE . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 72.140000000000001 106.744 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 64.549999999999997 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.420000000000002 109.228 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 65.310000000000002 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.430000000000007 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t . . . . . 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 62.340000000000003 111.936 -172.688 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 . . . . . 0 C--O 1.238 0.469 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 613' ' ' ASN . . . . . 0.475 HD21 ' HG3' ' A' ' 661' ' ' GLU . 1.1 t-20 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 62.299999999999997 107.862 -172.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.439999999999998 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 615' ' ' PHE . . . . . 0.414 ' HB2' ' HD2' ' A' ' 659' ' ' LYS . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.340000000000003 108.003 -173.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 616' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 598' ' ' ILE . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 61.210000000000001 107.797 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 43.329999999999998 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 618' ' ' LEU . . . . . 0.596 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 52.240000000000002 108.741 173.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.019999999999996 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.120000000000005 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 62.329999999999998 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.519999999999996 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.400000000000006 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.340000000000003 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 625' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.229999999999997 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear nobuild core ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 . . . . . 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.540000000000006 113.94 175.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . . . . . . 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 63.030000000000001 117.357 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 71.329999999999998 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 64.430000000000007 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 63.109999999999999 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.130000000000003 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.140000000000001 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.140000000000001 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 51.409999999999997 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 615' ' ' PHE . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.010000000000005 107.317 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 72.030000000000001 104.33 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' GLU . . . . . 0.475 ' HG3' HD21 ' A' ' 613' ' ' ASN . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.200000000000003 109.45 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.340000000000003 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.409999999999997 104.245 177.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 63.219999999999999 106.109 176.893 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.71 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -53.77 135.06 42.07 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 123.714 0.634 . . . . 0.0 109.36 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.38 159.59 41.18 Favored Glycine 0 C--O 1.223 -0.565 0 N-CA-C 119.106 2.402 . . . . 0.0 119.106 -168.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.541 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.18 141.01 17.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.57 -1.641 . . . . 0.0 106.57 173.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -114.31 132.38 56.2 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 123.574 0.546 . . . . 0.0 109.946 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.9 t -156.02 162.99 40.24 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -100.79 170.44 8.32 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -67.49 -46.07 74.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.6 m -132.59 171.34 13.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -171.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -104.12 -17.97 14.71 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 123.434 0.459 . . . . 0.0 111.135 175.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 11.5 m -142.97 134.11 25.82 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.412 0.625 . . . . 0.0 109.452 -172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.641 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -143.35 160.41 17.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 125.366 1.466 . . . . 0.0 108.997 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -127.32 133.71 50.07 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 172.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.421 HG22 HG12 ' A' ' 662' ' ' VAL . 34.3 m -124.78 -179.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 39.9 m -132.09 160.01 37.23 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 102.16 -3.274 . . . . 0.0 102.16 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -56.47 -41.71 77.0 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 122.407 1.099 . . . . 0.0 111.307 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 4.1 m -66.08 -4.6 7.65 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.745 -1.571 . . . . 0.0 115.05 -174.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.5 tt -66.04 -26.05 37.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.298 0.57 . . . . 0.0 109.533 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.19 -62.68 4.11 Favored Glycine 0 C--O 1.219 -0.8 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.838 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.7 p -147.99 127.33 4.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 122.095 0.95 . . . . 0.0 110.44 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.2 ppp? -86.72 153.17 21.93 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.095 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -136.04 143.42 44.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.405 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.47 144.49 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 104.768 -2.308 . . . . 0.0 104.768 171.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -95.34 132.23 40.58 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.46 122.27 58.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -103.05 160.23 14.81 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -140.53 132.98 28.51 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.67 HG23 ' H ' ' A' ' 557' ' ' GLY . 6.1 t -73.55 -179.27 3.44 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.885 0.374 . . . . 0.0 111.464 -176.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 64.2 p -65.8 3.97 0.69 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.67 ' H ' HG23 ' A' ' 555' ' ' THR . . . -74.36 6.28 23.72 Favored Glycine 0 C--O 1.207 -1.578 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.08 171.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.95 62.65 0.29 Allowed 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -102.31 114.24 28.23 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 177.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 83.2 -174.54 52.47 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.443 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.8 m -103.23 133.18 48.75 Favored 'General case' 0 C--O 1.212 -0.89 0 CA-C-O 122.183 0.992 . . . . 0.0 109.18 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.96 140.59 47.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 105.817 -1.92 . . . . 0.0 105.817 177.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.2 tt -106.56 139.14 28.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.01 115.08 11.95 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -75.38 157.19 41.29 Favored 'Trans proline' 0 CA--C 1.506 -0.911 0 N-CA-C 115.451 1.289 . . . . 0.0 115.451 173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -139.33 165.26 27.67 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.28 152.08 18.21 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.65 0.594 . . . . 0.0 109.638 174.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.4 m -81.65 135.7 35.53 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.102 0.477 . . . . 0.0 109.905 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 79.7 t -131.32 107.21 13.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -73.76 154.37 39.6 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.937 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.08 -72.96 0.85 Allowed Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 104.981 -3.248 . . . . 0.0 104.981 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.5 t -117.56 110.31 17.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 160.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -162.94 -175.22 4.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.455 ' HG3' ' HG2' ' A' ' 578' ' ' GLU . 0.1 OUTLIER -94.38 -34.43 12.78 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.14 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.96 -177.93 47.22 Favored Glycine 0 C--O 1.225 -0.449 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 80.81 -102.85 2.16 Favored Glycine 0 C--O 1.219 -0.8 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.56 11.92 8.4 Favored Glycine 0 C--O 1.222 -0.623 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . 0.455 ' HG2' ' HG3' ' A' ' 574' ' ' LYS . 21.5 tt0 -95.26 -40.86 9.34 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 117.789 2.514 . . . . 0.0 117.789 -162.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -113.42 -22.83 10.17 Favored 'General case' 0 N--CA 1.484 1.246 0 CA-C-O 122.523 1.154 . . . . 0.0 109.137 169.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -149.59 171.41 16.69 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -94.53 128.43 41.13 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -63.59 111.0 2.18 Favored 'General case' 0 CA--C 1.493 -1.245 0 CA-C-O 123.356 1.55 . . . . 0.0 108.552 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -110.73 105.15 13.92 Favored 'General case' 0 N--CA 1.423 -1.8 0 CA-C-N 111.865 -2.425 . . . . 0.0 110.872 -169.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -133.87 141.45 47.38 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.328 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.77 -171.89 37.24 Favored Glycine 0 CA--C 1.502 -0.772 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -119.39 149.34 42.01 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 14.9 mt -121.52 129.2 52.76 Favored 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 106.677 -1.601 . . . . 0.0 106.677 -178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -92.43 133.33 36.0 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 176.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -121.0 116.82 25.81 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.525 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 41.7 mttp -102.71 -178.97 3.83 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -42.06 -64.4 0.59 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -177.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -82.2 -25.88 33.84 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.63 1.205 . . . . 0.0 111.561 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.525 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 87.6 mt-10 -56.09 17.3 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.4 p -71.32 8.59 0.98 Allowed 'General case' 0 C--N 1.319 -0.749 0 O-C-N 121.521 -0.737 . . . . 0.0 112.754 -168.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 14.2 p -122.88 131.13 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 166.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.7 tppt? -149.08 174.29 12.48 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.1 154.89 46.14 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.24 127.81 75.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 175.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.1 mtm180 -107.43 129.96 54.88 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 124.082 0.864 . . . . 0.0 111.515 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 97.0 t -129.0 111.95 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -67.59 133.44 49.41 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.3 mm -100.73 145.77 10.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 27.2 m -99.22 143.69 13.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -118.08 123.85 46.64 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.959 -170.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -128.3 -21.23 3.58 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.18 168.01 0.14 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 116.617 2.08 . . . . 0.0 116.617 174.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 54.59 21.46 3.41 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.985 1.314 . . . . 0.0 113.703 -177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -77.59 135.69 38.18 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -175.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -91.75 12.61 20.73 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 19.2 ttp85 -135.05 135.56 41.4 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -75.31 131.51 40.34 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.071 -0.968 . . . . 0.0 108.43 173.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -105.29 152.31 23.06 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -143.83 128.06 17.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.599 0.714 . . . . 0.0 111.306 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -152.14 166.84 30.42 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.937 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.61 171.28 14.28 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -128.01 120.05 52.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.803 -1.555 . . . . 0.0 106.803 176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.429 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.9 150.89 25.94 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 69.8 mt -87.71 147.13 25.36 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.973 -1.012 . . . . 0.0 108.845 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.85 -85.66 0.54 Allowed Glycine 0 C--O 1.221 -0.67 0 CA-C-O 122.235 0.908 . . . . 0.0 112.053 -178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -151.72 120.71 3.42 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 114.836 -0.682 . . . . 0.0 109.366 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.422 ' HD3' HD21 ' A' ' 654' ' ' LEU . 80.7 Cg_endo -71.7 133.81 22.79 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 117.237 -1.375 . . . . 0.0 110.729 176.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -127.99 136.19 50.96 Favored 'General case' 0 C--O 1.211 -0.93 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.687 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.24 107.31 15.69 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -174.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.503 11.4 mmt -123.39 80.8 1.82 Allowed 'General case' 0 N--CA 1.421 -1.887 0 C-N-CA 115.895 -2.322 . . . . 0.0 113.536 166.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.36 2.5 tt0 -152.9 89.33 1.38 Allowed 'General case' 1 C--O 1.146 -4.344 1 CA-C-O 110.952 -4.356 . . . . 0.0 100.963 146.292 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.687 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 163.23 -55.02 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 127.894 4.861 . . . . 0.0 108.934 178.468 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.1 64.74 1.89 Allowed Glycine 0 C--O 1.227 -0.331 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.854 -174.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.3 tt -60.72 130.76 25.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 175.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 8.7 t -149.57 176.65 10.44 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.05 149.91 49.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.509 0.671 . . . . 0.0 110.621 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.31 81.27 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.81 -178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.7 m -70.23 -45.32 66.76 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 27.1 t0 -155.88 125.96 6.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.428 173.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 21.3 mmt85 -147.78 73.99 1.29 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 170.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -64.76 114.83 4.73 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 28.0 mt -136.98 -178.52 5.23 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -174.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -80.26 172.08 14.23 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.2 t -62.4 -44.81 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-O 121.663 0.744 . . . . 0.0 111.518 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.34 -42.4 95.61 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 122.525 1.155 . . . . 0.0 110.483 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -76.34 -19.54 58.12 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.365 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.54 -44.45 76.76 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 118.85 -0.595 . . . . 0.0 110.452 -176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -88.12 -50.08 6.61 Favored 'General case' 0 C--O 1.217 -0.632 0 C-N-CA 119.147 -1.021 . . . . 0.0 112.295 164.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.37 -44.98 92.66 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 -166.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -75.43 -38.39 59.78 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.9 ttm180 -58.54 -47.68 83.39 Favored 'General case' 0 C--O 1.219 -0.54 0 O-C-N 122.469 -0.145 . . . . 0.0 111.343 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.8 mt -62.56 -42.86 97.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.178 0.513 . . . . 0.0 109.96 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.08 -32.5 74.08 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.977 0.418 . . . . 0.0 111.298 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -74.17 -21.3 59.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.335 177.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.5 mtt -77.91 -41.7 35.63 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.557 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.37 16.99 30.39 Favored Glycine 0 C--O 1.217 -0.933 0 CA-C-O 118.888 -0.951 . . . . 0.0 115.324 170.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 16.8 mtmt -58.45 120.48 44.93 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 115.155 1.539 . . . . 0.0 115.155 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -74.68 165.35 31.75 Favored 'Trans proline' 0 C--N 1.35 0.631 0 O-C-N 122.117 0.535 . . . . 0.0 111.625 174.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -142.15 162.43 19.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.158 176.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . 0.422 HD21 ' HD3' ' A' ' 621' ' ' PRO . 85.2 mt -73.2 160.21 32.29 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.901 0.382 . . . . 0.0 110.368 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.7 -152.47 24.07 Favored Glycine 0 C--O 1.22 -0.753 0 N-CA-C 115.012 0.765 . . . . 0.0 115.012 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -74.97 -37.41 61.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.785 -0.707 . . . . 0.0 112.646 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -126.3 55.33 13.26 Favored Pre-proline 0 C--O 1.212 -0.902 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.87 26.64 0.4 Allowed 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 121.102 1.201 . . . . 0.0 114.079 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.429 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -156.28 149.4 24.28 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.405 HD23 HG12 ' A' ' 550' ' ' VAL . 18.9 tp -131.0 124.89 31.93 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 177.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -86.91 123.12 31.69 Favored 'General case' 0 C--O 1.219 -0.5 0 O-C-N 123.446 0.466 . . . . 0.0 110.7 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.641 HG13 HG23 ' A' ' 539' ' ' ILE . 3.2 t -113.3 134.99 54.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -113.28 133.66 58.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 50.4 mt -96.51 111.68 27.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -165.17 166.13 19.21 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -168.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.36 133.81 53.35 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.057 0.456 . . . . 0.0 110.288 174.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 4.6 t 52.05 -155.31 0.17 Allowed 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -153.0 165.53 35.26 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -130.92 139.83 50.12 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 24.9 p90 -147.67 153.16 38.98 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -152.56 160.53 43.21 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.8 p -152.42 160.39 43.28 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 9.1 t -160.45 158.19 28.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.8 t 70.35 140.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 O-C-N 125.001 1.438 . . . . 0.0 111.428 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 . . . . . 0 C--O 1.251 1.145 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.337 -178.332 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 . . . . . 0 CA--C 1.508 -0.635 0 N-CA-C 109.834 -0.432 . . . . 72.310000000000002 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -59.37 141.78 53.75 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 123.861 0.725 . . . . 52.130000000000003 110.394 -178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -65.85 149.36 51.52 Favored Glycine 0 C--O 1.22 -0.765 0 N-CA-C 117.231 1.652 . . . . 34.439999999999998 117.231 -172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.566 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -69.15 139.55 20.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 107.134 -1.432 . . . . 72.319999999999993 107.134 172.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -110.22 138.8 46.12 Favored 'General case' 0 CA--C 1.514 -0.43 0 O-C-N 123.51 0.506 . . . . 74.310000000000002 110.862 176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.79 162.04 39.75 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.825 -1.546 . . . . 64.219999999999999 106.825 -176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 21.6 m-30 -97.01 168.87 10.2 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.068 -0.715 . . . . 65.430000000000007 109.068 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . 0.488 ' HG3' HD21 ' A' ' 553' ' ' LEU . 21.5 mt-10 -65.58 -40.15 92.43 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.037 1.125 . . . . 71.430000000000007 114.037 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 94.2 m -143.08 176.27 9.23 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.137 -1.431 . . . . 74.430000000000007 107.137 -177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -119.37 2.34 11.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.035 -0.529 . . . . 61.439999999999998 110.016 176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 25.7 m -140.12 128.12 22.16 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.053 -0.721 . . . . 74.239999999999995 109.053 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.675 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -144.53 160.22 14.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.776 -1.565 . . . . 75.310000000000002 106.776 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -133.31 140.11 47.25 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.287 -2.116 . . . . 71.200000000000003 105.287 172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.444 HG11 ' HB2' ' A' ' 548' ' ' MET . 32.5 m -129.07 160.45 39.94 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.097 0 N-CA-C 108.09 -1.078 . . . . 73.549999999999997 108.09 170.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 9.5 t -104.81 151.44 23.8 Favored 'General case' 0 C--O 1.211 -0.952 0 N-CA-C 103.954 -2.61 . . . . 40.420000000000002 103.954 172.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -54.97 -32.85 61.91 Favored 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 123.125 0.57 . . . . 75.430000000000007 111.309 175.165 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.1 t -63.62 -12.55 34.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.495 -0.775 . . . . 62.140000000000001 112.816 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -68.67 -29.77 44.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 110.057 -0.349 . . . . 71.519999999999996 110.057 176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.12 -61.08 4.77 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.514 -0.85 . . . . 65.239999999999995 112.807 -177.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 72.7 t -133.24 118.54 32.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.273 0.558 . . . . 73.030000000000001 110.592 -176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.444 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -82.2 153.32 26.02 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.002 -1.11 . . . . 73.439999999999998 108.002 179.19 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.51 136.68 34.78 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.287 1.217 . . . . 73.5 114.287 174.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 598' ' ' ILE . 2.1 m -112.6 137.72 44.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 107.765 -1.198 . . . . 70.329999999999998 107.765 172.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -94.27 119.0 32.41 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.14 -1.43 . . . . 72.219999999999999 107.14 -174.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.12 118.13 49.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 123.071 0.548 . . . . 71.319999999999993 110.156 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.488 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.2 OUTLIER -107.54 161.85 14.47 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.222 0.609 . . . . 73.219999999999999 110.132 -179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.538 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -132.06 146.4 52.04 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 107.93 -1.137 . . . . 71.299999999999997 107.93 177.425 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.566 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -71.72 173.44 8.16 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 122.543 0.337 . . . . 44.32 110.665 176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -63.92 22.78 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 117.397 2.369 . . . . 72.450000000000003 117.397 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -95.73 22.76 37.42 Favored Glycine 0 C--O 1.205 -1.665 0 C-N-CA 123.328 0.49 . . . . 32.100000000000001 114.28 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.538 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -71.65 96.4 1.57 Allowed 'General case' 0 N--CA 1.472 0.636 0 O-C-N 119.478 -2.189 . . . . 54.329999999999998 113.702 -174.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -125.68 107.28 10.41 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.958 -1.497 . . . . 73.219999999999999 106.958 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.1 -157.67 29.6 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 115.451 0.94 . . . . 53.539999999999999 115.451 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.424 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 84.8 m -116.09 133.51 55.95 Favored 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.911 -1.514 . . . . 75.140000000000001 106.911 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 70.0 t -132.11 146.66 32.82 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 107.461 -1.311 . . . . 62.310000000000002 107.461 -173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -119.71 139.92 45.43 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 107.59 -1.263 . . . . 71.319999999999993 107.59 174.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.5 t -134.46 114.21 12.31 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 113.412 0.893 . . . . 72.439999999999998 113.412 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.04 156.31 42.8 Favored 'Trans proline' 0 CA--C 1.505 -0.951 0 N-CA-C 115.997 1.499 . . . . 64.140000000000001 115.997 174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 598' ' ' ILE . 55.3 p90 -143.22 162.24 36.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.654 -1.157 . . . . 70.310000000000002 108.408 175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.24 152.78 20.95 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.888 -0.782 . . . . 72.349999999999994 108.888 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 20.2 m -84.73 140.26 31.4 Favored 'General case' 0 C--O 1.216 -0.702 0 N-CA-C 109.377 -0.601 . . . . 74.5 109.377 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 65.3 t -134.12 113.05 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.533 0 N-CA-C 105.621 -1.992 . . . . 64.420000000000002 105.621 -172.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.452 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -78.66 148.91 32.98 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.068 -0.969 . . . . 62.5 111.108 -178.02 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.67 -77.58 1.09 Allowed Glycine 0 CA--C 1.506 -0.474 0 N-CA-C 107.78 -2.128 . . . . 74.340000000000003 107.78 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.23 110.32 17.99 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 103.703 -2.703 . . . . 73.099999999999994 103.703 161.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.77 161.33 9.12 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 105.6 -2.0 . . . . 74.329999999999998 105.6 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -86.98 -23.65 24.98 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 106.402 -1.703 . . . . 75.200000000000003 106.402 172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 53.92 -158.91 4.88 Favored Glycine 0 CA--C 1.52 0.389 0 N-CA-C 117.12 1.608 . . . . 40.229999999999997 117.12 172.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 77.57 -93.01 1.11 Allowed Glycine 0 C--O 1.224 -0.502 0 CA-C-N 115.049 -0.576 . . . . 75.209999999999994 111.975 176.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.38 4.98 9.43 Favored Glycine 0 C--O 1.205 -1.657 0 CA-C-O 118.18 -1.345 . . . . 42.32 112.425 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -95.94 -53.92 3.51 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 118.836 1.318 . . . . 73.030000000000001 113.858 -173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -85.75 -34.33 21.22 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 123.913 1.816 . . . . 72.519999999999996 108.919 -176.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -160.67 163.87 32.17 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 102.687 -3.079 . . . . 61.450000000000003 102.687 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -92.28 134.0 35.31 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 105.484 -2.043 . . . . 64.319999999999993 105.484 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -58.18 111.86 1.34 Allowed 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.964 1.84 . . . . 72.239999999999995 110.283 -176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -95.24 104.97 16.88 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 111.464 -2.607 . . . . 74.049999999999997 109.626 -175.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -139.79 149.93 44.12 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.145 -1.389 . . . . 73.120000000000005 111.31 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 173.5 -166.64 39.04 Favored Glycine 0 CA--C 1.505 -0.546 0 N-CA-C 109.117 -1.593 . . . . 74.209999999999994 109.117 177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -123.04 147.3 46.83 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.311 0.576 . . . . 75.120000000000005 109.478 175.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 13.2 mt -116.37 122.28 44.4 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.148 -0.933 . . . . 70.209999999999994 109.392 -177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 57.5 tt0 -82.99 127.47 33.58 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.191 -1.041 . . . . 64.150000000000006 108.191 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -118.76 137.93 53.03 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 106.788 -1.56 . . . . 62.399999999999999 106.788 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 56.3 mttp -128.92 173.62 10.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.927 -1.509 . . . . 64.129999999999995 106.927 178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -34.58 -60.31 0.43 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 116.981 2.215 . . . . 64.040000000000006 116.981 176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -82.08 -38.89 24.2 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.132 0.968 . . . . 74.150000000000006 112.781 177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.499 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.7 mt-10 -63.08 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.857 2.54 . . . . 73.409999999999997 117.857 -175.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.7 p -71.89 10.93 0.6 Allowed 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 114.573 1.323 . . . . 54.350000000000001 114.573 -171.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.99 123.71 72.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 104.638 -2.356 . . . . 75.430000000000007 104.638 173.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 597' ' ' THR . 8.6 tppt? -148.64 172.37 14.67 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.846 -0.342 . . . . 54.329999999999998 110.592 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.402 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.01 153.94 43.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 123.315 0.384 . . . . 74.349999999999994 112.007 -177.352 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 550' ' ' VAL . 94.0 mt -116.39 131.49 68.8 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 106.808 -1.553 . . . . 65.519999999999996 106.808 176.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -111.82 142.53 44.07 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.397 1.061 . . . . 75.150000000000006 111.467 -179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -136.24 144.52 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 105.745 -1.946 . . . . 63.219999999999999 105.745 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -92.08 128.1 37.8 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 107.515 -1.291 . . . . 64.109999999999999 107.515 175.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.406 HG21 ' HA ' ' A' ' 543' ' ' GLU . 35.7 mm -94.17 124.24 46.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 106.862 -1.533 . . . . 62.340000000000003 106.862 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.01 143.62 11.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 113.864 1.061 . . . . 75.099999999999994 113.864 -169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -69.11 142.5 54.42 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.213 -1.358 . . . . 71.450000000000003 109.569 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 26.3 pt-20 -68.54 145.22 54.2 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.489 1.292 . . . . 70.329999999999998 114.489 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -148.03 -41.74 0.17 Allowed 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.485 0.92 . . . . 72.409999999999997 113.485 173.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -109.91 -29.38 8.29 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 113.599 0.963 . . . . 73.450000000000003 113.599 -176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -109.79 163.85 13.12 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 116.158 1.91 . . . . 74.439999999999998 116.158 -171.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -123.02 170.92 9.66 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 107.538 -1.282 . . . . 75.230000000000004 107.538 177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 20.4 ttt-85 87.85 154.95 0.06 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 126.668 1.987 . . . . 74.200000000000003 112.828 172.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -57.92 130.95 48.86 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 105.148 -2.167 . . . . 64.150000000000006 105.148 166.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -117.49 164.14 15.35 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.336 -1.357 . . . . 52.299999999999997 107.336 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -145.83 142.48 28.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.726 0.774 . . . . 73.150000000000006 111.726 -173.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -147.96 170.98 16.52 Favored 'General case' 0 C--O 1.213 -0.825 0 CA-C-N 115.34 -0.845 . . . . 54.200000000000003 109.351 177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.43 169.88 17.03 Favored 'General case' 0 C--O 1.206 -1.207 0 N-CA-C 106.896 -1.52 . . . . 61.509999999999998 106.896 174.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.428 HD12 HG11 ' A' ' 550' ' ' VAL . 9.0 mt -126.69 123.13 62.31 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 N-CA-C 105.523 -2.029 . . . . 74.329999999999998 105.523 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.89 148.12 33.12 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.713 -0.847 . . . . 25.449999999999999 108.713 -177.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -88.39 143.26 27.11 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.266 -1.013 . . . . 74.25 108.266 179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -69.14 -84.56 0.14 Allowed Glycine 0 C--O 1.224 -0.512 0 CA-C-O 122.112 0.84 . . . . 72.030000000000001 111.064 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.39 131.16 4.08 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 106.147 -1.798 . . . . 65.209999999999994 106.147 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.84 138.2 31.1 Favored 'Trans proline' 0 CA--C 1.535 0.557 0 C-N-CA 117.618 -1.122 . . . . 70.420000000000002 110.305 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -128.83 145.55 51.17 Favored 'General case' 0 C--O 1.213 -0.839 0 N-CA-C 108.777 -0.824 . . . . 70.319999999999993 108.777 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.517 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.6 OUTLIER -83.61 115.03 21.95 Favored 'General case' 0 CA--C 1.498 -1.022 0 N-CA-C 109.194 -0.669 . . . . 72.299999999999997 109.194 -177.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.411 14.3 mmt -123.58 81.92 1.95 Allowed 'General case' 0 N--CA 1.433 -1.281 0 CA-C-O 125.799 2.714 . . . . 74.319999999999993 112.463 160.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.424 ' CB ' ' H ' ' A' ' 561' ' ' THR . 20.4 tt0 -152.82 164.67 37.39 Favored 'General case' 0 C--N 1.278 -2.528 3 N-CA-C 94.251 -6.203 . . . . 72.400000000000006 94.251 155.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.517 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 74.43 -40.72 0.46 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 120.25 1.386 . . . . 70.25 114.023 173.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.32 35.02 69.18 Favored Glycine 0 C--O 1.226 -0.354 0 N-CA-C 110.081 -1.208 . . . . 43.119999999999997 110.081 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 11.0 tp -61.39 139.8 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.956 0.884 . . . . 74.409999999999997 112.25 -174.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 48.0 t -146.4 -49.65 0.21 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.95 -2.241 . . . . 74.409999999999997 104.95 174.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.62 164.02 39.17 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.331 -3.211 . . . . 72.129999999999995 102.331 171.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.28 119.8 31.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 107.321 -1.363 . . . . 73.420000000000002 107.321 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 68.4 p -118.54 172.28 7.59 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.694 -0.685 . . . . 61.25 111.967 -172.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 22.1 t0 55.11 35.79 25.54 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 114.351 1.241 . . . . 61.210000000000001 114.351 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -93.86 57.11 2.42 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.482 -0.933 . . . . 73.349999999999994 108.482 174.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -67.84 115.76 7.74 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.422 -1.263 . . . . 73.140000000000001 108.446 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.46 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 24.4 mt -146.85 -172.96 4.1 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 105.483 -2.043 . . . . 74.109999999999999 105.483 -169.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -64.43 151.86 43.05 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 104.588 -2.375 . . . . 64.329999999999998 104.588 168.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 21.7 m -64.76 -24.04 34.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 113.066 0.765 . . . . 74.310000000000002 113.066 -161.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -68.93 -45.46 70.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.05 0.929 . . . . 72.129999999999995 109.208 176.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -77.43 -20.44 54.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.036 -0.983 . . . . 71.340000000000003 111.953 -177.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 1.8 mt-10 -58.2 -41.69 84.52 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.215 -0.291 . . . . 74.540000000000006 110.215 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -87.98 -48.76 7.52 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 119.55 -0.86 . . . . 74.129999999999995 111.904 167.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.1 -41.95 93.61 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.156 1.169 . . . . 73.420000000000002 114.156 -169.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.4 tppt? -73.92 -40.66 62.96 Favored 'General case' 0 C--O 1.219 -0.544 0 N-CA-C 108.787 -0.82 . . . . 75.420000000000002 108.787 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -60.26 -46.43 89.83 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.085 -0.507 . . . . 64.219999999999999 111.834 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.0 mt -62.72 -41.37 92.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.466 -0.568 . . . . 74.120000000000005 109.466 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.07 -34.01 77.4 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.106 -0.371 . . . . 71.129999999999995 110.832 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -70.96 -19.5 62.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.25 0.463 . . . . 51.340000000000003 112.25 176.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 65.0 mtt -69.82 -41.51 74.88 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 107.779 -1.193 . . . . 75.230000000000004 107.779 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.73 12.4 14.08 Favored Glycine 0 C--O 1.225 -0.414 0 N-CA-C 117.995 1.958 . . . . 53.009999999999998 117.995 169.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.3 mmmt -57.92 120.66 44.25 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 115.417 1.636 . . . . 71.519999999999996 115.417 -170.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.96 159.64 51.87 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 C-N-CA 117.787 -1.008 . . . . 74.510000000000005 111.251 174.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -138.71 165.2 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-N 115.071 -0.968 . . . . 72.25 110.773 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 79.4 mt -75.78 159.03 31.47 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 72.329999999999998 112.741 178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -102.12 -152.87 24.94 Favored Glycine 0 C--O 1.219 -0.796 0 N-CA-C 116.834 1.493 . . . . 61.409999999999997 116.834 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -71.59 -39.61 70.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.243 -0.978 . . . . 63.409999999999997 112.798 -178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -129.07 61.28 56.09 Favored Pre-proline 0 C--O 1.212 -0.881 0 N-CA-C 112.321 0.489 . . . . 64.340000000000003 112.321 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.75 29.13 0.47 Allowed 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 120.984 1.123 . . . . 71.109999999999999 113.661 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -158.12 146.16 18.6 Favored 'General case' 0 CA--C 1.509 -0.625 0 N-CA-C 107.377 -1.342 . . . . 74.400000000000006 107.377 -176.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.64 122.66 29.48 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.225 -1.769 . . . . 72.510000000000005 106.225 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -88.35 123.99 33.48 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 118.219 0.463 . . . . 73.030000000000001 109.788 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.675 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -112.0 141.17 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 106.923 -1.51 . . . . 52.409999999999997 106.923 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.3 mm -121.0 131.64 72.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 102.453 -3.166 . . . . 75.530000000000001 102.453 177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 84.4 mt -90.18 109.08 20.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.374 -0.973 . . . . 70.109999999999999 108.374 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -167.65 157.88 10.72 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 106.614 -1.624 . . . . 75.230000000000004 106.614 -170.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -71.27 80.93 0.73 Allowed 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 119.017 0.826 . . . . 72.019999999999996 110.835 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 1.8 p -167.65 172.03 9.68 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.102 -0.703 . . . . 55.240000000000002 109.102 -175.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.56 169.39 17.87 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.318 -0.993 . . . . 71.209999999999994 108.318 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -67.11 163.32 20.38 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.013 0.911 . . . . 54.109999999999999 111.935 176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -76.08 153.02 36.67 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.712 -1.588 . . . . 64.230000000000004 106.712 173.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.25 2.1 3.18 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 114.41 1.263 . . . . 74.450000000000003 114.41 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 19.6 p 58.0 -171.99 0.1 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.738 1.215 . . . . 74.120000000000005 110.695 -176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 4.9 t -158.41 157.15 31.72 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.286 -1.375 . . . . 73.209999999999994 107.286 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.56 127.34 30.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 102.745 -3.058 . . . . 74.040000000000006 102.745 175.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 . . . . . 0 C--O 1.259 1.573 0 N-CA-C 104.658 -2.349 . . . . 71.040000000000006 104.658 -175.306 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.842 0 N-CA-C 107.552 -1.277 . . . . 75.319999999999993 107.552 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.25 22.92 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.981 -1.118 . . . . 53.240000000000002 107.981 173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -85.84 174.02 47.61 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 117.957 1.943 . . . . 51.409999999999997 117.957 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.447 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -69.3 143.94 14.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.502 1.121 . . . . 71.230000000000004 109.022 176.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -118.31 131.77 56.32 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 123.541 0.526 . . . . 73.329999999999998 110.218 173.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -155.38 165.25 37.2 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.161 -1.051 . . . . 73.420000000000002 108.161 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.6 m-30 -100.18 167.06 10.69 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.216 0.532 . . . . 73.540000000000006 110.054 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -69.66 -34.82 74.52 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 114.478 1.288 . . . . 74.230000000000004 114.478 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 62.9 m -138.06 167.13 22.43 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.339 -1.356 . . . . 74.310000000000002 107.339 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.3 p30 -122.45 -1.14 9.14 Favored 'General case' 0 C--O 1.216 -0.677 0 O-C-N 123.48 0.488 . . . . 65.549999999999997 111.7 175.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 26.5 m -143.65 137.41 28.24 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 104.424 -2.435 . . . . 73.510000000000005 104.424 175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.69 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -152.23 160.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.802 1.241 . . . . 64.329999999999998 108.292 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -128.03 132.48 49.1 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.606 -0.887 . . . . 64.430000000000007 108.606 171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.66 -179.11 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 108.724 -0.843 . . . . 74.209999999999994 108.724 169.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -130.53 155.09 47.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 101.679 -3.452 . . . . 54.43 101.679 172.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.11 -34.88 66.45 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.571 0.7 . . . . 61.32 110.841 175.502 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.9 m -64.97 -10.22 27.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.939 -1.028 . . . . 75.049999999999997 113.307 -176.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.2 tt -68.17 -24.39 29.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 109.617 -0.512 . . . . 62.25 109.617 174.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.24 -61.93 4.57 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 121.02 -0.61 . . . . 74.120000000000005 111.907 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.9 p -145.03 123.75 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 121.993 0.901 . . . . 73.120000000000005 110.171 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.431 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.62 153.32 26.74 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.769 -1.105 . . . . 72.200000000000003 110.006 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -134.84 140.9 46.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.976 0.361 . . . . 71.099999999999994 111.976 177.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.504 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.4 m -117.91 140.04 42.7 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.682 0 N-CA-C 105.856 -1.905 . . . . 74.340000000000003 105.856 171.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -91.53 129.12 37.56 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 107.287 -1.375 . . . . 62.130000000000003 107.287 175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.2 t -107.27 122.53 61.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.073 -1.084 . . . . 75.439999999999998 108.073 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.16 161.86 13.89 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.387 0.613 . . . . 74.400000000000006 109.842 -178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -137.08 133.68 35.65 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 106.075 -1.824 . . . . 72.129999999999995 106.075 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.73 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.0 t -70.46 173.05 7.41 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 120.671 -0.412 . . . . 75.219999999999999 110.797 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.7 m -66.08 6.21 0.42 Allowed 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 115.41 1.633 . . . . 63.229999999999997 115.41 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.73 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.7 16.93 17.28 Favored Glycine 0 C--O 1.208 -1.495 0 N-CA-C 109.349 -1.5 . . . . 63.329999999999998 109.349 171.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.47 63.54 1.09 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.619 1.34 . . . . 72.120000000000005 114.619 -174.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmt180 -94.91 118.44 31.8 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.069 -1.456 . . . . 71.319999999999993 107.069 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.72 -173.34 53.75 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.59 -0.732 . . . . 72.5 114.115 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.4 m -103.11 133.45 48.19 Favored 'General case' 0 C--O 1.21 -0.996 0 CA-C-O 122.204 1.002 . . . . 43.399999999999999 109.507 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.14 146.29 29.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 N-CA-C 105.735 -1.95 . . . . 75.530000000000001 105.735 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.8 tt -111.8 139.32 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 105.812 -1.922 . . . . 74.319999999999993 105.812 173.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 8.8 t -132.97 115.32 14.19 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 113.624 0.972 . . . . 61.130000000000003 113.624 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.1 155.34 37.89 Favored 'Trans proline' 0 CA--C 1.505 -0.96 0 N-CA-C 115.993 1.497 . . . . 61.43 115.993 173.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -137.79 166.63 23.51 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 114.729 -1.123 . . . . 71.109999999999999 108.37 172.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.59 158.62 32.0 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.754 -0.832 . . . . 64.329999999999998 108.754 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.36 141.82 28.92 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.569 0.223 . . . . 73.430000000000007 110.649 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.05 115.16 35.21 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.298 0 N-CA-C 104.922 -2.251 . . . . 61.200000000000003 104.922 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -86.05 142.64 28.59 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.361 -1.29 . . . . 62.130000000000003 110.776 -179.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.08 -76.09 0.97 Allowed Glycine 0 C--O 1.226 -0.349 0 N-CA-C 106.749 -2.541 . . . . 63.539999999999999 106.749 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.7 112.23 20.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.114 -2.55 . . . . 73.200000000000003 104.114 161.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -171.72 163.83 6.53 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 103.48 -2.785 . . . . 63.439999999999998 103.48 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -81.99 -28.44 32.63 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.352 -0.61 . . . . 73.239999999999995 109.352 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.52 -171.12 30.13 Favored Glycine 0 C--O 1.224 -0.482 0 N-CA-C 115.039 0.776 . . . . 71.519999999999996 115.039 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.06 -106.62 2.01 Favored Glycine 0 C--O 1.215 -1.067 0 C-N-CA 121.132 -0.556 . . . . 75.510000000000005 112.176 175.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.86 9.78 9.04 Favored Glycine 0 C--O 1.218 -0.855 0 N-CA-C 110.091 -1.203 . . . . 72.109999999999999 110.091 172.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -95.89 -46.36 6.58 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 116.817 2.154 . . . . 72.200000000000003 116.817 -167.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -105.6 -34.86 7.62 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-O 123.07 1.414 . . . . 72.329999999999998 108.551 175.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -146.87 161.98 39.59 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.678 -2.712 . . . . 73.049999999999997 103.678 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -90.52 123.51 34.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.149 -1.426 . . . . 53.219999999999999 107.149 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -61.48 110.57 1.49 Allowed 'General case' 0 CA--C 1.494 -1.173 0 CA-C-O 123.842 1.782 . . . . 70.219999999999999 110.013 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.8 104.71 14.75 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 111.373 -2.649 . . . . 61.229999999999997 110.911 -172.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -134.11 141.24 47.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.277 -0.874 . . . . 75.040000000000006 108.821 177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.85 -170.97 38.55 Favored Glycine 0 CA--C 1.499 -0.907 0 N-CA-C 108.025 -2.03 . . . . 73.549999999999997 108.025 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -122.29 149.18 44.09 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.7 0.75 . . . . 71.439999999999998 110.973 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.0 mt -117.58 120.84 39.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.804 -1.089 . . . . 73.349999999999994 110.274 -176.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -79.19 126.63 31.0 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.841 -0.799 . . . . 75.439999999999998 108.841 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -121.18 117.1 26.26 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.33 -0.989 . . . . 71.099999999999994 108.33 174.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.602 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 22.3 mtpp -105.82 -173.47 2.31 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.3 -1.37 . . . . 72.400000000000006 107.3 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -46.23 -66.01 0.47 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 116.915 2.191 . . . . 74.310000000000002 116.915 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -81.59 -22.64 37.59 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-O 122.531 1.158 . . . . 65.120000000000005 112.219 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.602 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 69.6 mm-40 -58.35 17.95 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.732 2.493 . . . . 72.109999999999999 117.732 177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 82.5 p -71.43 15.55 0.13 Allowed 'General case' 0 C--N 1.322 -0.598 0 O-C-N 121.41 -0.806 . . . . 62.109999999999999 112.881 -170.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -128.61 122.24 56.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.658 -1.608 . . . . 64.299999999999997 106.658 171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -144.33 176.16 9.56 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 107.682 -1.229 . . . . 72.420000000000002 107.682 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.45 154.02 44.19 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 111.975 0.361 . . . . 61.43 111.975 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.504 ' HB ' HG22 ' A' ' 550' ' ' VAL . 69.4 mt -116.19 132.43 65.76 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.108 0 N-CA-C 106.224 -1.769 . . . . 64.219999999999999 106.224 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.7 mtt180 -111.22 130.21 55.72 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.082 0.863 . . . . 73.209999999999994 111.334 178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 61.0 t -129.16 113.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.006 -0.739 . . . . 54.549999999999997 109.006 176.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 41.0 tttm -71.52 135.46 47.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.674 -0.491 . . . . 70.120000000000005 109.674 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.419 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.4 mm -95.93 145.65 8.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.625 -1.62 . . . . 63.200000000000003 106.625 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.1 t -101.48 143.66 14.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.016 -1.105 . . . . 63.240000000000002 108.016 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -118.28 126.64 52.57 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.612 0.765 . . . . 73.129999999999995 109.663 -173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -154.72 147.76 24.68 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.575 -0.898 . . . . 71.019999999999996 108.575 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -81.31 9.13 7.56 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.647 1.351 . . . . 73.239999999999995 114.647 -174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -67.18 -33.45 75.42 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 117.878 2.547 . . . . 73.420000000000002 117.878 -173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -138.74 154.58 48.55 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 117.111 2.263 . . . . 73.409999999999997 117.111 -171.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.74 30.51 6.77 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 114.717 -1.129 . . . . 63.329999999999998 108.176 175.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 25.6 mtp-105 -98.63 153.73 18.46 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.6 1.333 . . . . 74.239999999999995 114.6 -171.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -78.87 130.61 35.85 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.44 -1.689 . . . . 72.420000000000002 106.44 171.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.4 158.71 22.08 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 109.804 -0.443 . . . . 62.039999999999999 109.804 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -145.8 124.56 12.61 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.733 0.778 . . . . 71.0 111.744 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -152.3 165.06 36.1 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.444 -0.947 . . . . 73.140000000000001 108.444 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -144.21 171.02 14.88 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 109.079 -0.712 . . . . 72.340000000000003 109.079 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.5 mt -129.25 120.22 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 107.315 -1.365 . . . . 75.519999999999996 107.315 178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.38 150.83 26.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.166 -1.05 . . . . 54.43 108.166 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.6 mt -87.83 148.26 24.75 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.329 -0.85 . . . . 71.200000000000003 108.776 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -78.38 -86.58 0.48 Allowed Glycine 0 C--O 1.221 -0.702 0 CA-C-O 122.457 1.032 . . . . 65.319999999999993 110.94 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -152.76 118.61 2.97 Favored Pre-proline 0 CA--C 1.506 -0.722 0 CA-C-N 114.55 -0.825 . . . . 74.310000000000002 110.364 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.49 135.63 31.59 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 116.393 -1.938 . . . . 74.319999999999993 110.235 175.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -128.26 137.99 52.24 Favored 'General case' 0 C--O 1.208 -1.119 0 N-CA-C 108.322 -0.992 . . . . 72.030000000000001 108.322 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.678 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.61 109.48 17.46 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 108.424 -0.954 . . . . 75.299999999999997 108.424 -175.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.499 12.1 mmt -123.67 80.45 1.8 Allowed 'General case' 0 N--CA 1.421 -1.912 0 C-N-CA 116.081 -2.248 . . . . 73.510000000000005 113.262 165.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.606 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.362 2.0 tt0 -153.19 88.74 1.32 Allowed 'General case' 1 C--O 1.153 -4.005 1 CA-C-O 111.501 -4.095 . . . . 71.349999999999994 101.621 146.537 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.678 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.4 mmm180 165.14 -52.0 0.0 OUTLIER 'General case' 0 N--CA 1.52 3.047 1 CA-C-N 127.238 4.563 . . . . 75.549999999999997 107.808 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.08 63.11 2.11 Favored Glycine 0 C--O 1.226 -0.378 0 N-CA-C 110.655 -0.978 . . . . 53.509999999999998 110.655 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 2.9 tt -55.95 121.53 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 108.308 -0.997 . . . . 44.450000000000003 108.308 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 33.7 m -146.24 164.16 33.18 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.0 -1.481 . . . . 70.400000000000006 107.0 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -69.19 144.72 53.67 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.306 -0.998 . . . . 75.200000000000003 108.306 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 19.7 m -133.94 155.22 39.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 108.201 -1.037 . . . . 71.129999999999995 108.201 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 23.2 p -111.04 -84.59 0.56 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.311 0.486 . . . . 74.519999999999996 112.311 -176.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -82.5 79.48 8.92 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 113.674 0.99 . . . . 71.439999999999998 113.674 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -90.06 59.76 4.62 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.373 -0.973 . . . . 74.420000000000002 108.373 175.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.04 99.59 0.1 Allowed 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.486 -1.234 . . . . 72.450000000000003 112.751 -176.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 56.5 mt -142.05 -179.15 6.06 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.996 -2.224 . . . . 73.129999999999995 104.996 -175.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 156.56 32.69 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 105.832 -1.914 . . . . 73.209999999999994 105.832 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 73.8 t -50.1 -45.41 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 113.153 0.797 . . . . 61.439999999999998 113.153 -174.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -58.21 -48.81 79.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.551 0.691 . . . . 74.420000000000002 111.462 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -77.5 -19.49 55.8 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.145 0.424 . . . . 53.530000000000001 112.145 -177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.7 -44.63 77.58 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.858 -0.423 . . . . 71.420000000000002 109.858 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -87.85 -47.9 8.24 Favored 'General case' 0 C--O 1.219 -0.509 0 C-N-CA 119.824 -0.75 . . . . 74.310000000000002 111.907 169.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.0 80.11 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 113.767 1.025 . . . . 52.109999999999999 113.767 -169.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 10.1 tppt? -78.84 -37.5 40.35 Favored 'General case' 0 C--O 1.213 -0.838 0 O-C-N 122.003 -0.436 . . . . 73.329999999999998 109.886 179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -61.25 -46.25 91.17 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.364 -0.38 . . . . 74.109999999999999 111.122 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.5 mt -63.77 -40.22 88.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.498 0.666 . . . . 73.239999999999995 109.648 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.78 -30.15 71.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.093 0.473 . . . . 74.530000000000001 111.343 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.88 -17.46 59.78 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.156 -0.474 . . . . 64.040000000000006 111.734 176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 54.4 mtt -79.56 -41.42 27.25 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.395 -1.705 . . . . 72.409999999999997 106.395 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.548 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.7 15.77 27.69 Favored Glycine 0 C--O 1.227 -0.286 0 N-CA-C 117.305 1.682 . . . . 62.450000000000003 117.305 166.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.9 mmmt -58.48 118.8 30.89 Favored Pre-proline 0 N--CA 1.444 -0.754 0 N-CA-C 115.059 1.503 . . . . 72.409999999999997 115.059 -168.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.38 163.71 37.81 Favored 'Trans proline' 0 CA--C 1.511 -0.649 0 O-C-N 122.0 0.474 . . . . 75.340000000000003 111.969 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.64 164.55 30.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.902 -1.045 . . . . 74.219999999999999 110.909 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.26 160.57 30.94 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.04 -0.527 . . . . 71.340000000000003 111.203 175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -100.37 -153.33 26.89 Favored Glycine 0 C--O 1.222 -0.628 0 N-CA-C 115.963 1.145 . . . . 64.439999999999998 115.963 -176.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -81.2 -30.49 34.29 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.813 -1.194 . . . . 74.530000000000001 111.411 -177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -131.81 60.17 49.88 Favored Pre-proline 0 N--CA 1.474 0.739 0 N-CA-C 112.466 0.543 . . . . 63.450000000000003 112.466 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.58 26.22 0.48 Allowed 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 121.123 1.216 . . . . 55.229999999999997 114.302 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -155.17 147.45 23.84 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.582 -0.896 . . . . 73.450000000000003 108.582 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.7 121.83 34.59 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 105.346 -2.094 . . . . 64.239999999999995 105.346 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.1 122.64 33.92 Favored 'General case' 0 C--O 1.21 -1.024 0 N-CA-C 110.079 -0.341 . . . . 73.120000000000005 110.079 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.69 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -113.92 135.86 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-O 121.882 0.849 . . . . 72.120000000000005 108.724 -172.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 7.8 mm -114.93 131.98 65.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 103.84 -2.652 . . . . 70.430000000000007 103.84 177.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.53 102.25 13.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 106.165 -1.791 . . . . 70.019999999999996 106.165 178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -172.48 138.16 0.88 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 106.437 -1.69 . . . . 74.109999999999999 106.437 -173.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -73.86 91.74 2.0 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.672 0.749 . . . . 73.519999999999996 109.648 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 23.2 t -166.85 -177.15 3.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 105.352 -2.092 . . . . 61.009999999999998 105.352 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.21 156.5 41.71 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.404 -1.702 . . . . 73.310000000000002 106.404 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.58 164.82 36.89 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.011 -1.107 . . . . 72.299999999999997 108.011 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 60.47 -179.36 0.1 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.557 1.143 . . . . 71.230000000000004 114.064 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.9 tptm 51.63 58.46 5.47 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.668 0.988 . . . . 72.430000000000007 113.668 177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 40.3 t -58.52 147.88 30.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.105 -0.952 . . . . 62.43 109.654 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 39.6 p -82.65 -10.23 59.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.203 -0.453 . . . . 60.32 111.606 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.8 m -135.42 160.49 40.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.293 -1.002 . . . . 74.420000000000002 108.293 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.9 t70 . . . . . 0 C--O 1.245 0.864 0 N-CA-C 103.444 -2.798 . . . . 62.329999999999998 103.444 178.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 . . . . . 0 CA--C 1.516 -0.327 0 N-CA-C 109.182 -0.674 . . . . 62.119999999999997 109.182 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -64.6 152.43 42.13 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.112 -0.699 . . . . 71.510000000000005 109.112 175.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -64.99 149.46 51.72 Favored Glycine 0 C--O 1.217 -0.929 0 N-CA-C 116.494 1.358 . . . . 64.099999999999994 116.494 -175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.631 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -77.1 142.97 13.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.716 -1.587 . . . . 74.400000000000006 106.716 172.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -115.45 138.64 50.8 Favored 'General case' 0 CA--C 1.514 -0.427 0 O-C-N 123.402 0.439 . . . . 70.329999999999998 110.942 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.0 t -156.87 161.72 39.68 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.361 -0.978 . . . . 72.329999999999998 108.361 -174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.604 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.3 m-30 -96.4 169.2 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.04 0.447 . . . . 63.149999999999999 110.303 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -66.1 -49.3 68.0 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 114.688 1.366 . . . . 70.129999999999995 114.688 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 82.5 m -132.37 172.4 12.51 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.568 -0.53 . . . . 70.519999999999996 109.568 -172.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -104.71 -16.62 14.91 Favored 'General case' 0 C--O 1.217 -0.647 0 O-C-N 123.289 0.368 . . . . 73.439999999999998 111.192 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 16.5 m -143.26 133.24 24.17 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 107.907 -1.145 . . . . 65.319999999999993 107.907 -174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.617 HG23 ' HA ' ' A' ' 662' ' ' VAL . 0.2 OUTLIER -131.85 147.51 32.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 105.759 -1.941 . . . . 72.129999999999995 105.759 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -118.55 122.61 43.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 105.42 -2.067 . . . . 75.109999999999999 105.42 169.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.34 171.17 6.84 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 N-CA-C 107.14 -1.43 . . . . 71.299999999999997 107.14 173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 24.3 m -121.16 161.61 21.55 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 101.673 -3.455 . . . . 61.539999999999999 101.673 171.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -64.02 -31.71 73.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 119.399 0.999 . . . . 72.299999999999997 109.166 177.412 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -9.77 15.23 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.182 -1.372 . . . . 72.150000000000006 113.554 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.2 tt -68.63 -25.58 31.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 121.0 0.429 . . . . 72.299999999999997 109.992 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.53 -65.42 3.8 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.541 -0.838 . . . . 61.310000000000002 111.326 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.1 p -144.28 125.32 9.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.847 0.832 . . . . 65.209999999999994 110.055 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -81.96 153.46 26.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.238 -0.892 . . . . 63.340000000000003 109.618 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.3 tt0 -135.78 139.52 43.59 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.7 0.286 . . . . 73.450000000000003 111.347 177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.4 143.01 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 N-CA-C 105.38 -2.081 . . . . 74.140000000000001 105.38 170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -95.93 128.44 42.83 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 105.978 -1.86 . . . . 75.209999999999994 105.978 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.41 118.84 51.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.456 -0.942 . . . . 74.329999999999998 108.456 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.6 161.48 14.33 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.836 -0.802 . . . . 75.329999999999998 108.836 -178.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.481 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -131.78 146.7 52.29 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.828 -0.804 . . . . 62.310000000000002 108.828 177.149 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.631 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -69.74 174.58 4.99 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 112.65 0.611 . . . . 73.510000000000005 112.65 177.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 8.7 t -70.88 38.21 0.05 Allowed 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 114.106 1.151 . . . . 61.43 114.106 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.22 17.16 19.55 Favored Glycine 0 C--O 1.211 -1.327 0 N-CA-C 114.708 0.643 . . . . 61.350000000000001 114.708 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.481 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -66.62 109.18 2.71 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 119.613 1.706 . . . . 73.319999999999993 113.09 -175.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -129.9 89.17 2.77 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.405 -1.332 . . . . 51.32 107.405 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 92.65 -157.65 23.83 Favored Glycine 0 C--O 1.237 0.298 0 C-N-CA 120.495 -0.859 . . . . 64.25 111.95 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 96.1 m -112.28 134.25 53.93 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 122.339 1.066 . . . . 72.400000000000006 109.602 -175.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 76.9 t -126.55 139.75 50.84 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-N 113.888 -1.506 . . . . 74.129999999999995 107.212 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.2 tt -107.69 139.45 29.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 106.239 -1.763 . . . . 72.140000000000001 106.239 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.2 t -134.21 112.74 12.2 Favored Pre-proline 0 N--CA 1.472 0.625 0 N-CA-C 112.741 0.645 . . . . 65.409999999999997 112.741 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.2 Cg_endo -73.39 156.53 50.31 Favored 'Trans proline' 0 CA--C 1.503 -1.074 0 N-CA-C 115.301 1.231 . . . . 72.239999999999995 115.301 173.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -137.08 165.37 26.22 Favored 'General case' 0 N--CA 1.442 -0.86 0 N-CA-C 107.929 -1.137 . . . . 74.329999999999998 107.929 172.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.55 155.44 28.37 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 108.942 -0.762 . . . . 72.310000000000002 108.942 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . 0.431 HG21 ' CE1' ' A' ' 580' ' ' PHE . 0.6 OUTLIER -81.85 142.29 32.66 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 109.361 -0.607 . . . . 71.109999999999999 109.361 176.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.81 122.86 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 102.72 -3.067 . . . . 64.310000000000002 102.72 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -89.31 143.93 26.46 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.352 -1.294 . . . . 72.439999999999998 109.545 179.121 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.16 -73.38 0.77 Allowed Glycine 0 C--O 1.226 -0.397 0 N-CA-C 107.162 -2.375 . . . . 65.430000000000007 107.162 177.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.3 t -117.08 110.59 18.4 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.381 -2.452 . . . . 65.209999999999994 104.381 161.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.66 166.52 2.63 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 104.848 -2.278 . . . . 61.229999999999997 104.848 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 14.4 mmtm -89.95 -30.85 17.55 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 109.508 -0.553 . . . . 64.310000000000002 109.508 177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.93 -166.3 53.95 Favored Glycine 0 N--CA 1.46 0.256 0 CA-C-N 115.758 -0.656 . . . . 70.209999999999994 114.725 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.12 -107.98 2.36 Favored Glycine 0 C--O 1.218 -0.865 0 C-N-CA 120.991 -0.624 . . . . 72.450000000000003 112.782 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.73 12.15 8.29 Favored Glycine 0 C--O 1.22 -0.771 0 N-CA-C 110.699 -0.96 . . . . 63.32 110.699 174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 67.4 tt0 -95.47 -48.13 5.97 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 115.918 1.821 . . . . 74.209999999999994 115.918 -166.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -104.86 -31.34 9.33 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-O 122.99 1.376 . . . . 74.230000000000004 109.709 176.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . 0.431 ' CE1' HG21 ' A' ' 568' ' ' THR . 11.6 p90 -154.19 165.61 35.71 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 102.113 -3.292 . . . . 70.209999999999994 102.113 178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -91.92 136.05 33.46 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.47 -0.567 . . . . 64.219999999999999 109.47 174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -61.35 92.73 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.043 0.925 . . . . 64.209999999999994 110.1 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -99.53 106.0 17.96 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 115.23 -0.896 . . . . 73.400000000000006 111.582 -175.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 28.0 p90 -135.53 142.54 45.43 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.498 -0.927 . . . . 74.109999999999999 108.498 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.42 -173.6 39.83 Favored Glycine 0 CA--C 1.501 -0.823 0 N-CA-C 108.985 -1.646 . . . . 75.439999999999998 108.985 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 30.2 mt-10 -116.64 148.51 40.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 117.531 0.666 . . . . 72.209999999999994 110.144 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.0 mt -119.02 125.27 48.97 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.918 -1.037 . . . . 74.310000000000002 108.229 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -88.46 122.26 31.74 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.252 -0.648 . . . . 74.25 109.252 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -115.47 116.7 28.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.124 -1.436 . . . . 64.420000000000002 107.124 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.611 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 57.0 mttp -100.49 -179.65 4.17 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 105.656 -1.979 . . . . 64.430000000000007 105.656 176.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -44.43 -55.69 4.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 116.834 2.161 . . . . 44.130000000000003 116.834 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -82.43 -36.97 26.12 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 122.303 1.049 . . . . 73.230000000000004 111.012 177.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.611 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 51.9 mt-10 -66.88 16.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.646 2.091 . . . . 60.350000000000001 116.646 -174.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 73.3 p -71.61 12.55 0.35 Allowed 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.722 1.378 . . . . 73.439999999999998 114.722 -173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.5 t -119.26 121.89 67.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 105.038 -2.208 . . . . 53.340000000000003 105.038 173.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.444 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.5 174.19 12.36 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 109.808 -0.441 . . . . 72.25 109.808 -177.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.444 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -138.05 154.52 49.28 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 112.609 0.596 . . . . 71.340000000000003 112.609 -177.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 616' ' ' ILE . 67.2 mt -114.55 130.83 68.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.019 0 N-CA-C 106.633 -1.617 . . . . 74.230000000000004 106.633 175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -111.73 131.88 55.01 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 123.934 0.771 . . . . 53.350000000000001 111.476 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.5 t -131.58 113.8 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 123.535 0.522 . . . . 63.119999999999997 109.788 175.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 10.4 ttpt -67.65 137.59 55.71 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.523 -0.547 . . . . 62.149999999999999 109.523 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 22.9 mm -101.05 135.88 35.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.475 -2.046 . . . . 71.450000000000003 105.475 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.92 143.64 10.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 108.026 -1.102 . . . . 52.399999999999999 108.026 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -114.08 134.8 54.63 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.912 0.885 . . . . 72.219999999999999 112.498 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 607' ' ' GLU . 10.4 tp10 -158.16 154.61 27.67 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 105.765 -1.939 . . . . 72.439999999999998 105.765 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -110.8 4.27 19.75 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.185 1.18 . . . . 72.519999999999996 114.185 -175.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.406 ' H ' ' HG3' ' A' ' 605' ' ' GLU . 31.4 tt0 -65.15 -38.45 90.62 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 116.787 2.143 . . . . 71.510000000000005 116.787 -171.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 40.5 t80 -144.07 137.36 27.53 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 116.055 1.872 . . . . 62.310000000000002 116.055 -170.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -79.22 112.99 16.99 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.539 -0.755 . . . . 70.349999999999994 110.42 176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 38.2 ttt180 -152.2 143.56 23.34 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 112.836 0.68 . . . . 72.019999999999996 112.836 178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -84.73 119.63 25.49 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 104.194 -2.521 . . . . 75.010000000000005 104.194 166.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -117.74 159.33 23.18 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.276 -1.379 . . . . 52.130000000000003 107.276 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.0 OUTLIER -147.34 135.36 21.37 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 118.755 0.707 . . . . 65.400000000000006 112.795 -170.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . 0.472 ' CE1' HG21 ' A' ' 662' ' ' VAL . 3.3 p90 -145.21 173.63 11.77 Favored 'General case' 0 C--O 1.208 -1.123 0 C-N-CA 119.313 -0.955 . . . . 75.150000000000006 109.756 173.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -148.67 168.64 22.33 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 118.76 0.709 . . . . 73.109999999999999 109.414 178.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.415 HG21 HG21 ' A' ' 598' ' ' ILE . 11.1 mt -129.65 119.57 48.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 107.768 -1.197 . . . . 54.030000000000001 107.768 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.03 143.66 34.81 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 106.881 -1.526 . . . . 72.25 106.881 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.604 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.5 mm? -77.06 154.02 33.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.904 -1.147 . . . . 72.219999999999999 107.904 172.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.6 -82.42 0.36 Allowed Glycine 0 C--O 1.223 -0.582 0 N-CA-C 109.792 -1.323 . . . . 74.420000000000002 109.792 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -159.21 131.05 4.1 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 105.688 -1.968 . . . . 73.019999999999996 105.688 174.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.86 136.4 30.01 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 117.101 -1.466 . . . . 73.049999999999997 110.424 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -126.89 137.49 53.16 Favored 'General case' 0 C--O 1.21 -0.993 0 N-CA-C 109.207 -0.664 . . . . 75.219999999999999 109.207 -176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.698 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.3 t90 -83.58 108.9 16.99 Favored 'General case' 0 CA--C 1.493 -1.23 0 O-C-N 121.754 -0.591 . . . . 71.530000000000001 110.161 -174.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.482 12.4 mmt -123.76 82.18 1.99 Allowed 'General case' 0 N--CA 1.424 -1.766 0 C-N-CA 115.965 -2.294 . . . . 61.130000000000003 114.004 164.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.345 1.3 tt0 -152.62 90.22 1.46 Allowed 'General case' 1 C--O 1.148 -4.238 1 CA-C-O 111.063 -4.304 . . . . 73.450000000000003 100.576 146.282 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.698 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 29.1 mmm180 164.3 -49.4 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.1 1 CA-C-N 127.828 4.831 . . . . 70.129999999999995 107.39 179.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.21 58.22 3.74 Favored Glycine 0 C--O 1.224 -0.488 0 N-CA-C 110.266 -1.134 . . . . 62.450000000000003 110.266 -176.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.429 HG22 ' H ' ' A' ' 628' ' ' ILE . 1.1 tt -52.1 123.16 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 114.924 -0.638 . . . . 73.230000000000004 111.228 -178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.4 m -151.0 154.81 37.79 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 104.649 -2.352 . . . . 60.299999999999997 104.649 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -85.41 153.29 22.6 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.489 -1.671 . . . . 75.450000000000003 106.489 173.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 10.3 p -148.28 140.16 18.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 108.46 -0.941 . . . . 72.209999999999994 108.46 -175.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.0 t -131.24 -3.05 3.91 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 115.83 1.789 . . . . 75.450000000000003 115.83 -171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -77.59 -21.01 53.08 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.914 0.864 . . . . 75.340000000000003 109.336 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 16.9 mtt-85 -83.36 72.66 10.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.234 -0.894 . . . . 72.319999999999993 111.537 -176.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -65.81 129.77 40.94 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.045 -0.98 . . . . 74.239999999999995 108.785 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.516 ' H ' ' HG3' ' A' ' 641' ' ' GLU . 91.8 mt -127.9 -173.58 2.97 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 103.592 -2.744 . . . . 71.420000000000002 103.592 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -65.35 149.99 49.04 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 103.387 -2.82 . . . . 60.43 103.387 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.0 m -64.06 -25.6 38.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 112.616 0.598 . . . . 73.109999999999999 112.616 -160.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.53 -49.85 65.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.994 0.902 . . . . 54.420000000000002 109.342 175.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -69.85 -25.49 63.76 Favored 'General case' 0 C--O 1.218 -0.583 0 CA-C-N 114.735 -1.121 . . . . 60.32 111.7 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . 0.516 ' HG3' ' H ' ' A' ' 636' ' ' LEU . 0.7 OUTLIER -59.38 -43.31 92.94 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.619 -0.832 . . . . 73.099999999999994 110.891 -177.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -88.21 -44.71 10.67 Favored 'General case' 0 C--O 1.214 -0.775 0 C-N-CA 119.009 -1.076 . . . . 75.109999999999999 111.317 171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.89 86.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.23 0.923 . . . . 72.439999999999998 112.361 -173.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.85 -42.06 70.61 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-O 121.031 0.443 . . . . 72.239999999999995 110.405 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -59.38 -46.13 89.51 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.995 -0.548 . . . . 64.230000000000004 111.64 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -63.32 -41.25 92.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.272 0.558 . . . . 75.420000000000002 109.684 177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.19 -31.61 72.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.527 0.679 . . . . 63.520000000000003 110.881 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -77.89 -17.94 56.74 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.963 -0.562 . . . . 73.140000000000001 111.907 177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 52.5 mtt -71.57 -41.2 69.33 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 106.907 -1.516 . . . . 74.109999999999999 106.907 173.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.439 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.47 13.45 22.98 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 116.891 1.516 . . . . 72.519999999999996 116.891 166.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -58.03 130.91 83.42 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 114.485 1.291 . . . . 75.530000000000001 114.485 -167.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.73 165.22 33.19 Favored 'Trans proline' 0 C--N 1.346 0.415 0 N-CA-C 110.491 -0.619 . . . . 61.299999999999997 110.491 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.31 167.66 25.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.675 -0.693 . . . . 74.519999999999996 110.962 178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.84 154.91 38.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.869 -0.605 . . . . 72.040000000000006 109.554 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -93.59 -158.5 33.94 Favored Glycine 0 CA--C 1.504 -0.599 0 N-CA-C 117.545 1.778 . . . . 70.310000000000002 117.545 -178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -78.51 -30.75 47.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.973 -1.113 . . . . 74.019999999999996 110.882 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 25.9 m-70 -130.92 60.77 55.43 Favored Pre-proline 0 N--CA 1.475 0.804 0 N-CA-C 112.745 0.646 . . . . 73.150000000000006 112.745 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -78.4 30.53 0.45 Allowed 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 121.097 1.198 . . . . 74.340000000000003 113.909 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -160.53 153.29 21.12 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.942 -1.133 . . . . 70.230000000000004 107.942 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 20.7 tp -134.13 130.52 37.47 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 105.976 -1.861 . . . . 72.299999999999997 105.976 175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -98.93 122.74 42.57 Favored 'General case' 0 C--O 1.215 -0.732 0 N-CA-C 113.799 1.037 . . . . 75.450000000000003 113.799 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.617 ' HA ' HG23 ' A' ' 539' ' ' ILE . 2.0 m -102.53 143.56 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.51 0 CA-C-O 122.103 0.954 . . . . 73.219999999999999 110.797 -176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.429 HD13 ' HB2' ' A' ' 613' ' ' ASN . 4.5 mm -124.79 131.28 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 103.193 -2.892 . . . . 75.129999999999995 103.193 174.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.3 mt -87.64 124.23 40.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.61 -1.626 . . . . 74.420000000000002 106.61 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.25 -179.68 0.17 Allowed 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 116.075 1.88 . . . . 63.229999999999997 116.075 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 63.8 -176.71 0.16 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.533 1.133 . . . . 72.549999999999997 112.108 -176.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 95.6 p -136.75 174.18 10.9 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.574 -0.528 . . . . 73.120000000000005 109.574 -175.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -162.03 158.28 24.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.63 -1.248 . . . . 73.519999999999996 107.63 176.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -113.91 133.39 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.232 -1.025 . . . . 74.430000000000007 108.232 172.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 38.7 m-85 -99.0 56.16 1.04 Allowed 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 107.699 -1.223 . . . . 72.099999999999994 107.699 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 22.4 ttmt -69.76 111.14 5.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.3 -1.318 . . . . 73.400000000000006 110.408 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 57.2 p -82.5 142.67 31.68 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.005 -0.543 . . . . 64.019999999999996 109.612 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 41.7 p -132.28 159.74 38.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 106.611 -1.626 . . . . 74.219999999999999 106.611 176.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.7 m -139.9 164.34 23.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.952 -1.87 . . . . 61.299999999999997 105.952 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.7 t70 . . . . . 0 C--O 1.244 0.811 0 N-CA-C 102.781 -3.044 . . . . 64.519999999999996 102.781 177.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 . . . . . 0 CA--C 1.507 -0.676 0 N-CA-C 105.28 -2.118 . . . . 74.310000000000002 105.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.08 139.49 58.44 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.705 -1.22 . . . . 75.430000000000007 107.705 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -58.48 147.59 39.24 Favored Glycine 0 C--O 1.22 -0.746 0 N-CA-C 117.595 1.798 . . . . 54.140000000000001 117.595 -169.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.02 141.14 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 107.107 -1.442 . . . . 45.299999999999997 107.107 175.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -111.44 131.78 54.95 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.443 0.639 . . . . 71.219999999999999 110.823 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.3 t -156.01 164.16 38.79 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.383 -1.71 . . . . 71.319999999999993 106.383 -172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.61 ' CE1' HD21 ' A' ' 618' ' ' LEU . 17.3 m-30 -103.54 168.85 8.89 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.626 -0.879 . . . . 63.420000000000002 108.626 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -68.31 -40.31 81.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.521 -1.218 . . . . 74.409999999999997 113.692 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.0 m -139.07 167.74 21.38 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.968 -1.123 . . . . 62.43 107.968 -175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 13.1 p30 -122.04 4.15 9.88 Favored 'General case' 0 C--O 1.214 -0.791 0 O-C-N 123.576 0.548 . . . . 61.409999999999997 112.441 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.3 m -145.58 133.47 21.27 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 106.213 -1.773 . . . . 74.230000000000004 106.213 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.31 160.43 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.769 1.228 . . . . 70.530000000000001 108.957 -178.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -127.78 131.49 49.61 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.129 -1.063 . . . . 70.310000000000002 108.129 171.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.406 HG22 HG12 ' A' ' 662' ' ' VAL . 30.0 m -121.07 172.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 107.937 -1.134 . . . . 73.109999999999999 107.937 169.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 31.9 m -117.79 159.24 23.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 102.301 -3.222 . . . . 61.229999999999997 102.301 169.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -65.1 -31.27 72.39 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 119.163 0.892 . . . . 71.310000000000002 110.926 178.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 58.0 m -66.98 -6.73 18.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.456 -0.793 . . . . 52.32 112.737 -178.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.9 tt -66.16 -26.01 37.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 109.527 -0.546 . . . . 75.099999999999994 109.527 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 85.64 -69.23 3.27 Favored Glycine 0 CA--C 1.502 -0.74 0 C-N-CA 120.407 -0.902 . . . . 62.329999999999998 111.598 -177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.0 t -134.22 118.54 28.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.472 -0.566 . . . . 53.229999999999997 109.472 -176.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.428 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -81.02 153.67 27.3 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.919 -1.141 . . . . 73.120000000000005 107.919 176.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -131.82 141.49 49.46 Favored 'General case' 0 CA--C 1.498 -1.024 0 CA-C-O 122.345 1.069 . . . . 62.030000000000001 112.334 175.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.536 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 1.1 t -112.01 127.9 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 105.58 -2.007 . . . . 53.210000000000001 105.58 177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -89.07 122.4 32.36 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.34 -1.356 . . . . 74.099999999999994 107.34 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.6 t -112.72 124.04 68.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 123.161 0.585 . . . . 75.530000000000001 109.969 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.01 161.85 14.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.581 0.705 . . . . 72.140000000000001 110.023 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -132.89 135.38 45.54 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.539 -2.393 . . . . 51.539999999999999 104.539 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.736 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.3 t -67.61 168.51 11.01 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.266 -0.573 . . . . 74.230000000000004 109.722 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 p -67.69 6.61 0.62 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 115.098 1.518 . . . . 43.109999999999999 115.098 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.736 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.47 32.38 3.12 Favored Glycine 0 C--O 1.213 -1.203 0 N-CA-C 109.049 -1.621 . . . . 65.319999999999993 109.049 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -76.52 60.92 1.68 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.076 -1.25 . . . . 75.239999999999995 113.925 -171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 -75.6 107.18 7.58 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.55 -1.205 . . . . 75.239999999999995 108.853 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 73.37 -162.9 54.77 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 116.024 1.17 . . . . 54.229999999999997 116.024 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -104.64 130.61 52.62 Favored 'General case' 0 C--O 1.214 -0.794 0 CA-C-O 122.21 1.005 . . . . 62.32 108.496 -175.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.71 140.2 49.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 106.26 -1.756 . . . . 63.100000000000001 106.26 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -107.23 139.61 28.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 106.339 -1.726 . . . . 64.120000000000005 106.339 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.72 113.89 14.1 Favored Pre-proline 0 N--CA 1.475 0.802 0 N-CA-C 114.188 1.181 . . . . 73.420000000000002 114.188 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.38 156.25 45.83 Favored 'Trans proline' 0 CA--C 1.503 -1.067 0 N-CA-C 115.853 1.444 . . . . 74.230000000000004 115.853 173.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -141.26 166.33 25.07 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.396 -0.964 . . . . 70.200000000000003 108.396 172.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.404 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.32 155.73 31.16 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 108.622 -0.881 . . . . 73.349999999999994 108.622 171.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 28.2 m -81.63 133.86 35.42 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 108.195 -1.039 . . . . 70.400000000000006 108.195 178.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.404 HG22 ' HD2' ' A' ' 567' ' ' ARG . 47.3 t -125.41 113.56 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 104.957 -2.238 . . . . 73.299999999999997 104.957 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.47 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -84.44 139.42 32.21 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.312 -1.313 . . . . 72.430000000000007 112.223 -178.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -107.2 -76.28 0.98 Allowed Glycine 0 C--O 1.227 -0.285 0 N-CA-C 106.758 -2.537 . . . . 43.009999999999998 106.758 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 1.9 t -117.1 110.51 18.29 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.58 -1.266 . . . . 52.109999999999999 107.58 164.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 170.51 2.44 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 103.027 -2.953 . . . . 62.409999999999997 103.027 177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -83.48 -31.8 26.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.911 0.863 . . . . 75.420000000000002 109.221 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 69.62 -168.49 46.18 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 114.526 -1.215 . . . . 62.229999999999997 114.823 -177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 75.03 -107.56 2.32 Favored Glycine 0 C--O 1.22 -0.728 0 N-CA-C 109.956 -1.258 . . . . 50.329999999999998 109.956 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.4 15.57 8.1 Favored Glycine 0 C--O 1.217 -0.914 0 CA-C-O 118.118 -1.379 . . . . 33.210000000000001 113.03 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.86 -46.23 6.64 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 117.042 2.238 . . . . 74.5 117.042 -167.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -106.98 -29.59 9.35 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.39 -1.337 . . . . 73.109999999999999 107.39 174.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -150.65 164.92 34.91 Favored 'General case' 0 CA--C 1.503 -0.853 0 N-CA-C 105.218 -2.141 . . . . 75.030000000000001 105.218 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -94.01 126.21 39.09 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.167 -0.679 . . . . 73.329999999999998 109.167 171.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -63.41 111.18 2.2 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-O 123.272 1.51 . . . . 64.400000000000006 108.263 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.469 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.38 105.85 14.6 Favored 'General case' 0 N--CA 1.424 -1.765 0 CA-C-N 111.818 -2.447 . . . . 61.340000000000003 110.581 -169.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -133.06 140.32 47.63 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.321 -0.854 . . . . 74.239999999999995 110.604 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -171.96 -170.35 35.8 Favored Glycine 0 CA--C 1.503 -0.698 0 N-CA-C 108.533 -1.827 . . . . 74.140000000000001 108.533 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -122.45 148.92 44.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 117.762 0.781 . . . . 73.319999999999993 111.285 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.6 mt -115.7 119.65 36.77 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.961 -1.018 . . . . 51.109999999999999 110.856 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -80.32 113.78 18.75 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.106 0.479 . . . . 54.32 110.306 177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -111.24 138.89 47.13 Favored 'General case' 0 C--O 1.214 -0.804 0 N-CA-C 109.091 -0.707 . . . . 74.439999999999998 109.091 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.655 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 88.8 mttt -132.54 -175.41 3.75 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.276 -1.379 . . . . 74.310000000000002 107.276 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -46.67 -60.34 2.45 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 116.141 1.904 . . . . 71.140000000000001 116.141 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.94 -33.21 30.43 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 122.612 1.196 . . . . 75.140000000000001 110.5 -177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.655 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 73.9 mm-40 -58.34 17.5 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 118.267 2.691 . . . . 64.319999999999993 118.267 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 67.5 p -71.01 9.21 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.566 0.95 . . . . 64.439999999999998 113.566 -170.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.3 t -123.25 126.45 73.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.839 -1.541 . . . . 71.409999999999997 106.839 173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.5 tppt? -148.56 173.25 13.35 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.094 -0.706 . . . . 65.349999999999994 109.094 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.407 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -139.77 151.24 45.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 112.505 0.557 . . . . 72.209999999999994 112.505 -179.377 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 63.1 mt -111.71 135.96 49.35 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.973 0 N-CA-C 105.308 -2.108 . . . . 65.420000000000002 105.308 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -116.09 134.5 54.88 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 123.724 0.64 . . . . 70.420000000000002 110.03 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.469 HG22 ' HB3' ' A' ' 583' ' ' ALA . 88.9 t -133.97 124.62 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 107.972 -1.122 . . . . 73.019999999999996 107.972 178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 34.2 tttm -80.94 135.87 35.95 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.204 -0.665 . . . . 74.409999999999997 109.204 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -96.64 144.56 10.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 106.157 -1.794 . . . . 73.109999999999999 106.157 177.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.65 142.46 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.328 -0.619 . . . . 71.129999999999995 109.328 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -85.38 156.07 21.02 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.709 0.803 . . . . 73.140000000000001 111.592 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -133.38 151.44 51.83 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.071 -1.085 . . . . 73.239999999999995 108.071 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -89.22 121.21 31.29 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.583 0.23 . . . . 62.32 110.842 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 63.63 -152.47 0.32 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.373 1.069 . . . . 74.400000000000006 113.318 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 61.01 -158.07 0.33 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.943 0.897 . . . . 72.150000000000006 112.232 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.81 -72.73 0.19 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 109.918 -0.401 . . . . 75.310000000000002 109.918 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 60.91 168.45 0.09 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.772 1.767 . . . . 63.240000000000002 115.772 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -147.41 83.57 1.55 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 104.056 -2.572 . . . . 65.439999999999998 104.056 173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -89.94 153.13 20.85 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 119.64 -0.824 . . . . 73.530000000000001 110.936 -170.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -135.43 128.28 31.24 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.592 -1.185 . . . . 73.129999999999995 109.446 -169.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -150.45 164.62 35.43 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 106.484 -1.673 . . . . 64.040000000000006 106.484 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -145.9 171.47 14.77 Favored 'General case' 0 C--O 1.209 -1.072 0 N-CA-C 107.038 -1.467 . . . . 65.109999999999999 107.038 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 18.0 mt -129.37 120.3 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 N-CA-C 106.573 -1.64 . . . . 74.209999999999994 106.573 178.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -109.54 141.57 41.83 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.211 -1.403 . . . . 31.32 107.211 -177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.61 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.4 mm? -76.82 151.67 35.82 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.107 -1.072 . . . . 64.430000000000007 108.107 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -84.86 0.31 Allowed Glycine 0 C--O 1.222 -0.633 0 CA-C-O 122.698 1.166 . . . . 72.400000000000006 110.529 177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -154.5 121.88 2.87 Favored Pre-proline 0 CA--C 1.506 -0.75 0 N-CA-C 108.458 -0.942 . . . . 74.319999999999993 108.458 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.83 136.25 41.11 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 116.169 -2.088 . . . . 63.43 110.927 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -126.46 136.89 53.21 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 108.171 -1.048 . . . . 75.340000000000003 108.171 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.625 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.35 109.79 17.59 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.579 -0.897 . . . . 73.129999999999995 108.579 -174.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.479 12.6 mmt -123.12 80.04 1.73 Allowed 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 116.123 -2.231 . . . . 64.140000000000001 112.358 165.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.273 18.9 tt0 -152.83 92.7 1.67 Allowed 'General case' 1 C--O 1.09 -7.297 3 CA-C-O 109.166 -5.207 . . . . 74.299999999999997 99.793 149.078 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.625 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.269 12.9 mmm180 157.04 -57.23 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.607 1 CA-C-N 130.154 5.888 . . . . 71.450000000000003 106.813 175.858 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.3 71.76 1.27 Allowed Glycine 0 C--O 1.223 -0.56 0 N-CA-C 109.525 -1.43 . . . . 62.350000000000001 109.525 -174.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 628' ' ' ILE . 1.3 tt -57.59 119.5 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.447 0.641 . . . . 74.510000000000005 109.827 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.0 t -164.13 161.46 22.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.878 -2.638 . . . . 73.299999999999997 103.878 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -96.37 137.06 36.01 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.834 -0.802 . . . . 74.120000000000005 108.834 176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 26.2 t -115.23 82.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.896 -1.52 . . . . 72.120000000000005 106.896 176.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.89 1.64 5.29 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.515 0.674 . . . . 73.409999999999997 112.362 -178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -78.38 4.19 13.69 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.927 0.87 . . . . 63.509999999999998 109.317 173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 72.9 mmt-85 -114.36 132.66 56.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.98 -0.748 . . . . 73.310000000000002 108.98 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -122.36 134.35 54.63 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 105.879 -1.897 . . . . 75.109999999999999 105.879 176.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 73.4 mt -136.49 176.2 8.92 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 105.849 -1.908 . . . . 75.099999999999994 105.849 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.5 t -63.91 150.36 45.16 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 104.366 -2.457 . . . . 70.430000000000007 104.366 169.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.05 -26.18 39.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 112.808 0.67 . . . . 70.150000000000006 112.808 -160.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -65.97 -47.53 74.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.895 0.855 . . . . 63.210000000000001 109.37 176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -74.38 -24.21 59.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.988 -1.006 . . . . 73.099999999999994 111.775 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.06 -39.16 88.81 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.404 -0.518 . . . . 62.200000000000003 110.087 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -87.75 -47.77 8.38 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 119.537 -0.865 . . . . 73.129999999999995 111.381 169.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.96 -46.64 87.56 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.331 0.863 . . . . 61.439999999999998 113.331 -170.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -69.29 -40.22 77.86 Favored 'General case' 0 C--O 1.216 -0.709 0 N-CA-C 109.14 -0.689 . . . . 44.200000000000003 109.14 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -62.63 -47.83 82.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.038 0.384 . . . . 75.140000000000001 112.038 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.5 mt -60.12 -41.99 88.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.055 0.455 . . . . 64.450000000000003 110.14 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -62.23 -34.43 76.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.044 0.45 . . . . 71.430000000000007 110.766 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -80.47 -17.13 52.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.649 0.611 . . . . 72.430000000000007 112.649 177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 60.4 mtm -74.51 -41.72 60.17 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.566 -1.642 . . . . 74.109999999999999 106.566 171.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.546 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.53 16.6 29.9 Favored Glycine 0 C--N 1.33 0.246 0 N-CA-C 116.931 1.532 . . . . 52.439999999999998 116.931 166.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 4.7 mmmt -58.75 118.33 27.99 Favored Pre-proline 0 N--CA 1.446 -0.653 0 N-CA-C 115.358 1.614 . . . . 75.239999999999995 115.358 -166.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.51 158.35 57.61 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 118.164 -0.757 . . . . 43.409999999999997 110.723 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.3 m -134.53 167.96 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.259 -0.882 . . . . 54.229999999999997 110.537 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -78.07 160.23 28.22 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.112 -0.494 . . . . 55.329999999999998 110.112 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.64 -153.58 25.75 Favored Glycine 0 C--O 1.221 -0.697 0 N-CA-C 115.86 1.104 . . . . 42.140000000000001 115.86 -176.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 57.4 mp0 -78.0 -28.45 49.2 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.196 -1.002 . . . . 75.349999999999994 112.763 -178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -134.16 59.55 38.45 Favored Pre-proline 0 N--CA 1.476 0.853 0 N-CA-C 112.777 0.658 . . . . 64.239999999999995 112.777 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -77.7 32.63 0.44 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 121.516 1.477 . . . . 62.340000000000003 114.475 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -161.27 150.27 16.31 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.659 -0.867 . . . . 75.450000000000003 108.659 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -126.79 121.09 30.95 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.121 -2.177 . . . . 64.450000000000003 105.121 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.88 125.13 34.8 Favored 'General case' 0 C--O 1.206 -1.19 0 N-CA-C 109.906 -0.405 . . . . 63.119999999999997 109.906 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 3.1 t -119.07 133.73 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 108.595 -0.891 . . . . 72.409999999999997 108.595 -172.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 4.6 mm -110.64 133.15 57.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 103.861 -2.644 . . . . 74.239999999999995 103.861 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 77.6 mt -92.03 92.57 3.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 105.989 -1.856 . . . . 73.310000000000002 105.989 176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -173.39 128.16 0.43 Allowed 'General case' 0 C--O 1.24 0.558 0 N-CA-C 105.586 -2.005 . . . . 73.319999999999993 105.586 -176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -72.37 135.52 45.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 118.637 0.653 . . . . 65.239999999999995 109.39 177.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 89.1 p -154.61 158.56 39.9 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.783 -0.451 . . . . 73.340000000000003 109.783 178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -82.41 142.1 32.22 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.111 -0.7 . . . . 71.409999999999997 109.111 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -138.34 161.92 35.69 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.108 -1.071 . . . . 54.399999999999999 108.108 176.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -148.95 142.38 25.25 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.324 -0.621 . . . . 75.200000000000003 109.324 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -124.29 138.67 54.36 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.551 -0.907 . . . . 70.340000000000003 108.551 176.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.7 m -78.33 163.06 26.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.207 -0.451 . . . . 61.399999999999999 109.958 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.5 t -149.01 163.18 38.26 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.608 -2.367 . . . . 73.209999999999994 104.608 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 7.4 m 51.31 -176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 125.825 1.65 . . . . 63.329999999999998 115.02 -176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 C--O 1.252 1.204 0 CA-C-O 118.528 -0.749 . . . . 73.140000000000001 111.202 -176.318 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 . . . . . 0 C--O 1.222 -0.35 0 N-CA-C 109.337 -0.616 . . . . 72.319999999999993 109.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -72.64 143.52 48.13 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.278 -0.638 . . . . 70.129999999999995 109.278 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -73.18 155.61 50.67 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 117.063 1.585 . . . . 74.349999999999994 117.063 -174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.52 140.97 18.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 113.661 -1.269 . . . . 74.340000000000003 108.887 176.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 82.7 m-85 -106.6 136.51 46.25 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.417 0.627 . . . . 73.219999999999999 111.014 174.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 9.9 t -155.4 170.97 20.68 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 103.743 -2.688 . . . . 63.399999999999999 103.743 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 17.1 m-30 -104.87 170.47 7.86 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 106.4 -1.704 . . . . 75.140000000000001 106.4 174.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -61.18 -43.75 98.38 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 113.664 0.987 . . . . 63.329999999999998 113.664 177.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 71.9 m -146.06 173.25 12.35 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.027 -1.842 . . . . 74.329999999999998 106.027 -175.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 20.3 p30 -122.8 6.6 9.37 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 113.285 0.846 . . . . 72.310000000000002 113.285 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 40.8 m -140.22 127.28 20.89 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 108.885 -0.783 . . . . 73.340000000000003 108.885 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.636 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.16 160.41 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.333 1.053 . . . . 72.209999999999994 109.568 -179.511 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -130.17 133.02 46.3 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.514 -0.921 . . . . 62.219999999999999 108.514 171.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.415 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -123.86 176.83 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 CA-C-O 120.965 0.412 . . . . 72.310000000000002 109.912 171.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 12.1 t -122.85 162.09 22.82 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 102.965 -2.976 . . . . 73.420000000000002 102.965 171.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.576 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 16.1 mp0 -62.47 -37.35 85.63 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 124.718 1.207 . . . . 60.219999999999999 108.798 177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 17.3 m -66.17 -7.39 17.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 113.844 -1.526 . . . . 61.530000000000001 114.028 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -67.69 -24.36 30.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.787 -0.449 . . . . 65.25 109.787 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 82.89 -65.66 4.09 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.625 -0.798 . . . . 24.010000000000002 112.474 -176.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.45 118.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.085 0.469 . . . . 74.409999999999997 110.434 -175.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.455 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -83.08 153.57 24.81 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 65.349999999999994 109.065 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -137.0 142.12 42.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.557 0.218 . . . . 64.439999999999998 111.557 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.488 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -119.15 142.5 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 N-CA-C 106.333 -1.729 . . . . 73.219999999999999 106.333 171.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -92.38 125.63 37.12 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.607 -1.257 . . . . 65.530000000000001 107.607 174.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 17.5 t -101.07 136.01 34.7 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 105.874 -1.899 . . . . 65.209999999999994 105.874 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 14.6 mt -120.2 159.73 24.34 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 123.581 0.55 . . . . 72.200000000000003 110.929 -174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 10.7 ttp180 -134.18 135.8 43.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 105.932 -1.877 . . . . 72.209999999999994 105.932 171.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.702 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -66.37 176.66 1.74 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.846 0.355 . . . . 51.439999999999998 110.815 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 61.8 p -67.24 7.72 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.814 1.413 . . . . 73.209999999999994 114.814 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 555' ' ' THR . . . -83.3 19.08 14.66 Favored Glycine 0 C--O 1.205 -1.679 0 N-CA-C 109.972 -1.251 . . . . 61.5 109.972 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -70.88 81.55 0.64 Allowed 'General case' 0 C--N 1.322 -0.624 0 O-C-N 120.811 -1.405 . . . . 74.349999999999994 114.588 -173.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 16.1 mmp_? -105.93 117.66 34.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.321 -0.992 . . . . 64.209999999999994 108.321 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 75.87 -164.06 53.68 Favored Glycine 0 C--O 1.245 0.827 0 N-CA-C 114.697 0.639 . . . . 34.130000000000003 114.697 176.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.5 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.2 m -111.97 133.07 54.38 Favored 'General case' 0 C--O 1.206 -1.218 0 CA-C-N 114.717 -0.741 . . . . 52.439999999999998 109.522 -176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.498 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.03 151.3 35.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 105.543 -2.021 . . . . 75.329999999999998 105.543 177.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . 0.444 HG12 ' HB3' ' A' ' 586' ' ' GLU . 3.4 tt -113.72 140.77 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 104.872 -2.27 . . . . 73.150000000000006 104.872 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -132.69 114.74 14.36 Favored Pre-proline 0 N--CA 1.473 0.701 0 N-CA-C 114.014 1.116 . . . . 64.129999999999995 114.014 -176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.53 153.54 34.76 Favored 'Trans proline' 0 CA--C 1.504 -0.995 0 N-CA-C 115.576 1.337 . . . . 62.109999999999999 115.576 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -140.72 165.71 26.73 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.73 -1.211 . . . . 74.400000000000006 107.73 173.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.406 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.3 OUTLIER -159.18 154.8 26.0 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.534 -1.284 . . . . 74.430000000000007 107.534 172.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . 0.416 ' HB ' ' HA ' ' A' ' 582' ' ' ASP . 78.0 m -81.88 133.47 35.32 Favored 'General case' 0 C--O 1.203 -1.355 0 N-CA-C 107.797 -1.186 . . . . 74.439999999999998 107.797 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.406 HG22 ' HD2' ' A' ' 567' ' ' ARG . 61.5 t -121.95 104.6 15.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 106.73 -1.582 . . . . 74.030000000000001 106.73 -175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.9 pm0 -76.37 139.97 41.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.305 -0.861 . . . . 65.510000000000005 110.728 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.69 -76.44 1.01 Allowed Glycine 0 C--O 1.227 -0.294 0 N-CA-C 108.29 -1.924 . . . . 64.430000000000007 108.29 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.62 110.43 18.51 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 105.931 -1.877 . . . . 65.209999999999994 105.931 165.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.32 168.76 1.04 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 101.721 -3.437 . . . . 74.019999999999996 101.721 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -79.53 -33.61 41.8 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 106.859 -1.534 . . . . 71.0 106.859 174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.29 -163.91 53.25 Favored Glycine 0 C--N 1.331 0.254 0 CA-C-N 115.032 -0.985 . . . . 61.149999999999999 113.87 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.16 -105.37 1.62 Allowed Glycine 0 C--O 1.21 -1.344 0 C-N-CA 120.932 -0.651 . . . . 61.409999999999997 113.392 175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.16 9.23 8.95 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 111.332 -0.707 . . . . 60.020000000000003 111.332 173.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -95.04 -46.49 6.8 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 115.479 1.659 . . . . 75.150000000000006 115.479 -165.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -103.82 -29.59 10.9 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 122.879 1.324 . . . . 71.049999999999997 109.095 177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -164.61 161.73 21.13 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 102.544 -3.132 . . . . 73.099999999999994 102.544 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -85.6 139.69 31.21 Favored 'General case' 0 C--N 1.316 -0.867 0 O-C-N 123.416 0.447 . . . . 62.240000000000002 110.837 178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . 0.416 ' HA ' ' HB ' ' A' ' 568' ' ' THR . 63.6 t0 -68.18 111.85 4.76 Favored 'General case' 0 CA--C 1.488 -1.421 0 N-CA-C 105.123 -2.177 . . . . 65.239999999999995 105.123 169.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.47 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -111.83 101.2 9.55 Favored 'General case' 0 N--CA 1.418 -2.071 0 CA-C-N 112.322 -2.217 . . . . 52.140000000000001 107.947 -169.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -130.09 141.43 50.7 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.868 -1.06 . . . . 71.209999999999994 110.943 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.64 -169.25 35.74 Favored Glycine 0 CA--C 1.5 -0.85 0 N-CA-C 107.862 -2.095 . . . . 65.230000000000004 107.862 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . 0.444 ' HB3' HG12 ' A' ' 563' ' ' ILE . 21.7 mt-10 -122.81 149.41 44.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 117.501 0.651 . . . . 70.340000000000003 110.387 176.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 22.8 mt -116.31 118.54 33.04 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.944 -1.026 . . . . 73.109999999999999 110.669 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -76.46 128.44 34.79 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.679 -1.23 . . . . 74.219999999999999 107.679 175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -124.91 116.73 22.66 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.789 -0.819 . . . . 73.109999999999999 108.789 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.556 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.9 mttp -107.85 -179.37 3.88 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.245 -1.02 . . . . 74.409999999999997 108.245 175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -38.97 -66.3 0.29 Allowed 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 117.366 2.358 . . . . 74.209999999999994 117.366 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.19 -24.58 34.88 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 122.347 1.07 . . . . 71.319999999999993 112.025 -176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.556 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.0 mt-10 -58.34 17.02 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 118.385 2.735 . . . . 64.409999999999997 118.385 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 76.3 p -71.22 11.21 0.46 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.004 0.742 . . . . 71.120000000000005 113.004 -169.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.55 124.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.321 -2.103 . . . . 70.219999999999999 105.321 168.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -145.3 174.45 11.09 Favored 'General case' 0 CA--C 1.504 -0.801 0 N-CA-C 106.949 -1.5 . . . . 73.200000000000003 106.949 -177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.68 155.37 46.51 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.615 0.969 . . . . 72.109999999999999 113.615 -177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -118.88 132.98 67.19 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 107.021 -1.474 . . . . 71.409999999999997 107.021 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 45.6 mtt-85 -112.95 132.11 55.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.958 0.786 . . . . 72.010000000000005 112.199 178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.3 t -128.21 126.69 66.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 107.701 -1.222 . . . . 71.540000000000006 107.701 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.76 136.28 35.44 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 106.902 -1.518 . . . . 62.240000000000002 106.902 -178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 12.1 mm -102.7 137.13 31.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 105.151 -2.166 . . . . 72.540000000000006 105.151 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 96.2 t -102.55 143.54 14.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.097 -2.186 . . . . 74.040000000000006 105.097 -175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -138.99 97.64 3.35 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 112.667 0.617 . . . . 64.040000000000006 112.667 -165.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -155.67 152.46 28.66 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 106.921 -1.511 . . . . 64.030000000000001 106.921 176.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -93.96 128.8 40.48 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.972 1.841 . . . . 73.329999999999998 115.972 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -150.0 -63.71 0.21 Allowed 'General case' 0 CA--C 1.552 1.038 0 N-CA-C 112.839 0.681 . . . . 74.209999999999994 112.839 169.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 27.66 0.68 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.224 1.194 . . . . 72.349999999999994 114.224 -172.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -74.94 155.28 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 114.356 1.243 . . . . 72.310000000000002 114.356 -170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.1 -153.02 0.44 Allowed 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 104.216 -2.512 . . . . 74.140000000000001 104.216 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -75.9 103.96 6.21 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.881 -1.526 . . . . 74.430000000000007 106.881 171.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -89.46 163.42 15.26 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.538 -0.541 . . . . 71.519999999999996 109.538 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.49 133.95 23.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.393 0.616 . . . . 72.150000000000006 110.584 -177.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -152.1 167.32 28.86 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.668 -0.864 . . . . 75.200000000000003 108.668 174.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.87 171.23 14.33 Favored 'General case' 0 C--O 1.205 -1.248 0 N-CA-C 106.65 -1.611 . . . . 64.420000000000002 106.65 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.423 HD12 HG11 ' A' ' 550' ' ' VAL . 27.3 mt -126.59 127.32 70.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.89 0 N-CA-C 105.355 -2.091 . . . . 64.219999999999999 105.355 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.16 42.49 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.601 0.715 . . . . 64.430000000000007 109.146 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.0 mt -86.01 144.05 27.8 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 107.836 -1.172 . . . . 72.200000000000003 107.836 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -66.33 -82.85 0.11 Allowed Glycine 0 C--O 1.223 -0.584 0 N-CA-C 110.343 -1.103 . . . . 60.039999999999999 110.343 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -162.54 133.01 3.49 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 105.812 -1.921 . . . . 73.310000000000002 105.812 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.21 136.61 37.94 Favored 'Trans proline' 0 C--N 1.33 -0.44 0 C-N-CA 116.243 -2.038 . . . . 62.030000000000001 110.479 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 6.0 mtpt -121.95 130.29 53.21 Favored 'General case' 0 C--O 1.199 -1.588 0 N-CA-C 106.857 -1.535 . . . . 62.420000000000002 106.857 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.717 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -84.2 111.04 19.0 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 108.968 -0.753 . . . . 75.299999999999997 108.968 -174.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . 0.498 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.481 12.9 mmt -123.34 81.46 1.89 Allowed 'General case' 0 N--CA 1.42 -1.972 0 CA-C-O 124.736 2.208 . . . . 31.34 114.211 167.148 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.353 10.6 tt0 -152.63 85.78 1.25 Allowed 'General case' 0 C--O 1.157 -3.802 2 N-CA-C 99.694 -4.187 . . . . 73.209999999999994 99.694 145.926 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.717 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.25 25.3 mmm180 164.32 -57.15 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.17 1 CA-C-N 127.457 4.662 . . . . 73.409999999999997 107.777 179.511 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 79.95 71.84 1.24 Allowed Glycine 0 C--O 1.224 -0.508 0 N-CA-C 107.932 -2.067 . . . . 61.539999999999999 107.932 -170.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -54.22 119.33 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 121.99 0.9 . . . . 72.129999999999995 110.458 -175.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 30.5 p -168.77 -172.14 1.54 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 102.255 -3.239 . . . . 74.439999999999998 102.255 -175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -136.14 161.07 36.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.201 0.455 . . . . 75.120000000000005 109.815 172.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.37 129.17 70.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.034 -1.469 . . . . 73.450000000000003 107.034 -177.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 11.9 t -94.9 -19.03 20.61 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.833 0.825 . . . . 63.329999999999998 110.166 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.2 -30.49 70.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.303 -0.862 . . . . 74.420000000000002 112.269 -176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.69 136.85 34.63 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.09 -0.707 . . . . 74.319999999999993 109.09 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -120.93 135.56 55.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.715 -1.217 . . . . 74.420000000000002 107.715 178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.77 -179.52 5.44 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.167 -2.16 . . . . 72.129999999999995 105.167 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.6 t -67.42 155.89 37.9 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 105.369 -2.086 . . . . 60.240000000000002 105.369 169.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.6 m -65.53 -25.11 36.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 113.08 0.77 . . . . 73.120000000000005 113.08 -162.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.56 -47.84 62.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.121 0.962 . . . . 62.130000000000003 109.302 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -72.79 -20.87 61.08 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 65.310000000000002 111.293 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.51 -41.97 91.12 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.185 -0.302 . . . . 71.310000000000002 110.185 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 25.9 pt-20 -87.69 -48.73 7.64 Favored 'General case' 0 C--O 1.212 -0.918 0 N-CA-C 112.746 0.647 . . . . 61.329999999999998 112.746 166.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.48 73.17 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.084 1.142 . . . . 72.340000000000003 114.084 -170.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -67.9 -40.03 83.51 Favored 'General case' 0 C--O 1.212 -0.903 0 N-CA-C 109.017 -0.734 . . . . 63.539999999999999 109.017 179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.76 -47.54 84.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 111.743 0.275 . . . . 73.140000000000001 111.743 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.4 mt -63.79 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.263 0.554 . . . . 71.299999999999997 109.891 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.63 84.49 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.417 -0.356 . . . . 63.030000000000001 110.446 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -73.73 -24.73 59.94 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.173 -0.467 . . . . 64.340000000000003 112.106 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.3 mtm -67.54 -41.27 84.58 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 106.919 -1.511 . . . . 64.230000000000004 106.919 172.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.56 24.82 57.3 Favored Glycine 0 C--O 1.225 -0.454 0 N-CA-C 116.178 1.231 . . . . 74.420000000000002 116.178 167.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 117.0 17.6 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 118.195 0.998 . . . . 54.549999999999997 112.637 -171.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.22 156.25 65.33 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 116.652 -1.765 . . . . 54.219999999999999 110.825 175.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.5 m -134.05 170.3 20.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.191 -0.913 . . . . 63.439999999999998 110.724 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.78 158.62 22.74 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.315 -0.624 . . . . 75.5 109.315 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -104.34 -151.51 21.66 Favored Glycine 0 C--O 1.221 -0.668 0 CA-C-N 115.586 -0.734 . . . . 72.219999999999999 113.449 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -78.01 -38.3 45.16 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 17.6 m-70 -123.62 54.4 7.24 Favored Pre-proline 0 C--O 1.214 -0.788 0 N-CA-C 112.908 0.707 . . . . 73.310000000000002 112.908 -176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.94 25.13 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 121.642 1.561 . . . . 74.439999999999998 113.366 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 4.9 ttpt -149.43 150.67 32.75 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.624 -1.251 . . . . 74.129999999999995 107.624 -175.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.488 HD23 HG12 ' A' ' 550' ' ' VAL . 21.0 tp -128.66 120.94 27.48 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.42 -1.326 . . . . 62.43 107.42 175.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -87.47 122.12 30.8 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.277 -0.638 . . . . 65.329999999999998 109.277 178.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.636 HG13 HG23 ' A' ' 539' ' ' ILE . 4.0 t -114.38 133.13 61.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 107.717 -1.216 . . . . 74.129999999999995 107.717 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 6.2 mm -112.04 134.31 54.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.915 0 N-CA-C 103.368 -2.827 . . . . 74.230000000000004 103.368 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 41.7 mt -96.4 109.58 23.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 106.232 -1.766 . . . . 63.539999999999999 106.232 177.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 667' ' ' SER . 77.9 tt0 -166.81 149.09 6.35 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 108.258 -1.015 . . . . 62.439999999999998 108.258 -172.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -68.57 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.51 0.672 . . . . 72.109999999999999 111.266 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 33.2 t -85.45 151.57 23.87 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.202 -0.666 . . . . 54.25 109.202 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -147.88 161.84 40.49 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.462 -0.94 . . . . 63.130000000000003 108.462 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -146.35 146.94 30.85 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.289 -1.004 . . . . 71.129999999999995 108.289 -177.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -136.58 132.25 34.89 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.977 -1.49 . . . . 74.430000000000007 106.977 176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -129.4 -3.01 4.92 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 115.658 1.725 . . . . 72.299999999999997 115.658 -174.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 35.6 t -69.51 129.78 40.64 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.121 -1.437 . . . . 73.099999999999994 107.121 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.0 m -139.21 -49.55 0.5 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.714 0.635 . . . . 51.130000000000003 112.714 -174.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 9.5 p -151.6 160.81 3.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 105.657 -1.979 . . . . 71.239999999999995 105.657 -177.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--O 1.26 1.65 0 N-CA-C 103.124 -2.917 . . . . 74.319999999999993 103.124 177.369 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 . . . . . 0 C--O 1.216 -0.669 0 N-CA-C 107.837 -1.171 . . . . 74.120000000000005 107.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -79.23 144.73 34.08 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.614 -0.884 . . . . 73.530000000000001 108.614 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -70.81 153.84 51.73 Favored Glycine 0 C--O 1.221 -0.672 0 N-CA-C 116.908 1.523 . . . . 71.25 116.908 -174.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.44 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -68.46 142.33 16.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 124.135 0.974 . . . . 43.549999999999997 108.689 175.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.76 135.02 52.93 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.492 0.495 . . . . 74.200000000000003 111.422 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -157.22 165.78 34.98 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.044 -1.095 . . . . 71.430000000000007 108.044 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 20.6 m-30 -101.61 168.37 9.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.316 0.579 . . . . 70.340000000000003 109.905 178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -68.44 -39.05 81.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.461 -1.245 . . . . 71.439999999999998 113.618 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.7 m -140.86 168.64 19.32 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 107.977 -1.12 . . . . 62.409999999999997 107.977 -176.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -121.96 3.17 9.96 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.666 0.617 . . . . 75.239999999999995 112.666 177.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.0 m -144.94 133.94 22.57 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 105.891 -1.892 . . . . 52.100000000000001 105.891 177.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.5 160.58 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.385 1.074 . . . . 71.200000000000003 109.492 -178.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -125.61 133.01 52.39 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.639 -0.504 . . . . 75.040000000000006 109.639 171.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 662' ' ' VAL . 35.4 m -123.88 -179.01 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 N-CA-C 108.687 -0.857 . . . . 74.200000000000003 108.687 167.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 2.7 t -134.51 155.73 49.87 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 101.072 -3.677 . . . . 74.129999999999995 101.072 176.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.455 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.09 -32.26 66.1 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.654 0.74 . . . . 71.129999999999995 111.14 176.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 66.0 m -64.98 -11.51 39.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.052 -0.976 . . . . 71.340000000000003 113.207 -177.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -70.16 -26.48 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 O-C-N 122.026 -0.421 . . . . 72.310000000000002 110.461 175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.41 -65.76 4.06 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.767 -0.73 . . . . 64.010000000000005 112.703 -177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.23 118.38 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.328 0.585 . . . . 72.510000000000005 110.023 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.411 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.4 ppp? -80.89 153.52 27.55 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.721 -0.672 . . . . 71.310000000000002 109.231 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.5 tt0 -137.75 139.32 40.02 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.527 0.195 . . . . 71.010000000000005 111.527 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.495 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -115.69 143.03 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.709 0 N-CA-C 105.927 -1.879 . . . . 73.430000000000007 105.927 170.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -94.58 130.96 40.81 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.362 -1.718 . . . . 74.420000000000002 106.362 177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.68 118.88 58.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 108.415 -0.958 . . . . 71.010000000000005 108.415 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.15 161.74 13.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.525 -0.917 . . . . 75.450000000000003 108.525 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -138.34 133.78 33.4 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 103.797 -2.668 . . . . 74.319999999999993 103.797 174.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.665 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.4 t -67.01 175.21 2.63 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.252 0.464 . . . . 64.239999999999995 112.252 -173.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.4 m -64.51 9.89 0.07 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 115.298 1.592 . . . . 74.209999999999994 115.298 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.665 ' H ' HG23 ' A' ' 555' ' ' THR . . . -90.97 17.72 54.14 Favored Glycine 0 C--O 1.201 -1.91 0 N-CA-C 109.389 -1.484 . . . . 61.210000000000001 109.389 174.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -66.55 84.77 0.1 Allowed 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.11 -1.229 . . . . 71.439999999999998 113.424 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 15.1 mmp_? -110.87 115.7 29.97 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.938 -1.134 . . . . 72.400000000000006 107.938 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.57 -164.81 54.7 Favored Glycine 0 C--O 1.243 0.681 0 C-N-CA 120.852 -0.689 . . . . 73.230000000000004 114.284 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.468 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 58.3 m -106.7 129.77 54.54 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 122.052 0.929 . . . . 71.120000000000005 109.367 -177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 54.9 t -126.31 141.16 46.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 105.675 -1.972 . . . . 70.510000000000005 105.675 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -106.89 139.21 29.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 105.852 -1.907 . . . . 74.219999999999999 105.852 175.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.5 t -133.47 114.76 13.49 Favored Pre-proline 0 N--CA 1.47 0.565 0 N-CA-C 112.478 0.547 . . . . 71.109999999999999 112.478 -178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -75.45 157.22 40.98 Favored 'Trans proline' 0 CA--C 1.504 -0.998 0 N-CA-C 115.17 1.181 . . . . 64.129999999999995 115.17 173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -139.5 165.31 27.57 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 107.009 -1.478 . . . . 54.409999999999997 107.009 172.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.73 152.1 22.85 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.11 -0.7 . . . . 75.450000000000003 109.11 172.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 33.2 m -81.77 137.69 35.29 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 108.941 -0.762 . . . . 64.219999999999999 108.941 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.54 107.85 14.81 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 107.408 -1.33 . . . . 65.450000000000003 107.408 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -79.46 140.27 37.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.931 -0.577 . . . . 73.310000000000002 109.56 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -103.45 -76.61 1.14 Allowed Glycine 0 CA--C 1.505 -0.562 0 N-CA-C 108.537 -1.825 . . . . 44.509999999999998 108.537 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -116.56 110.54 18.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 105.348 -2.093 . . . . 71.120000000000005 105.348 165.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.82 166.42 1.2 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 101.078 -3.675 . . . . 74.519999999999996 101.078 -177.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.2 -31.45 20.32 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 105.757 -1.942 . . . . 73.209999999999994 105.757 173.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 66.38 -166.3 38.36 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 116.147 1.219 . . . . 71.120000000000005 116.147 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.06 -97.32 1.77 Allowed Glycine 0 C--O 1.218 -0.879 0 O-C-N 122.059 -0.671 . . . . 71.450000000000003 112.678 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.12 11.33 8.67 Favored Glycine 0 C--O 1.218 -0.852 0 N-CA-C 110.418 -1.073 . . . . 50.219999999999999 110.418 172.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -57.12 2.51 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.737 1.384 . . . . 32.229999999999997 114.737 -171.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -86.52 -35.19 19.71 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 123.948 1.833 . . . . 72.439999999999998 108.755 -178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -160.54 173.88 14.87 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 102.535 -3.135 . . . . 72.319999999999993 102.535 -178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.32 127.92 45.39 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.507 -0.553 . . . . 72.230000000000004 109.507 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 56.3 t0 -58.62 111.19 1.17 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 123.368 1.556 . . . . 65.109999999999999 109.762 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.487 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -109.81 105.91 15.31 Favored 'General case' 0 N--CA 1.424 -1.754 0 CA-C-N 111.769 -2.469 . . . . 74.120000000000005 111.527 -170.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -134.36 141.88 47.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.275 -0.875 . . . . 75.450000000000003 109.969 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.95 -171.68 38.58 Favored Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 108.234 -1.946 . . . . 71.430000000000007 108.234 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -120.49 149.38 42.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.525 0.679 . . . . 64.209999999999994 110.53 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.0 mt -119.62 125.39 48.64 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.732 -1.122 . . . . 61.25 108.777 -177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -84.15 125.97 32.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.824 -0.806 . . . . 55.549999999999997 108.824 175.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -117.76 116.79 27.71 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.493 -0.928 . . . . 74.019999999999996 108.493 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.62 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.5 ttmt -106.0 -179.35 3.91 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 105.377 -2.083 . . . . 70.150000000000006 105.377 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -48.4 -58.0 5.25 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.313 1.227 . . . . 61.43 114.313 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 594' ' ' THR . 3.6 m-20 -81.91 -30.25 31.97 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.494 1.14 . . . . 72.409999999999997 110.305 -178.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.62 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 4.6 mm-40 -73.55 17.11 0.16 Allowed 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 113.438 -1.71 . . . . 71.230000000000004 112.732 178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 592' ' ' ASP . 10.4 t -71.79 13.72 0.26 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.371 1.068 . . . . 54.119999999999997 111.839 -172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 8.4 p -135.24 141.26 43.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 107.11 -1.441 . . . . 71.010000000000005 107.11 169.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.5 tppt? -155.0 -179.39 8.02 Favored 'General case' 0 C--O 1.219 -0.534 0 N-CA-C 108.882 -0.785 . . . . 74.140000000000001 108.882 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.459 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -140.77 155.0 46.51 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 122.884 0.474 . . . . 64.530000000000001 110.186 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.495 ' HB ' HG22 ' A' ' 550' ' ' VAL . 70.2 mt -115.82 137.33 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.993 0 N-CA-C 105.845 -1.909 . . . . 60.32 105.845 175.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -116.46 136.62 52.83 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.879 0.737 . . . . 74.319999999999993 110.939 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.487 HG22 ' HB3' ' A' ' 583' ' ' ALA . 58.2 t -133.24 127.56 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.53 -1.285 . . . . 74.439999999999998 107.53 176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.5 ttpt -80.49 131.7 35.6 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 108.418 -0.956 . . . . 74.239999999999995 108.418 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.3 mm -94.7 132.83 37.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.58 -2.007 . . . . 71.209999999999994 105.58 178.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.9 t -88.33 141.46 14.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.521 -0.548 . . . . 73.310000000000002 109.521 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -99.25 133.4 43.59 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.634 0.774 . . . . 74.120000000000005 111.006 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.24 172.04 18.77 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 106.465 -1.68 . . . . 65.329999999999998 106.465 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -108.12 -29.7 8.81 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 111.923 0.342 . . . . 73.420000000000002 111.923 177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -103.74 45.86 0.94 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.816 0.817 . . . . 75.329999999999998 111.472 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -72.43 161.79 30.34 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.424 -0.807 . . . . 71.010000000000005 110.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.17 48.01 1.41 Allowed 'General case' 0 CA--C 1.549 0.93 0 CA-C-O 122.611 1.196 . . . . 61.5 111.369 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 58.97 -117.65 0.91 Allowed 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.535 -1.211 . . . . 72.219999999999999 112.356 174.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -83.44 88.95 6.99 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.945 -0.761 . . . . 63.32 108.945 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -89.56 152.99 21.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.854 0.835 . . . . 74.439999999999998 108.97 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . 0.406 ' HB2' HD13 ' A' ' 663' ' ' ILE . 0.1 OUTLIER -139.44 129.93 25.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.977 -1.011 . . . . 72.099999999999994 109.296 -168.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -150.03 165.32 33.09 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.475 -1.238 . . . . 75.439999999999998 108.906 177.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.81 170.97 14.71 Favored 'General case' 0 C--O 1.206 -1.218 0 N-CA-C 106.962 -1.496 . . . . 73.420000000000002 106.962 -178.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 14.8 mt -129.33 119.49 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.828 0 N-CA-C 106.338 -1.727 . . . . 73.120000000000005 106.338 178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -107.42 150.08 27.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.834 -1.173 . . . . 54.509999999999998 107.834 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 73.0 mt -86.97 145.0 26.68 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.235 -1.024 . . . . 73.439999999999998 108.235 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -76.18 -86.3 0.35 Allowed Glycine 0 C--O 1.221 -0.713 0 CA-C-O 122.258 0.921 . . . . 53.210000000000001 111.878 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -152.44 120.6 3.21 Favored Pre-proline 0 C--N 1.323 -0.552 0 N-CA-C 108.408 -0.96 . . . . 74.200000000000003 108.408 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.456 ' HD3' HD21 ' A' ' 654' ' ' LEU . 76.9 Cg_endo -71.67 131.54 18.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 117.277 -1.349 . . . . 61.210000000000001 110.694 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.4 mtmt -125.33 134.55 52.18 Favored 'General case' 0 C--O 1.212 -0.911 0 N-CA-C 109.409 -0.589 . . . . 73.209999999999994 109.409 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.597 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.9 t90 -83.19 106.65 15.15 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 109.335 -0.617 . . . . 74.450000000000003 109.335 -173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.481 11.7 mmt -123.57 80.13 1.76 Allowed 'General case' 0 N--CA 1.423 -1.808 0 CA-C-O 125.296 2.474 . . . . 72.129999999999995 112.498 168.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.596 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.262 18.8 tt0 -152.61 93.13 1.74 Allowed 'General case' 1 C--O 1.069 -8.407 3 CA-C-O 108.464 -5.541 . . . . 72.420000000000002 97.051 150.021 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.597 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.294 23.5 mmm180 146.15 -46.92 0.01 OUTLIER 'General case' 0 N--CA 1.536 3.83 1 CA-C-N 130.287 5.949 . . . . 64.540000000000006 104.651 178.962 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.91 35.9 72.99 Favored Glycine 0 C--O 1.228 -0.271 0 N-CA-C 110.472 -1.051 . . . . 50.340000000000003 110.472 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.17 136.75 23.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 122.109 0.957 . . . . 71.340000000000003 113.036 -173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.2 m -131.76 -72.68 0.53 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 104.089 -2.56 . . . . 75.519999999999996 104.089 169.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -148.85 161.53 41.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 105.023 -2.214 . . . . 75.140000000000001 105.023 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.74 73.18 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 122.876 1.322 . . . . 62.109999999999999 108.204 175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 36.0 p -75.87 -9.22 58.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.156 -0.929 . . . . 74.310000000000002 112.189 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -80.83 -10.51 59.71 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.248 0.619 . . . . 74.219999999999999 112.308 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 71.1 mmt-85 -77.55 66.3 3.24 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.487 1.291 . . . . 64.120000000000005 114.487 -173.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.57 116.23 13.9 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 107.167 -1.42 . . . . 63.020000000000003 107.167 173.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 9.3 mt -132.73 -167.79 1.96 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.932 -0.766 . . . . 72.439999999999998 108.932 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -69.38 168.22 14.87 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 106.087 -1.82 . . . . 61.149999999999999 106.087 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 98.3 t -58.0 -46.5 87.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.723 0.773 . . . . 73.329999999999998 111.445 -171.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.51 -47.88 82.0 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.057 -0.974 . . . . 72.450000000000003 110.984 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -74.39 -19.79 60.3 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.929 -1.032 . . . . 53.5 112.189 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.44 -45.17 80.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 119.053 -0.499 . . . . 73.230000000000004 110.012 -176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -87.93 -49.27 7.18 Favored 'General case' 0 C--O 1.213 -0.817 0 C-N-CA 119.483 -0.887 . . . . 75.030000000000001 112.028 167.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.63 -44.73 90.11 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.931 1.086 . . . . 41.109999999999999 113.931 -168.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -74.63 -37.03 62.91 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 108.811 -0.811 . . . . 72.209999999999994 108.811 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -62.13 -46.76 87.57 Favored 'General case' 0 C--O 1.217 -0.618 0 CA-C-N 116.853 -0.158 . . . . 74.129999999999995 111.186 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.9 mt -60.48 -43.63 94.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 N-CA-C 109.645 -0.502 . . . . 74.439999999999998 109.645 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.83 -41.21 97.9 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.256 -0.278 . . . . 64.230000000000004 110.454 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.19 -22.96 64.79 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.805 0.442 . . . . 61.43 112.107 178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 11.9 mmt -70.42 -41.39 72.98 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 107.335 -1.357 . . . . 71.439999999999998 107.335 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 59.06 9.87 8.24 Favored Glycine 0 C--O 1.222 -0.627 0 N-CA-C 116.465 1.346 . . . . 75.129999999999995 116.465 170.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -64.2 121.85 74.37 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 117.608 0.704 . . . . 62.039999999999999 112.737 -164.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.0 165.06 32.12 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 120.425 0.75 . . . . 74.150000000000006 113.445 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.1 m -140.43 163.47 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 115.243 -0.89 . . . . 54.420000000000002 110.572 176.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . 0.456 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.4 mt -75.5 162.9 27.92 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 122.958 0.503 . . . . 74.540000000000006 111.853 175.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -101.2 -152.76 25.81 Favored Glycine 0 C--O 1.223 -0.539 0 N-CA-C 116.531 1.373 . . . . 32.539999999999999 116.531 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -81.01 -30.39 34.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 113.907 -1.147 . . . . 72.030000000000001 111.805 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -131.0 58.88 42.32 Favored Pre-proline 0 N--CA 1.474 0.771 0 N-CA-C 112.846 0.684 . . . . 73.239999999999995 112.846 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -77.7 28.33 0.45 Allowed 'Trans proline' 0 CA--C 1.537 0.67 0 C-N-CA 120.92 1.08 . . . . 44.229999999999997 114.132 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -155.85 146.72 22.19 Favored 'General case' 0 CA--C 1.509 -0.63 0 C-N-CA 123.278 0.631 . . . . 74.430000000000007 109.354 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -126.88 120.5 29.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.952 -1.87 . . . . 64.010000000000005 105.952 177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -90.6 120.95 32.1 Favored 'General case' 0 C--O 1.213 -0.857 0 C-N-CA 122.406 0.283 . . . . 62.32 110.918 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.72 HG13 HG23 ' A' ' 539' ' ' ILE . 2.5 t -113.15 135.98 50.93 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.835 0 N-CA-C 108.787 -0.819 . . . . 62.100000000000001 108.787 -173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.406 HD13 ' HB2' ' A' ' 613' ' ' ASN . 2.8 mm -113.79 130.81 67.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 103.979 -2.6 . . . . 72.209999999999994 103.979 176.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.5 mt -93.67 100.24 10.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 106.225 -1.768 . . . . 75.140000000000001 106.225 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -167.86 133.32 1.92 Allowed 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.851 -1.537 . . . . 64.099999999999994 106.851 -177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 83.74 2.92 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 122.043 0.925 . . . . 75.430000000000007 110.208 177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 85.6 p -162.45 158.32 23.61 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.76 -2.311 . . . . 53.210000000000001 104.76 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -145.79 132.17 19.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.99 0.424 . . . . 73.129999999999995 110.572 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 162.19 41.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 104.999 -2.223 . . . . 71.430000000000007 104.999 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -136.76 -12.75 1.73 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.296 0.85 . . . . 74.510000000000005 113.296 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.9 mptt 56.82 18.98 4.12 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.843 1.423 . . . . 71.099999999999994 114.843 177.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.98 125.54 26.96 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 122.016 -0.428 . . . . 74.299999999999997 110.34 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 -18.89 47.37 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.435 -0.348 . . . . 71.299999999999997 111.566 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 16.8 t 73.78 154.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 124.995 1.434 . . . . 55.210000000000001 107.693 -173.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.504 1.122 . . . . 65.450000000000003 110.693 -174.157 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 106.854 -1.536 . . . . 64.010000000000005 106.854 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -107.34 148.72 28.67 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.746 -0.835 . . . . 71.209999999999994 108.746 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.41 166.5 34.79 Favored Glycine 0 C--O 1.226 -0.389 0 N-CA-C 116.386 1.315 . . . . 42.109999999999999 116.386 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.1 141.64 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 124.112 0.965 . . . . 74.310000000000002 109.061 176.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . 0.564 ' CZ ' ' HD3' ' A' ' 554' ' ' ARG . 84.6 m-85 -112.91 138.5 49.67 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.495 0.497 . . . . 70.5 111.124 174.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.57 167.08 30.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 106.863 -1.532 . . . . 71.329999999999998 106.863 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.58 ' CE1' HD21 ' A' ' 618' ' ' LEU . 16.9 m-30 -103.26 174.28 5.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.509 0.595 . . . . 73.0 110.107 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.61 -47.99 50.98 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.44 1.274 . . . . 70.430000000000007 114.44 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 68.0 m -124.43 176.12 6.69 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 109.664 -0.495 . . . . 74.010000000000005 109.664 -173.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -116.16 -20.04 10.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.085 -0.507 . . . . 63.5 110.541 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 10.8 m -148.72 137.68 21.53 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.964 -1.495 . . . . 73.120000000000005 106.964 -175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.92 157.24 10.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 124.099 0.96 . . . . 65.129999999999995 110.311 -177.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -118.91 128.42 54.41 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.921 -0.77 . . . . 74.540000000000006 108.921 169.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 662' ' ' VAL . 23.4 m -117.16 172.68 4.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 N-CA-C 106.63 -1.618 . . . . 71.439999999999998 106.63 165.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 50.2 m -123.31 161.29 24.94 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 102.385 -3.191 . . . . 75.150000000000006 102.385 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.415 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.55 -29.7 70.92 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.045 0.926 . . . . 52.420000000000002 110.016 177.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -11.69 38.99 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.402 -1.272 . . . . 74.219999999999999 113.064 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 4.0 tt -70.02 -27.36 32.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 72.209999999999994 110.363 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.94 -67.92 3.63 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.404 -0.903 . . . . 74.409999999999997 112.233 -176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 89.9 t -134.56 117.91 25.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.472 0.653 . . . . 64.019999999999996 110.506 -175.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.47 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -80.71 153.72 27.7 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.584 -0.735 . . . . 73.439999999999998 109.577 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.12 139.98 39.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.196 0.443 . . . . 73.200000000000003 112.196 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.463 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.1 m -116.67 143.69 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 105.642 -1.985 . . . . 70.0 105.642 169.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -95.89 130.45 42.85 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 105.687 -1.968 . . . . 42.340000000000003 105.687 176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -106.7 124.04 62.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 108.222 -1.029 . . . . 72.549999999999997 108.222 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.43 161.48 14.79 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 123.01 0.524 . . . . 70.230000000000004 110.146 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.564 ' HD3' ' CZ ' ' A' ' 532' ' ' PHE . 20.5 ttp180 -139.9 140.26 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.423 -1.325 . . . . 71.219999999999999 107.423 172.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.695 HG23 ' H ' ' A' ' 557' ' ' GLY . 5.7 t -67.65 175.04 3.1 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.045 0.387 . . . . 74.230000000000004 112.045 -178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 67.4 p -68.44 9.97 0.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.611 1.337 . . . . 64.129999999999995 114.611 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.695 ' H ' HG23 ' A' ' 555' ' ' THR . . . -86.31 18.11 34.61 Favored Glycine 0 C--O 1.213 -1.188 0 N-CA-C 109.801 -1.32 . . . . 62.200000000000003 109.801 173.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.68 62.47 1.48 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 114.318 1.229 . . . . 70.129999999999995 114.318 -174.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -91.61 108.9 20.23 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.707 -1.219 . . . . 74.25 107.707 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.37 -167.78 37.75 Favored Glycine 0 C--O 1.242 0.626 0 CA-C-N 115.44 -0.8 . . . . 43.5 114.97 -178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.514 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 99.2 m -104.85 131.37 52.42 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 122.455 1.121 . . . . 62.539999999999999 109.287 -174.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 91.5 t -125.45 135.99 62.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 106.087 -1.82 . . . . 74.150000000000006 106.087 178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -104.3 138.07 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.306 -1.738 . . . . 72.409999999999997 106.306 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 20.1 t -134.37 113.29 12.17 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.385 0.513 . . . . 72.420000000000002 112.385 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.08 159.55 47.43 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 N-CA-C 114.896 1.075 . . . . 63.409999999999997 114.896 173.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -140.27 166.46 24.63 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 107.989 -1.115 . . . . 74.230000000000004 107.989 173.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.86 158.62 33.79 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 107.829 -1.174 . . . . 74.430000000000007 107.829 175.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 17.2 m -92.41 139.06 30.98 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.702 -0.851 . . . . 75.140000000000001 108.702 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 56.1 t -130.19 116.55 37.01 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.451 0 N-CA-C 104.261 -2.496 . . . . 71.439999999999998 104.261 -174.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.02 143.3 31.65 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.858 -1.065 . . . . 73.120000000000005 110.388 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.93 -76.29 0.99 Allowed Glycine 0 C--O 1.223 -0.571 0 N-CA-C 108.625 -1.79 . . . . 75.409999999999997 108.625 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.43 110.54 18.14 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 103.723 -2.695 . . . . 72.150000000000006 103.723 164.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.25 165.38 0.98 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 102.898 -3.001 . . . . 45.32 102.898 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -90.75 -25.73 19.85 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 106.718 -1.586 . . . . 74.129999999999995 106.718 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 63.53 -164.73 29.61 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 116.082 1.193 . . . . 62.450000000000003 116.082 173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.63 -100.47 2.06 Favored Glycine 0 C--O 1.223 -0.545 0 N-CA-C 111.513 -0.635 . . . . 75.230000000000004 111.513 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.57 12.79 8.83 Favored Glycine 0 C--O 1.218 -0.874 0 N-CA-C 110.483 -1.047 . . . . 71.200000000000003 110.483 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -48.31 5.78 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 114.655 1.354 . . . . 72.430000000000007 114.655 -171.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -98.74 -35.2 10.23 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 123.923 1.821 . . . . 75.340000000000003 109.209 -178.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -156.1 169.06 25.36 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 101.965 -3.346 . . . . 74.310000000000002 101.965 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -97.52 124.93 41.93 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.096 -1.446 . . . . 51.210000000000001 107.096 170.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -58.79 110.77 1.08 Allowed 'General case' 0 CA--C 1.49 -1.339 0 CA-C-O 123.652 1.691 . . . . 73.349999999999994 110.263 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.471 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -102.85 110.12 21.93 Favored 'General case' 0 N--CA 1.418 -2.046 0 CA-C-N 111.545 -2.57 . . . . 64.329999999999998 110.561 -172.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -136.25 141.25 43.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.668 -0.696 . . . . 75.430000000000007 110.193 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -173.59 -171.32 38.0 Favored Glycine 0 CA--C 1.506 -0.531 0 N-CA-C 108.613 -1.795 . . . . 61.420000000000002 108.613 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -120.3 149.11 42.82 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 118.022 0.911 . . . . 63.210000000000001 110.565 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.55 124.71 47.07 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 114.977 -1.01 . . . . 75.030000000000001 109.916 -176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.69 99.68 12.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.783 0.801 . . . . 63.340000000000003 111.984 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -93.12 116.68 29.27 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 121.811 -0.555 . . . . 70.129999999999995 110.165 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.406 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 10.8 mtmt -106.01 173.85 6.14 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.876 -1.527 . . . . 71.129999999999995 106.876 176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -38.19 -63.64 0.47 Allowed 'General case' 0 C--O 1.217 -0.65 0 N-CA-C 117.69 2.478 . . . . 75.5 117.69 -173.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -82.36 -30.94 30.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 122.775 1.274 . . . . 74.430000000000007 110.369 -179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.406 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 42.1 mt-10 -56.46 16.88 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 118.855 2.909 . . . . 54.229999999999997 118.855 176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 79.9 p -71.16 0.53 7.55 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 121.315 -0.866 . . . . 73.200000000000003 111.386 -171.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.8 t -107.88 119.76 58.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 106.247 -1.76 . . . . 73.040000000000006 106.247 171.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -142.63 174.63 10.47 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 106.189 -1.782 . . . . 75.140000000000001 106.189 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.11 154.87 48.2 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 118.148 0.431 . . . . 63.329999999999998 112.096 -178.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.463 ' HB ' HG22 ' A' ' 550' ' ' VAL . 78.4 mt -115.65 135.45 55.68 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.064 0 N-CA-C 106.199 -1.778 . . . . 72.120000000000005 106.199 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -115.42 136.89 52.62 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.092 0.87 . . . . 64.140000000000001 111.129 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.471 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.0 t -134.17 129.36 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.126 -1.064 . . . . 73.109999999999999 108.126 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 8.1 ttpt -81.26 132.41 35.34 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.7 -0.852 . . . . 70.340000000000003 108.7 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 29.6 mm -95.52 132.13 40.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 106.67 -1.604 . . . . 74.299999999999997 106.67 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 92.9 t -83.9 143.7 11.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.188 -1.041 . . . . 75.109999999999999 108.188 -177.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -123.0 -175.61 3.21 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.511 0.93 . . . . 72.5 113.511 -169.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 71.17 -35.65 0.34 Allowed 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 117.499 2.407 . . . . 75.040000000000006 117.499 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -129.69 163.57 25.83 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 119.411 1.005 . . . . 72.310000000000002 112.251 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -121.96 144.12 49.06 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.708 -0.849 . . . . 71.140000000000001 108.708 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -105.17 -51.57 3.0 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.294 0.497 . . . . 74.430000000000007 110.424 174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -128.5 6.24 5.71 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.86 0.838 . . . . 75.540000000000006 109.27 177.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 54.6 ttp85 64.89 -65.0 0.15 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.135 1.902 . . . . 71.329999999999998 116.135 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -93.1 72.86 4.67 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 106.213 -1.773 . . . . 71.519999999999996 106.213 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.39 148.57 23.42 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.728 -1.123 . . . . 63.119999999999997 108.025 -177.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -139.48 131.53 27.94 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 114.844 -1.071 . . . . 71.310000000000002 109.606 -170.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -141.4 169.74 17.04 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.956 -1.127 . . . . 64.109999999999999 107.956 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -143.35 167.6 21.79 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.163 -1.051 . . . . 74.549999999999997 108.163 177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.418 HG21 HG21 ' A' ' 598' ' ' ILE . 17.3 mt -126.37 123.91 64.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 106.554 -1.647 . . . . 62.219999999999999 106.554 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.17 140.13 48.18 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.227 -1.397 . . . . 71.400000000000006 107.227 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.58 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.1 mm? -73.12 149.28 43.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.462 -1.31 . . . . 72.120000000000005 107.462 173.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.38 -80.75 0.32 Allowed Glycine 0 C--O 1.222 -0.64 0 CA-C-O 121.942 0.745 . . . . 72.400000000000006 111.509 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -155.22 127.89 4.12 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 105.001 -2.222 . . . . 73.409999999999997 105.001 174.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.41 135.51 22.44 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 117.804 -0.997 . . . . 54.009999999999998 110.676 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -129.15 134.81 48.2 Favored 'General case' 0 C--O 1.209 -1.069 0 O-C-N 121.909 -0.494 . . . . 74.420000000000002 110.36 -174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.682 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.2 t90 -83.43 110.42 18.15 Favored 'General case' 0 CA--C 1.496 -1.125 0 N-CA-C 108.388 -0.967 . . . . 72.409999999999997 108.388 -175.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.484 11.5 mmt -122.97 80.46 1.76 Allowed 'General case' 0 N--CA 1.424 -1.745 0 C-N-CA 116.195 -2.202 . . . . 71.239999999999995 113.434 163.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.555 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.31 13.5 tt0 -152.93 91.98 1.6 Allowed 'General case' 1 C--O 1.122 -5.614 1 CA-C-O 110.214 -4.708 . . . . 72.019999999999996 101.297 147.666 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.682 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.251 24.2 mmm180 161.94 -58.34 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.516 1 CA-C-N 129.082 5.401 . . . . 73.549999999999997 107.604 177.598 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.16 69.06 1.41 Allowed Glycine 0 C--O 1.225 -0.417 0 N-CA-C 110.069 -1.213 . . . . 61.340000000000003 110.069 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -57.82 127.97 17.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.254 0.55 . . . . 71.219999999999999 110.537 -178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 12.7 t -160.1 168.51 25.35 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.755 -2.313 . . . . 74.120000000000005 104.755 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -141.92 150.02 40.92 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.389 -1.337 . . . . 74.109999999999999 107.389 175.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 15.7 t -133.99 134.64 55.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.204 -1.036 . . . . 75.5 108.204 -174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 60.3 p -85.31 -10.55 56.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 115.871 1.804 . . . . 61.130000000000003 115.871 -172.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -84.31 -8.52 58.99 Favored 'General case' 0 N--CA 1.476 0.872 0 O-C-N 121.553 -0.717 . . . . 51.140000000000001 110.003 178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 80.6 mmt-85 -81.82 60.74 4.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 122.05 0.929 . . . . 55.310000000000002 111.399 -177.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -64.54 135.43 56.0 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.178 -1.374 . . . . 74.439999999999998 108.834 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 78.7 mt -136.66 -176.8 4.47 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 104.319 -2.474 . . . . 72.329999999999998 104.319 -178.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.7 t -66.25 148.04 52.43 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 102.943 -2.984 . . . . 53.240000000000002 102.943 167.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -64.17 -24.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 N-CA-C 112.503 0.557 . . . . 62.140000000000001 112.503 -160.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.72 -45.94 77.08 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.701 0.763 . . . . 72.219999999999999 109.778 175.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -75.01 -25.02 58.5 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.379 -0.828 . . . . 65.040000000000006 111.608 -177.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -59.24 -39.6 83.3 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 121.121 -0.232 . . . . 75.129999999999995 110.681 179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.3 -49.22 7.4 Favored 'General case' 0 C--O 1.213 -0.824 0 C-N-CA 119.66 -0.816 . . . . 71.209999999999994 111.375 168.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.42 81.85 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.014 1.116 . . . . 54.509999999999998 114.014 -168.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -67.13 -40.2 86.74 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.565 -0.902 . . . . 72.040000000000006 108.565 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -63.87 -50.03 70.41 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.427 0.529 . . . . 74.219999999999999 112.427 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.7 -41.49 85.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.739 -0.467 . . . . 74.450000000000003 109.739 178.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -61.29 -42.77 99.21 Favored 'General case' 0 C--O 1.214 -0.768 0 N-CA-C 109.86 -0.422 . . . . 73.519999999999996 109.86 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -72.49 -20.4 61.38 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 113.161 0.8 . . . . 74.549999999999997 113.161 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 37.3 mtt -69.47 -41.42 76.21 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 106.673 -1.603 . . . . 75.409999999999997 106.673 173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.517 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.41 16.3 27.72 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 115.754 1.062 . . . . 71.040000000000006 115.754 172.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -58.63 121.5 53.92 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 113.349 0.87 . . . . 73.140000000000001 113.349 -168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.09 165.21 33.3 Favored 'Trans proline' 0 CA--C 1.508 -0.786 0 O-C-N 122.494 0.733 . . . . 64.5 111.229 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.94 158.82 33.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.161 -0.927 . . . . 70.140000000000001 109.851 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 86.7 mt -72.22 154.21 41.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.009 -0.541 . . . . 74.219999999999999 109.903 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.73 -148.25 15.13 Favored Glycine 0 C--O 1.222 -0.653 0 N-CA-C 117.525 1.77 . . . . 62.210000000000001 117.525 -173.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.08 -44.8 94.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.62 -0.79 . . . . 71.219999999999999 112.029 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -141.71 77.87 18.56 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 114.647 1.351 . . . . 73.420000000000002 114.647 176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -78.0 33.4 0.46 Allowed 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 124.654 3.57 . . . . 75.219999999999999 113.077 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -157.89 151.05 23.16 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.289 -0.634 . . . . 74.310000000000002 109.289 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.76 126.75 35.21 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.314 -2.106 . . . . 73.319999999999993 105.314 177.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -92.58 127.6 38.13 Favored 'General case' 0 C--O 1.216 -0.696 0 N-CA-C 108.974 -0.75 . . . . 74.120000000000005 108.974 178.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 4.8 t -124.62 127.3 72.76 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 108.669 -0.863 . . . . 74.319999999999993 108.669 -171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.6 mm -104.02 132.53 50.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 104.344 -2.465 . . . . 75.140000000000001 104.344 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 48.0 mt -93.68 110.28 23.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 106.305 -1.739 . . . . 65.319999999999993 106.305 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . 0.474 ' HG2' ' H ' ' A' ' 666' ' ' GLU . 13.7 tt0 -169.87 -159.72 0.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.529 -1.286 . . . . 74.239999999999995 107.529 -176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . 0.474 ' H ' ' HG2' ' A' ' 665' ' ' GLU . 40.3 tt0 -60.61 136.11 57.96 Favored 'General case' 0 C--O 1.247 0.939 0 O-C-N 121.835 -0.54 . . . . 72.25 110.161 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 12.9 t -158.15 160.13 36.91 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 107.235 -1.395 . . . . 61.409999999999997 107.235 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -153.12 147.45 25.82 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 108.198 -1.038 . . . . 72.510000000000005 108.198 177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 15.8 pm0 -77.65 164.26 25.47 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.739 0.78 . . . . 61.43 112.322 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -145.08 152.66 40.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.512 -0.921 . . . . 74.109999999999999 108.512 176.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.5 tttt -80.34 124.02 28.5 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.33 -0.989 . . . . 70.25 108.33 178.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 43.7 t -64.15 150.03 46.51 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 105.646 -1.983 . . . . 55.450000000000003 105.646 172.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 7.3 m -52.02 -54.53 28.88 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 114.076 1.139 . . . . 75.010000000000005 114.076 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 47.7 t 66.02 143.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 O-C-N 124.575 1.172 . . . . 65.430000000000007 110.648 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.332 -0.842 . . . . 73.450000000000003 111.082 -178.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 . . . . . 0 CA--C 1.506 -0.727 0 N-CA-C 102.697 -3.075 . . . . 65.019999999999996 102.697 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -90.95 163.51 14.33 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 73.400000000000006 107.462 171.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -81.18 163.39 45.07 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 116.229 1.252 . . . . 21.34 116.229 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.718 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -82.56 142.09 14.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.863 -1.903 . . . . 72.120000000000005 105.863 174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -115.3 133.63 55.86 Favored 'General case' 0 CA--C 1.511 -0.531 0 O-C-N 123.635 0.584 . . . . 74.140000000000001 110.276 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.8 t -155.83 163.26 40.04 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 105.86 -1.904 . . . . 74.230000000000004 105.86 -173.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.472 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 13.8 m-30 -100.58 172.11 7.3 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.697 -1.223 . . . . 64.239999999999995 107.697 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -64.24 -48.58 75.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.674 -1.148 . . . . 52.049999999999997 113.389 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 84.9 m -137.12 172.4 13.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.271 -1.381 . . . . 74.129999999999995 107.271 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.05 2.69 13.48 Favored 'General case' 0 C--O 1.213 -0.856 0 O-C-N 123.477 0.485 . . . . 73.450000000000003 110.463 174.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.0 m -145.59 130.46 18.18 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.895 0.379 . . . . 71.319999999999993 110.094 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.691 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.37 160.57 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.962 1.305 . . . . 65.109999999999999 108.682 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -129.44 131.36 46.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 107.707 -1.22 . . . . 65.519999999999996 107.707 171.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.426 HG22 HG12 ' A' ' 662' ' ' VAL . 30.2 m -119.85 -179.53 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.609 -0.886 . . . . 54.420000000000002 108.609 172.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.2 t -120.93 156.58 31.75 Favored 'General case' 0 C--O 1.218 -0.595 0 N-CA-C 102.684 -3.08 . . . . 40.420000000000002 102.684 171.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.29 -32.11 71.95 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.533 0.682 . . . . 74.140000000000001 110.033 175.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 73.4 m -66.64 -8.9 30.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.205 -0.907 . . . . 72.209999999999994 112.914 -177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 2.7 tt -66.71 -25.46 34.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.437 -0.579 . . . . 63.450000000000003 109.437 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.84 -66.58 3.84 Favored Glycine 0 N--CA 1.446 -0.676 0 C-N-CA 120.761 -0.733 . . . . 70.299999999999997 111.857 -178.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 97.2 t -135.17 118.5 24.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.06 -0.57 . . . . 75.150000000000006 109.562 -176.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.468 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.0 ppp? -82.04 153.58 26.08 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.506 -0.924 . . . . 72.329999999999998 108.506 177.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.86 142.04 48.74 Favored 'General case' 0 CA--C 1.506 -0.716 0 CA-C-O 122.446 1.117 . . . . 75.319999999999993 113.71 174.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.472 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.86 133.33 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 105.018 -2.215 . . . . 73.310000000000002 105.018 174.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 28.8 mttp -95.3 127.02 41.01 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.085 -1.45 . . . . 61.420000000000002 107.085 171.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.2 t -103.75 123.27 57.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.5 -0.926 . . . . 74.329999999999998 108.5 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.49 161.01 14.22 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.746 -0.835 . . . . 72.140000000000001 108.746 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -139.56 130.69 26.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 106.322 -1.732 . . . . 72.519999999999996 106.322 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.718 HG22 ' H ' ' A' ' 531' ' ' ILE . 1.9 t -69.52 173.46 5.96 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.839 -0.344 . . . . 73.120000000000005 111.554 -175.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.16 11.04 0.07 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 115.706 1.743 . . . . 74.129999999999995 115.706 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.663 ' H ' HG23 ' A' ' 555' ' ' THR . . . -88.13 10.17 71.99 Favored Glycine 0 C--O 1.208 -1.51 0 N-CA-C 108.923 -1.671 . . . . 73.329999999999998 108.923 173.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.53 91.72 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.604 -0.939 . . . . 74.150000000000006 112.869 -176.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -119.08 118.7 32.13 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.821 -1.548 . . . . 73.129999999999995 106.821 178.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 76.68 -157.77 47.88 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.533 -0.841 . . . . 40.140000000000001 113.339 177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 52.8 m -109.75 130.65 55.5 Favored 'General case' 0 C--O 1.211 -0.954 0 CA-C-O 122.035 0.922 . . . . 72.299999999999997 109.561 -175.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 82.6 t -124.91 141.38 45.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 N-CA-C 105.346 -2.094 . . . . 74.209999999999994 105.346 177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -109.4 139.63 31.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 106.022 -1.844 . . . . 72.549999999999997 106.022 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.4 t -135.27 114.53 11.57 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 114.115 1.154 . . . . 74.420000000000002 114.115 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.02 154.72 42.62 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 121.531 1.488 . . . . 64.140000000000001 115.519 173.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -138.86 166.4 24.55 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 107.915 -1.142 . . . . 74.099999999999994 107.915 172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.1 OUTLIER -156.86 152.25 26.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.367 -0.975 . . . . 63.399999999999999 108.367 172.029 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 18.2 m -81.33 136.02 35.73 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.504 -1.665 . . . . 74.25 106.504 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.446 HG22 ' HD2' ' A' ' 567' ' ' ARG . 57.6 t -126.15 112.17 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.736 0 N-CA-C 104.403 -2.443 . . . . 70.349999999999994 104.403 -170.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.89 138.23 36.15 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.607 -1.179 . . . . 63.130000000000003 111.699 -176.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -101.55 -79.32 1.4 Allowed Glycine 0 C--O 1.227 -0.332 0 N-CA-C 105.993 -2.843 . . . . 62.100000000000001 105.993 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.18 110.72 18.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 105.622 -1.992 . . . . 64.510000000000005 105.622 162.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -175.41 164.57 3.17 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 106.594 -1.632 . . . . 52.43 106.594 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 8.5 mmtp -79.96 -31.8 39.92 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.359 0.599 . . . . 74.209999999999994 110.883 178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 72.33 -166.68 53.7 Favored Glycine 0 C--O 1.233 0.086 0 CA-C-N 115.373 -0.83 . . . . 63.43 114.421 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 72.08 -109.23 2.74 Favored Glycine 0 C--O 1.215 -1.048 0 C-N-CA 121.212 -0.518 . . . . 64.120000000000005 112.792 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.59 9.69 8.66 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.587 -1.005 . . . . 61.109999999999999 110.587 174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -95.71 -47.58 6.13 Favored 'General case' 0 C--O 1.215 -0.713 0 N-CA-C 116.094 1.887 . . . . 75.129999999999995 116.094 -165.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -104.76 -29.64 10.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 123.327 1.537 . . . . 74.129999999999995 108.98 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -156.28 163.93 38.95 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 103.086 -2.931 . . . . 71.319999999999993 103.086 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -87.31 130.9 34.44 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.101 -0.703 . . . . 65.319999999999993 109.101 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -58.83 97.16 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.622 0.769 . . . . 71.200000000000003 109.226 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.439 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.58 104.38 16.4 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 121.594 0.711 . . . . 63.340000000000003 111.137 -173.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -135.57 142.91 45.41 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.02 -0.733 . . . . 72.400000000000006 109.02 177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.77 -173.85 41.83 Favored Glycine 0 CA--C 1.502 -0.781 0 N-CA-C 108.251 -1.94 . . . . 71.099999999999994 108.251 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 70.4 mt-10 -119.93 146.13 46.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.366 0.603 . . . . 64.400000000000006 109.714 177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.07 127.29 54.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 114.814 -1.084 . . . . 73.430000000000007 108.294 -177.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -84.51 139.44 32.15 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.288 -1.375 . . . . 71.010000000000005 107.288 173.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -128.47 116.59 19.95 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.267 -1.383 . . . . 72.510000000000005 107.267 171.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 47.4 tttp -115.32 111.02 20.25 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 112.633 0.605 . . . . 73.049999999999997 112.633 177.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.28 -86.37 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 116.216 1.932 . . . . 60.210000000000001 116.216 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -77.34 -22.94 51.06 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.326 1.05 . . . . 73.319999999999993 113.062 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -49.55 17.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.125 3.009 . . . . 73.430000000000007 119.125 170.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 70.9 p -71.91 15.31 0.16 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 120.523 -1.36 . . . . 74.319999999999993 112.507 -167.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -130.83 124.35 56.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 105.686 -1.968 . . . . 72.239999999999995 105.686 170.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.8 tppt? -147.47 172.4 14.01 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 106.542 -1.651 . . . . 73.420000000000002 106.542 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.28 155.54 49.34 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.925 0.713 . . . . 60.43 112.925 -177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 64.7 mt -119.2 133.96 64.36 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.118 0 N-CA-C 106.697 -1.594 . . . . 61.32 106.697 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -114.48 137.37 51.93 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 123.901 0.751 . . . . 75.019999999999996 111.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 59.0 t -134.28 125.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.316 -0.994 . . . . 74.420000000000002 108.316 177.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.3 ttpp -82.56 135.06 35.17 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.793 -0.817 . . . . 72.349999999999994 108.793 178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 19.3 mm -97.41 138.55 21.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 107.206 -1.405 . . . . 72.25 107.206 179.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.4 t -110.01 143.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 N-CA-C 108.811 -0.811 . . . . 74.040000000000006 108.811 -178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -100.51 147.26 26.09 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 114.593 1.331 . . . . 70.049999999999997 114.593 -174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -138.99 146.4 40.86 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.1 -1.074 . . . . 73.439999999999998 108.1 175.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -80.76 107.31 13.46 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 122.072 -0.392 . . . . 74.420000000000002 110.24 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.43 ' CD ' ' H ' ' A' ' 608' ' ' TYR . 1.5 tm-20 -157.16 -169.95 3.11 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 108.011 -1.107 . . . . 71.219999999999999 108.011 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . 0.43 ' H ' ' CD ' ' A' ' 607' ' ' GLU . 53.1 m-85 -129.85 -37.46 1.53 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 115.983 1.846 . . . . 65.219999999999999 115.983 -172.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -126.32 33.35 5.03 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 113.522 0.934 . . . . 72.129999999999995 113.522 -171.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -79.24 81.49 5.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 115.32 1.6 . . . . 74.549999999999997 115.32 -178.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -84.42 73.88 10.44 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 106.945 -1.502 . . . . 72.109999999999999 106.945 167.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.53 161.86 15.98 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.064 -0.717 . . . . 64.319999999999993 109.064 -178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.81 151.63 33.85 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 113.461 0.911 . . . . 71.129999999999995 113.461 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -151.95 167.59 27.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 107.115 -1.439 . . . . 73.150000000000006 107.115 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.95 171.37 14.56 Favored 'General case' 0 C--O 1.208 -1.11 0 N-CA-C 106.801 -1.555 . . . . 73.439999999999998 106.801 177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 11.7 mt -129.23 123.43 58.25 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 103.918 -2.623 . . . . 74.299999999999997 103.918 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.51 152.23 32.01 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 106.604 -1.628 . . . . 62.329999999999998 106.604 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 70.8 mt -86.55 150.83 23.96 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.362 -0.836 . . . . 71.230000000000004 108.817 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.75 -84.06 0.3 Allowed Glycine 0 C--O 1.222 -0.61 0 N-CA-C 109.508 -1.437 . . . . 71.319999999999993 109.508 177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -159.25 133.01 4.98 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 106.122 -1.807 . . . . 74.450000000000003 106.122 173.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.39 141.46 42.73 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 116.54 -1.84 . . . . 71.299999999999997 110.082 175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -129.32 136.24 49.77 Favored 'General case' 0 C--O 1.208 -1.111 0 N-CA-C 107.881 -1.155 . . . . 74.150000000000006 107.881 -178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.42 109.51 17.38 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 108.67 -0.863 . . . . 71.200000000000003 108.67 -175.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 11.5 mmt -123.38 81.01 1.84 Allowed 'General case' 0 N--CA 1.426 -1.634 0 C-N-CA 116.082 -2.247 . . . . 73.299999999999997 113.945 165.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.542 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.354 1.3 tt0 -152.72 88.33 1.34 Allowed 'General case' 0 C--O 1.159 -3.664 1 CA-C-O 111.42 -4.133 . . . . 72.099999999999994 101.005 146.192 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 8.9 mmm180 168.16 -50.34 0.01 OUTLIER 'General case' 0 N--CA 1.52 3.032 1 CA-C-N 127.769 4.804 . . . . 74.099999999999994 109.744 178.299 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.89 52.76 3.97 Favored Glycine 0 C--O 1.223 -0.56 0 N-CA-C 110.981 -0.848 . . . . 63.25 110.981 -175.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.52 128.62 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-O 121.466 0.65 . . . . 71.120000000000005 110.193 -178.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 32.7 t -160.87 168.8 23.94 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 103.669 -2.715 . . . . 71.310000000000002 103.669 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -70.06 141.9 52.76 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.968 -1.493 . . . . 62.310000000000002 106.968 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.4 m -115.35 122.15 68.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.58 0.705 . . . . 75.310000000000002 110.91 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 45.9 p -81.9 171.21 14.72 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.966 -0.753 . . . . 75.400000000000006 108.966 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 58.12 25.5 12.52 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 115.245 1.572 . . . . 75.340000000000003 115.245 170.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -77.19 124.05 27.28 Favored 'General case' 0 C--O 1.219 -0.529 0 N-CA-C 106.662 -1.607 . . . . 65.450000000000003 106.662 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -128.15 95.16 4.1 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.867 -1.16 . . . . 71.420000000000002 107.867 -178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 74.1 mt -134.53 173.57 11.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.342 -1.355 . . . . 70.510000000000005 107.342 -173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.0 t -66.95 153.28 43.96 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 104.95 -2.241 . . . . 74.310000000000002 104.95 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.2 m -65.36 -26.0 38.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 112.873 0.694 . . . . 73.019999999999996 112.873 -161.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.6 -45.31 75.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 122.196 0.998 . . . . 73.219999999999999 109.457 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -75.96 -21.52 56.92 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.045 -0.979 . . . . 63.039999999999999 111.486 -177.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.96 -41.31 82.6 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.496 -0.482 . . . . 41.539999999999999 109.86 -178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -87.95 -50.38 6.46 Favored 'General case' 0 C--O 1.213 -0.84 0 C-N-CA 119.878 -0.729 . . . . 54.340000000000003 111.568 167.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.81 -43.31 94.55 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.882 1.067 . . . . 72.430000000000007 113.882 -168.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -71.89 -42.2 67.06 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.801 -0.814 . . . . 73.140000000000001 108.801 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -59.16 -48.57 81.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.74 -0.664 . . . . 75.219999999999999 111.778 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.6 mt -62.57 -41.01 90.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.943 0.401 . . . . 75.549999999999997 110.233 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.76 -35.04 79.8 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.937 0.399 . . . . 74.510000000000005 110.469 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.86 -22.05 59.88 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.045 0.387 . . . . 73.219999999999999 112.045 176.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.5 mtm -74.44 -41.29 61.07 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.724 -1.584 . . . . 53.329999999999998 106.724 172.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.482 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.28 21.23 46.92 Favored Glycine 0 C--O 1.222 -0.646 0 N-CA-C 115.721 1.049 . . . . 53.020000000000003 115.721 169.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.61 116.19 14.34 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 118.435 1.117 . . . . 73.049999999999997 112.67 -169.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.84 157.79 59.05 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 117.67 -1.086 . . . . 63.140000000000001 110.967 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.96 169.94 21.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.333 -0.848 . . . . 70.519999999999996 109.926 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.12 161.19 24.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.05 -0.523 . . . . 63.109999999999999 109.747 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -91.53 -159.14 35.24 Favored Glycine 0 CA--C 1.498 -1.019 0 CA-C-O 122.592 1.107 . . . . 54.5 113.047 178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -81.44 -27.53 34.63 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 113.535 -1.332 . . . . 75.450000000000003 109.178 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 -133.13 61.45 55.55 Favored Pre-proline 0 N--CA 1.473 0.689 0 N-CA-C 114.901 1.445 . . . . 52.329999999999998 114.901 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -77.08 31.98 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 122.14 1.893 . . . . 70.329999999999998 113.179 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 24.8 ttpp -157.82 152.63 25.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.655 -0.702 . . . . 75.239999999999995 109.379 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.421 HD11 ' HB ' ' A' ' 539' ' ' ILE . 22.3 tp -133.69 124.18 26.26 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.56 -1.274 . . . . 62.409999999999997 107.56 174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -89.29 127.91 35.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 109.644 -0.502 . . . . 73.349999999999994 109.644 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.691 HG13 HG23 ' A' ' 539' ' ' ILE . 4.1 t -118.93 133.33 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 107.81 -1.182 . . . . 74.340000000000003 107.81 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -112.01 132.83 59.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 104.241 -2.503 . . . . 73.349999999999994 104.241 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 76.5 mt -91.15 110.38 22.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 105.626 -1.99 . . . . 63.409999999999997 105.626 176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -173.81 -44.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 114.665 -1.152 . . . . 72.540000000000006 109.898 -170.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 58.72 91.21 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.496 -1.229 . . . . 75.430000000000007 112.323 -169.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 36.5 m -77.58 80.51 4.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.37 -0.832 . . . . 72.200000000000003 110.475 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -58.95 142.76 50.08 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.799 -0.815 . . . . 70.319999999999993 108.799 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 58.29 38.54 26.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.388 0.675 . . . . 65.319999999999993 112.521 -175.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -53.78 -40.57 66.39 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.854 1.057 . . . . 63.450000000000003 113.854 178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 73.9 mttt 51.03 24.51 1.9 Allowed 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 116.899 2.185 . . . . 61.32 116.899 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 69.5 m -81.86 145.18 30.51 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.905 -0.776 . . . . 61.420000000000002 108.905 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.3 t -149.6 173.07 14.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.992 -1.484 . . . . 63.530000000000001 106.992 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -120.75 -5.68 9.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 O-C-N 123.293 0.37 . . . . 71.219999999999999 110.442 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.246 0.891 0 N-CA-C 105.306 -2.109 . . . . 64.439999999999998 105.306 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.512 -0.507 0 N-CA-C 109.752 -0.462 . . . . 62.140000000000001 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -102.94 153.38 20.28 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 107.726 -1.213 . . . . 61.130000000000003 107.726 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -94.01 179.34 38.06 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 116.648 1.419 . . . . 74.120000000000005 116.648 -173.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 555' ' ' THR . 1.4 mp -72.08 140.75 17.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 107.271 -1.381 . . . . 74.150000000000006 107.271 173.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.04 135.43 54.18 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 109.132 -0.692 . . . . 54.539999999999999 109.132 172.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 11.7 t -155.63 171.15 20.45 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 105.646 -1.983 . . . . 71.439999999999998 105.646 -173.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.573 ' CE1' HD21 ' A' ' 618' ' ' LEU . 19.1 m-30 -106.87 171.39 7.39 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.081 -1.081 . . . . 72.5 108.081 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -64.8 -40.81 95.84 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 114.155 1.169 . . . . 73.299999999999997 114.155 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 97.9 m -143.43 168.78 19.01 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.671 -0.863 . . . . 45.229999999999997 108.671 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -119.97 1.73 10.95 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.239 -0.891 . . . . 72.340000000000003 111.733 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 19.6 m -142.13 127.72 19.07 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.144 0.578 . . . . 62.420000000000002 109.649 178.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.658 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.05 160.46 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 124.896 1.279 . . . . 74.340000000000003 109.515 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 8.5 m170 -127.54 135.64 50.61 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.418 -1.327 . . . . 70.120000000000005 107.418 170.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.468 HG22 HG12 ' A' ' 662' ' ' VAL . 24.7 m -123.85 176.58 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 N-CA-C 108.533 -0.914 . . . . 75.010000000000005 108.533 170.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 49.5 m -127.83 157.42 40.48 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 102.343 -3.206 . . . . 52.299999999999997 102.343 172.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -60.21 -34.35 73.52 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 118.909 0.777 . . . . 64.400000000000006 111.564 179.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 75.1 m -64.81 -7.88 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.007 -0.997 . . . . 72.150000000000006 113.1 -177.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.6 tt -68.01 -26.72 35.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.945 -0.391 . . . . 74.109999999999999 109.945 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.86 -66.95 3.81 Favored Glycine 0 CA--C 1.505 -0.562 0 CA-C-O 122.235 0.908 . . . . 52.25 112.6 -177.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 87.1 t -135.64 119.25 24.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 114.89 -0.655 . . . . 53.130000000000003 109.742 -175.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -83.81 153.4 24.09 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.329 -0.989 . . . . 72.129999999999995 108.329 177.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -138.12 141.32 40.19 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.624 0.231 . . . . 75.239999999999995 111.624 177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.472 HG22 ' HB ' ' A' ' 598' ' ' ILE . 1.2 m -117.66 139.58 44.18 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 N-CA-C 106.245 -1.761 . . . . 74.439999999999998 106.245 171.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 20.2 mtmt -91.59 127.77 37.17 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.579 -1.267 . . . . 73.519999999999996 107.579 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.4 t -101.9 134.88 41.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 107.729 -1.211 . . . . 73.530000000000001 107.729 -177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 10.6 mt -122.06 158.91 28.18 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.772 -0.649 . . . . 73.540000000000006 110.358 -173.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -136.6 143.22 43.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.918 -0.771 . . . . 75.010000000000005 108.918 177.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.0 t -74.45 155.98 37.46 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 121.926 -0.484 . . . . 64.430000000000007 110.246 175.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 11.8 m -71.42 36.46 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.599 1.333 . . . . 74.319999999999993 114.599 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -114.37 -1.76 23.27 Favored Glycine 0 C--O 1.216 -1.001 0 N-CA-C 110.533 -1.027 . . . . 33.340000000000003 110.533 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.717 ' HB3' ' HD2' ' A' ' 554' ' ' ARG . . . -84.25 142.74 30.05 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.354 0.597 . . . . 45.340000000000003 109.647 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 88.1 mmt-85 -142.7 125.14 15.65 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 104.058 -2.571 . . . . 72.420000000000002 104.058 -176.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 87.93 -160.8 31.39 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.47 -0.871 . . . . 43.32 113.203 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.605 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 55.3 m -106.66 130.42 54.4 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 122.002 0.906 . . . . 74.349999999999994 109.349 -174.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 59.0 t -123.95 145.37 31.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 104.969 -2.234 . . . . 63.049999999999997 104.969 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.6 tt -115.85 140.47 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 105.77 -1.937 . . . . 74.510000000000005 105.77 175.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.9 t -134.1 110.14 11.78 Favored Pre-proline 0 N--CA 1.47 0.536 0 N-CA-C 113.449 0.907 . . . . 73.430000000000007 113.449 -178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 60.1 Cg_endo -72.62 156.64 53.47 Favored 'Trans proline' 0 CA--C 1.5 -1.185 0 N-CA-C 115.129 1.165 . . . . 75.439999999999998 115.129 173.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -142.19 165.46 27.37 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.854 -1.165 . . . . 65.010000000000005 107.854 173.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 567' ' ' ARG . 0.1 OUTLIER -157.6 158.73 36.09 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.164 -1.421 . . . . 73.010000000000005 107.164 171.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 22.0 m -89.57 133.76 34.45 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.874 -0.417 . . . . 70.040000000000006 109.874 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 62.0 t -126.65 114.91 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.434 0 N-CA-C 104.446 -2.427 . . . . 71.450000000000003 104.446 -171.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.54 146.32 29.26 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 114.669 -1.15 . . . . 71.200000000000003 111.195 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.35 -70.46 0.66 Allowed Glycine 0 C--O 1.222 -0.609 0 N-CA-C 107.285 -2.326 . . . . 74.5 107.285 178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.63 114.41 23.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.218 -2.141 . . . . 75.400000000000006 105.218 165.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -174.6 175.27 2.53 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 104.652 -2.351 . . . . 42.229999999999997 104.652 177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 16.2 mmtp -86.62 -38.25 17.27 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 105.435 -2.061 . . . . 72.219999999999999 105.435 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 74.11 -174.08 49.88 Favored Glycine 0 N--CA 1.452 -0.268 0 CA-C-N 114.512 -1.222 . . . . 74.310000000000002 115.366 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 81.3 -103.68 2.3 Favored Glycine 0 C--O 1.223 -0.588 0 N-CA-C 110.976 -0.85 . . . . 41.43 110.976 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.77 15.88 7.9 Favored Glycine 0 C--O 1.219 -0.823 0 CA-C-O 118.682 -1.065 . . . . 64.230000000000004 112.104 174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -95.69 -46.86 6.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 115.225 1.565 . . . . 70.099999999999994 115.225 -167.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -105.25 -34.25 7.96 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 122.387 1.089 . . . . 71.219999999999999 108.085 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -149.5 162.29 40.44 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.329 -2.471 . . . . 71.439999999999998 104.329 174.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -92.46 126.89 37.74 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.813 -1.181 . . . . 63.119999999999997 107.813 171.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -59.52 111.21 1.32 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 123.598 1.666 . . . . 75.400000000000006 108.374 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.444 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.85 110.18 22.2 Favored 'General case' 0 N--CA 1.417 -2.115 0 CA-C-N 111.649 -2.523 . . . . 62.450000000000003 109.32 -172.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -135.91 143.88 45.21 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.429 -0.805 . . . . 75.120000000000005 110.833 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.73 -170.87 38.36 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 108.395 -1.882 . . . . 72.439999999999998 108.395 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 22.1 mt-10 -119.72 150.08 40.95 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 109.044 -0.724 . . . . 74.040000000000006 109.044 175.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.2 mt -119.28 123.47 44.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.019 -0.991 . . . . 63.340000000000003 109.563 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -80.93 132.72 35.44 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.636 1.208 . . . . 70.420000000000002 109.111 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -125.34 116.75 22.4 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.817 -1.92 . . . . 75.120000000000005 105.817 171.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -107.75 85.55 2.14 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 108.532 -0.914 . . . . 62.049999999999997 108.532 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 53.69 -71.91 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 118.344 2.72 . . . . 43.100000000000001 118.344 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 594' ' ' THR . 71.1 m-20 -81.9 -22.91 36.55 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 125.463 1.505 . . . . 52.140000000000001 111.266 -175.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -53.87 17.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.072 2.249 . . . . 70.310000000000002 117.072 169.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 592' ' ' ASP . 2.6 t -72.23 12.99 0.36 Allowed 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.226 1.01 . . . . 62.310000000000002 112.273 -170.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.1 108.61 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.547 -2.39 . . . . 74.219999999999999 104.547 168.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -141.68 170.98 14.7 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 105.51 -2.033 . . . . 73.109999999999999 105.51 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.67 159.11 42.9 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 112.262 0.467 . . . . 71.400000000000006 112.262 -174.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.472 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.1 mt -119.78 131.21 72.88 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.931 0 N-CA-C 106.978 -1.49 . . . . 71.329999999999998 106.978 175.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 51.8 mtt180 -111.22 134.06 53.1 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.164 0.915 . . . . 74.010000000000005 112.202 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.478 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 58.3 t -131.23 130.55 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.907 -1.145 . . . . 73.120000000000005 107.907 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.86 134.54 34.69 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.689 -1.226 . . . . 75.019999999999996 107.689 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.8 mm -101.48 132.81 46.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 104.98 -2.23 . . . . 62.43 104.98 177.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 90.3 t -95.37 141.73 14.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.209 0.528 . . . . 75.120000000000005 110.666 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -72.86 135.01 45.09 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 108.6 -0.889 . . . . 71.340000000000003 108.6 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.19 160.65 38.39 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 122.377 0.271 . . . . 60.409999999999997 110.516 -174.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -92.98 -13.03 29.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 111.697 0.258 . . . . 73.129999999999995 111.697 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -128.46 159.55 35.06 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.904 0.705 . . . . 71.329999999999998 112.904 -178.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -105.85 -9.91 16.94 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.641 -0.709 . . . . 74.329999999999998 109.864 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 51.64 -98.57 0.07 Allowed 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 124.223 1.009 . . . . 63.409999999999997 113.388 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 30.16 1.71 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 119.909 1.232 . . . . 75.109999999999999 112.553 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 64.69 104.25 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.535 1.534 . . . . 70.129999999999995 109.962 -171.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -89.8 152.07 21.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.674 -1.148 . . . . 71.420000000000002 111.913 -173.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -142.94 133.39 24.87 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.301 -1.318 . . . . 62.43 109.59 -173.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -142.34 169.28 17.89 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 107.961 -1.126 . . . . 74.540000000000006 107.961 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.15 170.27 16.27 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 107.526 -1.287 . . . . 75.230000000000004 107.526 178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.425 HG21 HG21 ' A' ' 598' ' ' ILE . 13.8 mt -128.75 124.81 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.741 0 N-CA-C 105.661 -1.978 . . . . 74.120000000000005 105.661 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -113.57 140.16 48.4 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.556 -1.276 . . . . 63.210000000000001 107.556 -178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.573 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.3 mm? -74.82 148.11 40.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.758 -1.571 . . . . 54.0 106.758 174.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -67.4 -76.89 0.35 Allowed Glycine 0 C--O 1.223 -0.549 0 N-CA-C 109.384 -1.486 . . . . 74.140000000000001 109.384 177.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -163.34 132.81 3.09 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 104.39 -2.448 . . . . 75.420000000000002 104.39 172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -68.33 143.75 59.48 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 116.032 -2.178 . . . . 62.219999999999999 109.814 175.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -133.39 137.07 45.65 Favored 'General case' 0 C--O 1.203 -1.377 0 N-CA-C 108.586 -0.894 . . . . 74.109999999999999 108.586 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.712 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.61 110.73 18.49 Favored 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 108.989 -0.745 . . . . 75.329999999999998 108.989 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.496 11.4 mmt -123.72 81.6 1.92 Allowed 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 116.031 -2.268 . . . . 62.520000000000003 113.866 164.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.605 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.371 1.1 tt0 -152.71 86.59 1.27 Allowed 'General case' 0 C--O 1.164 -3.425 0 CA-C-O 111.961 -3.876 . . . . 74.439999999999998 101.27 146.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.712 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 2.0 mmm180 166.81 -56.07 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.015 1 CA-C-N 126.98 4.446 . . . . 74.510000000000005 107.814 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 81.0 70.9 1.31 Allowed Glycine 0 C--O 1.224 -0.527 0 N-CA-C 110.237 -1.145 . . . . 55.539999999999999 110.237 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -53.03 120.68 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.15 -0.685 . . . . 75.439999999999998 109.15 179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.8 m -148.66 169.36 20.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.761 -1.57 . . . . 74.349999999999994 106.761 -175.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.4 146.74 52.95 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.008 -0.738 . . . . 64.310000000000002 109.008 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.1 p -63.61 -29.13 46.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.936 -0.575 . . . . 71.340000000000003 112.029 -176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.58 -163.23 0.15 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.199 0.6 . . . . 75.239999999999995 110.223 -176.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -72.03 108.09 5.08 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.687 -0.633 . . . . 75.400000000000006 111.829 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 88.2 mmt-85 -130.68 133.86 46.45 Favored 'General case' 0 CA--C 1.502 -0.868 0 N-CA-C 103.021 -2.955 . . . . 73.549999999999997 103.021 172.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.81 105.7 14.04 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.063 -1.055 . . . . 72.150000000000006 109.993 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 65.4 mt -132.94 165.5 24.53 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.826 -1.079 . . . . 74.299999999999997 110.051 -173.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.2 t -79.94 170.56 16.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 106.354 -1.721 . . . . 72.129999999999995 106.354 172.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 78.3 t -59.28 -44.71 92.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.939 0.876 . . . . 73.409999999999997 111.21 -173.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -59.7 -44.58 93.61 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.008 -0.996 . . . . 60.219999999999999 110.999 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.82 -19.74 58.71 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.884 -1.053 . . . . 73.530000000000001 112.071 -176.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.39 -44.87 84.87 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.506 -0.553 . . . . 74.129999999999995 109.506 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -87.75 -44.01 11.46 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 120.208 -0.597 . . . . 72.340000000000003 112.335 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.76 -42.75 93.94 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.801 0.728 . . . . 65.140000000000001 112.514 -171.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -70.36 -46.1 64.78 Favored 'General case' 0 C--O 1.207 -1.137 0 N-CA-C 108.434 -0.95 . . . . 62.520000000000003 108.434 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -55.14 -46.87 75.67 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.724 0.638 . . . . 55.030000000000001 112.724 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.3 mt -62.19 -41.55 91.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.944 -0.391 . . . . 34.329999999999998 109.944 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.27 -34.31 77.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.411 0.624 . . . . 70.109999999999999 111.4 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -69.92 -24.25 63.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.123 -0.49 . . . . 71.400000000000006 110.321 178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -83.13 -41.49 18.46 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 118.81 -1.156 . . . . 71.140000000000001 109.51 174.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.664 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 57.88 12.98 12.0 Favored Glycine 0 C--O 1.225 -0.465 0 N-CA-C 115.981 1.152 . . . . 50.299999999999997 115.981 171.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.14 118.96 30.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 114.325 1.232 . . . . 72.099999999999994 114.325 -160.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.59 163.57 38.13 Favored 'Trans proline' 0 CA--C 1.51 -0.698 0 CA-C-O 121.53 0.554 . . . . 74.430000000000007 111.927 176.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.56 166.94 27.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 114.75 -1.114 . . . . 23.23 111.223 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -79.47 155.34 28.33 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.003 -0.74 . . . . 71.230000000000004 109.003 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -97.25 -156.55 30.54 Favored Glycine 0 C--O 1.219 -0.841 0 N-CA-C 115.89 1.116 . . . . 54.329999999999998 115.89 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -72.26 -39.52 68.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.615 -0.793 . . . . 63.409999999999997 112.707 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -127.72 62.18 54.46 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.757 -0.201 . . . . 74.239999999999995 111.276 -177.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -80.34 32.23 0.5 Allowed 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 121.579 1.519 . . . . 72.439999999999998 113.094 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 17.8 ttpp -160.51 151.95 19.44 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.525 -0.917 . . . . 42.109999999999999 108.525 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.32 120.3 24.13 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.565 -1.643 . . . . 73.319999999999993 106.565 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -88.11 126.8 35.31 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 108.975 -0.75 . . . . 65.230000000000004 108.975 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.658 HG13 HG23 ' A' ' 539' ' ' ILE . 5.6 t -124.19 126.9 72.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.624 0 N-CA-C 109.082 -0.71 . . . . 71.200000000000003 109.082 -171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 2.4 mm -103.65 134.83 43.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 104.66 -2.348 . . . . 72.319999999999993 104.66 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 82.1 mt -92.83 117.86 37.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 105.535 -2.024 . . . . 54.310000000000002 105.535 173.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -142.48 170.51 15.57 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.167 0.587 . . . . 64.310000000000002 110.72 -169.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -58.34 -23.31 56.33 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.818 0.847 . . . . 73.420000000000002 112.612 176.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 33.0 t -132.41 140.76 48.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.451 0.643 . . . . 74.140000000000001 111.144 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -98.33 161.87 13.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.404 -0.816 . . . . 74.109999999999999 109.896 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -109.76 137.48 47.5 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.342 -0.844 . . . . 74.010000000000005 108.731 -178.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -133.78 96.35 3.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.504 0.669 . . . . 75.329999999999998 109.318 177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -82.89 110.35 17.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.936 -0.575 . . . . 62.149999999999999 110.425 -177.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 60.7 p -99.2 160.5 14.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.459 -0.941 . . . . 64.219999999999999 108.459 177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 13.8 t -153.71 165.99 34.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.936 -1.505 . . . . 64.519999999999996 106.936 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 28.8 m -134.32 167.25 26.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 105.589 -2.004 . . . . 75.120000000000005 105.589 176.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 C--O 1.252 1.222 0 O-C-N 123.765 0.666 . . . . 65.430000000000007 109.403 176.412 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 107.711 -1.218 . . . . 63.32 107.711 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -63.53 153.92 34.15 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 124.077 0.861 . . . . 61.420000000000002 110.914 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -69.64 150.1 49.06 Favored Glycine 0 C--O 1.219 -0.803 0 N-CA-C 116.042 1.177 . . . . 44.210000000000001 116.042 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.687 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.43 139.81 19.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.937 -1.875 . . . . 72.040000000000006 105.937 171.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -112.35 134.55 53.83 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.22 0.533 . . . . 70.230000000000004 110.946 177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.2 t -154.75 171.31 19.77 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 104.439 -2.43 . . . . 75.230000000000004 104.439 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.6 m-30 -106.38 173.37 6.35 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.05 -1.092 . . . . 64.409999999999997 108.05 178.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -57.42 -47.18 82.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.936 -1.484 . . . . 65.230000000000004 114.095 176.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 90.6 m -149.23 -179.49 7.09 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.0 -1.852 . . . . 63.109999999999999 106.0 -175.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -118.4 5.44 11.79 Favored 'General case' 0 C--O 1.21 -1.024 0 O-C-N 123.53 0.519 . . . . 75.230000000000004 110.504 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 7.1 m -145.88 131.25 18.61 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.567 -0.531 . . . . 74.209999999999994 109.567 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.714 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.01 160.21 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.752 1.221 . . . . 72.010000000000005 109.454 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -125.66 128.6 48.1 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.212 -1.032 . . . . 71.150000000000006 108.212 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.474 HG22 HG12 ' A' ' 662' ' ' VAL . 27.4 m -119.3 -179.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.206 -1.035 . . . . 72.530000000000001 108.206 170.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.3 t -127.79 156.56 42.28 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.381 -3.192 . . . . 73.209999999999994 102.381 172.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.492 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.96 -33.87 71.14 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.436 0.636 . . . . 75.010000000000005 110.739 175.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.0 t -64.15 -10.46 22.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.208 -0.905 . . . . 74.209999999999994 112.947 -177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -68.54 -26.16 32.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.83 -0.433 . . . . 62.329999999999998 109.83 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.94 -63.77 4.34 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.704 -0.76 . . . . 55.229999999999997 112.316 -178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.7 t -137.93 121.22 20.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.06 -0.719 . . . . 73.109999999999999 109.06 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.465 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.2 ppp? -83.31 153.45 24.62 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.589 -0.893 . . . . 74.010000000000005 108.589 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -140.63 140.23 35.0 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.284 0.476 . . . . 70.299999999999997 112.284 176.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -115.09 138.37 45.61 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.965 0 N-CA-C 105.45 -2.056 . . . . 61.109999999999999 105.45 172.908 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 29.1 mttp -91.48 127.64 37.0 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 105.698 -1.964 . . . . 53.43 105.698 175.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.12 128.83 47.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 106.041 -1.837 . . . . 74.239999999999995 106.041 -176.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 17.9 mt -115.79 161.51 18.65 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.62 -0.718 . . . . 54.350000000000001 109.995 -170.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.433 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -143.43 146.42 33.43 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.58 -0.282 . . . . 75.219999999999999 110.287 -177.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.687 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.4 t -76.7 169.48 18.21 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 122.516 0.326 . . . . 73.120000000000005 110.632 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.5 m -61.56 18.53 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 118.201 2.667 . . . . 74.420000000000002 118.201 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.7 15.41 59.06 Favored Glycine 0 C--O 1.198 -2.147 0 C-N-CA 123.529 0.585 . . . . 63.039999999999999 113.171 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.433 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -65.63 110.5 2.78 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 119.816 -1.991 . . . . 70.120000000000005 111.919 -175.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.4 mmt-85 -140.07 117.09 11.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 105.993 -1.854 . . . . 75.349999999999994 105.993 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -146.59 35.31 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.496 -0.859 . . . . 74.409999999999997 113.201 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.467 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 87.3 m -127.0 135.55 51.0 Favored 'General case' 0 C--O 1.212 -0.907 0 N-CA-C 108.097 -1.075 . . . . 73.450000000000003 108.097 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.54 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -137.07 153.39 29.41 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 105.682 -1.97 . . . . 73.239999999999995 105.682 179.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.7 tt -117.86 141.67 35.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 106.433 -1.692 . . . . 72.200000000000003 106.433 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 14.4 t -135.67 114.02 11.08 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 112.498 0.555 . . . . 73.120000000000005 112.498 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.09 156.59 38.24 Favored 'Trans proline' 0 CA--C 1.511 -0.632 0 N-CA-C 115.558 1.33 . . . . 75.109999999999999 115.558 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -140.23 165.7 26.69 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.317 -0.994 . . . . 74.400000000000006 108.317 173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.63 157.21 33.2 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.722 -0.844 . . . . 74.540000000000006 108.722 173.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 23.8 m -90.69 137.41 32.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.034 -1.098 . . . . 62.350000000000001 108.034 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.8 t -126.96 114.84 39.13 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.539 0 N-CA-C 104.184 -2.524 . . . . 41.509999999999998 104.184 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.463 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.92 140.09 33.02 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.521 -1.218 . . . . 64.439999999999998 111.306 -178.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.45 -73.95 0.78 Allowed Glycine 0 C--O 1.223 -0.544 0 N-CA-C 108.717 -1.753 . . . . 55.140000000000001 108.717 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 2.4 t -116.9 110.38 18.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 103.905 -2.628 . . . . 61.130000000000003 103.905 164.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.36 165.22 1.01 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 106.882 -1.525 . . . . 54.240000000000002 106.882 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 10.1 mmtp -83.05 -30.31 28.16 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.8 -0.815 . . . . 74.430000000000007 108.8 172.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 67.59 -155.85 52.69 Favored Glycine 0 C--O 1.228 -0.246 0 CA-C-N 115.151 -0.931 . . . . 71.230000000000004 113.627 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 67.49 -110.16 3.3 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 111.659 -0.576 . . . . 72.519999999999996 111.659 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.6 13.76 8.19 Favored Glycine 0 C--O 1.219 -0.804 0 CA-C-O 118.929 -0.928 . . . . 62.020000000000003 111.572 173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -94.88 -49.87 5.38 Favored 'General case' 0 C--O 1.215 -0.726 0 N-CA-C 115.612 1.708 . . . . 62.219999999999999 115.612 -168.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -100.01 -31.63 11.35 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 123.041 1.401 . . . . 72.25 108.498 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -163.46 162.5 24.74 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 103.368 -2.827 . . . . 74.25 103.368 177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -88.78 136.08 33.19 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.493 -0.558 . . . . 73.420000000000002 109.493 179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.4 t0 -69.53 109.75 4.43 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 123.318 1.532 . . . . 65.530000000000001 107.702 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.465 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -107.7 111.27 23.39 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 111.749 -2.478 . . . . 71.299999999999997 109.296 -171.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -136.88 146.35 45.45 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.04 -0.982 . . . . 71.129999999999995 110.391 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -178.38 -172.2 42.51 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.657 -1.777 . . . . 71.209999999999994 108.657 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -119.23 143.34 47.35 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.336 0.589 . . . . 72.25 110.507 177.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 25.1 mt -112.23 118.89 36.56 Favored 'General case' 0 CA--C 1.509 -0.607 0 CA-C-N 115.061 -0.972 . . . . 63.420000000000002 110.04 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -77.06 127.48 32.75 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.598 -1.26 . . . . 73.239999999999995 107.598 175.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -119.27 116.91 27.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.725 -1.213 . . . . 63.43 107.725 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.609 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.1 mttp -106.21 -179.56 3.97 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.851 -1.166 . . . . 75.109999999999999 107.851 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -47.48 -60.37 2.58 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 115.669 1.729 . . . . 71.219999999999999 115.669 -178.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -82.22 -25.74 33.91 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.566 1.174 . . . . 73.310000000000002 112.024 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.609 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 89.2 mt-10 -63.52 17.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 118.125 2.639 . . . . 71.209999999999994 118.125 -178.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 34.0 p -72.31 12.14 0.49 Allowed 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 114.098 1.147 . . . . 74.340000000000003 114.098 -168.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.4 121.21 64.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 104.122 -2.547 . . . . 71.030000000000001 104.122 170.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.5 tppt? -143.98 171.6 14.03 Favored 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 107.184 -1.413 . . . . 74.409999999999997 107.184 -176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.63 157.4 44.44 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 112.336 0.495 . . . . 71.129999999999995 112.336 -176.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 78.2 mt -122.91 127.32 74.74 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 N-CA-C 107.38 -1.341 . . . . 62.119999999999997 107.38 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -107.04 134.94 49.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.188 0.93 . . . . 60.399999999999999 111.666 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.465 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 61.0 t -133.52 124.78 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.833 -1.173 . . . . 54.140000000000001 107.833 177.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.4 130.03 34.9 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 109.217 -0.66 . . . . 64.430000000000007 109.217 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.414 HG21 ' HA ' ' A' ' 543' ' ' GLU . 20.5 mm -96.2 127.07 48.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 106.175 -1.787 . . . . 74.349999999999994 106.175 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 93.0 t -85.93 143.62 11.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.321 0.581 . . . . 60.009999999999998 109.61 -172.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -67.41 136.01 54.06 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 114.728 -1.124 . . . . 72.099999999999994 113.458 -170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -78.62 142.6 37.1 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.36 0.664 . . . . 74.209999999999994 112.492 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -126.67 -53.65 1.44 Allowed 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 110.301 -0.259 . . . . 74.030000000000001 110.301 170.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -159.31 163.86 35.33 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.314 0.246 . . . . 75.140000000000001 110.758 173.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 74.99 170.14 0.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 126.447 1.899 . . . . 74.420000000000002 114.974 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 59.04 -177.03 0.09 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.692 1.197 . . . . 74.230000000000004 112.782 -178.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.85 -61.83 0.08 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 116.472 2.027 . . . . 61.310000000000002 116.472 -177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -127.31 77.17 1.72 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 106.917 -1.512 . . . . 74.019999999999996 106.917 -172.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -89.55 152.71 21.28 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.381 -0.827 . . . . 73.439999999999998 109.177 -174.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -142.17 135.27 28.82 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.078 -0.964 . . . . 71.430000000000007 111.331 -169.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -145.31 169.54 18.06 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.141 -1.059 . . . . 63.32 108.141 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.65 167.68 21.44 Favored 'General case' 0 C--O 1.21 -1.007 0 N-CA-C 108.119 -1.067 . . . . 75.140000000000001 108.119 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 15.5 mt -126.94 123.46 62.61 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.08 0 N-CA-C 103.639 -2.726 . . . . 73.129999999999995 103.639 176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -114.79 150.33 35.59 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.53 -1.656 . . . . 63.009999999999998 106.53 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -87.26 147.92 25.34 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.69 -0.687 . . . . 74.409999999999997 109.154 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.59 -81.48 0.46 Allowed Glycine 0 C--O 1.222 -0.609 0 CA-C-O 121.605 0.558 . . . . 63.030000000000001 112.466 -177.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -158.81 127.11 2.89 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 106.416 -1.698 . . . . 63.109999999999999 106.416 178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.27 132.71 14.02 Favored 'Trans proline' 0 CA--C 1.534 0.477 0 N-CA-C 110.558 -0.593 . . . . 53.140000000000001 110.558 179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -127.88 138.78 52.8 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 109.337 -0.616 . . . . 73.150000000000006 109.337 -174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.561 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.9 OUTLIER -83.32 115.17 21.87 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 107.942 -1.132 . . . . 73.25 107.942 -177.232 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . 0.54 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.444 14.8 mmt -123.59 81.53 1.91 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 125.876 2.75 . . . . 73.340000000000003 112.243 162.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.467 ' CB ' ' H ' ' A' ' 561' ' ' THR . 5.4 tp10 -152.74 164.91 36.87 Favored 'General case' 0 C--N 1.283 -2.306 3 N-CA-C 92.572 -6.825 . . . . 73.420000000000002 92.572 158.033 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.561 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 13.4 mmm-85 78.18 -53.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.25 1.944 . . . . 44.420000000000002 116.25 169.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 69.79 67.27 1.97 Allowed Glycine 0 C--O 1.227 -0.308 0 N-CA-C 109.311 -1.515 . . . . 65.150000000000006 109.311 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 3.2 tt -47.6 121.31 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-O 121.613 0.721 . . . . 73.239999999999995 111.198 -177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 63.2 m -143.53 173.39 11.68 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 107.722 -1.214 . . . . 72.319999999999993 107.722 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -80.6 -175.82 5.43 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.721 0.296 . . . . 71.409999999999997 110.523 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 18.5 m -126.32 39.14 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 113.438 0.903 . . . . 71.340000000000003 113.438 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.34 -21.1 61.68 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.058 0.762 . . . . 52.509999999999998 113.058 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -87.69 -21.81 25.01 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.832 0.678 . . . . 70.319999999999993 112.832 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 56.9 mmt-85 -81.18 130.29 34.96 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 108.309 -0.997 . . . . 61.130000000000003 108.309 -175.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -116.39 118.1 31.79 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.85 -1.537 . . . . 72.200000000000003 106.85 174.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 41.2 mt -134.88 175.76 9.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.528 -0.76 . . . . 73.109999999999999 109.693 -167.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.8 t -79.53 168.23 19.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.81 -1.922 . . . . 71.329999999999998 105.81 171.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 69.1 t -59.14 -43.42 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 122.061 0.934 . . . . 64.030000000000001 111.665 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -61.37 -44.22 97.54 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.178 -0.919 . . . . 72.140000000000001 110.852 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -77.22 -21.08 54.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.387 -0.824 . . . . 74.329999999999998 111.302 -177.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -57.43 -42.27 82.05 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.632 -0.506 . . . . 72.540000000000006 109.632 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -87.81 -46.85 9.08 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 119.676 -0.809 . . . . 62.399999999999999 112.144 167.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -60.23 -43.5 95.99 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.327 0.862 . . . . 63.32 113.327 -169.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.9 tppm? -73.37 -41.65 63.14 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 108.854 -0.795 . . . . 73.319999999999993 108.854 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -59.21 -49.31 78.35 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 112.207 0.447 . . . . 75.5 112.207 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -61.47 -42.3 93.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.067 0.461 . . . . 75.430000000000007 109.855 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -64.46 -35.87 82.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.76 0.314 . . . . 75.209999999999994 111.007 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -70.86 -28.37 64.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 70.120000000000005 110.747 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 40.7 mtt -69.78 -41.6 74.9 Favored 'General case' 0 CA--C 1.51 -0.585 0 N-CA-C 107.65 -1.241 . . . . 61.130000000000003 107.65 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.539 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.25 5.8 2.66 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 116.67 1.428 . . . . 34.409999999999997 116.67 168.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -70.18 144.57 92.61 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 116.085 1.883 . . . . 73.430000000000007 116.085 -160.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.3 167.48 23.02 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 C-N-CA 121.238 1.292 . . . . 74.5 112.804 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.2 m -142.65 164.58 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 107.99 -1.115 . . . . 64.519999999999996 107.99 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 75.9 mt -74.94 163.88 27.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.611 0.597 . . . . 70.450000000000003 112.611 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.16 -156.62 32.01 Favored Glycine 0 CA--C 1.497 -1.055 0 CA-C-O 122.757 1.198 . . . . 73.010000000000005 114.583 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -79.31 -25.67 42.35 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.198 -1.501 . . . . 73.349999999999994 109.729 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -136.98 61.96 37.39 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 114.659 1.355 . . . . 64.340000000000003 114.659 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.87 34.04 0.5 Allowed 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 121.503 1.469 . . . . 61.030000000000001 112.513 177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.5 ttpp -157.2 151.46 24.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.244 -0.889 . . . . 74.219999999999999 109.522 -176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 22.2 tp -133.64 122.5 23.55 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.612 -0.885 . . . . 75.400000000000006 108.612 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -88.99 129.93 35.56 Favored 'General case' 0 C--O 1.217 -0.642 0 C-N-CA 123.449 0.7 . . . . 75.140000000000001 109.257 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.714 HG13 HG23 ' A' ' 539' ' ' ILE . 5.2 t -125.77 128.44 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.572 0 N-CA-C 109.023 -0.732 . . . . 72.329999999999998 109.023 -171.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.9 mm -105.68 131.91 53.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.48 -2.044 . . . . 72.310000000000002 105.48 177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 72.2 mt -89.32 103.57 14.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 106.593 -1.632 . . . . 72.200000000000003 106.593 175.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -174.6 -32.67 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.742 -1.117 . . . . 64.519999999999996 111.722 -173.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 69.97 -49.51 0.63 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.604 1.562 . . . . 64.109999999999999 114.361 -175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 16.9 t -34.15 107.43 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.322 1.971 . . . . 74.349999999999994 116.322 -176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -91.68 63.33 4.65 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.982 -1.008 . . . . 73.340000000000003 112.709 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -81.82 -0.09 41.78 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.423 -0.798 . . . . 44.439999999999998 112.817 179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -80.41 59.94 3.65 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 107.955 -1.128 . . . . 72.519999999999996 107.955 171.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.54 -31.04 72.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 115.325 1.602 . . . . 70.430000000000007 115.325 -169.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 81.6 p -162.32 169.29 20.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.949 0.404 . . . . 54.329999999999998 111.232 -178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 24.2 m -138.17 142.77 40.07 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 103.072 -2.936 . . . . 72.310000000000002 103.072 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 48.2 t -126.42 -37.61 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.577 0.703 . . . . 64.150000000000006 110.309 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 C--O 1.245 0.844 0 N-CA-C 101.094 -3.669 . . . . 75.140000000000001 101.094 178.525 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 59.0 m-70 . . . . . 0 CA--C 1.514 -0.428 0 N-CA-C 110.277 -0.268 . . . . 55.409999999999997 110.277 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -76.65 142.88 40.45 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.549 -0.908 . . . . 72.129999999999995 108.549 175.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -74.53 166.27 54.8 Favored Glycine 0 C--O 1.225 -0.453 0 N-CA-C 118.659 2.224 . . . . 71.319999999999993 118.659 -173.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.431 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -64.17 143.25 15.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 113.419 -1.39 . . . . 54.130000000000003 108.883 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -114.85 132.8 56.38 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 123.557 0.536 . . . . 73.140000000000001 110.346 173.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.1 t -156.65 166.48 33.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.938 -1.134 . . . . 75.299999999999997 107.938 -173.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 618' ' ' LEU . 14.0 m-30 -100.64 173.62 6.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 118.437 0.562 . . . . 75.310000000000002 109.941 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -70.83 -48.92 51.46 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.233 1.197 . . . . 74.099999999999994 114.233 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.0 m -123.55 -179.1 4.22 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.658 -0.868 . . . . 64.099999999999994 108.658 -174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 27.4 p-10 -119.03 -17.95 8.88 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 122.869 0.468 . . . . 75.140000000000001 111.808 177.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.2 m -141.31 132.11 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.346 -1.353 . . . . 74.450000000000003 107.346 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.427 HD13 HG13 ' A' ' 541' ' ' VAL . 0.0 OUTLIER -135.86 160.57 39.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 107.598 -1.26 . . . . 53.210000000000001 107.598 177.76 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -124.37 125.84 44.99 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 106.742 -1.577 . . . . 74.420000000000002 106.742 171.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' A' ' 548' ' ' MET . 30.5 m -118.46 172.59 5.65 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.928 0 N-CA-C 106.732 -1.581 . . . . 73.310000000000002 106.732 169.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . 0.404 ' O ' HG22 ' A' ' 545' ' ' ILE . 66.4 m -136.45 153.67 50.99 Favored 'General case' 0 C--O 1.209 -1.028 0 N-CA-C 102.109 -3.293 . . . . 71.400000000000006 102.109 175.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -53.58 -37.63 63.14 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 112.86 0.689 . . . . 74.200000000000003 112.86 -178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 35.8 t -63.25 -10.0 13.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.559 0.948 . . . . 33.340000000000003 113.559 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 542' ' ' SER . 4.1 tt -68.4 -27.76 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 122.124 -0.36 . . . . 72.140000000000001 110.18 176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.87 -63.58 4.36 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.698 -0.763 . . . . 73.349999999999994 113.243 -175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 79.5 t -133.71 120.99 39.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.39 0.614 . . . . 62.530000000000001 110.586 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.51 ' HB2' HG11 ' A' ' 541' ' ' VAL . 1.9 ppp? -85.53 153.52 22.38 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.358 -1.349 . . . . 74.439999999999998 107.358 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -135.44 141.57 45.44 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.497 1.142 . . . . 70.120000000000005 113.962 173.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.463 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -111.75 133.49 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 104.216 -2.513 . . . . 63.520000000000003 104.216 173.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -98.59 127.87 44.68 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.257 -1.386 . . . . 74.510000000000005 107.257 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.19 125.6 63.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 N-CA-C 108.694 -0.854 . . . . 72.430000000000007 108.694 -178.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -107.75 161.78 14.58 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.728 -0.842 . . . . 75.340000000000003 108.728 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -134.14 137.03 44.24 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.479 -2.415 . . . . 74.030000000000001 104.479 175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.6 t -69.02 175.1 3.93 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 120.646 -0.422 . . . . 65.150000000000006 110.318 -176.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 2.7 m -65.13 6.77 0.23 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 115.357 1.614 . . . . 64.430000000000007 115.357 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.701 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.46 16.52 18.08 Favored Glycine 0 C--O 1.212 -1.261 0 N-CA-C 109.541 -1.423 . . . . 73.5 109.541 171.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -68.99 91.36 0.47 Allowed 'General case' 0 C--N 1.32 -0.689 0 O-C-N 121.003 -1.292 . . . . 61.310000000000002 112.575 -175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -118.14 116.01 25.97 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.616 -1.253 . . . . 73.319999999999993 107.616 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.02 -160.71 53.53 Favored Glycine 0 C--O 1.247 0.963 0 C-N-CA 120.824 -0.703 . . . . 75.430000000000007 114.266 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 92.1 m -111.48 131.87 54.91 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-O 122.101 0.953 . . . . 62.43 109.768 -175.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 77.2 t -127.49 138.76 53.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 106.812 -1.551 . . . . 52.32 106.812 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -105.59 138.76 29.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.746 -1.946 . . . . 64.319999999999993 105.746 174.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.93 113.77 12.75 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 112.39 0.515 . . . . 72.209999999999994 112.39 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.9 158.76 45.98 Favored 'Trans proline' 0 CA--C 1.498 -1.302 0 N-CA-C 114.76 1.023 . . . . 71.209999999999994 114.76 173.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . 0.452 ' CE2' HG23 ' A' ' 598' ' ' ILE . 51.1 p90 -141.74 165.36 27.69 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.587 -1.264 . . . . 63.310000000000002 107.587 173.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.07 153.53 22.3 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.357 -1.349 . . . . 73.540000000000006 107.357 173.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 59.5 m -83.12 136.48 34.44 Favored 'General case' 0 C--O 1.21 -1.016 0 N-CA-C 108.612 -0.884 . . . . 73.219999999999999 108.612 -178.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.8 t -123.48 106.91 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 104.623 -2.362 . . . . 73.349999999999994 104.623 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.488 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.1 pm0 -74.86 138.02 42.2 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.377 -0.829 . . . . 61.520000000000003 108.943 -178.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -102.34 -75.37 1.1 Allowed Glycine 0 CA--C 1.51 -0.252 0 N-CA-C 108.267 -1.933 . . . . 64.409999999999997 108.267 -178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 6.4 t -117.19 110.72 18.51 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.545 -2.391 . . . . 62.109999999999999 104.545 164.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 177.22 165.91 0.57 Allowed 'General case' 0 C--O 1.238 0.451 1 N-CA-C 99.961 -4.088 . . . . 72.239999999999995 99.961 -176.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . 0.453 ' HG2' ' CD ' ' A' ' 578' ' ' GLU . 17.9 mmtm -92.43 -28.12 17.05 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 105.436 -2.061 . . . . 75.150000000000006 105.436 175.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 79.49 -170.91 54.59 Favored Glycine 0 C--O 1.234 0.144 0 N-CA-C 115.978 1.151 . . . . 64.340000000000003 115.978 170.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 76.59 -91.47 0.96 Allowed Glycine 0 C--O 1.216 -0.986 0 C-N-CA 121.236 -0.507 . . . . 71.140000000000001 113.584 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.21 9.51 8.89 Favored Glycine 0 C--O 1.22 -0.746 0 CA-C-O 118.799 -1.001 . . . . 63.240000000000002 113.072 175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . 0.453 ' CD ' ' HG2' ' A' ' 574' ' ' LYS . 5.3 tm-20 -94.0 -66.32 0.93 Allowed 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.219 1.192 . . . . 74.439999999999998 114.219 -167.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.54 -34.71 31.0 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 123.562 1.648 . . . . 61.210000000000001 108.322 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -158.66 164.35 36.05 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 105.535 -2.024 . . . . 74.540000000000006 105.535 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.35 136.73 32.86 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.919 -1.141 . . . . 55.140000000000001 107.919 174.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -61.24 112.11 2.01 Favored 'General case' 0 CA--C 1.491 -1.308 0 CA-C-O 123.728 1.728 . . . . 52.229999999999997 108.797 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -96.75 105.3 17.39 Favored 'General case' 0 N--CA 1.414 -2.254 0 CA-C-N 111.635 -2.53 . . . . 51.140000000000001 108.464 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 47.0 p90 -140.94 145.19 35.73 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 113.852 -1.522 . . . . 73.310000000000002 110.235 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 177.67 -168.66 40.32 Favored Glycine 0 CA--C 1.502 -0.727 0 N-CA-C 108.25 -1.94 . . . . 61.420000000000002 108.25 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -121.07 146.28 46.9 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.429 0.633 . . . . 63.140000000000001 109.871 175.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 19.4 mt -117.46 121.34 40.77 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.897 -1.047 . . . . 73.239999999999995 109.661 -177.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 61.5 tt0 -83.94 120.69 26.4 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.667 -0.864 . . . . 73.409999999999997 108.667 175.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -108.93 116.54 32.18 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.625 -1.991 . . . . 64.340000000000003 105.625 173.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.659 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 5.9 ttpm? -121.45 98.66 6.07 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 122.887 0.475 . . . . 62.509999999999998 110.238 -175.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 46.2 -84.24 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 116.748 2.129 . . . . 74.400000000000006 116.748 -176.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 594' ' ' THR . 13.8 t0 -82.13 -22.64 36.06 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 121.912 0.863 . . . . 64.019999999999996 111.919 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.659 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 52.7 mt-10 -65.67 17.38 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 126.47 1.908 . . . . 64.409999999999997 113.533 171.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 592' ' ' ASP . 0.7 OUTLIER -71.64 -6.13 38.76 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 125.906 1.682 . . . . 74.040000000000006 109.014 -168.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.9 t -106.01 123.99 60.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 106.197 -1.779 . . . . 73.299999999999997 106.197 169.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 6.9 tppt? -145.54 172.43 13.23 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.262 -0.644 . . . . 73.129999999999995 109.262 -178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.19 153.63 50.39 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 112.812 0.671 . . . . 65.200000000000003 112.812 -178.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.452 HG23 ' CE2' ' A' ' 566' ' ' PHE . 76.3 mt -115.66 132.09 66.12 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.953 0 N-CA-C 105.975 -1.861 . . . . 74.310000000000002 105.975 175.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -116.03 140.61 49.1 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.927 0.767 . . . . 55.43 110.331 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.404 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.51 141.14 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 105.609 -1.997 . . . . 61.240000000000002 105.609 178.498 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.6 ttpt -95.06 126.92 40.72 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.81 -1.181 . . . . 72.150000000000006 107.81 176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.432 HG21 ' HA ' ' A' ' 543' ' ' GLU . 16.3 mm -93.58 136.94 23.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 105.581 -2.007 . . . . 74.510000000000005 105.581 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.65 143.67 12.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 123.056 0.543 . . . . 74.349999999999994 110.014 -171.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -133.53 136.17 44.83 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 122.944 0.498 . . . . 73.040000000000006 112.332 -177.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -152.93 39.55 0.53 Allowed 'General case' 0 N--CA 1.48 1.064 0 CA-C-O 121.848 0.832 . . . . 74.150000000000006 110.935 175.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 59.92 8.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 118.506 2.78 . . . . 55.509999999999998 118.506 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -85.72 177.17 7.77 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 118.847 0.749 . . . . 70.129999999999995 109.879 174.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.61 -30.22 1.89 Allowed 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 114.588 1.329 . . . . 61.25 114.588 -174.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 36.52 -107.28 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.407 1.262 . . . . 74.099999999999994 114.407 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 611' ' ' GLN . 0.0 OUTLIER -163.52 -177.38 5.22 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 105.353 -2.092 . . . . 65.030000000000001 105.353 -178.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 610' ' ' ARG . 43.4 tt0 -57.2 120.82 8.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.024 -0.732 . . . . 74.349999999999994 109.024 172.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -115.21 163.31 15.84 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.589 -2.374 . . . . 75.299999999999997 104.589 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.35 143.87 28.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.017 0.437 . . . . 74.019999999999996 110.864 -171.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 662' ' ' VAL . 11.0 p90 -144.52 178.44 7.95 Favored 'General case' 0 CA--C 1.505 -0.769 0 C-N-CA 119.315 -0.954 . . . . 74.400000000000006 111.195 174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.84 165.09 32.54 Favored 'General case' 0 C--O 1.21 -0.983 0 N-CA-C 107.735 -1.209 . . . . 71.319999999999993 107.735 175.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.6 mt -127.07 123.61 62.71 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 106.582 -1.636 . . . . 71.25 106.582 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -113.1 137.46 51.4 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.277 -0.638 . . . . 54.509999999999998 109.277 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 534' ' ' PHE . 0.8 OUTLIER -71.84 147.9 46.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.005 -1.109 . . . . 62.200000000000003 108.005 173.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -71.54 -84.39 0.21 Allowed Glycine 0 C--O 1.222 -0.6 0 CA-C-O 122.072 0.818 . . . . 72.450000000000003 111.194 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -152.08 124.04 3.87 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.144 -1.428 . . . . 71.439999999999998 107.144 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.419 ' HD3' HD21 ' A' ' 654' ' ' LEU . 72.6 Cg_endo -70.03 130.27 18.71 Favored 'Trans proline' 0 CA--C 1.533 0.441 0 C-N-CA 117.222 -1.385 . . . . 75.549999999999997 110.46 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.2 mtmt -123.04 132.76 54.25 Favored 'General case' 0 C--O 1.211 -0.966 0 N-CA-C 108.69 -0.855 . . . . 73.439999999999998 108.69 -176.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.704 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.6 t90 -83.16 107.55 15.8 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.769 -0.456 . . . . 74.209999999999994 109.769 -173.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.462 11.1 mmt -123.47 83.96 2.21 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 125.029 2.347 . . . . 62.340000000000003 113.608 167.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.6 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.362 11.3 tt0 -152.54 84.31 1.24 Allowed 'General case' 0 C--O 1.153 -3.999 2 N-CA-C 97.979 -4.823 . . . . 64.120000000000005 97.979 145.018 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.704 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.253 16.1 mmm180 162.08 -46.09 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.21 1 CA-C-N 126.757 4.344 . . . . 64.420000000000002 106.272 -179.301 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 70.09 37.67 73.0 Favored Glycine 0 C--O 1.224 -0.521 0 N-CA-C 108.97 -1.652 . . . . 75.209999999999994 108.97 -174.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 7.4 tp -64.78 143.05 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 N-CA-C 114.318 1.229 . . . . 73.409999999999997 114.318 -169.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.1 t -148.91 160.43 43.27 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 102.663 -3.088 . . . . 60.450000000000003 102.663 173.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -63.19 134.19 55.55 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 106.735 -1.579 . . . . 73.510000000000005 106.735 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 2.1 p -136.53 121.75 26.98 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.703 0.764 . . . . 73.109999999999999 110.043 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 18.8 p -86.84 -18.85 29.97 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.776 -0.647 . . . . 64.230000000000004 111.836 -176.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -67.36 -5.49 14.71 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.641 1.348 . . . . 54.119999999999997 114.641 -174.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 87.0 mtt-85 -79.81 59.29 3.08 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.067 0.46 . . . . 73.209999999999994 111.8 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -72.58 124.87 26.14 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.162 -1.051 . . . . 62.409999999999997 108.162 177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 48.1 mt -141.84 -172.29 3.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 105.895 -1.891 . . . . 70.319999999999993 105.895 -172.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.2 t -67.21 155.93 37.57 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 105.196 -2.149 . . . . 64.430000000000007 105.196 168.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 17.0 m -65.44 -23.13 32.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 113.713 1.005 . . . . 52.520000000000003 113.713 -161.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -74.92 -48.83 22.6 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.328 1.061 . . . . 71.420000000000002 109.173 176.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -69.84 -22.5 63.27 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.227 -1.351 . . . . 71.129999999999995 111.537 -177.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.79 -52.07 61.45 Favored 'General case' 0 C--O 1.214 -0.806 0 N-CA-C 109.684 -0.487 . . . . 73.200000000000003 109.684 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -87.66 -44.87 10.88 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 118.818 -1.153 . . . . 71.319999999999993 111.196 173.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.66 -43.36 93.97 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 113.509 0.929 . . . . 44.210000000000001 113.509 -171.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -80.34 -38.9 29.61 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.197 -0.601 . . . . 62.219999999999999 109.738 179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 32.8 ttm105 -59.32 -51.1 71.39 Favored 'General case' 0 C--O 1.211 -0.963 0 CA-C-O 119.047 -0.501 . . . . 72.219999999999999 110.781 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.1 -44.7 87.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 118.346 0.521 . . . . 54.520000000000003 111.039 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.36 -34.88 78.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.797 0.332 . . . . 63.420000000000002 110.912 179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -76.07 -26.39 56.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.388 0.514 . . . . 75.310000000000002 112.388 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 44.8 mtm -67.48 -41.71 84.14 Favored 'General case' 0 C--O 1.216 -0.705 0 N-CA-C 106.505 -1.665 . . . . 75.439999999999998 106.505 177.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 528' ' ' HIS . . . 58.74 13.76 19.48 Favored Glycine 0 C--O 1.225 -0.461 0 N-CA-C 116.986 1.555 . . . . 72.420000000000002 116.986 166.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -61.91 128.68 90.94 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 118.26 1.03 . . . . 73.319999999999993 112.772 -168.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -73.6 162.85 38.87 Favored 'Trans proline' 0 CA--C 1.513 -0.571 0 O-C-N 122.253 0.607 . . . . 72.230000000000004 111.806 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 28.9 m -140.26 162.08 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.483 -0.781 . . . . 64.329999999999998 110.784 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . 0.419 HD21 ' HD3' ' A' ' 621' ' ' PRO . 80.9 mt -72.15 157.27 38.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 72.109999999999999 110.684 173.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.35 -148.02 15.38 Favored Glycine 0 C--O 1.221 -0.658 0 N-CA-C 118.521 2.168 . . . . 72.129999999999995 118.521 -172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -69.69 -41.27 75.64 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.748 -1.226 . . . . 72.109999999999999 111.508 -175.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -141.99 77.38 18.49 Favored Pre-proline 0 N--CA 1.468 0.471 0 N-CA-C 112.739 0.644 . . . . 54.030000000000001 112.739 173.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -77.73 33.78 0.46 Allowed 'Trans proline' 0 CA--C 1.534 0.506 0 C-N-CA 124.174 3.249 . . . . 71.540000000000006 112.895 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.5 ttpt -157.25 156.41 32.46 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.117 -1.068 . . . . 73.519999999999996 108.117 -178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . . . . . . . . . 30.3 tp -133.95 127.49 32.51 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.229 -1.767 . . . . 73.25 106.229 173.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -87.68 136.04 33.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 108.583 -0.895 . . . . 64.120000000000005 108.583 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 614' ' ' PHE . 1.9 m -117.39 144.93 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 108.054 -1.091 . . . . 74.540000000000006 108.054 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 8.0 mm -122.5 129.8 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 104.223 -2.51 . . . . 74.150000000000006 104.223 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 13.3 mt -88.49 118.55 34.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 122.144 0.973 . . . . 72.25 108.623 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 52.57 -93.9 0.03 OUTLIER 'General case' 0 C--O 1.24 0.582 0 CA-C-N 113.129 -1.851 . . . . 63.310000000000002 115.443 -173.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -27.2 107.68 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.098 1.518 . . . . 72.329999999999998 115.098 -163.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 2.2 p -71.88 4.71 3.12 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.381 -1.281 . . . . 65.129999999999995 114.096 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.57 117.55 18.32 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.259 0.552 . . . . 74.129999999999995 109.8 175.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -151.82 166.09 32.47 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 105.913 -1.884 . . . . 53.149999999999999 105.913 176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -137.57 34.6 2.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.485 0.659 . . . . 73.109999999999999 110.385 -178.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 11.3 tptp -59.17 -48.01 83.17 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 115.599 -0.728 . . . . 71.219999999999999 112.351 -176.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 67.7 m -110.3 132.03 54.53 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.502 0.667 . . . . 72.239999999999995 112.748 -175.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 20.6 p -133.45 -47.02 0.82 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.025 -2.213 . . . . 73.109999999999999 105.025 173.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.36 160.64 19.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 100.532 -3.877 . . . . 74.129999999999995 100.532 167.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.259 1.597 0 N-CA-C 102.905 -2.998 . . . . 65.109999999999999 102.905 178.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 63.6 m-70 . . . . . 0 C--O 1.219 -0.514 0 N-CA-C 107.795 -1.187 . . . . 71.019999999999996 107.795 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -68.88 153.1 44.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.374 0.533 . . . . 63.420000000000002 110.615 179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -71.87 161.11 54.22 Favored Glycine 0 C--O 1.223 -0.568 0 N-CA-C 117.18 1.632 . . . . 21.329999999999998 117.18 -175.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.712 ' H ' HG22 ' A' ' 555' ' ' THR . 1.2 mp -85.45 144.8 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 104.251 -2.5 . . . . 75.200000000000003 104.251 171.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -120.97 138.16 54.28 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 109.236 -0.653 . . . . 72.010000000000005 109.236 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -154.95 167.15 31.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 105.766 -1.938 . . . . 63.310000000000002 105.766 -174.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -99.89 175.25 5.84 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 109.31 -0.626 . . . . 72.530000000000001 109.31 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . 0.469 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.1 mt-10 -63.41 -46.52 85.97 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.722 -0.672 . . . . 65.209999999999994 112.616 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.2 m -145.2 -179.49 6.67 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 104.673 -2.343 . . . . 74.540000000000006 104.673 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 660' ' ' LEU . 17.9 t0 -123.72 28.01 7.09 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 109.336 -0.616 . . . . 55.119999999999997 109.336 171.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 9.4 m -155.29 137.33 14.62 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 109.587 -0.523 . . . . 75.310000000000002 109.587 169.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.753 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -151.56 160.2 3.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 124.951 1.301 . . . . 71.319999999999993 108.194 179.647 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -125.46 127.85 47.15 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.13 -0.692 . . . . 64.420000000000002 109.13 170.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.41 HG22 HG12 ' A' ' 662' ' ' VAL . 28.4 m -117.23 -179.7 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 108.542 -0.91 . . . . 74.430000000000007 108.542 170.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 61.2 m -127.38 159.26 34.99 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 102.25 -3.241 . . . . 75.319999999999993 102.25 170.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -61.27 -31.93 71.76 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.929 0.871 . . . . 74.129999999999995 109.752 176.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -9.27 11.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.275 -1.329 . . . . 61.240000000000002 113.659 -177.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 5.2 tt -69.44 -25.7 29.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.061 0.458 . . . . 74.340000000000003 110.354 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.98 -68.87 2.94 Favored Glycine 0 C--O 1.218 -0.85 0 C-N-CA 120.312 -0.947 . . . . 63.420000000000002 111.37 -177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 1.4 p -143.1 125.81 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.899 0.857 . . . . 72.049999999999997 109.524 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.409 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -81.93 153.6 26.21 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.597 -1.183 . . . . 65.5 110.13 -178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.0 OUTLIER -137.19 140.49 41.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.871 0.367 . . . . 72.209999999999994 111.817 175.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -116.56 143.72 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 104.657 -2.349 . . . . 74.010000000000005 104.657 171.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -95.53 134.15 38.72 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 106.515 -1.661 . . . . 75.239999999999995 106.515 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.43 121.47 57.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 108.442 -0.947 . . . . 75.519999999999996 108.442 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -108.39 161.36 15.1 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 124.104 0.962 . . . . 64.540000000000006 109.064 -176.087 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -135.65 148.52 48.99 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 109.582 -0.525 . . . . 72.150000000000006 109.582 -176.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 531' ' ' ILE . 2.2 t -76.25 173.16 11.73 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.012 0.525 . . . . 53.130000000000003 111.595 175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 20.4 p -62.43 14.59 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 117.498 2.407 . . . . 73.329999999999998 117.498 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.04 17.68 56.1 Favored Glycine 0 C--O 1.205 -1.688 0 O-C-N 121.984 -0.447 . . . . 72.200000000000003 114.007 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.565 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -69.43 106.09 2.83 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 119.422 -2.222 . . . . 60.299999999999997 112.943 -174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -129.2 111.91 13.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.625 -1.62 . . . . 61.530000000000001 106.625 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 71.61 -150.4 46.51 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.013 -1.089 . . . . 60.020000000000003 113.786 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.495 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.8 m -116.68 132.17 56.76 Favored 'General case' 0 C--O 1.211 -0.951 0 CA-C-N 114.307 -0.947 . . . . 60.409999999999997 109.092 -177.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.418 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.2 OUTLIER -131.45 144.07 38.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 105.981 -1.859 . . . . 71.519999999999996 105.981 176.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.1 tt -108.12 140.48 26.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 106.819 -1.549 . . . . 74.200000000000003 106.819 -178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 6.6 t -133.57 112.17 12.74 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 113.597 0.962 . . . . 75.230000000000004 113.597 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.33 155.31 46.23 Favored 'Trans proline' 0 CA--C 1.511 -0.651 0 N-CA-C 115.94 1.477 . . . . 73.129999999999995 115.94 175.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -137.95 165.56 26.23 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.187 -1.042 . . . . 72.140000000000001 108.187 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 157.66 32.04 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 108.786 -0.82 . . . . 74.209999999999994 108.786 177.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.14 137.56 34.94 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.59 -0.522 . . . . 71.120000000000005 109.59 175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.62 109.01 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.718 0 N-CA-C 104.676 -2.342 . . . . 72.299999999999997 104.676 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -81.07 138.33 35.97 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 114.391 -1.277 . . . . 54.119999999999997 110.349 -179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -90.72 -77.84 1.35 Allowed Glycine 0 C--O 1.227 -0.299 0 N-CA-C 107.801 -2.12 . . . . 73.129999999999995 107.801 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.31 110.47 18.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 104.712 -2.329 . . . . 75.420000000000002 104.712 165.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -169.98 -179.39 3.19 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 106.288 -1.745 . . . . 71.140000000000001 106.288 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -109.98 -31.1 7.51 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 107.472 -1.307 . . . . 74.019999999999996 107.472 173.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.37 -174.13 53.76 Favored Glycine 0 C--O 1.234 0.156 0 CA-C-O 122.812 1.229 . . . . 73.439999999999998 115.526 177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 87.76 -101.71 2.73 Favored Glycine 0 C--O 1.214 -1.135 0 N-CA-C 109.99 -1.244 . . . . 52.509999999999998 109.99 -178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.78 10.7 8.43 Favored Glycine 0 C--O 1.217 -0.942 0 N-CA-C 110.342 -1.103 . . . . 75.450000000000003 110.342 173.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -48.4 9.65 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.251 1.574 . . . . 75.129999999999995 115.251 -163.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.4 -22.81 8.04 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.309 -0.86 . . . . 75.099999999999994 109.713 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 19.9 p90 -157.99 170.01 23.27 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 104.461 -2.422 . . . . 75.329999999999998 104.461 169.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -92.0 123.12 35.13 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.989 -0.745 . . . . 53.210000000000001 108.989 172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -63.2 110.74 1.96 Allowed 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 123.406 1.574 . . . . 71.310000000000002 110.481 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.504 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -112.76 106.66 15.07 Favored 'General case' 0 N--CA 1.428 -1.575 0 CA-C-N 111.711 -2.495 . . . . 73.209999999999994 112.145 -171.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -136.55 144.82 44.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.009 -0.996 . . . . 73.329999999999998 108.845 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.57 -171.77 39.81 Favored Glycine 0 CA--C 1.503 -0.657 0 N-CA-C 108.896 -1.682 . . . . 63.509999999999998 108.896 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -121.92 148.03 45.27 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 117.765 0.782 . . . . 73.200000000000003 110.849 177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 26.3 mt -115.76 119.52 36.32 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.075 -0.966 . . . . 62.549999999999997 111.023 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -77.93 102.49 7.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.945 0.879 . . . . 74.010000000000005 110.529 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -97.69 126.71 43.17 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.047 -0.723 . . . . 72.230000000000004 109.047 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.507 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 39.8 mttp -128.38 -178.56 4.61 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.984 -0.448 . . . . 72.420000000000002 110.645 -177.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -46.2 -59.86 2.65 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 117.019 2.229 . . . . 64.409999999999997 117.019 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -82.2 -33.6 29.33 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 122.815 1.293 . . . . 72.049999999999997 111.469 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 58.8 mt-10 -57.48 17.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 119.133 3.012 . . . . 74.099999999999994 119.133 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 71.8 p -72.04 10.2 0.78 Allowed 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 114.026 1.121 . . . . 72.019999999999996 114.026 -168.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 10.4 p -127.15 135.24 64.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 106.41 -1.7 . . . . 72.530000000000001 106.41 167.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.408 ' HG3' ' H ' ' A' ' 597' ' ' THR . 12.1 tppt? -148.25 175.79 10.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.48 -1.304 . . . . 63.210000000000001 107.48 -176.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.408 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -142.33 159.94 41.24 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 117.721 0.237 . . . . 72.230000000000004 111.323 -178.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 58.8 mt -125.62 132.88 70.36 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.979 0 N-CA-C 107.4 -1.333 . . . . 71.329999999999998 107.4 176.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 39.5 mtt180 -113.13 131.83 55.69 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.748 1.018 . . . . 72.129999999999995 113.748 179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 583' ' ' ALA . 60.2 t -131.71 115.2 27.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 O-C-N 123.814 0.696 . . . . 72.530000000000001 109.438 177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -72.26 141.14 48.92 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 122.194 -0.316 . . . . 62.420000000000002 110.439 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.417 HG21 ' HA ' ' A' ' 543' ' ' GLU . 15.0 mm -108.18 140.05 28.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.865 -1.532 . . . . 74.219999999999999 106.865 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.5 m -95.02 143.64 11.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.596 -0.52 . . . . 62.399999999999999 109.596 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -127.42 149.42 50.1 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.239 0.829 . . . . 72.239999999999995 113.239 -171.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 58.26 -5.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 119.319 3.081 . . . . 72.420000000000002 119.319 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -69.17 -33.67 73.75 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 118.616 0.644 . . . . 65.519999999999996 111.588 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -147.47 165.82 29.12 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 109.035 -0.728 . . . . 61.020000000000003 109.035 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -133.63 71.46 1.46 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.347 0.594 . . . . 72.230000000000004 112.566 -171.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.74 -179.42 7.43 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 115.96 -0.564 . . . . 65.109999999999999 110.546 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -93.05 -40.94 10.24 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 123.067 0.547 . . . . 73.140000000000001 110.764 -177.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -158.61 126.47 5.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.94 -0.763 . . . . 64.340000000000003 108.94 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -104.98 146.75 28.61 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 106.073 -1.825 . . . . 72.319999999999993 106.073 175.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -142.49 124.47 15.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.226 0.536 . . . . 64.319999999999993 109.572 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -153.94 164.85 37.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.082 -1.451 . . . . 64.340000000000003 107.082 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.92 171.13 14.78 Favored 'General case' 0 C--O 1.211 -0.922 0 N-CA-C 107.857 -1.164 . . . . 72.219999999999999 107.857 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 13.9 mt -126.02 118.5 51.86 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 105.226 -2.139 . . . . 44.409999999999997 105.226 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.59 150.88 26.89 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.216 -1.401 . . . . 61.530000000000001 107.216 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.56 150.81 23.98 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.519 -0.764 . . . . 51.539999999999999 108.951 178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.1 -82.82 0.37 Allowed Glycine 0 C--O 1.222 -0.606 0 N-CA-C 110.427 -1.069 . . . . 75.409999999999997 110.427 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -161.0 132.02 3.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 105.984 -1.858 . . . . 74.129999999999995 105.984 174.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.69 140.76 39.88 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 116.336 -1.976 . . . . 74.430000000000007 110.008 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -130.3 136.2 48.89 Favored 'General case' 0 C--O 1.198 -1.614 0 N-CA-C 107.262 -1.384 . . . . 72.299999999999997 107.262 -177.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.701 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.1 t90 -83.15 110.64 18.21 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.896 -0.779 . . . . 64.200000000000003 108.896 -175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . 0.418 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.477 11.1 mmt -123.77 81.44 1.91 Allowed 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 116.06 -2.256 . . . . 64.129999999999995 113.602 165.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.565 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.33 12.1 tt0 -153.02 90.35 1.44 Allowed 'General case' 1 C--O 1.138 -4.804 2 CA-C-O 111.022 -4.323 . . . . 75.439999999999998 100.268 147.332 . . . . . . . . 5 3 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.701 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.1 mmm180 162.79 -50.11 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 1 CA-C-N 128.21 5.004 . . . . 74.400000000000006 107.591 178.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 75.67 62.71 2.62 Favored Glycine 0 C--O 1.227 -0.303 0 N-CA-C 108.851 -1.699 . . . . 73.420000000000002 108.851 -173.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -50.98 119.31 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 121.925 0.869 . . . . 53.229999999999997 110.881 -175.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 46.1 m -146.51 154.88 42.07 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 103.912 -2.625 . . . . 74.140000000000001 103.912 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -84.86 77.12 10.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 118.316 0.507 . . . . 74.540000000000006 111.457 -178.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 73.0 t 62.05 120.38 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 117.196 2.295 . . . . 73.129999999999995 117.196 173.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 16.1 p -89.34 -49.56 6.64 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.275 -1.009 . . . . 40.25 108.275 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -154.88 114.45 3.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 109.044 -0.724 . . . . 74.420000000000002 109.044 173.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -147.54 80.12 1.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.607 -0.886 . . . . 73.409999999999997 108.607 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -72.84 117.56 14.7 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 106.974 -1.491 . . . . 72.209999999999994 106.974 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 34.8 mt -138.13 177.86 7.56 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.76 0.424 . . . . 71.129999999999995 110.477 -171.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.3 t -79.44 171.34 15.3 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 106.845 -1.539 . . . . 62.229999999999997 106.845 170.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.56 -45.11 99.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.822 0.82 . . . . 74.319999999999993 111.635 -172.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.87 -42.08 98.62 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 122.244 1.021 . . . . 63.210000000000001 110.869 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -76.67 -19.17 58.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.952 -1.022 . . . . 74.430000000000007 111.246 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.2 -40.94 78.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 119.105 -0.474 . . . . 71.329999999999998 110.01 -178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -88.25 -47.73 8.21 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 119.915 -0.714 . . . . 73.200000000000003 112.137 166.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.6 -40.4 83.11 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 113.372 0.879 . . . . 74.219999999999999 113.372 -169.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -79.24 -38.08 36.45 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 109.197 -0.668 . . . . 74.030000000000001 109.197 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 8.7 ttm180 -58.73 -46.15 88.03 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.579 0.228 . . . . 73.549999999999997 111.281 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.6 mt -63.63 -41.98 94.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.5 0.667 . . . . 74.329999999999998 109.495 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.18 -33.36 75.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.214 -0.448 . . . . 62.539999999999999 111.176 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -70.1 -27.77 64.86 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.223 0.209 . . . . 53.32 110.858 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.3 mtt -69.73 -41.69 74.96 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 107.234 -1.395 . . . . 64.319999999999993 107.234 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.443 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.4 20.0 42.96 Favored Glycine 0 C--O 1.224 -0.529 0 CA-C-N 115.313 -0.858 . . . . 44.520000000000003 115.028 172.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.16 116.11 13.6 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 117.863 0.832 . . . . 55.229999999999997 112.888 -169.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -69.42 158.65 56.62 Favored 'Trans proline' 0 CA--C 1.514 -0.485 0 C-N-CA 117.514 -1.191 . . . . 52.439999999999998 110.355 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.75 167.74 25.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.536 -0.756 . . . . 75.129999999999995 110.903 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.43 155.08 36.68 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.627 -0.879 . . . . 74.430000000000007 108.627 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.06 -163.67 39.64 Favored Glycine 0 CA--C 1.503 -0.661 0 CA-C-O 122.297 0.943 . . . . 75.420000000000002 115.074 177.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.9 mp0 -76.82 -34.2 57.91 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 113.85 -1.175 . . . . 62.219999999999999 110.71 -176.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -137.17 67.58 55.04 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-O 121.528 0.68 . . . . 61.130000000000003 111.957 177.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.0 33.89 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.508 3.472 . . . . 75.340000000000003 112.908 179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -153.59 154.45 34.25 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.385 -0.969 . . . . 71.439999999999998 108.385 -176.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 537' ' ' ASP . 22.6 tp -133.94 117.44 16.75 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 123.874 0.734 . . . . 75.0 109.657 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 124.89 29.29 Favored 'General case' 0 C--O 1.208 -1.105 0 N-CA-C 109.103 -0.703 . . . . 72.450000000000003 109.103 176.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.753 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.92 134.89 59.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.216 -1.402 . . . . 73.200000000000003 107.216 -179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 10.0 mm -113.58 131.6 64.9 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 103.573 -2.751 . . . . 71.310000000000002 103.573 175.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 7.3 mt -91.21 92.73 4.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 106.191 -1.781 . . . . 71.439999999999998 106.191 176.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -165.69 90.18 0.46 Allowed 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.662 -1.154 . . . . 73.219999999999999 108.235 -175.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 49.89 -126.28 2.19 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-N 115.721 -0.672 . . . . 72.340000000000003 111.596 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.6 p -136.88 27.99 2.93 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.681 -1.229 . . . . 65.230000000000004 107.681 178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -73.41 58.2 0.55 Allowed 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.458 1.281 . . . . 61.340000000000003 114.458 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -102.23 140.42 36.54 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.869 -0.519 . . . . 75.510000000000005 110.278 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.02 4.67 0.56 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.769 1.766 . . . . 63.130000000000003 115.769 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 55.9 mttt -83.36 43.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.966 0 O-C-N 121.316 -0.865 . . . . 71.129999999999995 111.5 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 16.4 m -78.11 152.3 32.91 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 122.218 -0.301 . . . . 73.430000000000007 111.742 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -149.66 162.73 39.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.341 -1.355 . . . . 72.340000000000003 107.341 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.9 p -151.04 160.19 4.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 105.453 -2.055 . . . . 55.0 105.453 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.77 -0.633 . . . . 74.140000000000001 109.715 176.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.22 -0.496 0 N-CA-C 108.11 -1.071 . . . . 73.129999999999995 108.11 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.19 145.5 21.22 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 109.329 -0.619 . . . . 52.299999999999997 109.329 172.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.31 147.65 47.33 Favored Glycine 0 C--O 1.22 -0.763 0 N-CA-C 117.574 1.79 . . . . 63.409999999999997 117.574 -173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.657 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.39 140.58 18.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 105.324 -2.102 . . . . 63.229999999999997 105.324 170.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -112.47 136.7 51.65 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.213 0.53 . . . . 64.540000000000006 110.573 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.0 t -156.77 170.99 21.17 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.696 -1.964 . . . . 62.32 105.696 -173.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 -107.61 171.73 7.22 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.556 -0.905 . . . . 71.400000000000006 108.556 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -61.66 -52.65 63.45 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 113.835 1.05 . . . . 75.329999999999998 113.835 176.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 83.6 m -133.63 172.44 12.75 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.391 -1.337 . . . . 61.329999999999998 107.391 -173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 9.9 p30 -123.22 6.12 9.13 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.178 0.807 . . . . 65.200000000000003 113.178 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 24.3 m -145.38 130.76 18.66 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 109.22 -0.659 . . . . 70.120000000000005 109.22 176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.706 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -148.54 158.82 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 C-N-CA 124.432 1.093 . . . . 71.25 110.878 -178.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -122.48 131.65 53.96 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 109.327 -0.62 . . . . 74.439999999999998 109.327 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 662' ' ' VAL . 27.7 m -121.15 167.65 14.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.643 0 CA-C-O 121.306 0.574 . . . . 71.140000000000001 109.625 166.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . 0.473 ' O ' HG22 ' A' ' 545' ' ' ILE . 44.1 p -101.76 162.03 13.22 Favored 'General case' 0 C--O 1.212 -0.913 0 N-CA-C 105.16 -2.163 . . . . 43.450000000000003 105.16 171.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.46 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -69.43 -34.92 75.15 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.522 -1.288 . . . . 63.130000000000003 107.522 168.624 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.14 -9.95 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.648 1.351 . . . . 71.540000000000006 114.648 -177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 542' ' ' SER . 7.6 tt -69.28 -27.45 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.882 0.372 . . . . 74.420000000000002 110.205 177.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 87.15 -68.79 3.13 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.03 -1.081 . . . . 51.530000000000001 111.851 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 84.0 t -133.84 121.34 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.206 0.527 . . . . 70.329999999999998 110.735 -174.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.456 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 1.9 ppp? -85.15 153.62 22.55 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.047 -0.723 . . . . 62.149999999999999 109.047 175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -138.95 144.17 38.89 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 111.939 0.348 . . . . 65.540000000000006 111.939 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.473 HG12 HD23 ' A' ' 660' ' ' LEU . 1.0 OUTLIER -119.57 139.89 45.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.68 0 N-CA-C 106.481 -1.674 . . . . 64.319999999999993 106.481 172.368 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -86.95 129.91 34.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.012 -1.477 . . . . 73.239999999999995 107.012 175.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 5.0 t -102.76 131.78 50.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 107.616 -1.253 . . . . 71.0 107.616 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 16.3 mt -121.28 161.62 21.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.379 -0.828 . . . . 74.400000000000006 110.275 -172.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.536 HH11 ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -141.37 152.2 44.15 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 109.547 -0.538 . . . . 75.109999999999999 109.547 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.657 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -81.04 -177.23 6.34 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.147 1.165 . . . . 52.43 114.147 178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 59.9 p -70.08 36.01 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.611 1.337 . . . . 72.329999999999998 114.611 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -105.0 6.31 43.25 Favored Glycine 0 C--O 1.21 -1.401 0 CA-C-O 121.956 0.753 . . . . 75.340000000000003 113.183 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.536 ' HB2' HH11 ' A' ' 554' ' ' ARG . . . -67.48 102.47 1.14 Allowed 'General case' 0 C--N 1.315 -0.909 0 O-C-N 120.642 -1.505 . . . . 55.409999999999997 114.053 -171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -140.73 104.44 4.72 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.383 -0.969 . . . . 72.140000000000001 108.383 177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 94.69 -161.61 23.92 Favored Glycine 0 C--N 1.321 -0.303 0 C-N-CA 120.912 -0.661 . . . . 75.129999999999995 113.939 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.463 ' H ' ' CB ' ' A' ' 625' ' ' GLU . 89.3 m -112.73 130.1 56.18 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 107.587 -1.264 . . . . 74.5 107.587 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 90.8 t -128.04 140.13 50.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 106.554 -1.647 . . . . 71.239999999999995 106.554 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 2.8 tt -111.05 138.83 37.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 106.638 -1.616 . . . . 71.340000000000003 106.638 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.6 t -135.07 113.92 11.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 112.142 0.423 . . . . 64.530000000000001 112.142 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.7 159.24 38.98 Favored 'Trans proline' 0 CA--C 1.505 -0.929 0 N-CA-C 115.438 1.284 . . . . 63.420000000000002 115.438 174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -141.07 164.86 29.13 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.352 -1.351 . . . . 62.310000000000002 107.352 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.08 154.65 31.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.283 -1.006 . . . . 75.120000000000005 108.283 171.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 26.4 m -81.75 132.96 35.3 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.45 -1.315 . . . . 70.25 107.45 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.1 110.41 26.3 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 N-CA-C 104.826 -2.287 . . . . 71.409999999999997 104.826 -168.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.471 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -80.44 139.78 36.29 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.207 -1.36 . . . . 74.430000000000007 110.349 -177.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -108.48 -83.04 1.48 Allowed Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 107.889 -2.084 . . . . 74.310000000000002 107.889 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.04 110.46 18.27 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 104.97 -2.233 . . . . 72.540000000000006 104.97 163.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.28 -163.98 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 102.716 -3.068 . . . . 73.25 102.716 -176.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -112.99 -36.62 5.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.301 0.572 . . . . 61.5 111.981 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.38 -168.79 54.8 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-O 121.894 0.719 . . . . 72.430000000000007 113.259 -178.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 71.96 -107.35 2.16 Favored Glycine 0 C--O 1.22 -0.772 0 N-CA-C 111.198 -0.761 . . . . 43.340000000000003 111.198 178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.55 8.2 Favored Glycine 0 C--O 1.218 -0.887 0 CA-C-O 118.396 -1.224 . . . . 64.310000000000002 113.033 175.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.76 -52.36 4.12 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.916 2.191 . . . . 71.010000000000005 116.916 -167.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -104.46 -25.78 12.66 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.777 1.171 . . . . 74.209999999999994 108.746 175.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -147.41 163.04 37.74 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.063 -1.458 . . . . 73.430000000000007 107.063 170.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.53 122.86 35.38 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.128 -1.434 . . . . 64.299999999999997 107.128 169.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -61.75 110.45 1.52 Allowed 'General case' 0 CA--C 1.489 -1.378 0 CA-C-O 123.522 1.629 . . . . 61.329999999999998 110.314 -177.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.438 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -106.46 111.17 23.62 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 111.478 -2.601 . . . . 61.450000000000003 110.59 -172.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -138.05 144.26 40.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.135 -0.939 . . . . 71.349999999999994 109.645 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.04 -174.89 41.25 Favored Glycine 0 CA--C 1.501 -0.813 0 N-CA-C 108.96 -1.656 . . . . 71.209999999999994 108.96 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -115.97 143.7 45.09 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.325 0.583 . . . . 70.540000000000006 109.644 176.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 20.7 mt -113.56 123.37 49.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.96 -1.018 . . . . 72.420000000000002 108.498 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 58.1 tt0 -82.65 124.54 30.28 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.032 -1.099 . . . . 72.129999999999995 108.032 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -115.8 137.97 51.59 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.388 -1.708 . . . . 73.120000000000005 106.388 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.598 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 55.9 mttp -122.79 -179.13 4.13 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.101 -1.815 . . . . 65.129999999999995 106.101 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -48.14 -56.68 7.26 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 114.692 1.368 . . . . 52.520000000000003 114.692 -177.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -82.28 -33.83 28.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.375 1.083 . . . . 70.239999999999995 111.376 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.598 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 84.3 mt-10 -67.62 17.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 117.34 2.348 . . . . 72.400000000000006 117.34 -173.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.417 ' CG2' ' HD3' ' A' ' 554' ' ' ARG . 65.0 p -71.66 13.15 0.28 Allowed 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 114.615 1.339 . . . . 62.420000000000002 114.615 -173.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.52 123.75 71.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 103.796 -2.668 . . . . 73.540000000000006 103.796 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . 0.443 ' HG3' ' H ' ' A' ' 597' ' ' THR . 10.6 tppt? -151.58 175.51 12.27 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 109.503 -0.554 . . . . 74.319999999999993 109.503 -175.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . 0.443 ' H ' ' HG3' ' A' ' 596' ' ' LYS . 0.0 OUTLIER -143.26 160.0 41.29 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 123.414 0.446 . . . . 45.039999999999999 111.517 -178.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 67.7 mt -124.47 129.78 73.74 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 N-CA-C 107.129 -1.434 . . . . 72.109999999999999 107.129 176.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.9 mtm180 -109.95 136.57 49.02 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.825 0.703 . . . . 71.349999999999994 111.868 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.456 ' HB ' ' HG3' ' A' ' 548' ' ' MET . 63.5 t -135.23 130.99 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 107.941 -1.133 . . . . 64.230000000000004 107.941 178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 7.1 ttpt -86.5 132.1 34.01 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 109.46 -0.57 . . . . 72.430000000000007 109.46 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.46 HG21 ' HA ' ' A' ' 543' ' ' GLU . 21.0 mm -96.42 139.39 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.627 -1.249 . . . . 72.340000000000003 107.627 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 45.1 t -104.6 143.56 15.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.28 -0.637 . . . . 72.129999999999995 109.28 -178.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.31 143.71 48.59 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.151 0.98 . . . . 71.519999999999996 112.219 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -75.3 129.71 37.86 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.489 0.662 . . . . 73.549999999999997 112.315 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.96 -28.1 64.22 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.3 0.571 . . . . 64.140000000000001 111.878 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -139.47 135.2 33.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 105.262 -2.125 . . . . 72.209999999999994 105.262 176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -66.82 164.05 18.1 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 116.098 1.888 . . . . 73.340000000000003 116.098 -170.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.72 37.74 15.58 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 113.979 -1.464 . . . . 72.030000000000001 111.337 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.18 104.77 16.76 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 121.332 0.587 . . . . 75.299999999999997 111.783 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -77.15 90.28 3.66 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.059 -0.719 . . . . 74.340000000000003 109.059 175.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -89.35 152.61 21.42 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 107.396 -1.335 . . . . 64.239999999999995 107.396 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -138.98 131.83 29.25 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.033 0.921 . . . . 73.209999999999994 111.107 -174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -151.73 167.77 27.15 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.772 -1.103 . . . . 73.519999999999996 108.942 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.62 171.11 14.5 Favored 'General case' 0 C--O 1.204 -1.32 0 N-CA-C 105.721 -1.955 . . . . 71.140000000000001 105.721 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 19.4 mt -127.68 125.55 65.47 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 105.472 -2.047 . . . . 73.0 105.472 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.411 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -112.3 146.48 38.17 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 108.632 -0.877 . . . . 62.109999999999999 108.632 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 63.4 mt -82.24 147.41 28.96 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.866 -1.531 . . . . 73.450000000000003 106.866 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -73.49 -82.72 0.34 Allowed Glycine 0 C--O 1.224 -0.505 0 N-CA-C 109.941 -1.264 . . . . 64.219999999999999 109.941 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -158.42 129.85 3.9 Favored Pre-proline 0 C--N 1.324 -0.501 0 N-CA-C 106.7 -1.593 . . . . 72.230000000000004 106.7 174.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -71.85 139.09 32.75 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 117.652 -1.099 . . . . 62.119999999999997 110.608 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -131.64 143.24 50.16 Favored 'General case' 0 C--O 1.211 -0.921 0 N-CA-C 109.332 -0.618 . . . . 71.549999999999997 109.332 -175.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.477 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 0.5 OUTLIER -83.23 114.02 21.08 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.221 -1.029 . . . . 74.019999999999996 108.221 -177.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.428 14.0 mmt -123.23 80.9 1.82 Allowed 'General case' 0 N--CA 1.434 -1.251 0 CA-C-O 125.554 2.597 . . . . 70.400000000000006 112.167 159.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.463 ' CB ' ' H ' ' A' ' 561' ' ' THR . 21.5 tt0 -152.25 164.99 36.28 Favored 'General case' 0 C--N 1.279 -2.495 3 N-CA-C 94.581 -6.081 . . . . 54.420000000000002 94.581 155.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.477 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 18.4 mmt180 77.89 -52.25 0.51 Allowed 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.711 1.374 . . . . 74.540000000000006 114.711 171.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.02 60.42 6.06 Favored Glycine 0 C--O 1.221 -0.69 0 N-CA-C 109.945 -1.262 . . . . 73.030000000000001 109.945 -176.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -35.33 -49.55 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 N-CA-C 115.901 1.815 . . . . 72.219999999999999 115.901 -175.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 7.5 t 52.75 -137.14 1.27 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.518 0.327 . . . . 64.109999999999999 110.697 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.98 140.23 52.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.644 -1.613 . . . . 64.310000000000002 106.644 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.45 84.78 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 108.362 -0.977 . . . . 55.420000000000002 108.362 -175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 85.2 m -116.53 -38.31 3.54 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.461 1.282 . . . . 71.200000000000003 114.461 -174.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.07 -2.12 11.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 114.552 1.315 . . . . 55.100000000000001 114.552 -176.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 25.6 mmt85 -81.97 79.11 8.58 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.912 -0.492 . . . . 74.530000000000001 111.895 -174.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.0 tptt -69.17 126.06 28.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.722 -1.214 . . . . 73.319999999999993 107.722 175.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.5 mt -136.82 -174.62 3.77 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 104.381 -2.452 . . . . 74.310000000000002 104.381 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.0 t -66.7 155.15 38.8 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 104.988 -2.227 . . . . 60.020000000000003 104.988 169.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.3 m -65.75 -23.22 32.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 113.311 0.856 . . . . 41.219999999999999 113.311 -161.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -72.32 -49.6 33.29 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.02 0.914 . . . . 73.420000000000002 109.082 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -70.42 -21.3 62.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.691 -1.141 . . . . 63.140000000000001 111.86 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -56.21 -46.86 79.33 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 119.275 -0.393 . . . . 74.230000000000004 110.587 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -87.93 -46.39 9.42 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 119.82 -0.752 . . . . 63.210000000000001 112.744 167.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.21 -49.58 77.29 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 113.404 0.89 . . . . 61.229999999999997 113.404 -169.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 3.2 tptm -65.99 -43.62 87.27 Favored 'General case' 0 C--O 1.21 -0.986 0 N-CA-C 108.184 -1.043 . . . . 65.319999999999993 108.184 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -56.83 -47.75 79.59 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 111.998 0.37 . . . . 72.310000000000002 111.998 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 52.1 mt -62.3 -42.08 94.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.13 0.491 . . . . 71.530000000000001 109.733 179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -65.8 -33.41 75.79 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 122.014 -0.429 . . . . 72.430000000000007 111.492 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -72.58 -23.52 60.97 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 122.242 0.217 . . . . 75.109999999999999 110.555 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 47.4 mtt -69.65 -41.78 75.11 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.168 -1.049 . . . . 72.239999999999995 108.168 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.41 15.85 25.88 Favored Glycine 0 C--O 1.22 -0.735 0 N-CA-C 116.348 1.299 . . . . 51.009999999999998 116.348 172.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -57.89 119.72 36.35 Favored Pre-proline 0 N--CA 1.469 0.523 0 N-CA-C 114.758 1.392 . . . . 62.399999999999999 114.758 -169.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.14 162.57 41.33 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 118.462 -0.559 . . . . 70.329999999999998 111.376 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.4 m -137.3 170.46 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 115.429 -0.805 . . . . 63.450000000000003 110.892 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.41 155.75 26.98 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 110.089 -0.337 . . . . 44.219999999999999 110.089 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -94.56 -158.5 33.3 Favored Glycine 0 C--O 1.224 -0.506 0 N-CA-C 115.959 1.144 . . . . 55.340000000000003 115.959 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 26.8 mp0 -82.0 -30.4 31.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.274 -0.963 . . . . 71.319999999999993 110.774 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -130.05 60.1 49.7 Favored Pre-proline 0 N--CA 1.474 0.748 0 N-CA-C 112.694 0.627 . . . . 75.230000000000004 112.694 178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -78.48 27.85 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 121.141 1.227 . . . . 74.340000000000003 112.847 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.411 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 6.3 ttpt -155.14 152.42 29.43 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 115.516 -0.765 . . . . 41.100000000000001 109.376 -174.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.473 HD23 HG12 ' A' ' 550' ' ' VAL . 20.5 tp -132.83 123.02 25.32 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.337 -1.357 . . . . 71.239999999999995 107.337 175.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -87.59 124.4 33.47 Favored 'General case' 0 C--O 1.221 -0.421 0 O-C-N 123.45 0.469 . . . . 43.5 109.805 177.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.706 HG13 HG23 ' A' ' 539' ' ' ILE . 3.4 t -117.87 134.68 60.7 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.742 0 N-CA-C 107.718 -1.215 . . . . 71.219999999999999 107.718 -176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.5 mm -109.88 133.01 56.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 103.302 -2.851 . . . . 42.140000000000001 103.302 175.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 75.8 mt -94.94 92.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 104.957 -2.238 . . . . 71.430000000000007 104.957 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -169.41 142.91 2.74 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 107.329 -1.36 . . . . 73.329999999999998 107.329 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 51.95 -173.63 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 115.888 1.81 . . . . 44.43 115.888 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 26.6 m -81.19 145.77 30.83 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.678 -0.639 . . . . 72.310000000000002 111.448 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 24.0 p90 -82.63 156.93 23.62 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.836 -0.62 . . . . 75.439999999999998 109.395 176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.79 -58.21 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.989 -1.486 . . . . 70.140000000000001 106.989 173.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 58.75 169.14 0.06 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 114.693 1.368 . . . . 75.219999999999999 114.693 178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -153.46 32.43 0.46 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.669 -0.696 . . . . 73.319999999999993 111.642 -175.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 30.3 p -77.64 38.95 0.26 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.964 0.727 . . . . 75.439999999999998 112.964 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 40.6 p -117.97 -3.58 11.14 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.985 -0.746 . . . . 61.329999999999998 108.985 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 20.2 m -143.63 169.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.581 -1.637 . . . . 71.150000000000006 106.581 -179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 28.5 t70 . . . . . 0 C--O 1.251 1.179 0 CA-C-O 116.707 -1.615 . . . . 61.130000000000003 106.965 175.917 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.222 -0.347 0 N-CA-C 108.627 -0.879 . . . . 74.519999999999996 108.627 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -80.97 152.06 28.18 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 109.308 -0.627 . . . . 55.43 109.308 175.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -87.58 176.46 46.36 Favored Glycine 0 C--O 1.225 -0.443 0 N-CA-C 119.386 2.515 . . . . 55.439999999999998 119.386 -173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.486 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -71.75 144.11 13.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 113.352 -1.424 . . . . 73.340000000000003 108.558 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -118.75 131.92 56.13 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.573 0.545 . . . . 73.140000000000001 109.95 173.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.6 t -156.27 168.1 28.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.911 -1.144 . . . . 73.319999999999993 107.911 -173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.483 ' CZ ' HG11 ' A' ' 550' ' ' VAL . 14.4 m-30 -105.2 167.7 9.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.397 0.617 . . . . 73.200000000000003 109.682 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -67.16 -40.6 86.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.502 -1.226 . . . . 73.010000000000005 114.102 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 78.3 m -140.95 167.72 21.52 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.726 -0.842 . . . . 60.43 108.726 -175.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.7 p30 -122.7 3.09 9.55 Favored 'General case' 0 C--O 1.215 -0.757 0 N-CA-C 113.071 0.767 . . . . 64.109999999999999 113.071 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 30.6 m -146.24 127.06 14.4 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.365 -0.976 . . . . 75.5 108.365 175.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.75 160.64 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 124.182 0.993 . . . . 52.049999999999997 108.692 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 7.0 m170 -126.69 125.14 41.34 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.146 -1.798 . . . . 73.109999999999999 106.146 171.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.4 m -114.05 174.37 2.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 104.679 -2.341 . . . . 62.329999999999998 104.679 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . 0.416 ' O ' HG22 ' A' ' 545' ' ' ILE . 6.6 m -137.83 161.55 36.3 Favored 'General case' 0 C--O 1.209 -1.078 0 N-CA-C 104.122 -2.548 . . . . 73.0 104.122 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.67 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 2.3 mp0 -57.75 -39.64 77.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 122.362 1.077 . . . . 61.030000000000001 111.162 -178.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 5.6 m -67.94 -8.39 36.55 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.343 -1.299 . . . . 71.409999999999997 114.111 -175.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . 0.416 HG22 ' O ' ' A' ' 542' ' ' SER . 2.8 tt -68.49 -26.26 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.724 -0.473 . . . . 74.230000000000004 109.724 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 81.96 -67.94 3.58 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.641 -0.79 . . . . 75.530000000000001 112.775 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 96.6 t -137.28 118.85 18.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.287 0.565 . . . . 61.240000000000002 109.689 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.478 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.8 ppp? -82.11 153.57 26.0 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.244 -0.65 . . . . 51.130000000000003 109.244 177.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -132.19 141.99 49.28 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.178 0.99 . . . . 53.5 113.387 174.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.483 HG11 ' CZ ' ' A' ' 534' ' ' PHE . 0.9 OUTLIER -112.22 132.52 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 105.081 -2.192 . . . . 64.140000000000001 105.081 174.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -95.07 126.86 40.7 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.829 -1.545 . . . . 72.439999999999998 106.829 174.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.4 t -109.51 123.86 65.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.917 -0.771 . . . . 74.120000000000005 108.917 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.2 161.61 13.88 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-O 121.406 0.622 . . . . 74.430000000000007 109.906 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -137.23 132.24 33.54 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 105.729 -1.952 . . . . 71.409999999999997 105.729 176.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.744 HG23 ' H ' ' A' ' 557' ' ' GLY . 4.7 t -69.8 175.58 4.21 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 120.895 -0.322 . . . . 73.310000000000002 111.309 -175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 77.1 p -68.13 6.37 0.75 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.45 1.278 . . . . 72.25 114.45 -178.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.744 ' H ' HG23 ' A' ' 555' ' ' THR . . . -81.32 16.66 16.44 Favored Glycine 0 C--O 1.206 -1.647 0 N-CA-C 109.527 -1.429 . . . . 71.120000000000005 109.527 170.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -74.83 66.21 1.48 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 115.575 1.695 . . . . 60.350000000000001 115.575 -172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -94.67 117.24 29.81 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.176 -1.046 . . . . 73.439999999999998 108.176 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 80.72 -170.39 53.13 Favored Glycine 0 C--N 1.318 -0.462 0 CA-C-N 115.877 -0.601 . . . . 74.310000000000002 114.443 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 87.4 m -107.67 135.03 49.79 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 123.699 0.8 . . . . 71.549999999999997 108.878 -176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . 0.526 ' HA ' ' H ' ' A' ' 624' ' ' MET . 0.3 OUTLIER -133.67 155.67 40.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 105.501 -2.037 . . . . 74.120000000000005 105.501 179.051 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 3.1 tt -117.29 141.1 37.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.471 -2.048 . . . . 75.420000000000002 105.471 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 5.1 t -133.45 112.24 12.89 Favored Pre-proline 0 N--CA 1.471 0.616 0 N-CA-C 114.056 1.132 . . . . 72.299999999999997 114.056 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.07 154.5 47.34 Favored 'Trans proline' 0 CA--C 1.509 -0.758 0 N-CA-C 115.712 1.389 . . . . 70.239999999999995 115.712 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -140.65 166.56 24.41 Favored 'General case' 0 CA--C 1.509 -0.611 0 N-CA-C 107.625 -1.25 . . . . 72.109999999999999 107.625 172.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.59 154.04 27.84 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.373 -0.973 . . . . 72.530000000000001 108.373 172.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 25.0 m -84.93 136.19 33.73 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.532 -1.284 . . . . 74.129999999999995 107.532 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 61.9 t -124.77 112.71 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.881 0 N-CA-C 104.035 -2.58 . . . . 65.430000000000007 104.035 -170.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.07 133.99 35.31 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 114.599 -1.182 . . . . 54.25 110.443 -179.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -98.98 -77.96 1.35 Allowed Glycine 0 CA--C 1.509 -0.333 0 N-CA-C 107.386 -2.285 . . . . 52.109999999999999 107.386 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.02 110.5 18.32 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.895 -1.891 . . . . 71.209999999999994 105.895 163.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -176.6 175.09 1.77 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.419 -2.808 . . . . 52.240000000000002 103.419 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -89.92 -34.94 15.86 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.634 0.73 . . . . 45.340000000000003 109.778 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 71.72 -166.27 53.24 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.145 -0.934 . . . . 42.420000000000002 113.941 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 73.54 -107.51 2.25 Favored Glycine 0 C--O 1.221 -0.708 0 N-CA-C 110.169 -1.172 . . . . 34.439999999999998 110.169 179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.64 16.37 7.91 Favored Glycine 0 C--O 1.219 -0.826 0 CA-C-O 118.224 -1.32 . . . . 65.310000000000002 112.971 174.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 63.2 tt0 -94.98 -48.87 5.8 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.549 1.685 . . . . 70.530000000000001 115.549 -167.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.37 -31.88 9.81 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.349 1.071 . . . . 73.200000000000003 108.125 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -151.32 161.31 42.95 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 105.987 -1.857 . . . . 72.310000000000002 105.987 177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -88.74 124.63 34.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.178 -1.416 . . . . 63.219999999999999 107.178 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -61.12 110.57 1.41 Allowed 'General case' 0 CA--C 1.489 -1.367 0 CA-C-O 123.549 1.643 . . . . 74.099999999999994 109.157 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.483 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.65 110.16 22.13 Favored 'General case' 0 N--CA 1.419 -1.985 0 CA-C-N 111.702 -2.499 . . . . 63.119999999999997 110.527 -171.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 13.5 p90 -136.55 144.74 44.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 71.420000000000002 109.677 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -177.77 -170.8 40.48 Favored Glycine 0 CA--C 1.501 -0.806 0 N-CA-C 108.173 -1.971 . . . . 42.439999999999998 108.173 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -121.24 148.84 43.73 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 117.547 0.673 . . . . 74.329999999999998 110.25 177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.3 mt -117.31 121.03 40.02 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-N 115.07 -0.968 . . . . 75.519999999999996 109.768 -177.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -75.73 135.94 40.33 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.952 -1.499 . . . . 73.409999999999997 106.952 174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -131.09 116.81 18.24 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.661 -1.154 . . . . 74.439999999999998 109.649 178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.649 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 47.9 mttp -106.06 -177.12 3.27 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 71.25 108.978 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -49.18 -54.48 16.26 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 116.456 2.021 . . . . 75.099999999999994 116.456 178.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.25 -27.06 32.67 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.452 1.12 . . . . 64.200000000000003 111.046 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.649 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 80.8 mt-10 -65.85 17.22 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 117.967 2.58 . . . . 75.239999999999995 117.967 -178.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 69.1 p -71.45 13.79 0.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.108 -0.995 . . . . 50.32 113.169 -168.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.17 122.1 57.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.296 -2.112 . . . . 72.219999999999999 105.296 168.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -143.72 170.49 15.76 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.86 -1.533 . . . . 74.209999999999994 106.86 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.84 152.58 47.96 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 113.147 0.795 . . . . 41.240000000000002 113.147 -178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . . . . . . . . . 66.8 mt -113.65 134.9 54.96 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.006 0 N-CA-C 105.745 -1.946 . . . . 75.109999999999999 105.745 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -115.47 136.4 53.12 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 123.587 0.555 . . . . 51.5 110.563 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.483 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.0 t -133.88 130.43 55.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 108.158 -1.053 . . . . 64.129999999999995 108.158 178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 56.7 mttt -77.01 141.67 40.25 Favored 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 109.145 -0.687 . . . . 55.530000000000001 109.145 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.52 129.91 57.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 104.312 -2.477 . . . . 72.409999999999997 104.312 172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 97.3 t -88.17 142.1 13.39 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 107.641 -1.244 . . . . 50.109999999999999 107.641 -176.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -133.75 119.2 18.98 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.884 -0.784 . . . . 73.310000000000002 108.884 -174.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -144.94 61.86 1.31 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.899 0.856 . . . . 62.509999999999998 109.111 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 63.83 -136.79 0.33 Allowed 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.621 -1.172 . . . . 63.240000000000002 113.205 177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -77.46 64.3 2.78 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.443 0.639 . . . . 44.119999999999997 112.173 -175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -90.83 113.98 26.28 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.203 0.816 . . . . 73.140000000000001 113.203 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 52.01 -137.42 1.2 Allowed 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 118.231 -0.89 . . . . 72.540000000000006 111.573 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.24 -44.98 0.07 Allowed 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 119.769 3.248 . . . . 63.539999999999999 119.769 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -150.15 79.81 1.36 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.538 -0.912 . . . . 74.450000000000003 108.538 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -89.65 149.03 22.98 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.777 -0.823 . . . . 75.319999999999993 108.777 -176.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -128.47 127.04 41.72 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.08 -1.081 . . . . 72.129999999999995 108.08 -169.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.48 169.58 17.31 Favored 'General case' 0 C--O 1.197 -1.674 0 N-CA-C 108.031 -1.1 . . . . 71.540000000000006 108.031 173.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.8 171.57 13.88 Favored 'General case' 0 C--O 1.208 -1.088 0 N-CA-C 104.921 -2.251 . . . . 74.209999999999994 104.921 177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 1.3 mt -131.38 114.84 26.93 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.187 -1.783 . . . . 73.239999999999995 106.187 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.414 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.22 149.91 26.39 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.897 -1.519 . . . . 74.140000000000001 106.897 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 66.3 mt -87.4 152.34 22.33 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.403 -0.962 . . . . 70.150000000000006 108.403 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.59 -83.91 0.41 Allowed Glycine 0 C--O 1.223 -0.545 0 N-CA-C 109.104 -1.599 . . . . 75.230000000000004 109.104 176.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -160.94 133.52 4.45 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 106.089 -1.819 . . . . 52.219999999999999 106.089 173.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.56 139.78 41.75 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 116.442 -1.905 . . . . 54.509999999999998 110.288 175.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -128.87 135.16 48.71 Favored 'General case' 0 C--O 1.198 -1.607 0 N-CA-C 108.074 -1.084 . . . . 70.230000000000004 108.074 -177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.674 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.9 t90 -83.12 109.61 17.31 Favored 'General case' 0 CA--C 1.494 -1.179 0 O-C-N 121.905 -0.497 . . . . 74.430000000000007 110.389 -173.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . 0.526 ' H ' ' HA ' ' A' ' 562' ' ' VAL 0.496 12.9 mmt -123.46 81.59 1.91 Allowed 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 124.678 2.18 . . . . 60.399999999999999 114.121 166.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.347 2.7 tt0 -152.6 88.67 1.36 Allowed 'General case' 1 C--O 1.143 -4.543 2 CA-C-O 110.883 -4.389 . . . . 64.010000000000005 99.585 146.074 . . . . . . . . 5 3 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.674 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 0.5 OUTLIER 162.2 -59.18 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.184 1 CA-C-N 128.073 4.942 . . . . 55.210000000000001 107.94 179.434 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 82.4 72.89 1.24 Allowed Glycine 0 C--O 1.225 -0.458 0 N-CA-C 109.962 -1.255 . . . . 65.319999999999993 109.962 -173.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 1.2 tt -58.36 121.48 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.246 -0.65 . . . . 54.32 109.246 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 16.0 t -165.44 -179.07 5.29 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 104.688 -2.338 . . . . 73.310000000000002 104.688 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -125.29 146.31 49.61 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.879 -0.786 . . . . 73.129999999999995 108.879 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.34 -19.67 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 116.031 -0.531 . . . . 74.319999999999993 111.35 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 56.87 -168.75 0.1 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.122 0.569 . . . . 75.319999999999993 110.514 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 32.3 t70 62.64 -14.8 0.06 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 116.98 2.215 . . . . 74.409999999999997 116.98 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.52 79.27 7.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 121.015 -1.053 . . . . 64.310000000000002 111.849 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -66.99 134.42 51.92 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 106.791 -1.559 . . . . 62.100000000000001 106.791 173.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 58.0 mt -136.88 -169.7 2.53 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 103.855 -2.646 . . . . 70.219999999999999 103.855 -176.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 12.3 t -70.05 149.79 47.3 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 102.386 -3.19 . . . . 71.310000000000002 102.386 166.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.4 m -65.5 -21.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.514 0.561 . . . . 72.549999999999997 112.514 -162.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -68.31 -47.64 67.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.971 0.891 . . . . 72.219999999999999 109.372 175.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -73.12 -21.28 60.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.021 -0.991 . . . . 72.439999999999998 112.296 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.31 -46.42 83.21 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.795 -0.362 . . . . 72.010000000000005 110.479 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -87.89 -43.03 12.1 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 119.236 -0.986 . . . . 74.310000000000002 112.632 169.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.42 94.85 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 119.008 0.822 . . . . 44.25 113.065 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -68.04 -40.8 82.77 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 108.576 -0.898 . . . . 65.109999999999999 108.576 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 48.9 ttt-85 -59.99 -46.68 88.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.069 0.396 . . . . 72.5 112.069 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.1 mt -63.56 -40.31 88.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.488 0.661 . . . . 63.229999999999997 109.681 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.66 -33.41 75.57 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.09 0.471 . . . . 61.329999999999998 110.989 179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -72.21 -24.91 61.47 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.04 -0.527 . . . . 73.120000000000005 111.335 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 50.8 mtt -73.59 -41.55 62.74 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.904 -1.147 . . . . 72.310000000000002 107.904 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.534 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.17 19.83 40.55 Favored Glycine 0 C--O 1.225 -0.458 0 N-CA-C 115.685 1.034 . . . . 32.140000000000001 115.685 169.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 116.36 14.7 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 113.996 1.11 . . . . 72.030000000000001 113.996 -167.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.68 160.06 51.13 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 118.416 -0.59 . . . . 75.420000000000002 111.267 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.78 169.58 21.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.513 -0.767 . . . . 75.219999999999999 111.488 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -81.65 162.99 22.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.767 -0.827 . . . . 73.409999999999997 108.767 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -106.47 -153.83 20.26 Favored Glycine 0 C--O 1.223 -0.564 0 CA-C-O 121.768 0.649 . . . . 74.430000000000007 113.954 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.503 ' H ' ' CD ' ' A' ' 656' ' ' GLU . 1.1 mp0 -79.34 -33.15 43.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.789 -0.706 . . . . 53.439999999999998 112.65 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . 0.413 ' CD2' ' HB2' ' A' ' 656' ' ' GLU . 18.4 m-70 -127.48 58.12 29.21 Favored Pre-proline 0 C--O 1.209 -1.057 0 N-CA-C 112.64 0.607 . . . . 74.329999999999998 112.64 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -76.02 26.59 0.41 Allowed 'Trans proline' 0 CA--C 1.544 0.999 0 N-CA-C 114.565 0.948 . . . . 42.240000000000002 114.565 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 28.1 ttpp -158.6 143.39 16.07 Favored 'General case' 0 CA--C 1.507 -0.702 0 C-N-CA 123.271 0.629 . . . . 62.340000000000003 109.404 -176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.447 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -117.4 122.87 45.01 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.078 -2.193 . . . . 54.009999999999998 105.078 176.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.57 136.47 33.77 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 108.039 -1.097 . . . . 71.230000000000004 108.039 175.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -124.01 147.1 28.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 C-N-CA 123.908 0.883 . . . . 61.439999999999998 109.793 -175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 3.6 mm -131.45 134.89 60.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 104.334 -2.469 . . . . 75.109999999999999 104.334 174.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 59.1 mt -88.39 112.92 24.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 105.468 -2.049 . . . . 72.319999999999993 105.468 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.88 161.06 14.99 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.386 0.674 . . . . 74.510000000000005 112.008 -175.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -88.35 -43.68 11.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.358 -1.349 . . . . 63.5 107.358 167.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.7 t -70.03 117.75 12.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.361 -0.836 . . . . 61.109999999999999 112.64 -174.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -146.93 146.28 30.08 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.106 -0.702 . . . . 72.430000000000007 109.106 176.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -135.78 129.8 33.07 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.335 -0.987 . . . . 72.319999999999993 108.335 174.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -84.59 134.23 34.4 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 107.108 -1.441 . . . . 74.219999999999999 107.108 174.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.7 tptt -125.93 -55.69 1.48 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.46 1.282 . . . . 74.409999999999997 114.46 -177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 7.3 t 59.17 -169.83 0.13 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.388 0.675 . . . . 72.150000000000006 110.206 -174.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 8.1 t -157.02 -33.49 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 64.340000000000003 111.61 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 12.7 t 70.34 150.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.81 1.244 . . . . 73.019999999999996 109.569 -176.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.245 0.821 0 N-CA-C 102.515 -3.143 . . . . 74.349999999999994 102.515 -179.031 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.501 -0.93 0 N-CA-C 106.388 -1.708 . . . . 73.129999999999995 106.388 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -97.0 159.69 14.76 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 106.198 -1.778 . . . . 73.140000000000001 106.198 170.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.61 175.11 43.67 Favored Glycine 0 C--O 1.223 -0.571 0 N-CA-C 118.18 2.032 . . . . 71.439999999999998 118.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.556 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -72.81 142.23 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 106.92 -1.511 . . . . 64.349999999999994 106.92 171.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -121.53 135.52 55.01 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 108.641 -0.874 . . . . 74.140000000000001 108.641 173.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 13.9 t -156.09 164.48 38.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.749 -0.834 . . . . 74.420000000000002 108.749 -172.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -97.68 171.55 8.26 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.513 -0.551 . . . . 70.340000000000003 109.513 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 553' ' ' LEU . 44.6 mt-10 -64.74 -50.52 66.53 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.637 -1.165 . . . . 73.439999999999998 113.514 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 67.9 m -136.47 -179.35 5.63 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.909 -1.145 . . . . 73.219999999999999 107.909 -174.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -128.3 7.47 5.92 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.836 0.68 . . . . 74.200000000000003 112.836 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 20.1 m -149.66 131.73 15.33 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 107.674 -1.232 . . . . 62.350000000000001 107.674 174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.732 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -146.78 159.78 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.308 1.043 . . . . 75.230000000000004 108.581 -179.386 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -121.69 128.55 51.96 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.752 -0.462 . . . . 71.129999999999995 109.752 171.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.477 HG22 HG12 ' A' ' 662' ' ' VAL . 29.6 m -119.76 172.6 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 N-CA-C 108.718 -0.845 . . . . 71.439999999999998 108.718 167.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 4.5 t -122.09 155.6 35.34 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 102.201 -3.259 . . . . 53.409999999999997 102.201 172.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -58.33 -33.4 69.47 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.628 0.727 . . . . 62.039999999999999 110.899 175.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 67.5 m -65.3 -9.0 20.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.017 -0.992 . . . . 64.340000000000003 113.132 -177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.1 tt -67.81 -26.47 35.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 122.107 -0.371 . . . . 74.239999999999995 110.148 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.62 -63.28 4.43 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.647 -0.787 . . . . 45.109999999999999 112.769 -178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.1 121.84 17.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.319 -0.623 . . . . 73.310000000000002 109.319 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.413 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.1 ppp? -85.02 153.64 22.61 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.584 -0.895 . . . . 71.540000000000006 108.584 176.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -139.3 143.35 37.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.221 0.452 . . . . 54.439999999999998 112.221 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.98 143.88 28.87 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.811 0 N-CA-C 105.068 -2.197 . . . . 72.310000000000002 105.068 170.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.4 mttp -97.37 133.62 41.72 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 107.305 -1.369 . . . . 74.540000000000006 107.305 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 2.6 t -103.39 120.98 54.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 63.509999999999998 109.332 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.435 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.3 OUTLIER -108.61 161.5 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.081 0.953 . . . . 65.219999999999999 108.696 -178.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.458 ' CD ' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -138.63 149.84 45.63 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 109.616 -0.512 . . . . 73.109999999999999 109.616 -177.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.556 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.4 t -75.86 175.22 8.97 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.291 0.636 . . . . 74.219999999999999 112.317 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.9 m -65.96 27.05 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 116.833 2.16 . . . . 45.420000000000002 116.833 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -103.51 13.86 54.18 Favored Glycine 0 C--O 1.209 -1.416 0 N-CA-C 114.413 0.525 . . . . 74.340000000000003 114.413 -179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.458 ' HB2' ' CD ' ' A' ' 554' ' ' ARG . . . -75.29 104.01 5.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.024 1.412 . . . . 61.020000000000003 111.956 -177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 77.4 mtt-85 -127.81 110.46 12.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 105.731 -1.951 . . . . 75.439999999999998 105.731 175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 85.41 -155.82 29.97 Favored Glycine 0 C--O 1.238 0.396 0 C-N-CA 120.559 -0.829 . . . . 54.240000000000002 113.807 -176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 94.8 m -113.17 135.33 53.93 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 122.258 1.027 . . . . 74.349999999999994 108.895 -176.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 72.0 t -129.08 143.85 39.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 106.652 -1.61 . . . . 65.109999999999999 106.652 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.13 141.01 35.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.573 -1.64 . . . . 61.340000000000003 106.573 175.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.3 t -136.23 117.74 11.63 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 113.252 0.834 . . . . 63.340000000000003 113.252 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.41 155.34 36.48 Favored 'Trans proline' 0 CA--C 1.503 -1.051 0 N-CA-C 115.648 1.365 . . . . 51.109999999999999 115.648 173.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -139.46 165.57 26.88 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 106.838 -1.542 . . . . 72.319999999999993 106.838 172.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.546 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -157.07 152.89 27.03 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.546 -1.279 . . . . 74.230000000000004 107.546 172.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 86.0 m -81.16 131.4 35.3 Favored 'General case' 0 C--O 1.209 -1.032 0 N-CA-C 105.862 -1.903 . . . . 74.409999999999997 105.862 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.546 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.2 t -120.15 106.17 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.822 0 N-CA-C 105.493 -2.04 . . . . 71.239999999999995 105.493 -175.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.634 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 1.5 pm0 -76.09 136.65 39.87 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 114.916 -1.038 . . . . 74.230000000000004 109.135 -179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -106.1 -74.12 0.9 Allowed Glycine 0 CA--C 1.509 -0.296 0 N-CA-C 107.917 -2.073 . . . . 71.230000000000004 107.917 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 5.4 t -117.54 110.49 18.02 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 103.238 -2.875 . . . . 51.039999999999999 103.238 164.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 170.66 163.79 0.07 Allowed 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 102.362 -3.199 . . . . 73.319999999999993 102.362 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 2.5 tptp -100.54 -16.58 17.45 Favored 'General case' 0 CA--C 1.557 1.236 0 CA-C-N 118.908 0.777 . . . . 71.340000000000003 109.288 177.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 65.1 -165.55 34.53 Favored Glycine 0 C--O 1.223 -0.534 0 O-C-N 121.813 -0.554 . . . . 75.209999999999994 113.488 176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 79.85 -104.4 2.2 Favored Glycine 0 C--O 1.218 -0.873 0 O-C-N 121.493 -1.004 . . . . 45.539999999999999 112.877 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.85 13.01 8.15 Favored Glycine 0 C--O 1.22 -0.759 0 CA-C-O 119.186 -0.786 . . . . 75.400000000000006 111.402 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.37 -64.18 1.09 Allowed 'General case' 0 C--O 1.213 -0.846 0 N-CA-C 116.01 1.855 . . . . 74.5 116.01 -162.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -97.09 -35.09 10.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 123.403 1.573 . . . . 75.109999999999999 107.329 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -160.05 165.74 31.27 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 103.699 -2.704 . . . . 73.510000000000005 103.699 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -86.4 149.83 24.74 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 112.114 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -68.09 88.45 0.29 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.934 0.873 . . . . 64.230000000000004 109.35 175.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -97.16 104.45 16.47 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.818 0.818 . . . . 71.409999999999997 112.029 -174.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 32.7 p90 -136.56 145.45 45.01 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.765 -0.652 . . . . 73.239999999999995 109.544 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -174.55 -173.63 40.64 Favored Glycine 0 CA--C 1.5 -0.867 0 N-CA-C 109.178 -1.569 . . . . 74.329999999999998 109.178 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -118.27 147.26 43.62 Favored 'General case' 0 CA--C 1.502 -0.904 0 CA-C-O 121.679 0.752 . . . . 65.299999999999997 109.428 175.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 21.1 mt -115.44 123.89 49.75 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.581 -1.19 . . . . 64.030000000000001 108.976 -177.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -82.39 127.12 32.95 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.726 -1.212 . . . . 70.510000000000005 107.726 174.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . 0.404 ' HD2' ' HA ' ' A' ' 594' ' ' THR . 79.6 m-85 -115.93 116.83 28.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 104.492 -2.41 . . . . 73.120000000000005 104.492 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.619 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 2.6 ttmp? -121.82 99.76 6.62 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 122.406 0.282 . . . . 74.450000000000003 110.7 -172.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 45.24 -76.64 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 118.276 2.695 . . . . 42.310000000000002 118.276 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 594' ' ' THR . 21.3 t0 -82.25 -33.03 29.4 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 113.577 0.955 . . . . 64.439999999999998 113.577 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.619 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 82.9 mt-10 -58.5 16.74 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 117.915 2.561 . . . . 75.230000000000004 117.915 -178.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.404 ' HA ' ' HD2' ' A' ' 589' ' ' PHE . 80.4 p -72.68 13.42 0.37 Allowed 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 124.837 1.255 . . . . 75.409999999999997 113.724 -171.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.9 t -116.74 116.89 53.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.382 -2.822 . . . . 72.140000000000001 103.382 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -144.23 173.5 11.7 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 108.56 -0.904 . . . . 71.349999999999994 108.56 -174.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.37 158.68 43.55 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.47 0.545 . . . . 53.409999999999997 112.47 -177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' A' ' 550' ' ' VAL . 73.6 mt -121.54 130.43 74.63 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.11 -1.441 . . . . 71.329999999999998 107.11 175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -110.36 137.2 48.39 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 124.066 0.854 . . . . 64.329999999999998 111.68 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 583' ' ' ALA . 62.1 t -134.32 124.15 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 107.491 -1.3 . . . . 64.109999999999999 107.491 176.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -80.74 130.55 35.14 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 108.48 -0.933 . . . . 73.340000000000003 108.48 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.423 HG21 ' HA ' ' A' ' 543' ' ' GLU . 18.0 mm -97.44 128.73 48.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 105.993 -1.854 . . . . 65.430000000000007 105.993 178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 88.0 t -82.35 142.23 13.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.768 -0.456 . . . . 73.099999999999994 109.768 -173.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -132.06 133.13 44.02 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.051 0.541 . . . . 71.5 112.44 -173.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -169.5 -65.42 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 105.949 -1.871 . . . . 62.539999999999999 105.949 175.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -152.27 158.63 43.08 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 102.81 -3.033 . . . . 72.400000000000006 102.81 171.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.04 -29.38 9.95 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 115.083 1.512 . . . . 62.219999999999999 115.083 -170.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 62.07 -58.71 0.12 Allowed 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 117.067 2.247 . . . . 62.009999999999998 117.067 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -87.18 176.49 7.55 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.484 -0.561 . . . . 65.439999999999998 109.484 179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -114.36 -20.49 10.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.71 1.004 . . . . 75.239999999999995 113.71 -175.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -153.08 84.81 1.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.89 0.7 . . . . 64.400000000000006 112.89 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -90.86 158.56 16.72 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.181 -1.044 . . . . 72.519999999999996 108.181 175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -145.68 130.74 18.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.026 0.441 . . . . 74.510000000000005 110.922 -175.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -142.43 171.58 13.86 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.331 -0.989 . . . . 74.219999999999999 108.331 177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.55 171.45 14.67 Favored 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.008 -0.738 . . . . 73.439999999999998 109.008 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.403 HG21 HG21 ' A' ' 598' ' ' ILE . 19.7 mt -128.58 117.34 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 N-CA-C 106.685 -1.598 . . . . 51.32 106.685 176.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.424 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.35 149.99 26.43 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.024 -1.102 . . . . 75.329999999999998 108.024 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 72.0 mt -86.79 146.47 26.23 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.869 -1.159 . . . . 75.430000000000007 107.869 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -75.31 -86.7 0.29 Allowed Glycine 0 C--O 1.22 -0.767 0 CA-C-O 123.038 1.354 . . . . 65.329999999999998 110.787 179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.57 118.41 3.24 Favored Pre-proline 0 CA--C 1.501 -0.939 0 CA-C-N 113.712 -1.244 . . . . 72.219999999999999 109.854 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.69 139.34 47.99 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 116.611 -1.793 . . . . 73.109999999999999 109.506 174.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -132.39 139.28 48.02 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 108.1 -1.074 . . . . 75.030000000000001 108.1 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 3.0 t90 -83.33 110.54 18.21 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 108.21 -1.033 . . . . 72.530000000000001 108.21 -177.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.47 11.5 mmt -123.44 81.8 1.93 Allowed 'General case' 0 N--CA 1.426 -1.67 0 C-N-CA 115.656 -2.418 . . . . 74.430000000000007 113.951 165.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.328 3.7 tt0 -153.08 91.82 1.56 Allowed 'General case' 1 C--O 1.138 -4.773 2 CA-C-O 110.42 -4.61 . . . . 72.209999999999994 101.168 146.868 . . . . . . . . 5 3 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP 0.256 10.3 mmm180 166.49 -76.13 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.212 1 CA-C-N 129.093 5.406 . . . . 72.519999999999996 112.061 176.556 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 95.13 106.16 2.06 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 105.105 -3.198 . . . . 74.519999999999996 105.105 -163.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.09 126.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.704 0.288 . . . . 74.420000000000002 110.251 -172.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 73.9 m 62.31 -33.02 0.1 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.647 2.832 . . . . 64.239999999999995 118.647 -178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.4 -170.2 0.16 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.416 0.687 . . . . 61.450000000000003 111.886 -177.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -34.06 126.43 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 C-N-CA 125.615 1.566 . . . . 74.120000000000005 114.794 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 20.2 p -72.23 -14.27 61.74 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 114.45 1.278 . . . . 64.519999999999996 114.45 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -77.94 12.93 1.55 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.75 0.648 . . . . 60.420000000000002 112.75 -177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -81.06 64.0 5.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.732 0.777 . . . . 74.329999999999998 112.042 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -64.5 136.29 56.9 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 107.451 -1.315 . . . . 75.049999999999997 107.451 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 27.0 mt -140.02 -172.29 3.37 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 106.104 -1.813 . . . . 54.409999999999997 106.104 -174.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 13.7 t -69.04 150.94 47.08 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 103.2 -2.889 . . . . 72.310000000000002 103.2 166.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 20.0 m -65.17 -23.69 33.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 112.802 0.668 . . . . 75.510000000000005 112.802 -161.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -68.11 -47.32 68.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.848 0.833 . . . . 73.549999999999997 109.522 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -74.11 -24.33 59.44 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.96 -1.018 . . . . 72.239999999999995 111.522 -177.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.3 -39.49 79.49 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 119.759 -0.162 . . . . 62.409999999999997 111.136 179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.76 -51.06 6.07 Favored 'General case' 0 C--O 1.213 -0.83 0 C-N-CA 119.334 -0.946 . . . . 74.530000000000001 111.832 165.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.1 -49.16 78.93 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 114.281 1.215 . . . . 44.140000000000001 114.281 -168.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -40.39 86.28 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 108.673 -0.862 . . . . 73.430000000000007 108.673 -179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -63.89 -46.47 84.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.716 -0.675 . . . . 73.109999999999999 112.291 -177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 54.8 mt -59.09 -40.93 82.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 122.941 0.496 . . . . 71.439999999999998 110.467 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.34 -36.6 84.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.663 0.744 . . . . 60.350000000000001 110.039 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -78.31 -17.58 56.38 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 112.579 0.585 . . . . 72.019999999999996 112.579 176.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 61.9 mtt -69.26 -41.29 77.1 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 106.232 -1.766 . . . . 72.25 106.232 173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.624 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.14 10.22 6.88 Favored Glycine 0 C--O 1.225 -0.429 0 N-CA-C 117.5 1.76 . . . . 72.329999999999998 117.5 167.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 3.1 mmmt -58.01 120.47 43.05 Favored Pre-proline 0 N--CA 1.44 -0.933 0 N-CA-C 114.32 1.23 . . . . 71.030000000000001 114.32 -166.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.73 160.81 48.32 Favored 'Trans proline' 0 CA--C 1.507 -0.854 0 C-N-CA 117.77 -1.02 . . . . 61.509999999999998 109.951 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 164.81 34.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.016 -0.993 . . . . 61.530000000000001 111.311 -179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -73.32 152.32 40.97 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.547 -0.909 . . . . 61.119999999999997 108.547 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -92.11 -160.35 35.96 Favored Glycine 0 CA--C 1.502 -0.739 0 N-CA-C 115.97 1.148 . . . . 63.009999999999998 115.97 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 45.1 mp0 -78.98 -28.97 43.58 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 113.644 -1.278 . . . . 73.109999999999999 112.199 -178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -133.64 62.56 59.68 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 122.194 -0.316 . . . . 71.540000000000006 110.846 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -79.8 25.7 0.58 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 121.806 1.67 . . . . 74.209999999999994 114.459 -176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.424 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.3 ttpp -156.9 148.35 22.31 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 108.569 -0.9 . . . . 72.430000000000007 108.569 -177.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 550' ' ' VAL . 29.5 tp -126.7 123.32 37.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.167 -1.419 . . . . 63.25 107.167 176.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.97 132.07 34.38 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 108.83 -0.804 . . . . 72.010000000000005 108.83 177.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.732 HG13 HG23 ' A' ' 539' ' ' ILE . 5.9 t -127.03 128.52 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 107.652 -1.24 . . . . 63.219999999999999 107.652 -173.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -104.5 131.73 52.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 103.672 -2.714 . . . . 63.520000000000003 103.672 178.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 78.7 mt -94.99 95.35 4.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 106.162 -1.792 . . . . 52.229999999999997 106.162 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -165.46 134.03 3.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 105.983 -1.858 . . . . 75.510000000000005 105.983 -176.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -8.19 21.58 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 115.435 1.643 . . . . 74.420000000000002 115.435 -177.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 79.0 p -69.91 152.39 44.55 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.952 -1.129 . . . . 73.329999999999998 107.952 175.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -104.2 151.11 23.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.712 0.634 . . . . 73.109999999999999 112.712 -174.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.37 153.4 20.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.496 -0.775 . . . . 72.239999999999995 110.187 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -156.91 137.49 13.13 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.598 -0.519 . . . . 73.439999999999998 109.598 178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -125.94 149.8 48.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.638 -0.875 . . . . 74.430000000000007 108.638 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 78.8 p -134.08 36.9 3.23 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.352 -1.351 . . . . 71.25 107.352 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 22.0 p -86.73 175.64 8.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.685 -1.143 . . . . 71.209999999999994 109.912 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 14.8 p -142.65 149.45 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 103.48 -2.785 . . . . 72.510000000000005 103.48 175.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 . . . . . 0 C--O 1.253 1.267 0 O-C-N 124.649 1.218 . . . . 65.340000000000003 112.248 -177.72 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.503 -0.847 0 N-CA-C 103.728 -2.693 . . . . 75.409999999999997 103.728 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -86.21 150.01 24.68 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.633 -0.877 . . . . 75.420000000000002 108.633 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -88.57 174.84 43.49 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 118.714 2.245 . . . . 75.439999999999998 118.714 -172.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.5 143.24 15.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 113.818 -1.191 . . . . 72.209999999999994 108.989 176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -118.64 129.62 55.4 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 123.527 0.517 . . . . 64.329999999999998 110.111 173.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 12.7 t -155.69 165.03 37.78 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.252 -1.018 . . . . 71.230000000000004 108.252 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -102.34 168.48 9.3 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.406 0.622 . . . . 73.109999999999999 109.338 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . 0.44 ' HG3' HD21 ' A' ' 553' ' ' LEU . 39.6 mt-10 -70.49 -37.83 74.26 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.523 -1.217 . . . . 73.150000000000006 113.787 -178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 63.3 m -137.73 168.01 20.55 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.535 -0.913 . . . . 73.349999999999994 108.535 -176.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.8 -1.06 11.62 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 123.569 0.543 . . . . 74.010000000000005 110.736 176.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 8.1 m -145.16 132.0 20.13 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 108.991 -0.744 . . . . 62.329999999999998 108.991 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.671 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -147.66 160.58 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.918 1.287 . . . . 75.519999999999996 108.814 -179.191 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -127.31 132.38 50.28 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.875 -1.528 . . . . 75.319999999999993 106.875 170.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.421 HG11 ' HB2' ' A' ' 548' ' ' MET . 27.0 m -120.86 168.17 13.56 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.879 0 N-CA-C 107.957 -1.127 . . . . 71.209999999999994 107.957 168.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.4 t -117.39 155.07 30.25 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 102.161 -3.274 . . . . 74.310000000000002 102.161 173.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -56.55 -34.42 67.07 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.525 0.679 . . . . 75.409999999999997 110.946 175.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 70.5 m -64.81 -10.16 25.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.003 -0.998 . . . . 73.430000000000007 113.186 -177.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.2 tt -68.85 -26.96 33.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 O-C-N 122.037 -0.415 . . . . 73.319999999999993 110.039 175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 83.16 -63.52 4.46 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-O 122.167 0.87 . . . . 50.450000000000003 112.854 -177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 99.1 t -134.99 118.26 24.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 114.987 -0.606 . . . . 74.219999999999999 110.121 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.421 ' HB2' HG11 ' A' ' 541' ' ' VAL . 0.1 OUTLIER -82.34 153.36 25.83 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.161 -1.422 . . . . 70.540000000000006 107.161 179.089 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.2 tt0 -139.05 141.95 38.21 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.774 0.287 . . . . 62.310000000000002 111.774 175.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 616' ' ' ILE . 0.9 OUTLIER -118.26 141.24 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.685 -1.598 . . . . 70.200000000000003 106.685 171.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 128.65 37.97 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.185 -1.043 . . . . 64.430000000000007 108.185 177.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 4.0 t -109.24 124.71 66.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.9 -0.778 . . . . 74.219999999999999 108.9 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.6 OUTLIER -104.81 161.65 13.99 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 121.289 0.566 . . . . 63.119999999999997 109.632 178.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 75.3 ttt180 -133.13 136.47 45.82 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 105.614 -1.995 . . . . 74.439999999999998 105.614 174.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.773 HG23 ' H ' ' A' ' 557' ' ' GLY . 1.5 t -68.52 173.93 4.59 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.569 -0.452 . . . . 73.219999999999999 111.51 -175.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.95 0.61 1.15 Allowed 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.404 1.631 . . . . 53.409999999999997 115.404 -178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.773 ' H ' HG23 ' A' ' 555' ' ' THR . . . -91.28 26.68 10.91 Favored Glycine 0 C--O 1.209 -1.467 0 CA-C-N 114.408 -1.269 . . . . 35.329999999999998 110.373 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . -75.65 54.4 0.78 Allowed 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 115.29 1.589 . . . . 75.230000000000004 115.29 -172.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 32.7 mmt180 -86.35 117.66 25.29 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.874 0.845 . . . . 72.430000000000007 110.411 -176.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 84.64 -179.82 51.39 Favored Glycine 0 C--N 1.315 -0.627 0 CA-C-N 114.272 -1.331 . . . . 44.350000000000001 112.086 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.564 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 99.3 m -98.85 132.66 44.03 Favored 'General case' 0 C--O 1.209 -1.04 0 CA-C-O 122.178 0.99 . . . . 62.219999999999999 108.661 -178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 63.2 t -124.82 142.6 41.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.58 -1.637 . . . . 74.430000000000007 106.58 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.5 tt -107.73 138.66 32.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 105.596 -2.001 . . . . 52.109999999999999 105.596 173.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 15.2 t -134.11 114.11 12.64 Favored Pre-proline 0 N--CA 1.47 0.55 0 N-CA-C 112.501 0.556 . . . . 72.239999999999995 112.501 -178.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.1 157.76 42.18 Favored 'Trans proline' 0 CA--C 1.504 -0.976 0 N-CA-C 115.222 1.201 . . . . 60.020000000000003 115.222 173.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 598' ' ' ILE . 54.2 p90 -139.97 164.03 31.08 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.804 -1.089 . . . . 74.140000000000001 108.098 173.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.08 153.08 27.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.134 -1.062 . . . . 71.030000000000001 108.134 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 12.2 m -83.98 142.1 30.74 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.653 -1.61 . . . . 63.240000000000002 106.653 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.68 117.63 42.5 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 102.439 -3.171 . . . . 64.430000000000007 102.439 -175.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.1 140.92 33.55 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.605 -1.179 . . . . 72.310000000000002 110.166 -177.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -104.56 -77.76 1.18 Allowed Glycine 0 CA--C 1.506 -0.502 0 N-CA-C 107.304 -2.318 . . . . 75.120000000000005 107.304 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 3.4 t -117.17 110.4 18.11 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.377 -2.453 . . . . 73.239999999999995 104.377 162.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 176.92 176.54 0.32 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 101.983 -3.34 . . . . 52.530000000000001 101.983 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.13 -32.22 7.61 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 108.563 -0.902 . . . . 64.310000000000002 108.563 175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 78.55 -173.87 55.2 Favored Glycine 0 C--O 1.237 0.299 0 N-CA-C 115.165 0.826 . . . . 54.329999999999998 115.165 177.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 88.65 -103.0 2.92 Favored Glycine 0 C--O 1.22 -0.731 0 N-CA-C 109.826 -1.31 . . . . 71.329999999999998 109.826 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.36 10.2 8.71 Favored Glycine 0 C--O 1.216 -1.023 0 N-CA-C 110.315 -1.114 . . . . 65.329999999999998 110.315 173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.52 -48.53 8.86 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.829 1.789 . . . . 73.049999999999997 115.829 -160.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -117.69 -21.5 8.46 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.236 1.017 . . . . 55.340000000000003 109.003 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.2 p90 -159.21 167.74 28.27 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.986 -2.598 . . . . 73.349999999999994 103.986 169.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -89.74 131.81 35.51 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.28 -1.007 . . . . 74.540000000000006 108.28 171.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -54.47 106.5 0.21 Allowed 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 122.179 0.99 . . . . 75.310000000000002 111.02 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . . . . . . . . . . . -94.71 113.6 25.41 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.836 -1.074 . . . . 63.329999999999998 110.752 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -148.92 148.58 29.99 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.413 -1.267 . . . . 75.140000000000001 109.595 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . 175.12 -170.58 43.69 Favored Glycine 0 CA--C 1.506 -0.494 0 N-CA-C 108.833 -1.707 . . . . 41.399999999999999 108.833 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -120.9 147.25 45.68 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.494 0.647 . . . . 65.329999999999998 109.456 175.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 10.5 mt -120.96 127.9 52.23 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 107.999 -1.112 . . . . 75.430000000000007 107.999 -178.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -85.07 139.2 31.92 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 107.809 -1.182 . . . . 70.430000000000007 107.809 172.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -129.59 117.11 19.9 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.87 -1.059 . . . . 72.299999999999997 108.398 174.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.422 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 50.8 mttp -97.84 -175.2 3.09 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.921 -1.511 . . . . 65.439999999999998 106.921 173.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -48.57 -63.43 1.09 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 116.111 1.893 . . . . 73.030000000000001 116.111 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -78.68 -22.85 46.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 122.429 1.109 . . . . 74.310000000000002 111.549 -174.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.422 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 90.4 mt-10 -58.69 17.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 118.571 2.804 . . . . 62.219999999999999 118.571 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 68.0 p -72.17 16.09 0.14 Allowed 'General case' 0 C--N 1.321 -0.632 0 O-C-N 121.569 -0.707 . . . . 72.129999999999995 112.905 -169.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -129.17 124.19 59.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 105.923 -1.88 . . . . 75.340000000000003 105.923 169.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 9.2 tppt? -148.27 175.03 11.41 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 107.564 -1.273 . . . . 62.240000000000002 107.564 -176.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.64 158.0 43.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 118.059 0.39 . . . . 75.510000000000005 111.915 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.425 ' HB ' HG22 ' A' ' 550' ' ' VAL . 63.5 mt -121.42 136.51 58.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.025 0 N-CA-C 106.22 -1.77 . . . . 71.299999999999997 106.22 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -117.47 138.83 51.6 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 123.907 0.754 . . . . 65.540000000000006 112.09 -178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.42 HG13 ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -131.09 141.73 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 105.006 -2.22 . . . . 65.230000000000004 105.006 178.777 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 4.7 mtmp? -96.89 138.55 34.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.458 -1.312 . . . . 74.400000000000006 107.458 176.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.415 HG21 ' HA ' ' A' ' 543' ' ' GLU . 17.6 mm -107.85 138.91 31.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 N-CA-C 105.741 -1.948 . . . . 70.140000000000001 105.741 -178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 17.0 m -95.35 143.55 11.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 122.819 0.447 . . . . 74.299999999999997 110.047 -177.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -113.6 135.48 53.86 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.421 0.897 . . . . 61.020000000000003 113.421 -175.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -163.6 165.38 23.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 103.049 -2.945 . . . . 72.129999999999995 103.049 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -80.39 -98.3 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.15 0.886 . . . . 71.219999999999999 110.786 176.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 60.03 174.36 0.09 Allowed 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.183 0.993 . . . . 74.129999999999995 113.108 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -138.3 49.37 1.92 Allowed 'General case' 0 C--N 1.328 -0.36 0 O-C-N 121.377 -0.827 . . . . 75.010000000000005 110.176 -174.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -94.03 -116.69 0.1 Allowed 'General case' 0 CA--C 1.562 1.441 0 N-CA-C 117.582 2.438 . . . . 72.439999999999998 117.582 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -119.79 166.42 13.27 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.094 -1.004 . . . . 62.399999999999999 113.607 -164.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -84.51 89.87 7.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.518 -1.66 . . . . 70.140000000000001 106.518 171.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -89.83 159.73 16.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.45 0.643 . . . . 74.409999999999997 111.767 -173.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -147.6 151.57 36.47 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.855 0.836 . . . . 63.229999999999997 112.677 -172.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -151.94 169.81 21.41 Favored 'General case' 0 C--O 1.216 -0.684 0 N-CA-C 107.668 -1.234 . . . . 62.43 107.668 177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.77 171.16 14.75 Favored 'General case' 0 C--O 1.211 -0.972 0 N-CA-C 107.548 -1.278 . . . . 71.420000000000002 107.548 175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.502 HD12 HG11 ' A' ' 550' ' ' VAL . 10.1 mt -128.49 120.37 52.63 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 105.585 -2.006 . . . . 62.539999999999999 105.585 176.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -110.43 151.19 27.8 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.361 -1.348 . . . . 64.030000000000001 107.361 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 67.4 mt -85.21 145.8 27.4 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.399 -0.964 . . . . 71.519999999999996 108.399 178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.45 -82.13 0.32 Allowed Glycine 0 C--O 1.224 -0.505 0 CA-C-O 121.918 0.732 . . . . 63.240000000000002 111.721 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -157.69 127.05 3.14 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 105.498 -2.038 . . . . 71.019999999999996 105.498 175.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . 0.417 ' HD3' HD21 ' A' ' 654' ' ' LEU . 95.6 Cg_endo -74.6 135.31 19.71 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 117.929 -0.914 . . . . 64.310000000000002 110.469 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -127.68 135.05 49.66 Favored 'General case' 0 C--O 1.208 -1.129 0 O-C-N 121.989 -0.444 . . . . 61.539999999999999 110.061 -175.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.71 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -82.79 108.66 16.31 Favored 'General case' 0 CA--C 1.496 -1.126 0 O-C-N 121.859 -0.526 . . . . 65.430000000000007 109.638 -174.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.493 12.4 mmt -123.76 81.77 1.94 Allowed 'General case' 0 N--CA 1.424 -1.737 0 CA-C-O 124.694 2.187 . . . . 64.329999999999998 113.574 165.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.333 2.6 tt0 -152.59 91.06 1.53 Allowed 'General case' 1 C--O 1.14 -4.659 2 CA-C-O 110.737 -4.459 . . . . 60.009999999999998 99.996 146.429 . . . . . . . . 5 3 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.71 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 39.0 mmm-85 162.28 -54.41 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.003 1 CA-C-N 128.358 5.072 . . . . 55.439999999999998 107.855 178.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 76.44 69.89 1.34 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 108.739 -1.744 . . . . 73.109999999999999 108.739 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.421 HG22 ' H ' ' A' ' 628' ' ' ILE . 0.5 OUTLIER -57.02 124.52 11.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.441 0.639 . . . . 73.310000000000002 109.39 -179.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.1 t -162.88 -177.21 5.36 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 104.302 -2.481 . . . . 72.319999999999993 104.302 -178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -148.8 163.23 37.99 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.823 -1.547 . . . . 70.209999999999994 106.823 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 9.7 p -138.19 134.69 44.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.519 -0.919 . . . . 54.350000000000001 108.519 -178.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 7.8 m -94.92 76.99 3.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.217 -1.031 . . . . 63.520000000000003 108.217 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -153.63 -74.5 0.13 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.842 -0.799 . . . . 74.239999999999995 108.842 -177.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.98 131.24 49.0 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.485 -0.561 . . . . 73.010000000000005 109.485 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -126.62 151.48 47.96 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.635 -1.246 . . . . 62.039999999999999 107.635 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 84.0 mt -129.94 -173.4 3.03 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.36 -1.719 . . . . 70.230000000000004 106.36 -174.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 15.3 t -66.21 156.34 34.45 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 105.506 -2.035 . . . . 73.120000000000005 105.506 170.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 16.2 m -65.6 -22.55 31.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 113.226 0.825 . . . . 74.140000000000001 113.226 -161.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -72.83 -48.3 38.98 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 122.198 0.999 . . . . 70.219999999999999 108.807 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . 0.406 ' HA ' ' HB3' ' A' ' 643' ' ' ALA . 4.1 mm-40 -72.16 -19.01 61.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.576 -1.193 . . . . 73.510000000000005 112.444 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -55.21 -52.46 63.29 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.798 -0.445 . . . . 64.109999999999999 109.798 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -87.94 -37.71 16.18 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 119.289 -0.964 . . . . 73.409999999999997 111.827 173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 640' ' ' GLU . . . -60.16 -44.1 95.25 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.469 1.031 . . . . 62.119999999999997 112.505 -174.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -72.63 -38.38 67.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.305 -0.628 . . . . 74.129999999999995 109.305 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 66.7 ttt-85 -58.61 -46.43 87.03 Favored 'General case' 0 C--O 1.218 -0.561 0 CA-C-O 120.431 0.158 . . . . 74.409999999999997 111.052 177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.1 mt -64.22 -39.64 86.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 122.088 -0.382 . . . . 71.129999999999995 110.528 178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -66.98 -32.51 73.79 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.933 -0.479 . . . . 65.099999999999994 111.074 178.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.49 -31.77 70.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.251 -0.277 . . . . 62.310000000000002 110.251 174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 2.3 mtt -73.01 -41.51 64.18 Favored 'General case' 0 C--O 1.223 -0.311 0 N-CA-C 109.4 -0.593 . . . . 64.120000000000005 109.4 176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.473 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.33 18.3 35.39 Favored Glycine 0 N--CA 1.461 0.316 0 N-CA-C 115.984 1.154 . . . . 64.439999999999998 115.984 169.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -58.57 127.31 81.75 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 114.243 1.201 . . . . 74.510000000000005 114.243 -167.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.9 167.3 27.66 Favored 'Trans proline' 0 CA--C 1.514 -0.51 0 O-C-N 122.401 0.685 . . . . 70.299999999999997 111.482 174.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.46 163.08 26.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.19 -0.914 . . . . 64.109999999999999 109.452 176.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . 0.417 HD21 ' HD3' ' A' ' 621' ' ' PRO . 82.2 mt -75.22 161.64 29.17 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.788 0.328 . . . . 71.349999999999994 111.215 174.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -96.42 -154.29 30.18 Favored Glycine 0 CA--C 1.5 -0.894 0 CA-C-O 122.858 1.255 . . . . 62.530000000000001 115.188 -176.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -78.17 -29.3 48.51 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 113.32 -1.44 . . . . 75.140000000000001 110.005 -179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -135.02 61.05 44.42 Favored Pre-proline 0 N--CA 1.476 0.843 0 N-CA-C 114.368 1.247 . . . . 73.349999999999994 114.368 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -77.49 31.66 0.43 Allowed 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 120.79 0.993 . . . . 74.400000000000006 113.739 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -158.96 151.61 21.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.652 -0.704 . . . . 73.109999999999999 109.657 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.435 HD11 ' HB ' ' A' ' 539' ' ' ILE . 20.0 tp -134.16 123.99 25.3 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.622 -1.251 . . . . 73.099999999999994 107.622 175.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -88.11 126.3 35.04 Favored 'General case' 0 C--O 1.216 -0.705 0 O-C-N 123.373 0.421 . . . . 62.229999999999997 110.177 175.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.671 HG13 HG23 ' A' ' 539' ' ' ILE . 3.6 t -116.39 140.12 40.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 107.274 -1.38 . . . . 63.329999999999998 107.274 -177.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.1 mm -116.84 136.98 52.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 N-CA-C 102.534 -3.136 . . . . 62.310000000000002 102.534 175.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 81.0 mt -96.33 107.19 19.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 106.307 -1.738 . . . . 72.030000000000001 106.307 176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -166.1 158.78 14.74 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 109.005 -0.739 . . . . 71.25 109.005 -173.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -65.74 -47.09 76.46 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 113.045 0.758 . . . . 73.409999999999997 113.045 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 28.0 t -68.76 148.2 50.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.454 0.645 . . . . 74.219999999999999 111.297 -174.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -137.34 135.58 37.17 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.783 -1.192 . . . . 62.539999999999999 107.783 177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -116.11 131.62 56.89 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.235 -0.654 . . . . 72.109999999999999 109.235 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -109.33 120.35 42.25 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 105.374 -2.084 . . . . 42.140000000000001 105.374 171.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -139.29 130.05 26.09 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.077 -0.342 . . . . 72.329999999999998 110.077 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 38.1 m -143.84 173.18 11.92 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.876 -1.157 . . . . 63.109999999999999 107.876 -177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 15.2 t -121.89 -176.85 3.43 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.213 -1.773 . . . . 73.140000000000001 106.213 175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -120.2 17.35 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 CA-C-O 121.04 0.448 . . . . 64.0 111.471 -173.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 . . . . . 0 C--O 1.252 1.188 0 CA-C-O 117.002 -1.475 . . . . 73.319999999999993 108.808 -179.478 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.45 0 N-CA-C 110.049 -0.352 . . . . 72.329999999999998 110.049 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -55.59 143.64 29.23 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.774 0.671 . . . . 64.099999999999994 110.161 175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -61.44 151.34 43.28 Favored Glycine 0 C--O 1.22 -0.722 0 N-CA-C 117.385 1.714 . . . . 52.450000000000003 117.385 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.678 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -76.99 143.54 12.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 104.89 -2.263 . . . . 73.099999999999994 104.89 170.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -118.36 139.11 51.87 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.569 0.543 . . . . 74.200000000000003 109.787 176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.6 t -156.12 164.07 38.86 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.064 -1.458 . . . . 71.439999999999998 107.064 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -97.97 168.47 10.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.314 0.578 . . . . 65.230000000000004 110.857 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.23 -43.04 87.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 114.173 1.175 . . . . 73.5 114.173 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 60.1 m -132.21 168.7 17.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.333 -1.358 . . . . 64.299999999999997 107.333 -171.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 -111.53 -14.09 13.74 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.967 -0.383 . . . . 64.310000000000002 109.967 173.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 13.6 m -144.11 134.03 23.97 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.326 -0.99 . . . . 75.540000000000006 108.326 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.718 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -140.36 160.49 25.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 C-N-CA 125.083 1.353 . . . . 72.209999999999994 108.434 -178.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -126.06 132.23 51.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.078 -1.082 . . . . 62.130000000000003 108.078 171.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 662' ' ' VAL . 27.0 m -122.62 178.42 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 108.399 -0.963 . . . . 74.200000000000003 108.399 168.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 66.8 m -125.79 157.81 36.55 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 103.012 -2.958 . . . . 53.149999999999999 103.012 171.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.418 ' HA ' HG21 ' A' ' 602' ' ' ILE . 0.0 OUTLIER -63.61 -30.55 71.65 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 119.32 0.964 . . . . 72.010000000000005 111.918 179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 57.8 m -66.46 -8.3 25.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.633 -0.712 . . . . 73.010000000000005 112.572 -178.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -67.01 -25.57 34.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 109.46 -0.57 . . . . 63.310000000000002 109.46 174.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 86.38 -61.05 4.49 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.89 -0.671 . . . . 41.509999999999998 111.849 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -148.44 123.26 2.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.813 0.816 . . . . 71.209999999999994 110.145 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.438 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.7 ppp? -81.16 153.61 27.15 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.526 -1.216 . . . . 64.040000000000006 111.087 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.1 tt0 -134.45 143.02 47.29 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.951 0.723 . . . . 73.299999999999997 112.951 175.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.421 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -118.24 144.35 26.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.836 0 N-CA-C 103.787 -2.671 . . . . 75.140000000000001 103.787 169.438 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -98.51 135.17 40.44 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.894 -1.521 . . . . 71.439999999999998 106.894 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -104.07 120.8 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.436 -0.802 . . . . 71.430000000000007 109.404 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.41 161.59 14.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.769 -0.826 . . . . 64.340000000000003 108.769 -178.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.427 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -139.55 149.88 44.4 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 109.704 -0.48 . . . . 62.539999999999999 109.704 -177.037 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.678 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.1 t -79.04 175.08 10.91 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.048 0.539 . . . . 73.450000000000003 112.196 176.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 34.2 p -69.51 31.47 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.727 1.751 . . . . 71.109999999999999 115.727 -178.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -96.06 11.0 67.88 Favored Glycine 0 C--O 1.216 -1.004 0 C-N-CA 123.655 0.645 . . . . 43.420000000000002 112.998 177.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.427 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -73.94 91.13 1.99 Allowed 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.518 -1.578 . . . . 74.349999999999994 114.233 -172.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -125.66 111.47 15.0 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.597 -1.631 . . . . 73.430000000000007 106.597 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 81.42 -154.08 34.27 Favored Glycine 0 C--O 1.239 0.454 0 C-N-CA 120.722 -0.751 . . . . 73.230000000000004 113.337 -177.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 91.5 m -114.57 133.15 56.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 122.394 1.092 . . . . 72.439999999999998 108.686 -176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 92.3 t -126.72 143.46 40.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 N-CA-C 105.735 -1.95 . . . . 62.039999999999999 105.735 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.9 tt -115.48 140.48 36.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 106.756 -1.572 . . . . 74.530000000000001 106.756 176.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 11.8 t -136.04 114.28 10.81 Favored Pre-proline 0 N--CA 1.474 0.772 0 N-CA-C 113.547 0.943 . . . . 54.310000000000002 113.547 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -75.26 156.27 41.83 Favored 'Trans proline' 0 CA--C 1.507 -0.843 0 N-CA-C 115.906 1.464 . . . . 63.219999999999999 115.906 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -139.32 165.7 26.49 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.506 -1.294 . . . . 73.239999999999995 107.506 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.79 158.49 33.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 107.985 -1.117 . . . . 72.409999999999997 107.985 176.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 19.4 m -90.64 138.79 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.515 -0.92 . . . . 74.120000000000005 108.515 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . . . . . . . . . 57.4 t -128.7 117.03 43.61 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.456 0 N-CA-C 103.44 -2.8 . . . . 73.040000000000006 103.44 -173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -83.21 142.32 31.25 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 114.759 -1.109 . . . . 64.239999999999995 110.418 -179.334 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -105.65 -78.49 1.2 Allowed Glycine 0 C--O 1.226 -0.354 0 N-CA-C 107.478 -2.249 . . . . 73.349999999999994 107.478 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.16 110.35 18.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 105.918 -1.882 . . . . 71.040000000000006 105.918 163.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 178.82 -175.65 0.21 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 100.53 -3.878 . . . . 60.229999999999997 100.53 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 4.5 tptp -110.67 -33.6 6.52 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 106.932 -1.507 . . . . 73.010000000000005 106.932 175.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 75.07 175.4 36.02 Favored Glycine 0 C--O 1.228 -0.281 0 N-CA-C 116.061 1.184 . . . . 71.310000000000002 116.061 174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 100.22 -96.45 1.6 Allowed Glycine 0 C--O 1.214 -1.096 0 N-CA-C 110.641 -0.984 . . . . 63.119999999999997 110.641 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.39 11.71 8.51 Favored Glycine 0 C--O 1.217 -0.911 0 N-CA-C 110.274 -1.13 . . . . 64.200000000000003 110.274 173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.3 -60.7 1.89 Allowed 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 115.924 1.824 . . . . 62.109999999999999 115.924 -162.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.46 -17.97 12.1 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 122.928 1.347 . . . . 72.209999999999994 107.658 -175.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -156.92 163.31 39.29 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 104.275 -2.491 . . . . 72.349999999999994 104.275 169.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -93.07 125.83 37.86 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 106.934 -1.506 . . . . 70.540000000000006 106.934 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -63.39 109.89 1.75 Allowed 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 123.598 1.666 . . . . 70.430000000000007 108.981 -179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -103.66 108.06 19.18 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 111.496 -2.593 . . . . 74.430000000000007 109.779 -171.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -135.24 141.1 45.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.42 -0.809 . . . . 71.129999999999995 109.865 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -172.47 -174.68 39.95 Favored Glycine 0 CA--C 1.501 -0.802 0 N-CA-C 108.346 -1.902 . . . . 63.329999999999998 108.346 178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -117.15 146.58 43.1 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-N 117.551 0.675 . . . . 62.119999999999997 109.831 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 23.5 mt -114.32 122.32 46.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.71 -1.132 . . . . 72.329999999999998 109.785 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -75.4 131.18 40.03 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.4 -1.333 . . . . 75.549999999999997 107.4 171.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -120.75 116.79 25.92 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 104.047 -2.575 . . . . 63.119999999999997 104.047 167.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.698 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 3.0 ttmp? -125.54 96.06 4.67 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.322 -0.399 . . . . 74.200000000000003 110.036 -170.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 46.53 -77.6 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 117.853 2.538 . . . . 72.129999999999995 117.853 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -82.09 -27.58 32.8 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 113.877 1.065 . . . . 65.340000000000003 113.877 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.698 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 86.5 mt-10 -60.6 17.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 117.873 2.546 . . . . 61.039999999999999 117.873 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . . . . . . . . . 18.2 p -71.69 12.61 0.35 Allowed 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 113.94 1.089 . . . . 63.210000000000001 113.94 -170.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.1 116.2 50.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 103.414 -2.81 . . . . 71.540000000000006 103.414 171.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -144.22 172.13 13.33 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.997 -1.112 . . . . 71.299999999999997 107.997 -174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.95 161.59 37.46 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 117.809 0.277 . . . . 53.450000000000003 111.705 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 616' ' ' ILE . 66.6 mt -124.11 131.51 72.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 106.981 -1.488 . . . . 72.010000000000005 106.981 176.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 71.7 mtt-85 -113.28 132.46 55.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.433 0.901 . . . . 72.310000000000002 113.433 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.526 HG22 ' HB3' ' A' ' 583' ' ' ALA . 55.2 t -131.67 118.88 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.305 0.642 . . . . 72.439999999999998 110.459 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 13.5 tmtt? -71.01 132.94 45.9 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 109.585 -0.524 . . . . 71.519999999999996 109.585 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.418 HG21 ' HA ' ' A' ' 543' ' ' GLU . 30.3 mm -98.02 131.79 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.583 -1.266 . . . . 73.040000000000006 107.583 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.75 137.98 34.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.307 0.575 . . . . 63.520000000000003 110.306 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.42 134.49 42.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.043 -0.981 . . . . 63.420000000000002 112.303 -176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -133.88 24.79 3.96 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 107.627 -1.249 . . . . 72.120000000000005 107.627 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 62.82 -171.99 0.16 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.554 1.141 . . . . 72.400000000000006 112.13 -174.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 62.3 178.35 0.13 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.424 1.09 . . . . 63.210000000000001 113.154 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -162.2 -24.21 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.228 0.825 . . . . 61.149999999999999 113.228 -178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -69.03 -18.45 64.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.565 0.697 . . . . 54.340000000000003 110.105 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -31.4 70.54 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.643 0.979 . . . . 72.510000000000005 113.643 -176.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 46.46 102.73 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 116.152 1.908 . . . . 65.129999999999995 116.152 -178.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -90.58 151.04 21.48 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.033 -0.729 . . . . 53.030000000000001 109.033 -177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.33 132.48 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.674 0.749 . . . . 75.030000000000001 110.209 -177.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -153.46 168.82 24.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.093 -0.958 . . . . 74.540000000000006 108.709 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -142.46 170.85 14.94 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 108.467 -0.938 . . . . 73.349999999999994 108.467 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.408 HG21 HG21 ' A' ' 598' ' ' ILE . 19.5 mt -128.2 120.05 52.38 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 N-CA-C 106.474 -1.676 . . . . 73.420000000000002 106.474 177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.4 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -107.34 149.29 28.0 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.154 -1.054 . . . . 54.420000000000002 108.154 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 65.7 mt -86.13 150.36 24.48 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 107.496 -1.298 . . . . 73.209999999999994 107.496 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -74.07 -83.33 0.35 Allowed Glycine 0 C--O 1.222 -0.639 0 N-CA-C 109.427 -1.469 . . . . 71.349999999999994 109.427 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -159.84 132.09 4.32 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 105.874 -1.898 . . . . 70.120000000000005 105.874 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.76 143.88 52.22 Favored 'Trans proline' 0 C--N 1.328 -0.501 0 C-N-CA 116.551 -1.832 . . . . 75.439999999999998 109.823 176.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -133.96 137.97 45.17 Favored 'General case' 0 C--O 1.206 -1.223 0 N-CA-C 108.397 -0.964 . . . . 61.420000000000002 108.397 -177.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.672 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.7 t90 -83.27 110.64 18.26 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.426 -0.953 . . . . 74.409999999999997 108.426 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.477 11.4 mmt -123.62 80.68 1.82 Allowed 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 115.71 -2.396 . . . . 60.299999999999997 113.882 165.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.334 1.4 tt0 -152.72 92.48 1.66 Allowed 'General case' 1 C--O 1.142 -4.584 1 CA-C-O 110.299 -4.667 . . . . 71.109999999999999 101.841 146.677 . . . . . . . . 5 3 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.672 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 10.9 mmm180 167.13 -74.05 0.0 OUTLIER 'General case' 0 N--CA 1.524 3.257 1 CA-C-N 129.06 5.391 . . . . 65.129999999999995 110.498 176.72 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 103.53 83.95 1.75 Allowed Glycine 0 C--O 1.216 -1.001 0 N-CA-C 108.444 -1.862 . . . . 41.399999999999999 108.444 -171.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -69.22 -20.87 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 114.832 -0.684 . . . . 61.0 111.52 -175.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 13.2 p -56.39 140.87 44.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.32 -0.4 . . . . 63.140000000000001 110.455 177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -62.45 142.0 58.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.594 0.711 . . . . 74.400000000000006 111.761 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.73 128.91 74.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.123 -0.944 . . . . 73.209999999999994 108.84 -176.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 37.1 p -76.55 -14.5 60.01 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 114.346 1.239 . . . . 74.549999999999997 114.346 -172.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -78.34 -11.5 59.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.132 -0.355 . . . . 71.420000000000002 111.137 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 65.9 mmt-85 -81.13 36.27 0.41 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 112.698 0.629 . . . . 74.420000000000002 112.698 -177.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 49.9 tptt -70.1 121.41 17.44 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.074 -1.084 . . . . 72.319999999999993 108.074 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.72 -168.74 2.32 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 106.807 -1.553 . . . . 74.25 106.807 -175.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -68.63 167.23 15.57 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 106.113 -1.81 . . . . 63.130000000000003 106.113 171.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 85.8 t -58.48 -45.25 90.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.812 0.815 . . . . 62.32 111.302 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -61.55 -47.06 87.29 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.038 -0.983 . . . . 41.409999999999997 111.06 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -73.82 -23.73 59.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.349 -0.841 . . . . 72.329999999999998 111.475 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -59.43 -40.64 87.37 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.815 -0.439 . . . . 72.030000000000001 109.815 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -87.85 -47.55 8.51 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 120.04 -0.664 . . . . 73.450000000000003 111.524 170.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -58.49 -41.2 84.78 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 113.295 0.85 . . . . 51.109999999999999 113.295 -171.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 6.1 tppt? -74.26 -42.19 60.04 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.198 -0.667 . . . . 70.239999999999995 109.198 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -61.32 -46.33 90.71 Favored 'General case' 0 C--O 1.211 -0.964 0 CA-C-N 115.575 -0.739 . . . . 72.310000000000002 112.244 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 51.4 mt -60.49 -40.85 85.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.133 0.492 . . . . 72.519999999999996 109.803 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -67.42 -32.41 73.27 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.853 -0.529 . . . . 62.509999999999998 110.665 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -74.78 -20.73 59.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 122.555 0.342 . . . . 75.530000000000001 111.537 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 34.8 mtt -75.27 -41.31 57.52 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 106.703 -1.591 . . . . 71.340000000000003 106.703 174.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.594 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.46 21.03 47.64 Favored Glycine 0 CA--C 1.507 -0.421 0 N-CA-C 115.573 0.989 . . . . 71.400000000000006 115.573 166.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 115.71 12.84 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 113.478 0.918 . . . . 74.510000000000005 113.478 -167.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.88 161.07 47.33 Favored 'Trans proline' 0 CA--C 1.51 -0.682 0 C-N-CA 117.883 -0.945 . . . . 41.149999999999999 110.994 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 34.5 m -131.09 168.36 24.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 CA-C-N 115.032 -0.986 . . . . 64.129999999999995 111.045 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -78.67 156.32 29.05 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.937 -0.764 . . . . 75.109999999999999 108.937 -178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -89.6 -161.36 37.4 Favored Glycine 0 CA--C 1.502 -0.74 0 CA-C-O 122.362 0.979 . . . . 62.299999999999997 115.379 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -78.43 -32.9 48.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.761 -1.22 . . . . 64.319999999999993 110.072 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -129.75 61.31 57.2 Favored Pre-proline 0 C--O 1.218 -0.565 0 N-CA-C 113.023 0.749 . . . . 71.209999999999994 113.023 179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.99 27.48 0.52 Allowed 'Trans proline' 0 CA--C 1.535 0.572 0 C-N-CA 121.621 1.547 . . . . 72.430000000000007 113.258 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 27.7 ttpp -157.3 146.75 20.24 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.183 -0.673 . . . . 71.319999999999993 109.183 -176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.459 HD11 ' HB ' ' A' ' 539' ' ' ILE . 18.6 tp -128.45 123.69 34.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.474 -0.936 . . . . 71.340000000000003 108.474 177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -87.91 124.13 33.37 Favored 'General case' 0 C--O 1.216 -0.694 0 O-C-N 123.62 0.575 . . . . 73.420000000000002 109.86 178.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.718 HG13 HG23 ' A' ' 539' ' ' ILE . 2.9 t -116.45 135.33 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.816 0 N-CA-C 107.805 -1.183 . . . . 63.439999999999998 107.805 -175.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 1.5 mm -110.61 133.31 56.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 103.487 -2.783 . . . . 74.209999999999994 103.487 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 71.2 mt -95.44 112.31 27.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 104.732 -2.322 . . . . 65.040000000000006 104.732 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -166.69 -115.39 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 105.34 -2.096 . . . . 71.120000000000005 105.34 -171.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -122.98 150.06 43.48 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.185 -2.154 . . . . 74.319999999999993 105.185 174.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 34.3 m -79.9 46.24 0.77 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.304 0.573 . . . . 43.450000000000003 112.057 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -63.4 -43.68 96.85 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.602 1.334 . . . . 64.230000000000004 114.602 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -140.31 148.87 42.02 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 114.218 1.192 . . . . 52.210000000000001 114.218 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -134.08 144.09 48.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 106.153 -1.795 . . . . 72.510000000000005 106.153 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -73.74 116.91 14.89 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.861 0.362 . . . . 75.430000000000007 110.094 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 66.6 p -85.77 169.45 13.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.272 -0.422 . . . . 75.510000000000005 110.24 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.3 t -142.62 170.95 14.74 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.482 -1.673 . . . . 73.099999999999994 106.482 178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 32.3 m -129.84 162.79 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 122.461 0.304 . . . . 53.520000000000003 110.454 -177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 35.1 t70 . . . . . 0 C--O 1.257 1.453 0 CA-C-O 117.581 -1.199 . . . . 74.439999999999998 111.08 178.367 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 118.78 -0.629 . . . . 71.409999999999997 110.198 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -62.93 154.29 30.82 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 123.799 0.687 . . . . 55.340000000000003 110.256 173.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -66.7 150.16 51.76 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 116.974 1.55 . . . . 73.450000000000003 116.974 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.739 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -81.13 140.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 105.795 -1.928 . . . . 74.109999999999999 105.795 172.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -113.66 139.06 49.36 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.667 0.604 . . . . 62.399999999999999 110.843 178.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 14.8 t -158.05 170.75 21.59 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 104.797 -2.297 . . . . 64.439999999999998 104.797 -173.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -105.59 172.4 6.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.031 0.832 . . . . 74.310000000000002 109.52 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -61.18 -61.37 2.61 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 114.3 1.222 . . . . 75.239999999999995 114.3 178.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 79.5 m -114.72 -176.34 2.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.691 -0.686 . . . . 51.109999999999999 109.549 -172.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -109.88 -30.75 7.68 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.869 -1.059 . . . . 61.109999999999999 111.037 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 66.1 m -139.19 135.99 34.57 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 104.892 -2.262 . . . . 64.150000000000006 104.892 -174.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.734 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -138.47 158.66 31.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 C-N-CA 125.375 1.47 . . . . 73.420000000000002 107.384 -179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . 0.63 ' H ' ' HB2' ' A' ' 669' ' ' GLU . 17.6 m-70 -130.19 127.5 39.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.318 -0.993 . . . . 72.530000000000001 108.318 174.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.53 173.91 5.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.995 -0.743 . . . . 71.420000000000002 108.995 171.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 3.9 t -123.1 154.42 38.62 Favored 'General case' 0 C--O 1.213 -0.822 0 N-CA-C 102.945 -2.983 . . . . 43.030000000000001 102.945 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.417 ' CD ' ' H ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.36 -32.43 66.76 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.375 0.607 . . . . 75.219999999999999 110.699 175.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 37.2 t -64.4 -11.07 29.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.425 -0.807 . . . . 63.25 112.864 -178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.3 tt -69.4 -26.36 31.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.902 -0.407 . . . . 75.450000000000003 109.902 176.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.28 -64.94 4.18 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-O 122.036 0.798 . . . . 72.25 112.47 -177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 85.7 t -135.8 116.45 18.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 115.011 -0.595 . . . . 71.400000000000006 109.528 -176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.407 ' HG3' ' HB ' ' A' ' 600' ' ' VAL . 2.3 ppp? -77.92 153.57 32.44 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.787 -0.642 . . . . 72.519999999999996 109.532 178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 598' ' ' ILE . 1.4 tt0 -138.19 142.66 40.01 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 112.267 0.469 . . . . 74.0 112.267 176.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.423 HG12 HD23 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -117.65 141.8 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.949 0 N-CA-C 104.284 -2.487 . . . . 70.140000000000001 104.284 169.166 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -93.93 133.86 36.92 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 104.27 -2.493 . . . . 53.009999999999998 104.27 174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 12.5 t -103.99 129.21 56.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 106.867 -1.531 . . . . 73.140000000000001 106.867 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . . . . . . . . . 21.2 mt -115.41 161.81 18.02 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.406 -0.815 . . . . 74.299999999999997 110.362 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.435 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -142.2 144.06 33.21 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.125 -0.489 . . . . 73.439999999999998 109.874 -177.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 531' ' ' ILE . 3.0 t -78.01 167.82 20.86 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 117.788 0.267 . . . . 65.129999999999995 110.582 175.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 3.1 m -62.02 18.45 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 117.94 2.57 . . . . 71.209999999999994 117.94 -178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -89.5 16.64 55.74 Favored Glycine 0 C--O 1.195 -2.329 0 C-N-CA 123.565 0.602 . . . . 43.520000000000003 112.076 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.435 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -64.9 111.09 2.67 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 119.666 -2.079 . . . . 74.209999999999994 111.671 -176.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 83.9 mmt-85 -135.69 109.24 7.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 105.662 -1.977 . . . . 74.439999999999998 105.662 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 74.92 -155.06 47.53 Favored Glycine 0 C--N 1.318 -0.432 0 C-N-CA 120.397 -0.906 . . . . 74.200000000000003 114.476 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 95.3 m -112.01 132.48 54.77 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.124 -1.038 . . . . 71.109999999999999 108.28 -178.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 71.5 t -127.89 142.28 44.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 N-CA-C 105.382 -2.081 . . . . 75.120000000000005 105.382 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 5.8 tt -109.28 143.02 20.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 106.367 -1.716 . . . . 73.109999999999999 106.367 175.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 10.6 t -136.1 108.6 9.7 Favored Pre-proline 0 N--CA 1.473 0.704 0 N-CA-C 113.52 0.933 . . . . 71.340000000000003 113.52 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 586' ' ' GLU . 59.1 Cg_endo -73.08 157.12 51.26 Favored 'Trans proline' 0 CA--C 1.508 -0.801 0 N-CA-C 115.314 1.236 . . . . 70.150000000000006 115.314 174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -138.66 166.13 25.15 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.38 -0.97 . . . . 74.109999999999999 108.38 172.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.428 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.0 OUTLIER -157.8 150.67 22.97 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.257 -1.016 . . . . 55.439999999999998 108.257 171.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 82.2 m -81.8 138.9 35.06 Favored 'General case' 0 C--O 1.21 -0.976 0 N-CA-C 106.414 -1.699 . . . . 75.209999999999994 106.414 -178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.428 HG22 ' HD2' ' A' ' 567' ' ' ARG . 58.3 t -132.88 118.4 33.42 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 103.352 -2.833 . . . . 75.25 103.352 -171.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.447 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 0.0 OUTLIER -82.68 146.68 28.93 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-N 114.813 -1.085 . . . . 64.319999999999993 111.1 -177.468 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -109.83 -77.58 0.96 Allowed Glycine 0 C--O 1.224 -0.506 0 N-CA-C 107.851 -2.1 . . . . 63.210000000000001 107.851 178.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.34 110.33 17.92 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 103.918 -2.623 . . . . 73.310000000000002 103.918 162.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . 179.38 168.44 1.06 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.244 -1.761 . . . . 74.200000000000003 106.244 -176.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -89.89 -32.38 16.89 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.856 0.36 . . . . 71.299999999999997 110.652 175.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 76.26 -160.32 51.0 Favored Glycine 0 N--CA 1.463 0.443 0 C-N-CA 121.43 -0.414 . . . . 51.530000000000001 113.99 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 68.81 -106.83 1.87 Allowed Glycine 0 C--O 1.212 -1.253 0 C-N-CA 121.181 -0.533 . . . . 42.130000000000003 114.092 176.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -123.76 12.51 8.24 Favored Glycine 0 C--O 1.217 -0.931 0 N-CA-C 110.305 -1.118 . . . . 61.5 110.305 174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -95.16 -63.29 1.18 Allowed 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 115.657 1.725 . . . . 65.319999999999993 115.657 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -88.57 -35.04 17.13 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 123.153 1.454 . . . . 62.240000000000002 109.148 176.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -163.39 166.84 22.43 Favored 'General case' 0 CA--C 1.503 -0.84 0 N-CA-C 102.307 -3.22 . . . . 72.310000000000002 102.307 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.9 145.14 28.76 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.499 0.926 . . . . 72.230000000000004 113.499 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.99 87.43 2.33 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 105.398 -2.075 . . . . 71.329999999999998 105.398 168.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -98.65 114.68 27.26 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 113.064 -1.88 . . . . 75.310000000000002 108.723 -174.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -138.48 146.21 41.76 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.794 -1.094 . . . . 73.420000000000002 109.597 -179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -175.27 -174.03 41.53 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 109.14 -1.584 . . . . 75.209999999999994 109.14 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 565' ' ' PRO . 31.1 mt-10 -117.47 143.83 45.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 117.45 0.625 . . . . 73.420000000000002 110.548 178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 42.2 mt -113.04 120.76 42.45 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.599 -0.728 . . . . 44.539999999999999 111.015 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -73.59 123.19 23.52 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.357 -0.609 . . . . 75.510000000000005 109.357 174.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -123.09 134.03 54.26 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.768 -0.827 . . . . 64.340000000000003 108.768 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.535 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 51.6 mttp -134.24 -178.95 5.27 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.474 -0.935 . . . . 73.519999999999996 108.474 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -45.25 -61.2 1.75 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.36 1.615 . . . . 64.209999999999994 115.36 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.29 -29.3 31.24 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 122.74 1.257 . . . . 71.400000000000006 112.377 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.535 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 18.8 mm-40 -63.24 17.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 117.547 2.425 . . . . 51.409999999999997 117.547 -177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.445 ' H ' HG23 ' A' ' 594' ' ' THR . 14.9 p -71.67 13.13 0.29 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 113.812 1.041 . . . . 71.0 113.812 -168.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.44 120.79 60.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 106.717 -1.586 . . . . 62.25 106.717 174.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -145.74 172.25 13.57 Favored 'General case' 0 CA--C 1.499 -0.988 0 N-CA-C 107.766 -1.198 . . . . 72.200000000000003 107.766 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.02 44.59 Favored 'General case' 0 N--CA 1.437 -1.092 0 O-C-N 123.121 0.263 . . . . 61.539999999999999 110.585 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 549' ' ' GLU . 73.7 mt -118.95 132.91 67.48 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 N-CA-C 105.569 -2.012 . . . . 73.510000000000005 105.569 174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 77.8 mtt180 -114.01 135.3 54.15 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 124.262 0.976 . . . . 74.209999999999994 110.259 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.457 HG22 ' HB3' ' A' ' 583' ' ' ALA . 91.2 t -135.17 126.57 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 107.324 -1.361 . . . . 64.099999999999994 107.324 177.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -75.35 137.2 40.93 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 108.662 -0.866 . . . . 75.409999999999997 108.662 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . 0.413 HG21 ' HA ' ' A' ' 543' ' ' GLU . 27.0 mm -96.0 129.8 45.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 103.692 -2.707 . . . . 71.319999999999993 103.692 172.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 91.6 t -85.72 143.59 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.789 -1.189 . . . . 74.200000000000003 107.789 -174.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -127.93 161.14 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.334 -0.848 . . . . 72.409999999999997 112.146 -168.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 66.4 -30.52 0.15 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 117.905 2.557 . . . . 75.299999999999997 117.905 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -81.66 58.71 3.87 Favored 'General case' 0 CA--C 1.551 1.01 0 N-CA-C 113.475 0.917 . . . . 75.319999999999993 113.475 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 608' ' ' TYR . 3.8 tp10 62.5 -169.33 0.18 Allowed 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.368 1.067 . . . . 75.510000000000005 112.088 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . 0.547 ' H ' ' HG3' ' A' ' 607' ' ' GLU . 3.3 p90 -164.14 173.85 11.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 107.74 -1.207 . . . . 75.120000000000005 107.74 -176.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -136.83 70.55 1.41 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.75 0.648 . . . . 62.109999999999999 112.75 176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 66.84 -55.59 0.43 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 116.459 2.022 . . . . 63.530000000000001 116.459 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -172.14 109.09 0.23 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 104.763 -2.31 . . . . 62.130000000000003 104.763 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -89.43 150.9 22.3 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 107.82 -1.178 . . . . 74.150000000000006 107.82 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . 0.421 ' C ' HD22 ' A' ' 613' ' ' ASN . 0.1 OUTLIER -137.35 124.79 22.02 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 106.023 -1.843 . . . . 62.340000000000003 106.023 -178.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -151.3 170.29 19.87 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.532 -0.914 . . . . 74.030000000000001 108.532 177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -147.35 171.28 15.69 Favored 'General case' 0 C--O 1.211 -0.953 0 N-CA-C 108.487 -0.931 . . . . 63.229999999999997 108.487 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . . . . . . . . . 16.8 mt -130.62 119.5 45.86 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 106.222 -1.77 . . . . 72.310000000000002 106.222 178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . 0.405 ' HB2' ' HD3' ' A' ' 659' ' ' LYS . . . -106.39 151.68 24.58 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.362 -1.347 . . . . 44.520000000000003 107.362 -178.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . . . . . . . . . 71.9 mt -88.67 147.79 24.34 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.246 -1.02 . . . . 73.420000000000002 108.246 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -72.42 -82.23 0.31 Allowed Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.904 -0.878 . . . . 71.450000000000003 110.904 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.95 131.14 3.87 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 105.734 -1.95 . . . . 71.209999999999994 105.734 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -71.86 131.26 18.04 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 116.83 -1.647 . . . . 70.530000000000001 109.97 176.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -122.87 137.44 54.94 Favored 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 108.24 -1.022 . . . . 72.349999999999994 108.24 -177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.693 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.5 t90 -83.08 110.32 17.9 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 109.402 -0.592 . . . . 74.109999999999999 109.402 -175.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.49 13.2 mmt -123.9 81.49 1.92 Allowed 'General case' 0 N--CA 1.426 -1.661 0 C-N-CA 115.552 -2.459 . . . . 70.310000000000002 113.146 164.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.554 ' O ' ' HG2' ' A' ' 626' ' ' ARG 0.322 5.3 tt0 -152.48 92.49 1.69 Allowed 'General case' 1 C--O 1.13 -5.23 2 CA-C-O 110.301 -4.666 . . . . 73.299999999999997 99.773 147.154 . . . . . . . . 5 3 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.693 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 11.7 mmm180 161.46 -48.26 0.0 OUTLIER 'General case' 0 N--CA 1.525 3.294 1 CA-C-N 129.039 5.382 . . . . 74.209999999999994 106.739 177.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 67.74 54.02 20.82 Favored Glycine 0 C--O 1.228 -0.261 0 N-CA-C 109.201 -1.56 . . . . 52.420000000000002 109.201 -175.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.569 HD13 ' HA ' ' A' ' 649' ' ' MET . 1.1 tp -52.58 116.14 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.953 0.883 . . . . 62.439999999999998 110.22 -176.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 6.1 p -146.52 155.94 42.89 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 103.081 -2.933 . . . . 31.449999999999999 103.081 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -74.82 130.38 39.35 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.493 -0.483 . . . . 73.439999999999998 110.073 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.7 127.25 40.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.302 -1.37 . . . . 73.040000000000006 107.302 178.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 47.2 p -67.02 -24.32 66.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 113.816 1.043 . . . . 73.519999999999996 113.816 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -137.39 104.78 5.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.948 0.88 . . . . 73.450000000000003 111.775 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -126.7 35.96 4.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.82 -1.178 . . . . 74.030000000000001 107.82 176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -62.42 112.75 2.57 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.928 -1.033 . . . . 72.409999999999997 109.011 177.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 57.9 mt -146.51 179.01 7.84 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.158 -1.793 . . . . 72.549999999999997 106.158 -170.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 10.5 t -61.99 148.35 44.16 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 105.467 -2.049 . . . . 75.109999999999999 105.467 169.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 22.3 m -59.89 -25.08 31.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 114.524 1.305 . . . . 43.210000000000001 114.524 -165.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -66.45 -46.14 77.45 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.684 0.754 . . . . 74.340000000000003 109.421 174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -78.57 -21.81 48.08 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.181 -0.918 . . . . 74.340000000000003 111.839 -174.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.6 -41.49 90.43 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.352 -0.24 . . . . 73.349999999999994 110.352 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -88.01 -47.09 8.8 Favored 'General case' 0 C--O 1.213 -0.848 0 C-N-CA 119.394 -0.922 . . . . 73.400000000000006 111.166 169.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.79 -43.28 94.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.419 0.896 . . . . 71.129999999999995 113.419 -171.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 2.2 tppm? -70.84 -38.01 73.18 Favored 'General case' 0 C--O 1.215 -0.742 0 N-CA-C 109.242 -0.651 . . . . 61.210000000000001 109.242 179.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -63.13 -46.23 88.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 120.51 0.195 . . . . 74.510000000000005 110.775 178.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.6 -41.93 94.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 110.031 -0.359 . . . . 52.340000000000003 110.031 177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.04 -35.74 81.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.817 0.342 . . . . 21.109999999999999 110.975 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -71.45 -25.41 62.29 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.128 -0.487 . . . . 74.549999999999997 110.311 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . 0.569 ' HA ' HD13 ' A' ' 628' ' ' ILE . 35.4 mtt -75.43 -42.17 54.1 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 118.616 -1.234 . . . . 73.209999999999994 108.405 176.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.462 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 59.09 -2.08 0.29 Allowed Glycine 0 N--CA 1.467 0.7 0 N-CA-C 117.183 1.633 . . . . 50.140000000000001 117.183 166.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -64.32 139.54 97.73 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 117.44 2.385 . . . . 74.430000000000007 117.44 -159.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.22 168.38 21.84 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 121.703 1.602 . . . . 61.350000000000001 112.445 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.52 167.23 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 115.307 -0.861 . . . . 71.319999999999993 110.632 176.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.42 154.32 37.16 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.901 -0.407 . . . . 74.340000000000003 109.901 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.6 -160.72 33.29 Favored Glycine 0 C--O 1.22 -0.769 0 N-CA-C 118.008 1.963 . . . . 65.420000000000002 118.008 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.78 -43.5 93.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 113.178 -1.511 . . . . 70.109999999999999 111.79 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -140.72 77.46 22.19 Favored Pre-proline 0 N--CA 1.469 0.51 0 N-CA-C 112.247 0.462 . . . . 74.329999999999998 112.247 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -77.96 31.38 0.44 Allowed 'Trans proline' 0 CA--C 1.534 0.51 0 C-N-CA 124.159 3.239 . . . . 61.399999999999999 111.892 174.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 617' ' ' ALA . 25.0 ttpp -155.02 149.5 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.618 -1.253 . . . . 74.200000000000003 107.618 -176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.423 HD23 HG12 ' A' ' 550' ' ' VAL . 37.7 tp -133.74 127.23 32.36 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 105.986 -1.857 . . . . 74.439999999999998 105.986 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.85 127.52 36.39 Favored 'General case' 0 C--O 1.207 -1.14 0 O-C-N 123.868 0.73 . . . . 64.230000000000004 110.602 -178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.734 HG13 HG23 ' A' ' 539' ' ' ILE . 2.7 t -120.21 133.35 67.23 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 CA-C-O 121.921 0.867 . . . . 71.540000000000006 108.943 -173.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . . . . . . . . . 11.1 mm -109.72 130.61 62.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 N-CA-C 104.283 -2.488 . . . . 74.430000000000007 104.283 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 62.1 mt -96.45 122.56 48.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 105.302 -2.11 . . . . 64.150000000000006 105.302 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -164.08 171.98 14.4 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 107.639 -1.245 . . . . 75.420000000000002 107.639 -168.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -75.49 56.09 0.85 Allowed 'General case' 0 CA--C 1.553 1.086 0 CA-C-O 121.914 0.864 . . . . 52.109999999999999 109.717 173.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 74.7 m -149.04 159.6 44.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 121.261 -0.899 . . . . 74.439999999999998 111.659 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -135.01 131.38 37.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.108 -1.812 . . . . 72.340000000000003 106.108 175.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . 0.63 ' HB2' ' H ' ' A' ' 540' ' ' HIS . 7.2 tp10 -81.44 136.79 35.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 113.814 1.042 . . . . 74.510000000000005 113.814 -174.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -131.24 124.02 29.67 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.343 -0.984 . . . . 74.140000000000001 108.343 174.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -136.49 151.64 49.67 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.036 -1.468 . . . . 64.120000000000005 107.036 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 77.5 p -159.04 173.7 16.06 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.938 -1.134 . . . . 53.310000000000002 107.938 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 14.5 t -151.16 169.66 21.34 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.764 -1.939 . . . . 75.129999999999995 105.764 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 167.21 26.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 105.919 -1.882 . . . . 73.319999999999993 105.919 176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 . . . . . 0 C--O 1.256 1.396 0 CA-C-O 117.411 -1.281 . . . . 73.420000000000002 109.118 176.157 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.348 0 N-CA-C 108.159 -1.052 . . . . 72.299999999999997 108.159 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' ALA . . . . . . . . . . . . . . . -99.34 165.92 11.45 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.696 -1.224 . . . . 61.310000000000002 107.696 171.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' GLY . . . . . . . . . . . . . . . -89.87 169.6 35.45 Favored Glycine 0 C--O 1.222 -0.594 0 N-CA-C 116.059 1.184 . . . . 71.439999999999998 116.059 -177.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' ILE . . . . . 0.664 ' H ' HG22 ' A' ' 555' ' ' THR . 1.3 mp -84.55 142.62 13.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.665 -1.976 . . . . 74.129999999999995 105.665 173.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -119.2 135.6 54.6 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 123.776 0.672 . . . . 73.439999999999998 109.605 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' THR . . . . . . . . . . . . . 15.3 t -155.57 163.16 40.34 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.308 -1.367 . . . . 51.409999999999997 107.308 -174.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' PHE . . . . . 0.596 ' CE1' HD21 ' A' ' 618' ' ' LEU . 15.3 m-30 -98.38 170.9 8.53 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.213 -0.662 . . . . 73.329999999999998 109.213 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' GLU . . . . . 0.448 ' HG3' HD21 ' A' ' 553' ' ' LEU . 47.1 mt-10 -61.75 -49.02 78.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.58 -1.191 . . . . 74.109999999999999 113.168 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' CYS . . . . . . . . . . . . . 80.9 m -138.43 177.46 7.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 107.289 -1.375 . . . . 54.25 107.289 -174.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -122.08 5.22 9.82 Favored 'General case' 0 C--O 1.21 -1.009 0 CA-C-N 115.984 -0.553 . . . . 75.439999999999998 111.251 176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' THR . . . . . . . . . . . . . 29.5 m -145.12 132.45 20.62 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 106.938 -1.505 . . . . 72.040000000000006 106.938 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' ILE . . . . . 0.575 HG23 HG13 ' A' ' 662' ' ' VAL . 0.0 OUTLIER -150.05 160.43 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.897 1.279 . . . . 52.32 108.321 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -129.34 133.89 47.64 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 107.912 -1.144 . . . . 73.230000000000004 107.912 173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' VAL . . . . . . . . . . . . . 27.0 m -124.74 162.2 27.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.083 -0.71 . . . . 51.210000000000001 109.083 169.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' SER . . . . . . . . . . . . . 10.0 t -110.11 153.83 24.13 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 102.797 -3.038 . . . . 53.219999999999999 102.797 171.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' GLU . . . . . 0.535 ' H ' ' CD ' ' A' ' 543' ' ' GLU . 0.0 OUTLIER -57.47 -34.56 69.14 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 121.561 0.696 . . . . 72.349999999999994 111.145 175.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' SER . . . . . . . . . . . . . 36.9 t -63.54 -9.32 12.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.873 . . . . 74.109999999999999 113.353 -178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' ILE . . . . . . . . . . . . . 3.0 tt -68.29 -26.3 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 120.845 0.355 . . . . 74.239999999999995 110.355 176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 84.5 -58.1 5.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.649 -0.786 . . . . 63.109999999999999 113.285 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' VAL . . . . . . . . . . . . . 2.8 p -148.87 124.99 2.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 121.847 0.832 . . . . 72.530000000000001 109.795 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -83.1 153.67 24.75 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.037 -0.983 . . . . 62.100000000000001 109.317 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -130.92 141.65 50.3 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 122.644 1.211 . . . . 74.319999999999993 113.877 173.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' VAL . . . . . 0.573 HG22 HD12 ' A' ' 660' ' ' LEU . 0.9 OUTLIER -112.06 130.85 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 N-CA-C 103.584 -2.746 . . . . 71.230000000000004 103.584 173.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -97.88 129.12 44.84 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 106.613 -1.625 . . . . 74.5 106.613 173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.64 124.91 56.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.759 -0.655 . . . . 75.120000000000005 109.323 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' LEU . . . . . 0.448 HD21 ' HG3' ' A' ' 535' ' ' GLU . 0.4 OUTLIER -110.42 161.94 15.16 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.173 -1.047 . . . . 60.219999999999999 108.173 -179.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.577 ' HD2' ' HB2' ' A' ' 558' ' ' ALA . 0.0 OUTLIER -140.99 144.11 34.86 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.998 -0.741 . . . . 75.25 108.998 -177.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' THR . . . . . 0.664 HG22 ' H ' ' A' ' 531' ' ' ILE . 4.7 t -69.25 163.78 24.23 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.687 -0.857 . . . . 63.119999999999997 108.687 175.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' SER . . . . . . . . . . . . . 1.5 m -61.92 21.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.999 2.592 . . . . 65.239999999999995 117.999 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -92.38 16.41 59.94 Favored Glycine 0 C--O 1.211 -1.3 0 CA-C-O 119.038 -0.868 . . . . 74.319999999999993 115.247 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . 0.577 ' HB2' ' HD2' ' A' ' 554' ' ' ARG . . . -77.33 69.15 3.56 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 119.667 1.734 . . . . 73.340000000000003 112.901 -178.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -83.75 89.4 7.16 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 104.677 -2.342 . . . . 74.109999999999999 104.677 175.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLY . . . . . . . . . . . . . . . 102.46 -155.48 18.45 Favored Glycine 0 C--O 1.24 0.488 0 C-N-CA 120.576 -0.821 . . . . 64.109999999999999 113.834 -175.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 561' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 625' ' ' GLU . 93.1 m -113.56 134.07 54.9 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 122.353 1.073 . . . . 73.019999999999996 109.503 -175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 562' ' ' VAL . . . . . . . . . . . . . 89.0 t -125.87 141.38 45.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 106.842 -1.54 . . . . 75.129999999999995 106.842 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 563' ' ' ILE . . . . . . . . . . . . . 1.4 tt -111.42 141.08 27.89 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 106.953 -1.499 . . . . 74.519999999999996 106.953 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 564' ' ' VAL . . . . . . . . . . . . . 12.2 t -136.85 114.83 10.18 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.674 0.62 . . . . 70.209999999999994 112.674 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 565' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.04 157.48 42.58 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 N-CA-C 115.006 1.118 . . . . 71.409999999999997 115.006 173.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 566' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -139.71 167.05 22.99 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 108.086 -1.079 . . . . 74.450000000000003 108.086 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 567' ' ' ARG . . . . . 0.497 ' HD2' HG22 ' A' ' 569' ' ' VAL . 0.2 OUTLIER -156.8 154.42 29.89 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 106.335 -1.728 . . . . 75.239999999999995 106.335 171.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 568' ' ' THR . . . . . . . . . . . . . 87.0 m -81.9 125.3 30.56 Favored 'General case' 0 C--O 1.207 -1.146 0 N-CA-C 104.528 -2.397 . . . . 74.510000000000005 104.528 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 569' ' ' VAL . . . . . 0.497 HG22 ' HD2' ' A' ' 567' ' ' ARG . 60.3 t -106.26 104.16 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.832 0 N-CA-C 104.303 -2.48 . . . . 73.230000000000004 104.303 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 570' ' ' GLU . . . . . 0.609 ' H ' ' CD ' ' A' ' 570' ' ' GLU . 2.5 pm0 -77.78 143.69 37.74 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.275 -1.329 . . . . 71.209999999999994 109.611 178.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 571' ' ' GLY . . . . . . . . . . . . . . . -81.87 -92.77 0.54 Allowed Glycine 0 C--O 1.23 -0.11 0 N-CA-C 108.501 -1.84 . . . . 61.119999999999997 108.501 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 572' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -117.4 110.21 17.75 Favored 'General case' 0 C--O 1.201 -1.475 0 N-CA-C 103.035 -2.95 . . . . 74.340000000000003 103.035 166.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 573' ' ' ALA . . . . . . . . . . . . . . . -156.35 167.87 29.1 Favored 'General case' 0 CA--C 1.501 -0.913 0 O-C-N 121.198 -0.939 . . . . 75.219999999999999 109.961 -174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 574' ' ' LYS . . . . . . . . . . . . . 27.6 mmtp -74.02 -28.6 61.51 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.61 -0.723 . . . . 73.450000000000003 110.971 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 575' ' ' GLY . . . . . . . . . . . . . . . 59.2 -159.49 19.16 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.771 -0.649 . . . . 54.399999999999999 114.661 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 576' ' ' GLY . . . . . . . . . . . . . . . 65.91 -109.44 2.89 Favored Glycine 0 C--O 1.221 -0.66 0 CA-C-O 121.402 0.445 . . . . 71.150000000000006 112.867 176.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 577' ' ' GLY . . . . . . . . . . . . . . . -122.92 10.66 8.87 Favored Glycine 0 C--O 1.217 -0.937 0 N-CA-C 110.764 -0.934 . . . . 71.129999999999995 110.764 174.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 578' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -95.07 -56.8 2.61 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 117.5 2.407 . . . . 74.319999999999993 117.5 -170.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 579' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.15 -35.0 21.99 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-O 123.852 1.787 . . . . 72.310000000000002 108.167 -178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 580' ' ' PHE . . . . . . . . . . . . . 3.0 p90 -174.71 167.56 3.74 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 100.834 -3.765 . . . . 71.349999999999994 100.834 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 581' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -76.78 143.71 39.67 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 113.138 0.792 . . . . 70.329999999999998 113.138 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 582' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -72.14 85.23 1.03 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 106.466 -1.679 . . . . 73.329999999999998 106.466 168.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 583' ' ' ALA . . . . . 0.506 ' HB3' HG22 ' A' ' 600' ' ' VAL . . . -95.79 105.52 17.54 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.549 -0.75 . . . . 75.140000000000001 111.631 -172.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 584' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -136.62 145.97 45.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.983 -0.553 . . . . 74.420000000000002 110.646 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 585' ' ' GLY . . . . . . . . . . . . . . . -176.42 -172.0 40.68 Favored Glycine 0 CA--C 1.504 -0.615 0 N-CA-C 109.608 -1.397 . . . . 65.420000000000002 109.608 177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 586' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -116.99 147.03 42.65 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 109.214 -0.661 . . . . 53.539999999999999 109.214 175.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 587' ' ' LEU . . . . . . . . . . . . . 16.1 mt -119.93 130.08 54.64 Favored 'General case' 0 CA--C 1.507 -0.705 0 N-CA-C 106.393 -1.706 . . . . 64.420000000000002 106.393 -178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 588' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.05 138.21 31.71 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.773 -1.195 . . . . 73.120000000000005 107.773 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 589' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -124.27 116.79 23.22 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 105.222 -2.14 . . . . 72.420000000000002 105.222 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 590' ' ' LYS . . . . . 0.567 ' H ' ' HB2' ' A' ' 593' ' ' GLU . 7.5 ttpm? -124.32 97.15 5.2 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.977 0.418 . . . . 62.350000000000001 110.369 -174.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 591' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 47.72 -85.18 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 116.38 1.993 . . . . 52.009999999999998 116.38 -177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 592' ' ' ASP . . . . . 0.407 ' C ' ' H ' ' A' ' 594' ' ' THR . 14.1 t0 -82.05 -22.74 36.25 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.073 0.939 . . . . 63.43 112.111 -177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 593' ' ' GLU . . . . . 0.567 ' HB2' ' H ' ' A' ' 590' ' ' LYS . 23.4 mt-10 -66.83 16.92 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.377 1.471 . . . . 73.239999999999995 114.516 174.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 594' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 594' ' ' THR . 0.1 OUTLIER -70.9 -6.55 39.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.285 1.034 . . . . 75.510000000000005 110.201 -170.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 595' ' ' VAL . . . . . . . . . . . . . 3.3 t -98.85 111.83 29.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 105.343 -2.095 . . . . 73.420000000000002 105.343 173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 596' ' ' LYS . . . . . . . . . . . . . 10.3 tppt? -142.04 168.62 19.32 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.894 -1.15 . . . . 64.439999999999998 107.894 -178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 597' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.03 152.81 47.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 113.208 0.818 . . . . 64.340000000000003 113.208 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 598' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 616' ' ' ILE . 85.0 mt -114.68 128.45 71.76 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 106.744 -1.576 . . . . 72.140000000000001 106.744 175.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 599' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -111.28 129.7 55.9 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 123.966 0.791 . . . . 64.549999999999997 112.028 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 600' ' ' VAL . . . . . 0.506 HG22 ' HB3' ' A' ' 583' ' ' ALA . 59.4 t -129.64 113.93 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 N-CA-C 109.228 -0.656 . . . . 75.420000000000002 109.228 177.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 601' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -66.23 141.9 57.88 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.863 -0.335 . . . . 65.310000000000002 110.376 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 602' ' ' ILE . . . . . . . . . . . . . 20.4 mm -106.2 129.52 59.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 103.923 -2.621 . . . . 70.430000000000007 103.923 175.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 603' ' ' VAL . . . . . . . . . . . . . 95.6 t -88.9 143.59 10.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 121.51 0.672 . . . . 62.340000000000003 111.936 -172.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 604' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -80.72 104.69 11.41 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.815 1.246 . . . . 74.25 113.136 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 605' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.84 160.36 43.31 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.205 -1.406 . . . . 74.040000000000006 107.205 176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 606' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -86.1 -25.61 25.71 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.213 -1.032 . . . . 65.310000000000002 108.213 176.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 607' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 61.6 175.06 0.12 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.743 1.217 . . . . 61.240000000000002 114.279 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 608' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -143.08 -11.95 0.74 Allowed 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 113.675 0.991 . . . . 72.209999999999994 113.675 -167.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 609' ' ' GLU . . . . . . . . . . . . . 55.2 tp10 -101.27 -85.0 0.43 Allowed 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.97 1.47 . . . . 63.409999999999997 114.97 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 610' ' ' ARG . . . . . . . . . . . . . 33.3 mtm105 -157.44 178.43 10.31 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 121.57 -0.706 . . . . 75.400000000000006 111.76 -169.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 611' ' ' GLN . . . . . 0.406 HE21 HD12 ' A' ' 663' ' ' ILE . 50.5 tt0 -59.69 125.73 24.78 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 105.757 -1.942 . . . . 61.409999999999997 105.757 159.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 612' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -111.35 162.12 15.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.576 0.703 . . . . 75.25 111.117 -178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 613' ' ' ASN . . . . . 0.475 HD21 ' HG3' ' A' ' 661' ' ' GLU . 1.1 t-20 -135.85 126.07 26.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.696 1.198 . . . . 62.299999999999997 107.862 -172.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 614' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -143.91 159.43 42.57 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 106.189 -1.782 . . . . 75.439999999999998 106.189 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 615' ' ' PHE . . . . . 0.414 ' HB2' ' HD2' ' A' ' 659' ' ' LYS . 0.0 OUTLIER -143.64 171.55 14.03 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 108.003 -1.11 . . . . 73.340000000000003 108.003 -173.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 616' ' ' ILE . . . . . 0.485 HG21 HG21 ' A' ' 598' ' ' ILE . 16.6 mt -129.45 118.28 45.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 107.797 -1.186 . . . . 61.210000000000001 107.797 176.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 617' ' ' ALA . . . . . . . . . . . . . . . -108.07 143.86 36.22 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.576 -1.268 . . . . 43.329999999999998 107.576 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 618' ' ' LEU . . . . . 0.596 HD21 ' CE1' ' A' ' 534' ' ' PHE . 1.2 mm? -78.65 151.81 32.05 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.741 -0.837 . . . . 52.240000000000002 108.741 173.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 619' ' ' GLY . . . . . . . . . . . . . . . -70.63 -82.24 0.24 Allowed Glycine 0 C--O 1.224 -0.528 0 N-CA-C 110.668 -0.973 . . . . 64.019999999999996 110.668 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 620' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -157.34 130.47 4.52 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 105.779 -1.934 . . . . 72.120000000000005 105.779 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.35 142.36 40.93 Favored 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 117.485 -1.21 . . . . 62.329999999999998 109.418 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -134.59 137.94 44.15 Favored 'General case' 0 C--O 1.207 -1.139 0 N-CA-C 108.728 -0.842 . . . . 74.519999999999996 108.728 -176.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' TRP . . . . . 0.689 ' CZ3' ' HG3' ' A' ' 626' ' ' ARG . 2.6 t90 -83.62 111.05 18.77 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.975 -1.121 . . . . 73.400000000000006 107.975 -176.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' MET . . . . . . . . . . . . 0.492 11.4 mmt -124.06 81.53 1.93 Allowed 'General case' 0 N--CA 1.425 -1.708 0 C-N-CA 115.596 -2.442 . . . . 73.340000000000003 113.781 164.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' GLU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 561' ' ' THR 0.335 1.4 tt0 -153.51 92.47 1.59 Allowed 'General case' 1 C--O 1.146 -4.358 1 CA-C-O 110.49 -4.576 . . . . 63.229999999999997 101.973 146.864 . . . . . . . . 5 3 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' ARG . . . . . 0.689 ' HG3' ' CZ3' ' A' ' 623' ' ' TRP . 9.9 mmm180 172.38 -53.51 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.216 1 CA-C-N 129.121 5.418 . . . . 74.540000000000006 113.94 175.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' GLY . . . . . . . . . . . . . . . 86.26 66.67 1.38 Allowed Glycine 0 C--N 1.322 -0.23 0 CA-C-O 122.699 1.166 . . . . 74.430000000000007 110.88 -172.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' ILE . . . . . 0.435 HG22 ' H ' ' A' ' 628' ' ' ILE . 0.4 OUTLIER -59.3 127.68 18.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.241 -0.979 . . . . 63.229999999999997 110.041 -179.151 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 29.3 m 58.31 17.12 4.47 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 116.025 1.861 . . . . 62.240000000000002 116.025 178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -68.8 145.33 53.85 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.82 -0.807 . . . . 75.409999999999997 108.82 174.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' VAL . . . . . . . . . . . . . 21.1 t 56.93 91.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-O 122.324 1.059 . . . . 72.239999999999995 112.186 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' THR . . . . . . . . . . . . . 39.2 p -73.09 -9.91 59.22 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.836 -0.62 . . . . 64.400000000000006 111.146 177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -84.59 14.69 4.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.717 0.77 . . . . 74.230000000000004 112.218 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' ARG . . . . . . . . . . . . . 27.2 mtt-85 -79.13 74.3 5.69 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 121.6 -0.687 . . . . 72.5 110.071 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.78 132.4 47.98 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.491 -0.929 . . . . 74.200000000000003 108.491 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . . . . . . . . . 67.8 mt -135.14 -177.19 4.53 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 105.465 -2.05 . . . . 73.519999999999996 105.465 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' THR . . . . . . . . . . . . . 14.7 t -67.32 157.25 34.43 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 105.83 -1.915 . . . . 73.409999999999997 105.83 170.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' VAL . . . . . . . . . . . . . 18.4 m -66.89 -23.64 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 112.847 0.684 . . . . 62.450000000000003 112.847 -162.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -70.24 -48.97 54.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 122.446 1.117 . . . . 63.009999999999998 109.091 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -71.68 -23.76 61.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.432 -1.258 . . . . 74.319999999999993 112.305 -177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.4 -47.53 66.22 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 119.115 -0.469 . . . . 74.099999999999994 110.888 -176.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -88.03 -49.84 6.79 Favored 'General case' 0 C--O 1.213 -0.847 0 C-N-CA 119.441 -0.904 . . . . 71.030000000000001 112.749 165.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.48 81.5 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 114.655 1.354 . . . . 74.439999999999998 114.655 -167.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -68.79 -39.77 79.99 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.273 -1.01 . . . . 74.239999999999995 108.273 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -58.59 -49.03 78.94 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 122.483 -0.136 . . . . 71.420000000000002 111.334 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.24 -42.3 89.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 122.817 0.447 . . . . 52.450000000000003 110.743 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' ALA . . . . . . . . . . . . . . . -63.29 -36.22 82.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.139 0.495 . . . . 74.209999999999994 110.515 179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -76.75 -17.07 59.28 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.086 -0.506 . . . . 60.200000000000003 112.199 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' MET . . . . . . . . . . . . . 53.4 mtt -73.02 -40.74 64.91 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 106.82 -1.548 . . . . 60.299999999999997 106.82 173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.601 ' HA3' ' CZ3' ' A' ' 623' ' ' TRP . . . 58.0 16.74 26.68 Favored Glycine 0 C--O 1.225 -0.422 0 N-CA-C 117.357 1.703 . . . . 63.030000000000001 117.357 166.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.09 117.66 21.3 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 118.094 0.947 . . . . 72.0 113.068 -169.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.28 165.47 32.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 CA-C-O 121.477 0.532 . . . . 71.329999999999998 113.092 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' VAL . . . . . . . . . . . . . 31.1 m -134.17 163.91 35.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 114.939 -1.028 . . . . 64.430000000000007 110.194 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' LEU . . . . . . . . . . . . . 57.6 mt -75.64 161.93 28.68 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 122.856 0.463 . . . . 63.109999999999999 112.03 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' GLY . . . . . . . . . . . . . . . -95.76 -154.89 30.83 Favored Glycine 0 C--O 1.224 -0.525 0 N-CA-C 116.07 1.188 . . . . 53.130000000000003 116.07 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -79.5 -29.87 41.75 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.139 -1.031 . . . . 74.140000000000001 111.511 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -131.83 61.95 61.23 Favored Pre-proline 0 C--O 1.213 -0.832 0 N-CA-C 112.383 0.512 . . . . 74.140000000000001 112.383 178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.65 32.3 0.48 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.149 1.233 . . . . 51.409999999999997 113.907 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 615' ' ' PHE . 26.1 ttpp -162.02 148.69 13.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.317 -1.364 . . . . 74.010000000000005 107.317 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' LEU . . . . . 0.573 HD12 HG22 ' A' ' 550' ' ' VAL . 0.0 OUTLIER -125.08 123.86 40.66 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 104.33 -2.471 . . . . 72.030000000000001 104.33 177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' GLU . . . . . 0.475 ' HG3' HD21 ' A' ' 613' ' ' ASN . 1.0 OUTLIER -91.96 121.14 33.26 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 109.45 -0.574 . . . . 74.200000000000003 109.45 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' VAL . . . . . 0.575 HG13 HG23 ' A' ' 539' ' ' ILE . 4.3 t -115.06 131.68 66.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 108.442 -0.947 . . . . 73.340000000000003 108.442 -170.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' ILE . . . . . 0.406 HD12 HE21 ' A' ' 611' ' ' GLN . 7.2 mm -109.34 133.93 52.98 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 104.245 -2.502 . . . . 74.409999999999997 104.245 177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' ILE . . . . . . . . . . . . . 49.0 mt -88.81 92.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 N-CA-C 106.109 -1.812 . . . . 63.219999999999999 106.109 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -175.07 129.09 0.29 Allowed 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 104.072 -2.566 . . . . 73.319999999999993 104.072 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.44 117.04 12.48 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 119.148 0.886 . . . . 65.400000000000006 110.987 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' SER . . . . . . . . . . . . . 30.6 m -160.61 154.01 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.014 -1.476 . . . . 53.030000000000001 107.014 174.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -145.64 152.54 39.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.536 -0.542 . . . . 74.319999999999993 109.536 177.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.34 165.01 37.6 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.68 -1.6 . . . . 73.030000000000001 106.68 -177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -142.75 136.51 28.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.141 0.496 . . . . 71.420000000000002 111.775 178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 31.8 mmtm -140.62 159.74 41.54 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 106.704 -1.591 . . . . 72.310000000000002 106.704 177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' SER . . . . . . . . . . . . . 65.1 p -149.91 165.72 31.75 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.009 -1.478 . . . . 51.020000000000003 107.009 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' THR . . . . . . . . . . . . . 73.4 p -133.2 -173.56 3.24 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.455 -0.943 . . . . 73.040000000000006 108.455 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 10.5 p -120.83 160.53 21.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 103.702 -2.703 . . . . 72.219999999999999 103.702 174.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 C--O 1.252 1.196 0 CA-C-O 118.312 -0.851 . . . . 63.119999999999997 110.716 178.746 . . . . . . . . 0 0 . 1 stop_ save_